
<html lang="en"     class="pb-page"  data-request-id="be312a38-2c42-411e-9a38-7545730c173a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2018.61.issue-21;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.8b01183;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Synthesis, Receptor Affinity, and Antiallodynic Activity of Spirocyclic σ Receptor Ligands with Exocyclic Amino Moiety" /></meta><meta name="dc.Creator" content="Melanie  Bergkemper" /></meta><meta name="dc.Creator" content="Elisabeth  Kronenberg" /></meta><meta name="dc.Creator" content="Simone  Thum" /></meta><meta name="dc.Creator" content="Frederik  Börgel" /></meta><meta name="dc.Creator" content="Constantin  Daniliuc" /></meta><meta name="dc.Creator" content="Dirk  Schepmann" /></meta><meta name="dc.Creator" content="Francisco Rafael  Nieto" /></meta><meta name="dc.Creator" content="Peter  Brust" /></meta><meta name="dc.Creator" content="Raquel F.  Reinoso" /></meta><meta name="dc.Creator" content="Inés  Alvarez" /></meta><meta name="dc.Creator" content="Bernhard  Wünsch" /></meta><meta name="dc.Description" content="In order to detect novel σ receptor ligands, the rigid spiro[[2]benzopyran-1,1′-cyclohexan]-4′-one was connected with amino moieties derived from σ2 receptor preferring lead compounds resulting in ..." /></meta><meta name="Description" content="In order to detect novel σ receptor ligands, the rigid spiro[[2]benzopyran-1,1′-cyclohexan]-4′-one was connected with amino moieties derived from σ2 receptor preferring lead compounds resulting in ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 12, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01183" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01183" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01183" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01183" /></link>
        
    
    

<title>Synthesis, Receptor Affinity, and Antiallodynic Activity of Spirocyclic σ Receptor Ligands with Exocyclic Amino Moiety | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01183" /></meta><meta property="og:title" content="Synthesis, Receptor Affinity, and Antiallodynic Activity of Spirocyclic σ Receptor Ligands with Exocyclic Amino Moiety" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0017.jpeg" /></meta><meta property="og:description" content="In order to detect novel σ receptor ligands, the rigid spiro[[2]benzopyran-1,1′-cyclohexan]-4′-one was connected with amino moieties derived from σ2 receptor preferring lead compounds resulting in mixtures of trans- and cis-configured amines 6, 18, and 27. In a four step synthesis the methyl acetals 6 were converted into fluoroethyl derivatives 13 and 30. The most promising σ2 receptor ligand is the methyl acetal 6a bearing a 2,4-dimethylbenzylamino moiety. The fluoroethyl derivatives 13c and 13d reveal high σ1 affinity but moderate selectivity over the σ2 subtype. In mice 13c and 13d showed antiallodynic activity that is stronger than that of the reference σ1 antagonist BD-1063 (34). Since the antiallodynic activity of 13c could only be partially reversed by the σ1 agonist PRE-084 (35), it is postulated that a second mechanism contributes to its overall antiallodynic effect. In contrast, the antiallodynic effect of its diastereomer 13d can be totally explained by a σ1 antagonism." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01183"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01183">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01183&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01183&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01183&amp;href=/doi/10.1021/acs.jmedchem.8b01183" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 9666-9690</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01126" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01196" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis, Receptor Affinity, and Antiallodynic Activity of Spirocyclic σ Receptor Ligands with Exocyclic Amino Moiety</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Melanie Bergkemper</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Melanie Bergkemper</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institut für Pharmazeutische und Medizinische Chemie der Universität Münster, Corrensstraße 48, D-48149 Münster, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Melanie++Bergkemper">Melanie Bergkemper</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Elisabeth Kronenberg</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Elisabeth Kronenberg</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institut für Pharmazeutische und Medizinische Chemie der Universität Münster, Corrensstraße 48, D-48149 Münster, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Elisabeth++Kronenberg">Elisabeth Kronenberg</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Simone Thum</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Simone Thum</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institut für Pharmazeutische und Medizinische Chemie der Universität Münster, Corrensstraße 48, D-48149 Münster, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Simone++Thum">Simone Thum</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Frederik Börgel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Frederik Börgel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institut für Pharmazeutische und Medizinische Chemie der Universität Münster, Corrensstraße 48, D-48149 Münster, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Frederik++B%C3%B6rgel">Frederik Börgel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Constantin Daniliuc</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Constantin Daniliuc</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Organisch-Chemisches Institut der Westfälischen Wilhelms-Universität Münster, Corrensstraße 40, D-48149 Münster, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Constantin++Daniliuc">Constantin Daniliuc</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dirk Schepmann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dirk Schepmann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institut für Pharmazeutische und Medizinische Chemie der Universität Münster, Corrensstraße 48, D-48149 Münster, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dirk++Schepmann">Dirk Schepmann</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Francisco Rafael Nieto</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Francisco Rafael Nieto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Institute of Neuroscience, School of Medicine and Biomedical Research Center, University of Granada, Avenida de la Investigación 11, 18016 Granada, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Francisco+Rafael++Nieto">Francisco Rafael Nieto</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Peter Brust</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peter Brust</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institut für Radiopharmazeutische Krebsforschung, Forschungsstelle Leipzig, Helmholtz-Zentrum Dresden-Rossendorf, Permoserstraße 15, 04318 Leipzig, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Brust">Peter Brust</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5555-7058" title="Orcid link">http://orcid.org/0000-0001-5555-7058</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Raquel F. Reinoso</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Raquel F. Reinoso</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Esteve Pharmaceuticals S.A, Baldiri Reixach 4-8, 08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Raquel+F.++Reinoso">Raquel F. Reinoso</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Inés Alvarez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Inés Alvarez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Esteve Pharmaceuticals S.A, Baldiri Reixach 4-8, 08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=In%C3%A9s++Alvarez">Inés Alvarez</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Bernhard Wünsch</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bernhard Wünsch</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institut für Pharmazeutische und Medizinische Chemie der Universität Münster, Corrensstraße 48, D-48149 Münster, Germany</div><div class="loa-info-affiliations-info">Cells-in-Motion Cluster of Excellence (EXC 1003-CiM), Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +49-251-8333311. Fax: +49-8332144. E-mail: <a href="/cdn-cgi/l/email-protection#abdcdecec5d8c8c3ebdec5c286c6decec5d8dfced985cfce"><span class="__cf_email__" data-cfemail="7f080a1a110c1c173f0a111652120a1a110c0b1a0d511b1a">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bernhard++W%C3%BCnsch">Bernhard Wünsch</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9030-8417" title="Orcid link">http://orcid.org/0000-0002-9030-8417</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01183&amp;href=/doi/10.1021%2Facs.jmedchem.8b01183" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 9666–9690</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 12, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 July 2018</li><li><span class="item_label"><b>Published</b> online</span>12 October 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 November 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01183" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01183</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9666%26pageCount%3D25%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMelanie%2BBergkemper%252C%2BElisabeth%2BKronenberg%252C%2BSimone%2BThum%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D21%26contentID%3Dacs.jmedchem.8b01183%26title%3DSynthesis%252C%2BReceptor%2BAffinity%252C%2Band%2BAntiallodynic%2BActivity%2Bof%2BSpirocyclic%2B%25CF%2583%2BReceptor%2BLigands%2Bwith%2BExocyclic%2BAmino%2BMoiety%26numPages%3D25%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9690%26publicationDate%3DNovember%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01183"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1083</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">6</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01183" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis, Receptor Affinity, and Antiallodynic Activity of Spirocyclic σ Receptor Ligands with Exocyclic Amino Moiety&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Melanie&quot;,&quot;last_name&quot;:&quot;Bergkemper&quot;},{&quot;first_name&quot;:&quot;Elisabeth&quot;,&quot;last_name&quot;:&quot;Kronenberg&quot;},{&quot;first_name&quot;:&quot;Simone&quot;,&quot;last_name&quot;:&quot;Thum&quot;},{&quot;first_name&quot;:&quot;Frederik&quot;,&quot;last_name&quot;:&quot;Börgel&quot;},{&quot;first_name&quot;:&quot;Constantin&quot;,&quot;last_name&quot;:&quot;Daniliuc&quot;},{&quot;first_name&quot;:&quot;Dirk&quot;,&quot;last_name&quot;:&quot;Schepmann&quot;},{&quot;first_name&quot;:&quot;Francisco&quot;,&quot;last_name&quot;:&quot;Rafael Nieto&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Brust&quot;},{&quot;first_name&quot;:&quot;Raquel&quot;,&quot;last_name&quot;:&quot;F. Reinoso&quot;},{&quot;first_name&quot;:&quot;Inés&quot;,&quot;last_name&quot;:&quot;Alvarez&quot;},{&quot;first_name&quot;:&quot;Bernhard&quot;,&quot;last_name&quot;:&quot;Wünsch&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;9666-9690&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01183&quot;},&quot;abstract&quot;:&quot;In order to detect novel σ receptor ligands, the rigid spiro[[2]benzopyran-1,1′-cyclohexan]-4′-one was connected with amino moieties derived from σ2 receptor preferring lead compounds resulting in mixtures of trans- and cis-configured amines 6, 18, and 27. In a four step synthesis the methyl acetals 6 were converted into fluoroethyl derivatives 13 and 30. The most promising σ2 receptor ligand is the methyl acetal 6a bearing a 2,4-dimethylbenzylamino moiety. The fluoroethyl derivatives 13c and 13d reveal high σ1 affinity but moderate selectivity over the σ2 subtype. In mice 13c and 13d showed antiallodynic activity that is stronger than that of the reference σ1 antagonist BD-1063 (34). Since the antiallodynic activity of 13c could only be partially reversed by the σ1 agonist PRE-084 (35), it is postulated that a second mechanism contributes to its overall antiallodynic effect. In contrast, the antiallodynic effect of its diastereomer 13d can be totally explained by a σ1 antagonism.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01183&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01183" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01183&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01183" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01183&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01183" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01183&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01183&amp;href=/doi/10.1021/acs.jmedchem.8b01183" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01183" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01183" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01183%26sid%3Dliteratum%253Aachs%26pmid%3D30350997%26genre%3Darticle%26aulast%3DBergkemper%26date%3D2018%26atitle%3DSynthesis%252C%2BReceptor%2BAffinity%252C%2Band%2BAntiallodynic%2BActivity%2Bof%2BSpirocyclic%2B%25CF%2583%2BReceptor%2BLigands%2Bwith%2BExocyclic%2BAmino%2BMoiety%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D21%26spage%3D9666%26epage%3D9690%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292200" title="Layers">Layers</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=292349" title="Alkyls">Alkyls</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/jmcmar.2018.61.issue-21/20181108/jmcmar.2018.61.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01183&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In order to detect novel σ receptor ligands, the rigid spiro[[2]benzopyran-1,1′-cyclohexan]-4′-one was connected with amino moieties derived from σ<sub>2</sub> receptor preferring lead compounds resulting in mixtures of <i>trans</i>- and <i>cis</i>-configured amines <b>6</b>, <b>18</b>, and <b>27</b>. In a four step synthesis the methyl acetals <b>6</b> were converted into fluoroethyl derivatives <b>13</b> and <b>30</b>. The most promising σ<sub>2</sub> receptor ligand is the methyl acetal <b>6a</b> bearing a 2,4-dimethylbenzylamino moiety. The fluoroethyl derivatives <b>13c</b> and <b>13d</b> reveal high σ<sub>1</sub> affinity but moderate selectivity over the σ<sub>2</sub> subtype. In mice <b>13c</b> and <b>13d</b> showed antiallodynic activity that is stronger than that of the reference σ<sub>1</sub> antagonist BD-1063 (<b>34</b>). Since the antiallodynic activity of <b>13c</b> could only be partially reversed by the σ<sub>1</sub> agonist PRE-084 (<b>35</b>), it is postulated that a second mechanism contributes to its overall antiallodynic effect. In contrast, the antiallodynic effect of its diastereomer <b>13d</b> can be totally explained by a σ<sub>1</sub> antagonism.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70204" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70204" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Although a lot of research was performed in the field of σ receptors, their biological function is not totally understood. The σ receptor was first described as opioid receptor subtype, since some of the pharmacological effects of the racemic benzomorphan SKF-10,047 (<i>N</i>-allylnormetazocine) could be antagonized by the opioid antagonist naltrexone.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Later it was observed that (+)-SKF-10,047 acts as a σ agonist, whereas (−)-SKF-10,047 shows affinity toward MOR (μ opioid receptor) and KOR (κ opioid receptor).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Moreover, the effects of (+)-SKF-10,047 could not be blocked by the opioid antagonist naloxone.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> This led to the classification of σ receptors as their own class of receptors with two subtypes, σ<sub>1</sub> and σ<sub>2</sub> receptors.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> Their endogenous ligands are still unknown, although different endogenous compounds with affinity toward σ<sub>1</sub> receptors including neuroactive steroids,<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6−8)</a><i>N</i>,<i>N</i>-dimethyltryptamine,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and sphingosine derivatives<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> were identified.</div><div class="NLM_p">The σ<sub>1</sub> receptor has been cloned from different tissues like guinea pig liver,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> mouse kidney,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and human placental choriocarcinoma cells. The human σ<sub>1</sub> receptor consists of 223 amino acids<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and has a molecular weight of 25 kDa.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Its sequence shows a similarity of 66% with the yeast Δ<sup>8</sup>/Δ<sup>7</sup> sterol isomerase but no similarity to any other mammalian protein. Indeed, sterol isomerase activity could not be observed for the σ<sub>1</sub> receptor.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> In 2016, the σ<sub>1</sub> receptor was crystallized by Kruse et al. showing a trimeric organization of the receptor with one transmembrane domain for each monomer.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> σ<sub>1</sub> receptors are particularly enriched in mitochondrion-associated endoplasmic reticulum (ER) membranes (MAM)<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> of neuronal<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and peripheral cells like liver cells<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> or cardiac myocytes.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Under stress situations σ<sub>1</sub> receptors can also translocate to the plasma membrane<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> or ER-associated membranes,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> where they can regulate other proteins. The cellular mechanisms connected to the σ<sub>1</sub> receptor are not elucidated in detail. The σ<sub>1</sub> receptor seems to act as a chaperone<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> interacting with IP<sub>3</sub> receptor and modulating Ca<sup>2+</sup>, K<sup>+</sup>, Na<sup>+</sup>, and Cl<sup>–</sup> channels.<a onclick="showRef(event, 'ref23 ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref26 ref27">(23−27)</a> It is involved in pathomechanisms of neurological diseases like addiction,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Alzheimer’s disease,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> depression,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and schizophrenia.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Moreover, it has an influence on pain<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and allodynia, which makes it an interesting target for the therapy of these diseases.</div><div class="NLM_p">Allodynia belongs to the symptoms of neuropathic pain, which is induced by several CNS diseases like postherpetic neuralgia, multiple sclerosis, or stroke. It is characterized by the evocation of pain by stimuli, which normally do not provoke pain. Therapeutic options for the treatment of allodynia are tricyclic antidepressants, serotonin–norepinephrine reuptake inhibitors, gabapentinoids, opioids, cannabinoids, lamotrigine, mexiletine, lidocaine gel, and botulinum toxin-A. Besides Na<sup>+</sup> channels, protein kinases, glutamate, and tyrosine kinase receptors,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> the σ<sub>1</sub> receptor is involved in the molecular mechanisms that cause allodynia. The knockout of the σ<sub>1</sub> receptor in mice led to the inhibition of capsaicin-induced mechanical allodynia. The same effect was observed dose-dependently by treatment of wild-type mice with σ<sub>1</sub> receptor antagonists. Moreover, this antiallodynic effect could be blocked by σ<sub>1</sub> receptor agonists.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Therefore, σ<sub>1</sub> receptor antagonists offer a new possibility for the treatment of allodynia. The most developed candidate is the σ<sub>1</sub> receptor antagonist S1RA, which shows high activity in different models of neuropathic pain. After successful completion of phase I, the phase II clinical trial for neuropathic pain of S1RA is currently ongoing.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div class="NLM_p">Recently, the identity of the σ<sub>2</sub> receptor and TMEM97, an endoplasmic reticulum-resident transmembrane protein, was demonstrated, which also led to the identification of the gene coding for the σ<sub>2</sub> receptor.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The σ<sub>2</sub> receptor has a molecular weight of 21.5 kDa <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and is located in the central nervous system<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and in peripheral tissues like liver and kidney.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> On the cellular level it is located in mitochondria and ER membranes.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Although the signal transduction of the σ<sub>2</sub> receptor is not yet fully understood, its influence on cell differentiation and survival is well-known.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> It seems to have an influence on Ca<sup>2+</sup> and K<sup>+</sup> channels<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39,40)</a> and interacts with caspase-3 and the mTOR signaling pathway.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> These findings can explain the apoptotic effect of σ<sub>2</sub> receptor ligands.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div><div class="NLM_p">Both the σ<sub>1</sub> and σ<sub>2</sub> receptor are expressed in fast proliferating cells like prostate cancer, breast carcinoma, or leukemia cells. For the σ<sub>2</sub> receptor it was observed that the expression in proliferating cancer cells is 10-fold higher than in quiescent cancer cells, which still show higher expression than the surrounding tissue. Additionally, in stem cells as a type of proliferating cells the σ<sub>2</sub> receptor density is higher than in differentiated cells.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Therefore, the σ<sub>2</sub> receptor can be considered as a biomarker for the proliferative status of cells, offering new opportunities for cancer diagnosis and therapy.</div><div class="NLM_p">Various compound classes with affinity toward σ<sub>1</sub> and σ<sub>2</sub> receptors are described in the literature. Compounds bearing a cyclohexylpiperazine moiety such as PB28 (<b>1</b>) show high σ<sub>1</sub> and σ<sub>2</sub> affinity (<i>K</i><sub>i</sub>(σ<sub>1</sub>) = 0.38 nM; <i>K</i><sub>i</sub>(σ<sub>2</sub>) = 0.68 nM).<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> The 1-(4-fluorophenyl)-substituted indole derivative siramesine (<b>2</b>) displays a preference for the σ<sub>2</sub> receptor (<i>K</i><sub>i</sub>(σ<sub>1</sub>) = 17 nM; <i>K</i><sub>i</sub>(σ<sub>2</sub>) = 0.12 nM).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> A high selectivity toward the σ<sub>2</sub> receptor was achieved by compounds of type <b>3</b> (<i>K</i><sub>i</sub>(σ<sub>1</sub>) = 12.9 μM; <i>K</i><sub>i</sub>(σ<sub>2</sub>) = 8.2 nM) containing a benzamide and an isoquinoline moiety connected by an aliphatic spacer (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> A common feature of these compounds is the conformationally flexible linker between the basic amino moiety and the aromatic system.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of σ receptor ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01183&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In our group different σ ligands with a spirocyclic ring system as conformationally restricted scaffold were synthesized.<a onclick="showRef(event, 'ref47 ref48 ref49 ref50 ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref47 ref48 ref49 ref50 ref51 ref52">(47−52)</a> The spirocyclic 2-benzopyrans <b>4a</b> and <b>4b</b> with exocyclic amino moiety show moderate affinity toward both σ receptors (<b>4a</b>, <i>K</i><sub>i</sub>(σ<sub>1</sub>) = 538 nM, <i>K</i><sub>i</sub>(σ<sub>2</sub>) > 1000 nM; <b>4b</b>, <i>K</i><sub>i</sub>(σ<sub>1</sub>) = 158 nM, <i>K</i><sub>i</sub>(σ<sub>2</sub>) > 1000 nM).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> On the basis of these affinity data, combination of the spirocyclic 2-benzopyran with pharmacophoric moieties of the reference compounds <b>1</b>–<b>3</b> was envisaged to obtain compounds with high σ<sub>1</sub> and/or σ<sub>2</sub> affinity. Furthermore, exchanging the methoxy group in 3-position of the 2-benzopyrans <b>4a</b> and <b>4b</b> by a fluoroethyl side chain should increase the metabolic stability of the compounds. An overview of all synthesized compounds is shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. The influence of the introduction of a fluoroethyl side chain at 3-position of the 2-benzopyran on σ<sub>1</sub> and σ<sub>2</sub> receptor affinity will be investigated. Promising candidates will be selected for further pharmacological characterization in in vitro and in vivo experiments to determine the antiallodynic activity of these σ receptor ligands.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Synthesized Spirocyclic Compounds with Modification of the Basic Moiety and the Residue in 3-Position of the 2-Benzopyran Scaffold</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0011.gif" alt="" id="GRAPHIC-d7e816-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0012.gif" alt="" id="gr11" /></img><div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">2.  Synthesis</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76714" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76714" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">For the synthesis of the designed σ ligands the spirocyclic ketone <b>5</b>, which was obtained in four steps starting from 2-bromobenzaldehyde,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> served as an important intermediate. The reductive amination of ketone <b>5</b> with 2,4-dimethylbenzylamine (<b>7</b>) and NaBH(OAc)<sub>3</sub> in THF and HOAc led to the diastereomeric amines <b>6a</b> and <b>6b</b>, which were separated by fc. Performing this reaction under the same conditions with 1-cyclohexylpiperazine (<b>8</b>) led to amines <b>6c</b> and <b>6d</b>. Because of low solubility of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride (<b>9</b>·HCl) in THF, the synthesis of amines <b>6e</b> and <b>6f</b> was conducted in CH<sub>2</sub>Cl<sub>2</sub> and without HOAc (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Spirocyclic σ Receptor Ligands with Exocyclic Amino Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01183&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and reaction conditions: (a) 2,4-dimethylbenzylamine, NaBH(OAc)<sub>3</sub>, HOAc, THF, 20 h, rt; <b>6a</b>, 30%; <b>6b</b>, 44%; (b) 1-cyclohexylpiperazine, NaBH(OAc)<sub>3</sub>, HOAc, THF, 23 h, rt; <b>6c</b>, 9%; <b>6d</b>, 38%; (c) 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride, NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 43 h, rt; <b>6e</b>, 19%; <b>6f</b>, 37%.</p></p></figure><div class="NLM_p">According to the isolated yields, the formation of the diastereomers <b>6b</b>, <b>6d</b>, and <b>6f</b> with the amino moiety in equatorial orientation is preferred. This can be explained by stereoelectronic effects during the hydride transfer to intermediate iminium ions. The attack of the hydride in axial orientation at the cyclohexane ring can be stabilized by an overlap of the doubly occupied σ orbital of the newly formed C–H bond and the unoccupied, axial oriented σ* orbitals of the C–H bonds in α position.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Therefore, the axial hydride attack is more favorable than the equatorial approach, which leads to an excess of the diastereomer with the amino moiety in equatorial orientation. By use of secondary amines instead of primary amines for the reductive amination, the difference between the yields of the diastereomers is higher.</div><div class="NLM_p">To determine the configuration of the spirocyclic amines in 1-position of the 2-benzopyran, X-ray crystal structures of the isoquinoline derivatives <b>6e</b> and <b>6f</b> were recorded exemplarily. As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, the oxygen atom of the 2-benzopyran of both diastereomers is in axial orientation and the aromatic moiety is equatorially oriented regarding the cyclohexane chair. Therefore, in compounds <b>6a</b>, <b>6c</b>, and <b>6e</b> with the amino moiety in axial orientation, the O- and N-atoms are <i>trans</i>-oriented, and therefore the compounds are termed <i>trans</i>-configured in this manuscript. On the other side, in compounds <b>6b</b>, <b>6d</b>, and <b>6f</b> O- and N-atoms are <i>cis</i>-oriented with respect to the cyclohexane chair and are termed <i>cis</i>-diastereomers in this manuscript.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal structures of the <i>trans</i>- and <i>cis</i>-configured acetalic isoquinoline derivatives <b>6e</b> and <b>6f</b>. Thermal ellipsoids are shown at 30% and 50%, respectively. CCDC numbers are the following: <b>6e</b>, 1855388; <b>6f</b>, 1855389.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01183&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Hydrolysis of the acetals <b>6a</b>–<b>f</b> resulted in the formation of lactols <b>10a</b>–<b>f</b>. Afterward, a tandem reaction with (ethoxycarbonylmethylene)triphenylphosphorane in toluene was performed. The first step in this one pot reaction is the opening of the lactol to afford a hydroxyaldehyde, followed by a Wittig reaction and an intramolecular Michael addition at the formed α,β-unsaturated ester.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The esters <b>11a</b>–<b>f</b> were obtained in yields of 39–94%. The following reduction of the esters with LiAlH<sub>4</sub> in Et<sub>2</sub>O gave the alcohols <b>12a</b>–<b>f</b> in high yields. Fluorination of the alcohols <b>12a</b>–<b>f</b> with DAST (diethylaminosulfur trifluoride) led to compounds <b>13a</b>–<b>f</b> in yields of 13–67% (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Spirocyclic σ Receptor Ligands with Fluoroethyl Side Chain<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01183&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and reaction conditions: (a) HCl, THF, 3–4 d, rt; <b>10a</b>, 71%; <b>10b</b>, 80%; <b>10c</b>, 86%; <b>10d</b>, 81%; <b>10e</b>, 86%; <b>10f</b>, 74%. (b) Ph<sub>3</sub>P═CHCO<sub>2</sub>Et, toluene, 3–5 d, reflux; <b>11a</b>, 39%; <b>11b</b>, 79%; <b>11c</b>, 52%; <b>11d</b>, 89%; <b>11e</b>, 94%; <b>11f</b>, 77%; (c) LiAlH<sub>4</sub>, Et<sub>2</sub>O, 2–4 h, −20 °C; <b>12a</b>, 79%; <b>12b</b>, 82%; <b>12c</b>, 85%; <b>12d</b>, 82%; <b>12e</b>, 71%; <b>12f</b>, 69%; (d) DAST, CH<sub>2</sub>Cl<sub>2</sub>, 1 h, −78 °C, then 20 h, rt; <b>13a</b>, 67%; <b>13b</b>, 22%; <b>13c</b>, 67%; <b>13d</b>, 13%, <b>13e</b>, 21%; <b>13f</b>, 27%. <b>10</b>–<b>13a</b>,<b>b</b>: NR<sub>2</sub> = 2,4-dimethylbenzylamino. <b>10</b>–<b>13c</b>,<b>d</b>: NR<sub>2</sub> = 4-cyclohexylpiperazin-1-yl. <b>10</b>–<b>13e</b>,<b>f</b>: NR<sub>2</sub> = 6,7-dimethoxyisoquinolin-2-yl. For structures see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</p></p></figure><div class="NLM_p">Since compounds with a 1-(4-fluorophenyl)indole moiety like <b>2</b> show high affinity toward σ receptors with a preference for the σ<sub>2</sub> subtype,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> spirocyclic cyclohexylamine derivatives with this residue were envisaged. In the first step of the synthesis 3-(indol-3-yl)propionic acid (<b>14</b>) was arylated with 1-bromo-4-fluorobenzene by an Ullmannn reaction to obtain the arylated propionic acid <b>15</b> in 78% yield. Activation of acid <b>14</b> with ethyl chloroformate and subsequent treatment with NH<sub>3</sub> provided the primary amide <b>16</b> in 97% yield. Reduction of the amide <b>16</b> with LiAlH<sub>4</sub> in THF led to the primary amine <b>17</b>, which was used for the aforementioned reductive amination of ketone <b>5</b>. The diastereomeric amines <b>18a</b> and <b>18b</b> were separated by fc (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Spirocyclic σ Receptor Ligands with [1-(4-Fluorophenyl)indol-3-yl]propyl Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01183&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and reaction conditions: (a) 1-bromo-4-fluorobenzene, CuI, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 2 d, reflux; 78%; (b) ClCO<sub>2</sub>Et, NH<sub>3</sub>, Et<sub>3</sub>N, THF, 3 h, 0 °C; 97%; (c) LiAlH<sub>4</sub>, THF, 2 h, reflux; 64%; (d) ketone <b>5</b>, NaBH(OAc)<sub>3</sub>, HOAc, THF, 20 h, rt; <b>18a</b>, 30%; <b>18b</b>, 42%.</p></p></figure><div class="NLM_p">In order to get fast access to diverse spirocyclic amines with fluoroethyl side chain, a spirocyclic ketone with fluoroethyl side chain (<b>24</b>) was envisaged. The synthesis of <b>24</b> was conducted according to the aforementioned synthesis of amines <b>13a</b>–<b>f</b>. Hydrolysis of the acetalic moiety of ketone <b>5</b> led to the lactol <b>19</b> in high yield, which was transformed to the ester <b>20</b> by (ethoxycarbonylmethylene)triphenylphosphorane and Cs<sub>2</sub>CO<sub>3</sub>. In order to avoid reduction, the ketone <b>20</b> was protected with ethylene glycol to afford the cyclic ketal <b>21</b>. Reduction of the ester <b>21</b> was performed with LiAlH<sub>4</sub> and gave alcohol <b>22</b> in 81% yield. Compound <b>23</b> was obtained after fluorination of the alcohol <b>22</b> with DAST. In the last step, the ketal was hydrolyzed with diluted HCl to provide the ketone <b>24</b> in a yield of 95% (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the Spirocyclic Building Block <b>24</b> with Fluoroethyl Side Chain<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01183&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and reaction conditions: (a) HCl, THF, 3 d, rt; 95%; (b) Ph<sub>3</sub>P═CHCO<sub>2</sub>Et, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 2 d, reflux; 63%; (c) ethylene glycol, CH(OCH<sub>3</sub>)<sub>3</sub>, <i>p</i>-toluenesulfonic acid (<i>p</i>-TsOH), CH<sub>2</sub>Cl<sub>2</sub>, 17 h, rt; 88%; (d) LiAlH<sub>4</sub>, Et<sub>2</sub>O, 2 h, 81%; (e) DAST, CH<sub>2</sub>Cl<sub>2</sub>, 1 h, −78 °C, then 20 h rt; 49%; (f) 2 M HCl, Et<sub>2</sub>O, 3 d, 40 °C; 95%.</p></p></figure><div class="NLM_p">Benzo[7]annulenamines <b>27a</b>,<b>b</b> and tetrahydroisoquinolines <b>6e</b>,<b>f</b> have comparable sizes but show different hydrogen bonding properties. To investigate the influence of these different properties on the σ affinity, benzo[7]annulene derivatives <b>27</b> with acetalic moiety and <b>30</b> with fluoroethyl side chain were synthesized. As shown in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>, debenzylation of benzylamines <b>4a</b> and <b>4b</b> with H<sub>2</sub> and Pd/C as catalyst led to the primary amines <b>25a</b> and <b>25b</b> in 72% and 89% yield, respectively. Reductive alkylation of the primary amines <b>25a</b> and <b>25b</b> with benzo[7]annulenone <b>26</b> and NaBH(OAc)<sub>3</sub> provided the secondary amines <b>27a</b> and <b>27b</b> in yields of 48% and 28%, respectively.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Spirocyclic σ Receptor Ligands with Benzo[7]annulenyl Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01183&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and reaction conditions: (a) H<sub>2</sub>, 10% Pd/C, CH<sub>3</sub>OH, 20 h, rt; <b>25a</b>, 72%; <b>25b</b>, 89%; (b) NaBH(OAc)<sub>3</sub>, HOAc, CH<sub>2</sub>Cl<sub>2</sub>, 3 h, rt; <b>27a</b>, 48%; (c) NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 12 h, rt; <b>27b</b>, 28%.</p></p></figure><div class="NLM_p">For the synthesis of benzo[7]annulene derivatives <b>30a</b> and <b>30b</b> with fluoroethyl side chain, ketone <b>24</b> was reductively aminated with benzylamine and NaBH(OAc)<sub>3</sub>. The obtained amines <b>28a</b> and <b>28b</b> were separated and afterward debenzylated using ammonium formate as hydrogen source and Pd/C as catalyst. Reductive alkylation of the primary amines <b>29a</b> and <b>29b</b> with benzo[7]annulenone <b>26</b> and NaBH(OAc)<sub>3</sub> led to the secondary amines <b>30a</b> and <b>30b</b> in yields of 76% and 81%, respectively (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>).</div><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Spirocyclic σ Receptor Ligands with Benzo[7]annulenyl Moiety and Fluoroethyl Side Chain<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01183&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and reaction conditions: (a) benzylamine, NaBH(OAc)<sub>3</sub>, HOAc, THF, 3 h, rt; <b>28a</b>, 45%; <b>28b</b>, 45%; (b) NH<sub>4</sub>HCO<sub>2</sub>, 10% Pd/C, CH<sub>3</sub>OH, 2–4.5 h, 65 °C; <b>29a</b>, 96%; <b>29b</b>, 88%; (c) NaBH(OAc)<sub>3</sub>, HOAc, CH<sub>2</sub>Cl<sub>2</sub>, 1 d, rt; <b>30a</b>, 76%; <b>30b</b>, 81%.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">3.  σ<sub>1</sub> and σ<sub>2</sub> Receptor Affinity</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43308" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43308" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The affinity of all synthesized spirocyclic amines toward σ<sub>1</sub> and σ<sub>2</sub> receptors was determined by radioligand binding assays. The σ<sub>1</sub> assay was performed with homogenates of guinea pig brains as receptor material and [<sup>3</sup>H]-(+)-pentazocine as σ<sub>1</sub> selective radioligand. Homogenates of rat liver were used as receptor material for the σ<sub>2</sub> assay. Due to the lack of a σ<sub>2</sub> selective radioligand, the assay was performed with the nonselective radioligand [<sup>3</sup>H]-1,3-di(<i>o</i>-tolyl)guanidine (DTG) and an excess of nontritiated (+)-pentazocine to selectively occupy σ<sub>1</sub> receptors.<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47,48)</a> Since the amino acid sequence of the human σ<sub>1</sub> receptor shows 93% identity with the guinea pig σ<sub>1</sub> receptor, affinity data for the guinea pig and human σ<sub>1</sub> receptor are comparable.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Until now, the sequence of the human σ<sub>2</sub> receptor is unknown, but binding studies with σ<sub>2</sub> selective ligands reveal comparable affinity data for rat and human σ<sub>2</sub> receptors.<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54,55)</a> The determined affinities of the synthesized compounds and some reference and lead compounds toward both receptors are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. σ<sub>1</sub> and σ<sub>2</sub> Receptor Affinity of Spirocyclic Amines and Reference Compounds<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0013.gif" alt="" id="GRAPHIC-d7e1732-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0014.gif" alt="" id="gr12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last"><i>n</i> = 3 if SEM is given, otherwise <i>n</i> = 1. The asterisk ∗ indicates no correlation between concentration and receptor affinity.</p></div></div><div></div></div><div class="NLM_p">The introduction of two methyl groups in <i>o</i>- and <i>p</i>-position of the benzyl moiety of lead compounds <b>4a</b> and <b>4b</b> led to considerably increased σ<sub>2</sub> affinity of amines <b>6a</b> (<i>K</i><sub>i</sub>(σ<sub>2</sub>) = 7.6 nM) and <b>6b</b> (<i>K</i><sub>i</sub>(σ<sub>2</sub>) = 54 nM). Amine <b>6a</b> shows very high σ<sub>2</sub> affinity and selectivity over the σ<sub>1</sub> subtype with a <i>K</i><sub>i</sub> values of 7.6 nM for the σ<sub>2</sub> receptor and 736 nM for the σ<sub>1</sub> receptor. Also, amines <b>6e</b> and <b>6f</b> with the isoquinolinyl moiety and amines <b>27a</b> and <b>27b</b> with benzannulenyl moiety display a preference for the σ<sub>2</sub> receptor. In contrast, amines <b>6c</b> and <b>6d</b> bearing the cyclohexylpiperazinyl moiety show high σ<sub>1</sub> affinity with 10- to 50-fold selectivity over the σ<sub>2</sub> receptor. Unexpectedly, siramesine derived amines <b>18a</b> and <b>18b</b> with indolylpropyl moiety show only very low affinity toward both σ receptor subtypes. Due to the very low σ affinity of the methoxy derivatives, <b>18a</b> and <b>18b</b> were not transformed into the corresponding fluoroethyl derivatives.</div><div class="NLM_p">The affinity of the lactols <b>10a</b>–<b>e</b> toward both σ receptors is slightly lower than the affinity of the corresponding methyl acetals. Up to a test compound concentration of 1 μM, lactol <b>10f</b> did not compete with the radioligands for the σ receptors. With elongation of the side chain the affinity toward both σ receptor subtypes decreased for esters <b>11a</b> and <b>11b</b> with dimethylbenzylamino moiety and <b>11e</b> and <b>11f</b> with isoquinolinyl residue. The reduction of the esters to the alcohols <b>12a</b>, <b>12b</b>, <b>12e</b>, and <b>12f</b> did not change the affinity toward the σ receptors. Also, the fluorination did not lead to increased σ affinity of compounds <b>13a</b>, <b>13b</b>, <b>13e</b>, and <b>13f</b>. In comparison to the acetals <b>27a</b> and <b>27b</b> the introduction of the fluoroethyl side chain led to a decrease in σ<sub>2</sub> affinity for the compounds with benzannulenyl moiety <b>30a</b> and <b>30b</b>.</div><div class="NLM_p last">Esters <b>11c</b> and <b>11d</b> with cyclohexylpiperazinyl moiety show comparable σ<sub>1</sub> affinity as the acetals <b>6c</b> and <b>6d</b>. In comparison to ester <b>11c</b>, alcohol <b>12c</b> shows a small decrease in σ<sub>1</sub> affinity and increase in σ<sub>2</sub> affinity resulting in lower σ<sub>1</sub>/σ<sub>2</sub> selectivity. The diastereomeric alcohol <b>12d</b> displays a higher σ<sub>1</sub>/σ<sub>2</sub> selectivity due to the 10-fold reduced σ<sub>2</sub> affinity of <b>12d</b> compared to the σ<sub>2</sub> affinity of the ester <b>11d</b>. The fluorinated compound <b>13c</b> shows high affinity toward both σ receptors with <i>K</i><sub>i</sub> values of 12 nM for the σ<sub>1</sub> receptor and 45 nM for the σ<sub>2</sub> receptor. A preference for one of the σ receptors was not observed. However, the diastereomeric fluoroethyl derivative <b>13d</b> reveals high σ<sub>1</sub> affinity and selectivity (<i>K</i><sub>i</sub>(σ<sub>1</sub>) = 19 nM; <i>K</i><sub>i</sub>(σ<sub>2</sub>) = 432 nM).</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">4.  Pharmacological in Vitro Characterization of Selected Compounds <b>10d</b>, <b>11d</b>, <b>13c</b>, and <b>13d</b></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83487" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83487" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Due to their high σ<sub>1</sub> and σ<sub>2</sub> affinity, lactol <b>10d</b>, ester <b>11d</b>, and fluoroethyl compounds <b>13c</b> and <b>13d</b> bearing the cyclohexylpiperazinyl moiety were selected for further characterization in vitro. At first, the selectivity over a panel of receptors and transporters was investigated. All four compounds show low affinity toward μ-opiod receptors (MOR), κ-opiod receptors (KOR), δ-opiod receptors (DOR) and the phencyclidine (PCP) binding site of the <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate (NMDA) receptor (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). However, they display high affinity to the ifenprodil binding site of GluN2B subunit containing NMDA receptors. At a concentration of 1 μM, the compounds <b>10d</b>, <b>11d</b>, and <b>13c</b> did not interact with 5-HT<sub>2B</sub> receptor, norepinephrine transporter (NET), dopamine transporter (DAT), and serotonin transporter (SERT). However, they displayed low affinity toward hERG channel, 5-HT<sub>1A</sub>, α<sub>1A</sub>, and H<sub>1</sub> receptor (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). With measurement of the functional activity at MOR by determination of the intracellular cAMP concentration, only fluoroethyl derivative <b>13c</b> showed a very weak effect (EC<sub>50</sub> = 1757 nM). Nevertheless, <b>13c</b> displayed the best selectivity profile for σ receptors.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Affinity toward σ Receptors, Opioid Receptors, PCP Binding Site, And Ifenprodil Binding Site of GluN2B Subunit Containing NMDA Receptors of Amines <b>10d</b>, <b>11d</b>, <b>13c</b>, and <b>13d</b><a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0015.gif" alt="" id="GRAPHIC-d7e2113-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center"><i>K</i><sub>i</sub> [nM]<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>10d</b></th><th class="colsep0 rowsep0" align="center"><b>11d</b></th><th class="colsep0 rowsep0" align="center"><b>13c</b></th><th class="colsep0 rowsep0" align="center"><b>13d</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><i>cis</i></th><th class="colsep0 rowsep0" align="center"><i>cis</i></th><th class="colsep0 rowsep0" align="center"><i>trans</i></th><th class="colsep0 rowsep0" align="center"><i>cis</i></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">R = OH</th><th class="colsep0 rowsep0" align="center">R = CH<sub>2</sub>CO<sub>2</sub>Et</th><th class="colsep0 rowsep0" align="center">R = CH<sub>2</sub>CH<sub>2</sub>F</th><th class="colsep0 rowsep0" align="center">R = CH<sub>2</sub>CH<sub>2</sub>F</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">σ<sub>1</sub></td><td class="colsep0 rowsep0" align="left">47 ± 10</td><td class="colsep0 rowsep0" align="left">12 ± 4</td><td class="colsep0 rowsep0" align="left">12 ± 2</td><td class="colsep0 rowsep0" align="left">19 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">σ<sub>2</sub></td><td class="colsep0 rowsep0" align="left">27 ± 16</td><td class="colsep0 rowsep0" align="left">51 ± 5</td><td class="colsep0 rowsep0" align="left">45 ± 14</td><td class="colsep0 rowsep0" align="left">432 ± 168</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MOR</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">458</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">434</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">KOR</td><td class="colsep0 rowsep0" align="left">781</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DOR</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">647</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PCP</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GluN2B</td><td class="colsep0 rowsep0" align="left">34 ± 7</td><td class="colsep0 rowsep0" align="left">54 ± 6</td><td class="colsep0 rowsep0" align="left">65 ± 9</td><td class="colsep0 rowsep0" align="left">31 ± 9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup><sup>a</sup></sup><p class="last"><i>n</i> = 3 if SEM is given, otherwise <i>n</i> = 1.</p></div><div class="footnote" id="t3fn1"><sup><sup>b</sup></sup><p class="last">Results are the mean of at least two replicates.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Inhibition of σ, α<sub>1</sub>, H<sub>1</sub>, 5-HT<sub>1A</sub>, and 5-HT<sub>2B</sub> Receptor, hERG Channel, NET, DAT, and SERT and Functional Activity at MOR of Amines <b>10d</b>, <b>11d</b>, and <b>13c</b><a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0016.gif" alt="" id="GRAPHIC-d7e2330-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>10d</b></th><th class="colsep0 rowsep0" align="center"><b>11d</b></th><th class="colsep0 rowsep0" align="center"><b>13c</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><i>cis</i></th><th class="colsep0 rowsep0" align="center"><i>cis</i></th><th class="colsep0 rowsep0" align="center"><i>trans</i></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">R = OH</th><th class="colsep0 rowsep0" align="center">R = CH<sub>2</sub>CO<sub>2</sub>Et</th><th class="colsep0 rowsep0" align="center">R = CH<sub>2</sub>CH<sub>2</sub>F</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K</i><sub>i</sub> [nM]</td><td class="colsep0 rowsep0" align="left">σ<sub>1</sub></td><td class="colsep0 rowsep0" align="left">47 ± 10</td><td class="colsep0 rowsep0" align="left">12 ± 4</td><td class="colsep0 rowsep0" align="left">12 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">σ<sub>2</sub></td><td class="colsep0 rowsep0" align="left">27 ± 16</td><td class="colsep0 rowsep0" align="left">51 ± 5</td><td class="colsep0 rowsep0" align="left">45 ± 14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EC<sub>50</sub> [nM]</td><td class="colsep0 rowsep0" align="left">MOR</td><td class="colsep0 rowsep0" align="left">>10000</td><td class="colsep0 rowsep0" align="left">>10000</td><td class="colsep0 rowsep0" align="left">1757</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> [nM]</td><td class="colsep0 rowsep0" align="left">hERG</td><td class="colsep0 rowsep0" align="left">3207</td><td class="colsep0 rowsep0" align="left">1753</td><td class="colsep0 rowsep0" align="left">2620</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">% inhibition [1 μM]</td><td class="colsep0 rowsep0" align="left">α<sub>1A</sub></td><td class="colsep0 rowsep0" align="left"><50</td><td class="colsep0 rowsep0" align="left">78</td><td class="colsep0 rowsep0" align="left"><50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">H<sub>1</sub></td><td class="colsep0 rowsep0" align="left">76</td><td class="colsep0 rowsep0" align="left">98</td><td class="colsep0 rowsep0" align="left"><50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">5-HT<sub>1A</sub></td><td class="colsep0 rowsep0" align="left">55</td><td class="colsep0 rowsep0" align="left">68</td><td class="colsep0 rowsep0" align="left">62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">5-HT<sub>2B</sub></td><td class="colsep0 rowsep0" align="left"><50</td><td class="colsep0 rowsep0" align="left"><50</td><td class="colsep0 rowsep0" align="left"><50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NET</td><td class="colsep0 rowsep0" align="left"><50</td><td class="colsep0 rowsep0" align="left"><50</td><td class="colsep0 rowsep0" align="left"><50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">DAT</td><td class="colsep0 rowsep0" align="left"><50</td><td class="colsep0 rowsep0" align="left"><50</td><td class="colsep0 rowsep0" align="left"><50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">SERT</td><td class="colsep0 rowsep0" align="left"><50</td><td class="colsep0 rowsep0" align="left"><50</td><td class="colsep0 rowsep0" align="left"><50</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup><sup>a</sup></sup><p class="last"><i>n</i> = 3 if SEM is given, otherwise <i>n</i> = 1.</p></div></div></div><div class="NLM_p">In order to determine the chemical stability of compounds <b>10d</b>, <b>11d</b>, and <b>13d</b>, they were dissolved in aqueous solution at pH 2 (aqueous HCl) and pH 7.4 (phosphate buffer). The remaining amount of parent compound was determined by HPLC. After a period of 24 h the parent compounds remained completely intact indicating high chemical stability under these conditions.</div><div class="NLM_p">Since amines <b>13c</b> and <b>13d</b> were chosen for in vivo tests in mice, the metabolic stability of these compounds during incubation with mouse liver microsomes over a period of 1 h was investigated (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Imipramine served as reference compound. With a concentration of 25 μM, both <b>13c</b> and <b>13d</b> showed high metabolic stability. After a period of 60 min, 72% and 70% of the parent compound remained intact. These findings allow the in vivo application of <b>13c</b> and <b>13d</b> in experiments with a duration of 1 h.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Metabolic Stability of Imipramine (Reference Compound) and Amines <b>13c</b> and <b>13d</b> after Incubation with Mouse Liver Microsomes for 1 h (<i>n</i> = 3)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">remaining parent compound ± SEM [%]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">imipramine</td><td class="colsep0 rowsep0" align="left">17 ± 1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13c</b></td><td class="colsep0 rowsep0" align="left">71.8 ± 2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13d</b></td><td class="colsep0 rowsep0" align="left">69.5 ± 1.6</td></tr></tbody></table></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">5.  In Vivo Activity of Amine 13c and 13d in Mechanical Allodynia Assay</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05631" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05631" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">For the in vivo investigations the fluoroethyl derivatives <b>13c</b> and <b>13d</b> were selected. <b>13c</b> shows promising affinity toward both σ receptor subtypes, a very good selectivity profile over other receptors and transporters and, moreover, does not contain an acid labile acetal or hemiacetal moiety. Its diastereomer <b>13d</b> indeed displays high σ<sub>1</sub> receptor affinity and selectivity. Since it has been reported that σ<sub>1</sub> receptors are involved in the development of pain,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> the effect of amines <b>13c</b> and <b>13d</b> on mechanical allodynia was analyzed. By use of the σ<sub>1</sub> selective <b>13d</b> and the dual σ<sub>1</sub>/σ<sub>2</sub> ligand <b>13c</b>, the influence of the different σ receptor binding profile on the antiallodynic activity was determined.</div><div class="NLM_p">Fluoroethyl derivatives <b>13c</b> and <b>13d</b>, the σ<sub>1</sub> receptor antagonist BD-1063 (1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine, <b>34</b>)<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> as positive control, and their solvent hydroxypropylmethylcellulose (HPMC) as negative control were administered subcutaneously (sc) to mice, and capsaicin-induced mechanical allodynia was evaluated.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, <b>13c</b>, <b>13d</b>, and <b>34</b> have a strong effect on allodynia. In both assays <b>13c</b> and <b>13d</b> were more potent than <b>34</b>, since lower doses of <b>13c</b> and <b>13d</b> than <b>34</b> were necessary to achieve the same effects.</div><figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effects of fluoroethyl derivatives <b>13c</b> (left) and <b>13d</b> (right) and the reference compound <b>34</b> (left and right) on mechanical allodynia induced by intraplantar (ipl) administration of capsaicin in mice. Animals were treated sc with <b>13c</b>, <b>13d</b>, <b>34</b> or their solvent (HPMC, dose 0) 30 min before capsaicin. Each bar and vertical line represents the mean ± SEM of values obtained in 6–8 animals. One-way analysis of variance followed by the Bonferroni test was used to determine statistically significant differences between values obtained in mice treated with <b>13c</b>, <b>13d</b>, or <b>34</b> in comparison with control animals (HPMC-treated, dose 0) value (<sup>##</sup><i>P</i> < 0.01) and between the values obtained in mice treated with the same dose of <b>13c</b> and <b>34</b> (left) or the same dose of <b>13d</b> and <b>34</b> (right) (**<i>P</i> < 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01183&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In order to evaluate the influence of σ<sub>1</sub> affinity on the antiallodynic effects of <b>13c</b> and <b>13d</b>, the experiment was repeated with pretreatment of the mice with σ<sub>1</sub> agonist PRE-084 2-(morpholin-4-yl)ethyl 1-phenylcyclohexane-1-carboxylate, <b>35</b>, 32 mg/kg).<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> It was observed that for low doses of <b>13c</b> (8–16 mg/kg), <b>35</b> was able to antagonize the antiallodynic effect. At higher doses of <b>13c</b> (32 mg/kg), reversion of the antiallodynic effect could not be observed (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). This indicates an involvement of the σ<sub>1</sub> receptor in the antiallodynic effect of <b>13c</b>. However, since the σ<sub>1</sub> agonist <b>35</b> was not able to antagonize the effect of <b>13c</b> completely at higher doses, the antiallodynic effect of <b>13c</b> at least at high doses will be mediated by a second unknown mechanism. In contrast, when compound <b>13d</b> was associated with <b>35</b>, a parallel shift to the right of the dose–response line of <b>13d</b> was observed (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), indicating that the antiallodynic effect of <b>13d</b> is probably due only to its interaction with σ<sub>1</sub> receptor.</div><figure id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of fluoroethyl derivatives <b>13c</b> (left) or <b>13d</b> (right) alone and in combination with the σ<sub>1</sub> receptor agonist <b>35</b> on mechanical allodynia induced by intraplantar (ipl) administration of capsaicin in mice. Animals were treated sc with <b>35</b> 5 min before administration of <b>13c</b> or <b>13d</b>, which were sc administered 30 min before capsaicin. Each bar and vertical line represents the mean ± SEM of values obtained in 6–8 animals. One-way analysis of variance followed by the Bonferroni test was used to determine statistically significant differences between values obtained in mice treated with <b>13c</b>, <b>13d</b>, or their combination with <b>35</b> in comparison with the value obtained in control animals (HPMC-treated, dose 0) (<sup>##</sup><i>P</i> < 0.01) and between the values obtained in mice treated with <b>13c</b> and <b>13c</b> + <b>35</b> (left) or <b>13d</b> and <b>13d</b> + <b>35</b> (right) (**<i>P</i> < 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01183&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">6.  Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88633" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88633" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A series of spirocyclic 2-benzopyrans bearing exocyclic amino moieties derived from ligands preferring the σ<sub>2</sub> receptor subtype was designed, synthesized, and evaluated pharmacologically. Whereas compounds with the 4-cyclohexylpiperazinyl moiety show high σ<sub>1</sub> affinity, ligands bearing the dimethylbenzylamino, 6,7-dimethoxyisoquinolinyl, or benzo[7]annulenyl residue display a preference for the σ<sub>2</sub> receptor. The affinity toward both σ receptors decreases with elongation of the side chain in position 3 of the 2-benzopyran system: OCH<sub>3</sub> = OH > CH<sub>2</sub>CO<sub>2</sub>Et = CH<sub>2</sub>CH<sub>2</sub>OH = CH<sub>2</sub>CH<sub>2</sub>F. Introduction of the indolylpropyl moiety derived from the high-affinity σ<sub>2</sub> ligand siramesine led to considerably reduced affinity toward both σ receptors.</div><div class="NLM_p last">Further pharmacological properties of the most promising 4-cyclohexylpiperazinyl derivatives <b>10d</b>, <b>11d</b>, and <b>13c</b> were investigated in in vitro experiments. In the mouse model of mechanical allodynia the most selective, fluorinated compound <b>13c</b> and its diastereomer <b>13d</b> showed high antiallodynic activity that can be partially explained by σ<sub>1</sub> receptor antagonism. A second mechanism was postulated to explain the complete antiallodynic effect of <b>13c</b>. In contrast, the antiallodynic effect of <b>13d</b> can be totally explained by σ<sub>1</sub> receptor antagonism.</div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">7.  Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83465" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83465" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20">7.1.  Chemistry, General</h3><div class="NLM_p last">Unless otherwise noted, moisture sensitive reactions were conducted under dry nitrogen. CH<sub>2</sub>Cl<sub>2</sub> was distilled over CaH<sub>2</sub>. THF was distilled over sodium/benzophenone. Et<sub>2</sub>O and toluene were dried over molecular sieves 0.4 Å. Thin layer chromatography (tlc): silica gel 60 F254 plates (Merck). Flash chromatography (fc): silica gel 60, 40–64 μm (Merck); parentheses include diameter of the column (<i>d</i>), length of the stationary phase (<i>l</i>), fraction size (<i>V</i>), eluent. Melting point: Melting point apparatus Mettler Toledo MP50 melting point system, uncorrected. MS: microTOF-Q II (Bruker Daltonics); APCI, atmospheric pressure chemical ionization. IR: FT-IR spectrophotometer MIRacle 10 (Shimadzu) equipped with ATR technique. Nuclear magnetic resonance (NMR) spectra were recorded on Agilent 600-MR (600 MHz for <sup>1</sup>H, 151 MHz for <sup>13</sup>C) or Agilent 400-MR spectrometer (400 MHz for <sup>1</sup>H, 101 MHz for <sup>13</sup>C); δ in ppm related to tetramethylsilane and measured referring to CHCl<sub>3</sub> (δ = 7.26 ppm (<sup>1</sup>H NMR) and δ = 77.2 ppm (<sup>13</sup>C NMR)), CHD<sub>2</sub>OD (δ = 3.31 ppm (<sup>1</sup>H NMR) and δ = 49.0 ppm (<sup>13</sup>C NMR)) and DMSO-<i>d</i><sub>6</sub> (δ = 2.54 ppm (<sup>1</sup>H NMR) and δ = 39.5 ppm (<sup>13</sup>C NMR)). Coupling constants are given with 0.5 Hz resolution. The assignments of <sup>13</sup>C and <sup>1</sup>H NMR signals were supported by 2D NMR techniques where necessary. HPLC: pump, LPG-3400SD; degasser, DG-1210; autosampler, ACC-3000T; UV detector, VWD-3400RS; interface, DIONEX UltiMate 3000; data acquisition, Chromeleon 7 (Thermo Fisher Scientific); column, LiChrospher 60 RP-select B (5 μm); LiChroCART 250–4 mm cartridge; guard column, LiChrospher 60 RP-select B (5 μm), LiChroCART 4–4 mm cartridge (no. 1.50963.0001); manu-CART NT cartridge holder; flow rate, 1.0 mL/min; injection volume, 5.0 μL; detection at λ = 210 nm; solvent A, method 1, water with 0.05% (v/v) trifluoroacetic acid; method 2, water; solvent B, method 1, acetonitrile with 0.05% (v/v) trifluoroacetic acid; method 2, acetonitrile. Gradient elution (A %), 0–4 min, 90%; 4–29 min, 90 → 0%; 29–31 min, 0%, 31–31.5 min, 0 → 90%; 31.5–40 min, 90%. The purity of all compounds was determined by this method. Unless otherwise mentioned, the purity of all test compounds is higher than 95%.</div></div><div id="sec7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21">7.2.  Synthetic Procedures</h3><div id="sec7_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22">7.2.1.  <i>trans</i>-<i>N</i>-(2,4-Dimethylbenzyl)-3-methoxy-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-4′-amine (<b>6a</b>) and <i>cis</i>-<i>N</i>-(2,4-Dimethylbenzyl)-3-methoxy-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexane]-4′-amine (<b>6b</b>)</h4><div class="NLM_p">A solution of ketone <b>5</b> (201 mg, 0.82 mmol), 2,4-dimethylbenzylamine (161 mg, 1.19 mmol, 1.5 equiv), and acetic acid (50 μL, 0.88 mmol, 1.1 equiv) in THF (30 mL) was stirred under N<sub>2</sub> atmosphere at rt. After 2.5 h, NaBH(OAc)<sub>3</sub> (310 mg, 1.46 mmol, 1.9 equiv) was added and the mixture was stirred for 20 h at rt. 1 M NaOH (20 mL) was added, and the aqueous layer was extracted with Et<sub>2</sub>O (4 × 30 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 3 cm, <i>l</i> = 26 cm, <i>V</i> = 20 mL, cyclohexane/ethyl acetate 90:10 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). <b>6a</b> was eluted first and <b>6b</b> afterward. <b>6b</b> was purified again by fc (<i>d</i> = 2 cm, <i>l</i> = 16 cm, <i>V</i> = 10 mL, cyclohexane/ethyl acetate 80:20 + 1% <i>N</i>,<i>N</i>-dimethylethanamine).</div><div id="sec7_2_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> <i>trans-</i><b>6a</b></h5><div class="NLM_p last">Pale yellow solid, mp 74 °C, yield 91 mg (30%). C<sub>24</sub>H<sub>31</sub>NO<sub>2</sub> (365.6 g/mol). <i>R<sub>f</sub></i> = 0.30 (cyclohexane/ethyl acetate 90:10 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 366.2437 (calcd 366.2428 for C<sub>24</sub>H<sub>32</sub>NO<sub>2</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ (ppm) = 1.57 (dq, <i>J</i> = 13.5/3.1 Hz, 1H, 2′-<i>H</i><sub>equ</sub>), 1.74–1.79 (m, 2H, 3′-<i>H</i>, 5′-<i>H</i>), 1.82 (dq, <i>J</i> = 13.3/2.8 Hz, 1H, 6′-<i>H</i><sub>equ</sub>), 1.98–2.16 (m, 3H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i><sub>ax</sub>), 2.29–2.34 (m, 1H, 2′-<i>H</i><sub>ax</sub>), 2.30 (s, 1H, 4–C<i>H</i><sub>3</sub>), 2.39 (s, 3H, 2–C<i>H</i><sub>3</sub>), 2.79 (dd, <i>J</i> = 15.6/7.5 Hz, 1H, 4-<i>H</i>), 2.91 (dd, <i>J</i> = 15.6/3.1 Hz, 1H, 4-<i>H</i>), 3.01 (quint, <i>J</i> = 3.1 Hz, 1H, 4′-<i>H</i><sub>equ</sub>), 3.54 (s, 3H, OC<i>H</i><sub>3</sub>), 3.77 (s, 2H, ArC<i>H</i><sub>2</sub>NH), 4.90 (dd, <i>J</i> = 7.7/3.1 Hz, 1H, 3-<i>H</i>), 6.96–7.04 (m, 2H, 3-<i>H</i><sub>benzyl</sub>, 5-<i>H</i><sub>benzyl</sub>), 7.06 (dd, <i>J</i> = 7.6/1.2 Hz, 1H, 5-<i>H</i>), 7.13 (td, <i>J</i> = 7.4/1.4 Hz, 1H, 6-<i>H</i>), 7.16–7.20 (m, 1H, 7-<i>H</i>), 7.23 (d, <i>J</i> = 7.6 Hz, 1H, 6-<i>H</i><sub>benzyl</sub>), 7.33 (dd, <i>J</i> = 7.8/1.3 Hz, 1H, 8-<i>H</i>). A signal for the NH proton is not observed in the spectrum. <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ (ppm) = 19.2 (1C, 2-<i>C</i>H<sub>3</sub>), 21.1 (1C, 4-<i>C</i>H<sub>3</sub>), 26.6 (1C, <i>C</i>-3′), 26.8 (1C, <i>C</i>-5′), 31.6 (1C, <i>C</i>-6′), 34.3 (1C, <i>C</i>-2′), 36.3 (1C, <i>C</i>-4), 50.2 (1C, Ar<i>C</i>H<sub>2</sub>NH), 52.4 (1C, <i>C</i>-4′), 56.3 (1C, O<i>C</i>H<sub>3</sub>), 78.3 (1C, <i>C</i>-1), 97.8 (1C, <i>C</i>-3), 126.1 (1C, <i>C</i>-8), 127.47 (1C, <i>C</i>-7), 127.52 (1C, <i>C</i>-6), 127.6 (1C, <i>C</i>-5<sub>benzyl</sub>), 130.0 (1C, <i>C</i>-5), 130.2 (1C, <i>C</i>-6<sub>benzyl</sub>), 132.0 (1C, <i>C</i>-3<sub>benzyl</sub>), 132.4 (1C, <i>C</i>-4a), 136.2 (1C, <i>C</i>-1<sub>benzyl</sub>), 137.4 (1C, <i>C</i>-2<sub>benzyl</sub>), 137.8 (1C, <i>C</i>-4<sub>benzyl</sub>), 143.5 (1C, <i>C</i>-8a). FT-IR (neat): ν [cm<sup>–1</sup>] = 3310 (N–H), 2948, 2930, 2851 (C–H<sub>alkyl</sub>), 1615, 1476 (C═C<sub>arom</sub>). Purity (HPLC): 96.7%, <i>t</i><sub>R</sub> = 19.8 min.</div></div><div id="sec7_2_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> <i>cis-</i><b>6b</b></h5><div class="NLM_p last">Pale yellow solid, mp 93 °C, yield 131 mg (44%). C<sub>24</sub>H<sub>31</sub>NO<sub>2</sub> (365.6 g/mol). <i>R<sub>f</sub></i> = 0.09 (cyclohexane/ethyl acetate 90:10 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 366.2390 (calcd 366.2428 for C<sub>24</sub>H<sub>32</sub>NO<sub>2</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ (ppm) = 1.70 (td, <i>J</i> = 13.4/3.5 Hz, 1H, 2′-<i>H</i><sub>ax</sub>), 1.74–1.83 (m, 1H, 3′-<i>H</i>), 1.83–1.96 (m, 4H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>), 1.96–2.05 (m, 1H, 6′-<i>H</i>), 2.13 (dq, <i>J</i> = 13.6/2.7 Hz, 1H, 2′-<i>H</i><sub>equ</sub>), 2.31 (s, 3H, 4-C<i>H</i><sub>3</sub>), 2.36 (s, 3H, 2–C<i>H</i><sub>3</sub>), 2.77 (tt, <i>J</i> = 10.8/3.9 Hz, 1H, 4′-<i>H</i><sub>ax</sub>), 2.83 (dd, <i>J</i> = 16.1/7.4 Hz, 1H, 4-<i>H</i>), 2.94 (dd, <i>J</i> = 15.7/3.0 Hz, 1H, 4-<i>H</i>), 3.59 (s, 3H, OC<i>H</i><sub>3</sub>), 3.83 (s, 2H, ArC<i>H</i><sub>2</sub>NH), 4.93 (dd, <i>J</i> = 7.4/3.2 Hz, 1H, 3-<i>H</i>), 6.99–7.05 (m, 2H, 3-<i>H</i><sub>benzyl</sub>, 5-<i>H</i><sub>benzyl</sub>), 7.10 (d, <i>J</i> = 7.6 Hz, 1H, 5-<i>H</i>), 7.14–7.21 (m, 3H, 6-<i>H</i>, 7-<i>H</i>, 8-<i>H</i>), 7.22 (d, <i>J</i> = 7.5 Hz, 1H, 6-<i>H</i><sub>benzyl</sub>). A signal for the NH proton is not observed in the spectrum. <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ (ppm) = 19.1 (1C, 2-<i>C</i>H<sub>3</sub>), 21.1 (1C, 4-<i>C</i>H<sub>3</sub>), 29.1 (1C, <i>C</i>-5′), 29.1 (1C, <i>C</i>-3′), 36.2 (1C, <i>C</i>-4), 36.6 (1C, <i>C</i>-2′), 39.1 (1C, <i>C</i>-6′), 48.7 (1C, Ar<i>C</i>H<sub>2</sub>NH), 56.5 (1C, O<i>C</i>H<sub>3</sub>), 57.2 (1C, <i>C</i>-4′), 77.5 (1C, <i>C</i>-1), 97.8 (1C, <i>C</i>-3), 125.7 (1C, <i>C</i>-8), 127.5 (1C, <i>C</i>-7), 127.6 (1C, <i>C</i>-5<sub>benzyl</sub>), 127.7 (1C, <i>C</i>-6), 129.9 (1C, <i>C</i>-6<sub>benzyl</sub>), 130.1 (1C, <i>C</i>-5), 132.1 (1C, <i>C</i>-3<sub>benzyl</sub>), 132.6 (1C, <i>C</i>-4a), 135.8 (1C, <i>C</i>-1<sub>benzyl</sub>), 137.2 (1C, <i>C</i>-2<sub>benzyl</sub>), 137.9 (1C, <i>C</i>-4<sub>benzyl</sub>), 142.7 (1C, <i>C</i>-8a). FT-IR (neat): ν [cm<sup>–1</sup>] = 3290 (N–H), 2941, 2918 (C–H<sub>alkyl</sub>), 1614, 1488 (C═C<sub>arom</sub>). Purity (HPLC): 95.6%, <i>t</i><sub>R</sub> = 19.53 min.</div></div></div><div id="sec7_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25">7.2.2.  <i>trans</i>-1-Cyclohexyl-4-(3-methoxy-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-4′-yl)piperazine (<b>6c</b>) and <i>cis</i>-1-Cyclohexyl-4-(3-methoxy-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-4′-yl)piperazine (<b>6d</b>)</h4><div class="NLM_p">A solution of ketone <b>5</b> (80 mg, 0.32 mmol), 1-cyclohexylpiperazine (76 mg, 0.45 mmol, 1.4 equiv), and acetic acid (22 μL, 0.39 mmol, 1.2 equiv) in THF (10 mL) was stirred under N<sub>2</sub> atmosphere at rt. After 3 h, NaBH(OAc)<sub>3</sub> (129 mg, 0.61 mmol, 1.9 equiv) was added and the mixture was stirred for 23 h at rt. 1 M NaOH (20 mL) was added, and the aqueous layer was extracted with Et<sub>2</sub>O (4 × 30 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 2 cm, <i>l</i> = 26 cm, <i>V</i> = 5 mL, cyclohexane/ethyl acetate 66:33 + 2% <i>N</i>,<i>N</i>-dimethylethanamine). <b>6c</b> was eluted first and <b>6d</b> afterward.</div><div id="sec7_2_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> <i>trans-</i><b>6c</b></h5><div class="NLM_p last">Colorless solid, mp 146 °C, yield 13 mg (9%). C<sub>25</sub>H<sub>38</sub>N<sub>2</sub>O<sub>2</sub> (398.6 g/mol). <i>R<sub>f</sub></i> = 0.34 (cyclohexane/ethyl acetate 90:10 + 2% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 399.3013 (calcd 399.3006 for C<sub>25</sub>H<sub>39</sub>N<sub>2</sub>O<sub>2</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ (ppm) = 1.13–1.21 (m, 1H, 4-<i>H</i><sub>cyclohexyl</sub>), 1.13–1.37 (m, 4H, 2-<i>H</i><sub>cyclohexyl</sub>, 3-<i>H</i><sub>cyclohexyl</sub>, 5-<i>H</i><sub>cyclohexyl</sub>, 6-<i>H</i><sub>cyclohexyl</sub>), 1.51 (dq, <i>J</i> = 13.3/3.1 Hz, 1H, 2′-<i>H</i><sub>equ</sub>), 1.64–1.71 (m, 1H, 4-<i>H</i><sub>cyclohexyl</sub>), 1.76 (dq, <i>J</i> = 12.6/3.3/2.8/2.3 Hz, 1H, 6′-<i>H</i><sub>equ</sub>), 1.82–1.88 (m, 2H, 3-<i>H</i><sub>cyclohexyl</sub>, 5-<i>H</i><sub>cyclohexyl</sub>), 1.90–2.05 (m, 7H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i><sub>ax</sub>, 2-<i>H</i><sub>cyclohexyl</sub>, 6-<i>H</i><sub>cyclohexyl</sub>), 2.22–2.30 (m, 3H, 2′-<i>H</i><sub>ax</sub>, 4′-<i>H</i><sub>equ</sub>, 1-<i>H</i><sub>cyclohexyl</sub>), 2.45–2.66 (broad signal, 4H, 2-<i>H</i><sub>piperazine</sub> and 6-<i>H</i><sub>piperazine</sub> or 3-<i>H</i><sub>piperazine</sub> and 5-<i>H</i><sub>piperazine</sub>), 2.66–2.76 (broad signal, 4H, 2-<i>H</i><sub>piperazine</sub> and 6-<i>H</i><sub>piperazine</sub> or 3-<i>H</i><sub>piperazine</sub> and 5-<i>H</i><sub>piperazine</sub>), 2.78 (dd, <i>J</i> = 15.4/7.7 Hz, 1H, 4-<i>H</i>), 2.90 (dd, <i>J</i> = 15.6/3.2 Hz, 1H, 4-<i>H</i>), 3.54 (s, 3H, OC<i>H</i><sub>3</sub>), 4.89 (dd, <i>J</i> = 7.5/3.1 Hz, 1H, 3-<i>H</i>), 7.04–7.08 (m, 1H, 5-<i>H</i>), 7.11–7.15 (m, 1H, 6-<i>H</i>), 7.16–7.22 (m, 2H, 7-<i>H</i>, 8-<i>H</i>). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ (ppm) = 24.9 (1C, <i>C</i>-3′), 25.0 (1C, <i>C</i>-5′), 26.9 (2C, <i>C</i>-2<sub>cyclohexyl</sub>, <i>C</i>-6<sub>cyclohexyl</sub>), 27.3 (1C, <i>C</i>-4<sub>cyclohexyl</sub>), 29.8 (2C, <i>C</i>-3<sub>cyclohexyl</sub>, <i>C</i>-5<sub>cyclohexyl</sub>), 32.1 (1C, <i>C</i>-6′), 34.8 (1C, <i>C</i>-2′), 36.2 (1C, <i>C</i>-4), 50.6 (2C, <i>C</i>-2<sub>piperazine</sub> and <i>C</i>-6<sub>piperazine</sub> or <i>C</i>-3<sub>piperazine</sub> and <i>C</i>-5<sub>piperazine</sub>), 51.4 (2C, <i>C</i>-2<sub>piperazine</sub> and <i>C</i>-6<sub>piperazine</sub> or <i>C</i>-3<sub>piperazine</sub> and <i>C</i>-5<sub>piperazine</sub>), 56.3 (1C, O<i>C</i>H<sub>3</sub>), 59.4 (1C, <i>C</i>-4′), 65.0 (1C, <i>C</i>-1<sub>cyclohexyl</sub>), 78.4 (1C, <i>C</i>-1), 97.9 (1C, <i>C</i>-3), 125.9 (1C, <i>C</i>-8), 127.4 (1C, <i>C</i>-7), 127.5 (1C, <i>C</i>-6), 130.0 (1C, <i>C</i>-5), 132.5 (1C, <i>C</i>-4a), 143.6 (1C, <i>C</i>-8a). FT-IR (neat): ν [cm<sup>–1</sup>] = 2947, 2914 (C–H<sub>alkyl</sub>), 2800, 2758 (N–CH<sub>2</sub>), 1486 (C═C<sub>arom</sub>). Purity (HPLC): 98.1%, <i>t</i><sub>R</sub> = 14.42 min.</div></div><div id="sec7_2_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> <i>cis-</i><b>6d</b></h5><div class="NLM_p last">Colorless solid, mp 146 °C, yield 48 mg (38%). C<sub>25</sub>H<sub>38</sub>N<sub>2</sub>O<sub>2</sub> (398.6 g/mol). <i>R<sub>f</sub></i> = 0.17 (cyclohexane/ethyl acetate 90:10 + 2% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 399.2996 (calcd 399.3006 for C<sub>25</sub>H<sub>39</sub>N<sub>2</sub>O<sub>2</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ (ppm) = 1.10–1.20 (m, 1H, 4-<i>H</i><sub>cyclohexyl</sub>), 1.20–1.35 (m, 4H, 2-<i>H</i><sub>cyclohexyl</sub>, 3-<i>H</i><sub>cyclohexyl</sub>, 5-<i>H</i><sub>cyclohexyl</sub>, 6-<i>H</i><sub>cyclohexyl</sub>), 1.63–1.68 (m, 1H, 4-<i>H</i><sub>cyclohexyl</sub>), 1.68–1.74 (m, 1H, 2′-<i>H</i><sub>ax</sub>), 1.78–1.92 (m, 7H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>, 2-<i>H</i><sub>cyclohexyl</sub>, 6-<i>H</i><sub>cyclohexyl</sub>), 1.92–2.03 (m, 3H, 6′-<i>H</i>, 3-<i>H</i><sub>cyclohexyl</sub>, 5-<i>H</i><sub>cyclohexyl</sub>), 2.14 (dq, <i>J</i> = 14.2/3.2 Hz, 1H, 2′-<i>H</i><sub>equ</sub>), 2.25 (tt, <i>J</i> = 11.0/3.4 Hz, 1H, 1-<i>H</i><sub>cyclohexyl</sub>), 2.47 (tt, <i>J</i> = 10.6/4.3 Hz, 1H, 4′-<i>H</i><sub>ax</sub>), 2.61–2.76 (broad signal, 8H, <i>H</i><sub>piperazine</sub>), 2.79 (dd, <i>J</i> = 15.6/7.5 Hz, 1H, 4-<i>H</i>), 2.91 (dd, <i>J</i> = 15.7/3.1 Hz, 1H, 4-<i>H</i>), 3.55 (s, 3H, OC<i>H</i><sub>3</sub>), 4.90 (dd, <i>J</i> = 7.5/3.1 Hz, 1H, 3-<i>H</i>), 7.07 (d, <i>J</i> = 7.3 Hz, 1H, 5-<i>H</i>), 7.11–7.16 (m, 1H, 6-<i>H</i>), 7.16–7.19 (m, 2H, 7-<i>H</i>, 8-<i>H</i>). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ (ppm) = 24.86 (1C, <i>C</i>-3′ or <i>C</i>-5′), 24.89 (1C, <i>C</i>-3′ or <i>C</i>-5′), 26.9 (2C, <i>C</i>-2<sub>cyclohexyl</sub>, <i>C</i>-6<sub>cyclohexyl</sub>), 27.3 (1C, <i>C</i>-4<sub>cyclohexyl</sub>), 29.7 (2C, <i>C</i>-3<sub>cyclohexyl</sub>, <i>C</i>-5<sub>cyclohexyl</sub>), 36.2 (1C, <i>C</i>-4), 36.9 (1C, <i>C</i>-2′), 39.4 (1C, <i>C</i>-6′), 49.9 (2C, <i>C</i>-3<sub>piperazine</sub>, <i>C</i>-5<sub>piperazine</sub>), 50.1 (2C, <i>C</i>-2<sub>piperazine</sub>, <i>C</i>-6<sub>piperazine</sub>), 56.4 (1C, O<i>C</i>H<sub>3</sub>), 63.9 (1C, <i>C</i>-4′), 64.9 (1C, <i>C</i>-1<sub>cyclohexyl</sub>), 77.3 (1C, <i>C</i>-1), 97.8 (1C, <i>C</i>-3), 125.7 (1C, <i>C</i>-8), 127.5 (1C, <i>C</i>-7), 127.7 (1C, <i>C</i>-6), 130.1 (1C, <i>C</i>-5), 132.6 (1C, <i>C</i>-4a), 142.6 (1C, <i>C</i>-8a). FT-IR (neat): ν [cm<sup>–1</sup>] = 2926 (C–H<sub>alkyl</sub>), 2827, 2798 (N–CH<sub>2</sub>), 1489 (C═C<sub>arom</sub>). Purity (HPLC): 99.7%, <i>t</i><sub>R</sub> = 13.9 min.</div></div></div><div id="sec7_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28">7.2.3.  <i>trans</i>-6,7-Dimethoxy-2-(3-methoxy-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-4′-yl)-1,2,3,4-tetrahydroisoquinoline (<b>6e</b>) and <i>cis</i>-6,7-Dimethoxy-2-(3-methoxy-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-4′-yl)-1,2,3,4-tetrahydroisoquinoline (<b>6f</b>)</h4><div class="NLM_p">A solution of ketone <b>5</b> (205 mg, 0.83 mmol) and 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride (262 mg, 1.14 mmol, 1.4 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (30 mL) was stirred under N<sub>2</sub> atmosphere at rt. After 4 h, NaBH(OAc)<sub>3</sub> (395 mg, 1.87 mmol, 2.3 equiv) was added and the mixture was stirred for 43 h at rt. 1 M NaOH (20 mL) was added, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (4 × 30 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 2 cm, <i>l</i> = 20 cm, <i>V</i> = 10 mL, cyclohexane/ethyl acetate 80:20 + 1% <i>N</i>,<i>N</i>-dimethylethanamine → 66:33 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). <b>6e</b> was eluted first and <b>6f</b> afterward. <b>6f</b> was purified twice by fc (<i>d</i> = 2 cm, <i>l</i> = 16 cm, <i>V</i> = 10 mL, cyclohexane/ethyl acetate 50:50 + 1% HCOOH → 66:33 + 1% <i>N</i>,<i>N</i>-dimethylethanamine; <i>d</i> = 2 cm, <i>l</i> = 20 cm, <i>V</i> = 10 mL, cyclohexane/ethyl acetate 80:20 + 1% <i>N</i>,<i>N</i>-dimethylethanamine → 60:40 + 1% <i>N</i>,<i>N</i>-dimethylethanamine).</div><div id="sec7_2_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> <i>trans-</i><b>6e</b></h5><div class="NLM_p last">Yellow solid, mp 158 °C, yield 66 mg (19%). C<sub>26</sub>H<sub>33</sub>NO<sub>4</sub> (423.6 g/mol). <i>R<sub>f</sub></i> = 0.67 (cyclohexane/ethyl acetate 50:50 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 424.2454 (calcd 424.2482 for C<sub>26</sub>H<sub>34</sub>NO<sub>4</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) = 1.48 (dq, <i>J</i> = 12.3/2.7 Hz, 1H, 2′-<i>H</i>), 1.70–1.78 (m, 1H, 6′-<i>H</i>), 1.86–2.07 (m, 5H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>), 2.21 (td, <i>J</i> = 12.8/3.9 Hz, 1H, 2′-<i>H</i>), 2.36–2.44 (m, 1H, 4′-<i>H</i><sub>equ</sub>), 2.69–2.77 (m, 3H, 4-<i>H</i>, 3-<i>H</i><sub>isoquinoline</sub>), 2.77–2.82 (m, 2H, 4-<i>H</i><sub>isoquinoline</sub>), 2.90 (dd, <i>J</i> = 15.8/3.1 Hz, 1H, 4-<i>H</i>), 3.46 (s, 3H, 3-OC<i>H</i><sub>3</sub>), 3.63 (s, 2H, 1-<i>H</i><sub>isoquinoline</sub>), 3.72 (s, 3H, 6-OC<i>H</i><sub>3</sub>), 3.74 (s, 3H, 7-OC<i>H</i><sub>3</sub>), 4.90 (dd, <i>J</i> = 7.2/3.1 Hz, 1H, 3-<i>H</i>), 6.71 (s, 2H, 5-<i>H</i><sub>isoquinoline</sub>, 8-<i>H</i><sub>isoquinoline</sub>), 7.03 (dd, <i>J</i> = 7.0/2.0 Hz, 1H, 8-<i>H</i>), 7.08 (dd, <i>J</i> = 7.3/1.8 Hz, 1H, 5-<i>H</i>), 7.11–7.19 (m, 2H, 6-<i>H</i>, 7-<i>H</i>). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) = 23.9 (1C, <i>C</i>-3′ or <i>C</i>-5′), 24.1 (1C, <i>C</i>-3′ or <i>C</i>-5′), 28.7 (1C, <i>C</i>-4<sub>isoquinoline</sub>), 30.9 (1C, <i>C</i>-6′), 33.3 (1C, <i>C</i>-2′), 34.7 (1C, <i>C</i>-4), 47.0 (1C, <i>C</i>-3<sub>isoquinoline</sub>), 52.9 (1C, <i>C</i>-1<sub>isoquinoline</sub>), 55.0 (1C, 3-O<i>C</i>H<sub>3</sub>), 55.45 (1C, 6-O<i>C</i>H<sub>3</sub> or 7-O<i>C</i>H<sub>3</sub>), 55.50 (1C, 6-O<i>C</i>H<sub>3</sub> or 7-O<i>C</i>H<sub>3</sub>), 56.5 (1C, <i>C</i>-4′), 76.0 (1C, <i>C</i>-1), 95.8 (1C, <i>C</i>-3), 110.3 (1C, <i>C</i>-8<sub>isoquinoline</sub>), 111.6 (1C, <i>C</i>-5<sub>isoquinoline</sub>), 124.4 (1C, <i>C</i>-8), 126.2 (1C, <i>C</i>-4a<sub>isoquinoline</sub>), 126.2 (1C, <i>C</i>-6 or <i>C</i>-7), 126.3 (1C, <i>C</i>-6 or <i>C</i>-7), 127.0 (1C, <i>C</i>-8a<sub>isoquinoline</sub>), 128.8 (1C, <i>C</i>-5), 131.1 (1C, <i>C</i>-4a), 142.1 (1C, <i>C</i>-8a), 146.9 (1C, <i>C</i>-6<sub>isoquinoline</sub> or <i>C</i>-7<sub>isoquinoline</sub>), 147.1 (1C, <i>C</i>-6<sub>isoquinoline</sub> or <i>C</i>-7<sub>isoquinoline</sub>). FT-IR (neat): ν [cm<sup>–1</sup>] = 2943, 2920, 2832 (C–H<sub>alkyl</sub>), 1516, 1447 (C═C<sub>arom</sub>). Purity (HPLC): 98.8%, <i>t</i><sub>R</sub> = 17.7 min. A sample was recrystallized from CH<sub>2</sub>Cl<sub>2</sub> to obtain crystals, which were suitable to for X-ray crystal structure analysis.</div></div><div id="sec7_2_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> <i>cis-</i><b>6f</b></h5><div class="NLM_p last">Yellow solid, mp 180 °C, yield 133 mg (37%). C<sub>26</sub>H<sub>33</sub>NO<sub>4</sub> (423.6 g/mol). <i>R<sub>f</sub></i> = 0.22 (cyclohexane/ethyl acetate 50:50 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 424.2439 (calcd 424.2482 for C<sub>26</sub>H<sub>34</sub>NO<sub>4</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) = 1.61–1.71 (m, 1H, 2′-<i>H</i>), 1.71–1.85 (m, 5H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>), 1.85–2.02 (m, 1H, 6′-<i>H</i>), 2.02–2.11 (m, 1H, 2′-<i>H</i>), 2.64–2.76 (m, 5H, 4-<i>H</i>, 4′-<i>H</i><sub>ax</sub>, 4-<i>H</i><sub>isoquinoline</sub>), 2.80 (t, <i>J</i> = 5.7 Hz, 2H, 3-<i>H</i><sub>isoquinoline</sub>), 2.90 (dd, <i>J</i> = 15.9/3.2 Hz, 1H, 4-<i>H</i>), 3.47 (s, 3H, 3-OC<i>H</i><sub>3</sub>), 3.70 (s, 8H, 1-<i>H</i><sub>isoquinoline</sub>, 6-OC<i>H</i><sub>3</sub>, 7-OC<i>H</i><sub>3</sub>), 4.89 (dd, <i>J</i> = 7.2/3.1 Hz, 1H, 3-<i>H</i>), 6.65 (s, 1H, 5-<i>H</i><sub>isoquinoline</sub>), 6.66 (s, 1H, 8-<i>H</i><sub>isoquinoline</sub>), 7.09 (dd, <i>J</i> = 7.3/1.8 Hz, 1H, 5-<i>H</i>), 7.12–7.21 (m, 2H, 6-<i>H</i>, 7-<i>H</i>), 7.25 (dd, <i>J</i> = 7.4/1.8 Hz, 1H, 8-<i>H</i>). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) = 23.3 (2C, <i>C</i>-3′, <i>C</i>-5′), 28.7 (1C, <i>C</i>-4<sub>isoquinoline</sub>), 34.6 (1C, <i>C</i>-4), 35.6 (1C, <i>C</i>-2′), 37.9 (1C, <i>C</i>-6′), 46.7 (1C, <i>C</i>-3<sub>isoquinoline</sub>), 50.5 (1C, <i>C</i>-1<sub>isoquinoline</sub>), 55.2 (1C, 3-OC<i>H</i><sub>3</sub>), 55.46 (1C, 6-OC<i>H</i><sub>3</sub> or 7-O<i>C</i>H<sub>3</sub>), 55.52 (1C, 6-OC<i>H</i><sub>3</sub> or 7-O<i>C</i>H<sub>3</sub>), 61.4 (1C, <i>C</i>-4′), 75.4 (1C, <i>C</i>-1), 95.7 (1C, <i>C</i>-3), 110.2 (1C, <i>C</i>-8<sub>isoquinoline</sub>), 111.7 (1C, <i>C</i>-5<sub>isoquinoline</sub>), 124.5 (1C, <i>C</i>-8), 126.0 (1C, <i>C</i>-8a<sub>isoquinoline</sub>), 126.2 (1C, <i>C</i>-6 or <i>C</i>-7), 126.3 (1C, <i>C</i>-6 or <i>C</i>-7), 126.6 (1C, <i>C</i>-4a<sub>isoquinline</sub>), 128.9 (1C, <i>C</i>-5), 131.3 (1C, <i>C</i>-4a), 141.5 (1C, <i>C</i>-8a), 146.8 (1C, <i>C</i>-6<sub>isoquinoline</sub> or <i>C</i>-7<sub>isoquinoline</sub>), 147.1 (1C, <i>C</i>-6<sub>isoquinoline</sub> or <i>C</i>-7<sub>isoquinoline</sub>). FT-IR (neat): ν [cm<sup>–1</sup>] = 2978, 2940, (C–H<sub>alkyl</sub>), 1516, 1466, 1450 (C═C<sub>arom</sub>). Purity (HPLC): 95.3%, <i>t</i><sub>R</sub> = 17.9 min. A sample was recrystallized from CH<sub>2</sub>Cl<sub>2</sub> to obtain crystals, which were suitable for X-ray crystal structure analysis.</div></div></div><div id="sec7_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31">7.2.4.  <i>trans</i>-4′-[(2,4-Dimethylbenzyl)amino]-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-3-ol (<b>10a</b>)</h4><div class="NLM_p last">A solution of acetal <b>6a</b> (254 mg, 0.69 mmol) and 0.2 M HCl (17 mL, 3.5 mmol, 5.0 equiv) in THF (20 mL) was stirred at rt for 3 d. 1 M NaOH (10 mL) was added, and the aqueous layer was extracted with Et<sub>2</sub>O (4 × 10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 2 cm, <i>l</i> = 20 cm, <i>V</i> = 10 mL, cyclohexane/ethyl acetate 80:20 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). Pale yellow solid, mp 142 °C, yield 173 mg (71%). C<sub>23</sub>H<sub>29</sub>NO<sub>2</sub> (351.5 g/mol). <i>R<sub>f</sub></i> = 0.11 (cyclohexane/ethyl acetate 80:20 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 352.2277 (calcd 352.2271 for C<sub>23</sub>H<sub>30</sub>NO<sub>2</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.60–1.74 (m, 3H, 2′-<i>H</i>, 3′-<i>H</i>, 5′-<i>H</i>), 1.74–1.81 (m, 1H, 6′-<i>H</i>), 1.94–2.15 (m, 3H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>), 2.25–2.40 (m, 1H, 2′-<i>H</i>), 2.32 (s, 1H, 4–C<i>H</i><sub>3</sub>), 2.41 (s, 3H, 2–C<i>H</i><sub>3</sub>), 2.85 (dd, <i>J</i> = 15.5/8.0 Hz, 1H, 4-<i>H</i>), 3.01 (dd, <i>J</i> = 15.5/3.0 Hz, 1H, 4-<i>H</i>), 3.03–3.07 (m, 1H, 4′-<i>H</i><sub>equ</sub>), 3.75 (s, 2H, ArC<i>H</i><sub>2</sub>NH), 5.28 (dd, <i>J</i> = 7.8/2.9 Hz, 1H, 3-<i>H</i>), 6.98–7.04 (m, 2H, 3-<i>H</i><sub>benzyl</sub>, 5-<i>H</i><sub>benzyl</sub>), 7.06–7.11 (m, 1H, 5-<i>H</i>), 7.13–7.26 (m, 4H, 6-<i>H,</i> 7-<i>H,</i> 8-<i>H</i>, 6-<i>H</i><sub>benzyl</sub>). Signals for the NH and OH protons are not observed in the spectrum. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 19.2 (1C, 2-<i>C</i>H<sub>3</sub>), 21.2 (1C, 4-<i>C</i>H<sub>3</sub>), 26.1 (1C, <i>C</i>-3′ or <i>C</i>-5′), 26.3 (1C, <i>C</i>-3′ or <i>C</i>-5′), 30.6 (1C, <i>C</i>-6′), 33.5 (1C, <i>C</i>-2′), 37.3 (1C, <i>C</i>-4), 49.9 (1C, Ar<i>C</i>H<sub>2</sub>NH), 51.4 (1C, <i>C</i>-4′), 77.9 (1C, <i>C</i>-1), 89.7 (1C, <i>C</i>-3), 125.2 (1C, <i>C</i>-8), 126.6 (1C, <i>C</i>-6 or <i>C</i>-7), 126.7 (2C, <i>C</i>-6 or <i>C</i>-7<sub>,</sub><i>C</i>-5<sub>benzyl</sub>), 129.1 (1C, <i>C</i>-6<sub>benzyl</sub>), 129.2 (1C, <i>C</i>-5), 131.2 (1C, <i>C</i>-4a), 131.3 (1C, <i>C</i>-3<sub>benzyl</sub>), 136.1 (1C, <i>C</i>-1<sub>benzyl</sub>), 136.7 (1C, <i>C</i>-2<sub>benzyl</sub>), 136.8 (1C, <i>C</i>-4<sub>benzyl</sub>), 142.5 (1C, <i>C</i>-8a). FT-IR (neat): ν [cm<sup>–1</sup>] = 3337 (N–H/O–H), 2924 (C–H<sub>alkyl</sub>), 1454, 1435 (C═C<sub>arom</sub>). Purity (HPLC): 98.6%, <i>t</i><sub>R</sub> = 19.5 min.</div></div><div id="sec7_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32">7.2.5.  <i>cis</i>-4′-[(2,4-Dimethylbenzyl)amino]-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-3-ol (<b>10b</b>)</h4><div class="NLM_p last">A solution of acetal <b>6b</b> (201 mg, 0.55 mmol) and 2 M HCl (3 mL, 6.0 mmol, 11 equiv) in THF (10 mL) was stirred at rt for 3 d. 1 M NaOH (10 mL) was added, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (4 × 10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 2 cm, <i>l</i> = 16 cm, <i>V</i> = 10 mL, cyclohexane/ethyl acetate 50:50 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). Colorless solid, mp 177 °C, yield 156 mg (80%). C<sub>23</sub>H<sub>29</sub>NO<sub>2</sub> (351.5 g/mol). <i>R<sub>f</sub></i> = 0.03 (cyclohexane/ethyl acetate 50:50 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 352.2254 (calcd 352.2271 for C<sub>23</sub>H<sub>30</sub>NO<sub>2</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.62 (td, <i>J</i> = 13.6/3.6 Hz, 1H, 2′-<i>H</i><sub>ax</sub>), 1.68–1.81 (m, 1H, 3′-<i>H</i>), 1.81–1.93 (m, 4H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>), 1.93–2.01 (m, 1H, 6′-<i>H</i>), 2.07 (dq, <i>J</i> = 13.9/3.0 Hz, 1H, 2′-<i>H</i><sub>equ</sub>), 2.30 (s, 3H, 4–C<i>H</i><sub>3</sub>), 2.34 (s, 3H, 2–C<i>H</i><sub>3</sub>), 2.69 (m, 1H, 4′-<i>H</i><sub><i>ax</i></sub>), 2.83 (dd, <i>J</i> = 15.6/7.7 Hz, 1H, 4-<i>H</i>), 2.97 (dd, <i>J</i> = 15.7/3.1 Hz, 1H, 4-<i>H</i>), 3.82 (s, 2H, ArC<i>H</i><sub>2</sub>NH), 5.26 (dd, <i>J</i> = 7.7/3.0 Hz, 1H, 3-<i>H</i>), 6.96–7.02 (m, 2H, 3-<i>H</i><sub>benzyl</sub>, 5-<i>H</i><sub>benzyl</sub>), 7.07–7.13 (m, 2H, 5-<i>H</i><sub>,</sub> 8-<i>H</i>), 7.14–7.23 (m, 3H, 6-<i>H</i>, 7-<i>H</i>, 6-<i>H</i><sub>benzyl</sub>). Signals for the NH and OH protons are not observed in the spectrum. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 19.1 (1C, 2-<i>C</i>H<sub>3</sub>), 21.1 (1C, 4-<i>C</i>H<sub>3</sub>), 28.7 (1C, <i>C</i>-3′), 28.8 (1C, <i>C</i>-5′), 35.6 (1C, <i>C</i>-6′), 36.9 (1C, <i>C</i>-4), 38.3 (1C, <i>C</i>-2′), 48.5 (1C, Ar<i>C</i>H<sub>2</sub>NH), 56.2 (1C, <i>C</i>-4′), 77.4 (1C, <i>C</i>-1), 89.5 (1C, <i>C</i>-3), 124.6 (1C, <i>C</i>-8), 126.6 (1C, <i>C</i>-6 or <i>C</i>-7), 126.7 (1C, <i>C</i>-5<sub>benzyl</sub>), 126.8 (1C, <i>C</i>-6 or <i>C</i>-7), 128.8 (1C, <i>C</i>-6<sub>benzyl</sub>), 129.4 (1C, <i>C</i>-5), 131.3 (1C, <i>C</i>-3<sub>benzyl</sub>), 131.7 (1C, <i>C</i>-4a), 135.3 (1C, <i>C</i>-1<sub>benzyl</sub>), 136.2 (1C, <i>C</i>-2<sub>benzyl</sub>), 136.8 (1C, <i>C</i>-4<sub>benzyl</sub>), 141.7 (1C, <i>C</i>-8a). FT-IR (neat): ν [cm<sup>–1</sup>] = 3256 (N–H), 2932 (C–H<sub>alkyl</sub>), 1454, 1366 (C═C<sub>arom</sub>). Purity (HPLC): 99.5%, <i>t</i><sub>R</sub> = 17.5 min.</div></div><div id="sec7_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33">7.2.6.  <i>trans</i>-4′-(4-Cyclohexylpiperazin-1-yl)-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-3-ol (<b>10c</b>)</h4><div class="NLM_p last">A solution of acetal <b>6c</b> (174 mg, 0.44 mmol) and 0.2 M HCl (11 mL, 2.2 mmol, 5 equiv) in THF (10 mL) was stirred at rt for 3 d. 1 M NaOH (5 mL) was added, and the aqueous layer was extracted with Et<sub>2</sub>O (4 × 10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 2 cm, <i>l</i> = 15 cm, <i>V</i> = 10 mL, cyclohexane/ethyl acetate 50:50 + 2% <i>N</i>,<i>N</i>-dimethylethanamine). Pale yellow solid, mp 214 °C, yield 145 mg (86%). C<sub>24</sub>H<sub>36</sub>N<sub>2</sub>O<sub>2</sub> (384.6 g/mol). <i>R<sub>f</sub></i> = 0.10 (cyclohexane/ethyl acetate 50:50 + 2% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 385.2885 (calcd 385.2850 for C<sub>24</sub>H<sub>37</sub>N<sub>2</sub>O<sub>2</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.07–1.19 (m, 1H, 4-<i>H</i><sub>cyclohexyl</sub>), 1.19–1.34 (m, 4H, 2-<i>H</i><sub>cyclohexyl</sub>, 3-<i>H</i><sub>cyclohexyl</sub>, 5-<i>H</i><sub>cyclohexyl</sub>, 6-<i>H</i><sub>cyclohexyl</sub>), 1.58 (dq, <i>J</i> = 13.7/3.5/3.0 Hz, 1H, 2′-<i>H</i><sub>equ</sub>), 1.62–1.67 (m, 1H, 4-<i>H</i><sub>cyclohexyl</sub>), 1.70 (dq, <i>J</i> = 13.4/3.0 Hz, 1H, 6′-<i>H</i><sub>equ</sub>), 1.78–1.91 (m, 5H, 3′-<i>H</i>, 5′-<i>H</i>, 2-<i>H</i><sub>cyclohexyl</sub>, 6-<i>H</i><sub>cyclohexyl</sub>), 1.91–2.04 (m, 4H, 3′-<i>H</i> or 5′-<i>H</i>, 6′-<i>H</i><sub>ax</sub>, 3-<i>H</i><sub>cyclohexyl</sub>, 5-<i>H</i><sub>cyclohexyl</sub>), 2.22 (td, <i>J</i> = 13.2/3.6 Hz, 1H, 2′-<i>H</i><sub>ax</sub>), 2.25–2.36 (m, 2H, 4′-<i>H</i><sub>equ</sub>, 1-<i>H</i><sub>cyclohexyl</sub>), 2.69 (broad signal, 7H, <i>H</i><sub>piperazine</sub>), 2.85 (dd, <i>J</i> = 15.5/7.8 Hz, 2H, 4-<i>H</i>, <i>H</i><sub>piperazine</sub>), 3.00 (dd, <i>J</i> = 15.5/2.9 Hz, 1H, 4-<i>H</i>), 5.28 (dd, <i>J</i> = 7.8/3.5 Hz, 1H, 3-<i>H</i>), 7.08 (d, <i>J</i> = 7.5 Hz, 1H, 5-<i>H</i>), 7.15–7.24 (m, 3H, 6-<i>H</i>, 7-<i>H</i>, 8-<i>H</i>). A signal for the OH proton is not observed in the spectrum. <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ (ppm) = 24.0 (1C, <i>C</i>-3′ or <i>C</i>-5′), 24.2 (1C, <i>C</i>-3′ or <i>C</i>-5′), 26.0 (2C, <i>C</i>-2<sub>cyclohexyl</sub>, <i>C</i>-6<sub>cyclohexyl</sub>), 26.4 (1C, <i>C</i>-4<sub>cyclohexyl</sub>), 29.2 (2C, <i>C</i>-3<sub>cyclohexyl</sub>, <i>C</i>-5<sub>cyclohexyl</sub>), 31.0 (1C, <i>C</i>-6′), 34.1 (1C, <i>C</i>-2′), 37.3 (1C, <i>C</i>-4), 49.9 (2C, <i>C</i>-2<sub>piperazine</sub> and <i>C</i>-6<sub>piperazine</sub> or <i>C</i>-3<sub>piperazine</sub> and <i>C</i>-5<sub>piperazine</sub>), 50.5 (2C, <i>C</i>-2<sub>piperazine</sub> and <i>C</i>-6<sub>piperazine</sub> or <i>C</i>-3<sub>piperazine</sub> and <i>C</i>-5<sub>piperazine</sub>), 57.5 (1C, <i>C</i>-4′), 63.8 (1C, <i>C</i>-1<sub>cyclohexyl</sub>), 78.0 (1C, <i>C</i>-1), 89.7 (1C, <i>C</i>-3), 125.2 (1C, <i>C</i>-8), 126.6 (2C, <i>C</i>-6, <i>C</i>-7), 129.2 (1C, <i>C</i>-5), 131.3 (1C, <i>C</i>-4a), 142.6 (1C, <i>C</i>-8a). FT-IR (neat): ν [cm<sup>–1</sup>] = 3325 (O–H), 2959, 2932, 2805 (C–H<sub>alkyl</sub>), 1454 (C═C<sub>arom</sub>). Purity (HPLC): 97.4%, <i>t</i><sub>R</sub> = 12.7 min.</div></div><div id="sec7_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34">7.2.7.  <i>cis</i>-4′-(4-Cyclohexylpiperazin-1-yl)-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-3-ol (<b>10d</b>)</h4><div class="NLM_p last">A solution of acetal <b>6d</b> (273 mg, 0.68 mmol) and 0.5 M HCl (7 mL, 3.5 mmol, 5 equiv) in THF (10 mL) was stirred at rt for 4 d. 1 M NaOH (8 mL) was added, and the aqueous layer was extracted with Et<sub>2</sub>O (4 × 8 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 3 cm, <i>l</i> = 18 cm, <i>V</i> = 20 mL, cyclohexane/ethyl acetate 50:50 + 2% <i>N</i>,<i>N</i>-dimethylethanamine). Colorless solid, mp 204 °C, yield 211 mg (81%). C<sub>24</sub>H<sub>36</sub>N<sub>2</sub>O<sub>2</sub> (384.6 g/mol). <i>R<sub>f</sub></i> = 0.03 (cyclohexane/ethyl acetate 50:50 + 2% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 385.2874 (calcd 385.2850 for C<sub>24</sub>H<sub>37</sub>N<sub>2</sub>O<sub>2</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.05–1.16 (m, 1H, 4-<i>H</i><sub>cyclohexyl</sub>), 1.17–1.34 (m, 4H, 2-<i>H</i><sub>cyclohexyl</sub>, 3-<i>H</i><sub>cyclohexyl</sub>, 5-<i>H</i><sub>cyclohexyl</sub>, 6-<i>H</i><sub>cyclohexyl</sub>), 1.58–1.67 (m, 2H, 2′-<i>H</i><sub>ax</sub>, 4-<i>H</i><sub>cyclohexyl</sub>), 1.75–1.86 (m, 5H, 3′-<i>H</i>, 5′-<i>H</i>, 2-<i>H</i><sub>cyclohexyl</sub>, 6-<i>H</i><sub>cyclohexyl</sub>), 1.86–1.97 (m, 4H, 5′-<i>H</i>, 6′-<i>H</i><sub>ax</sub>, 3-<i>H</i><sub>cyclohexyl</sub>, 5-<i>H</i><sub>cyclohexyl</sub>), 1.99 (dq, <i>J</i> = 9.6/3.0/2.6 Hz, 1H, 6′-<i>H</i><sub>equ</sub>), 2.11 (dq, <i>J</i> = 14.3/3.3 Hz, 1H, 2′-<i>H</i><sub>equ</sub>), 2.27 (broad signal, 1H, 1-<i>H</i><sub>cyclohexyl</sub>), 2.40–2.48 (m, 1H, 4′-<i>H</i><sub>ax</sub>), 2.58–2.81 (broad signal, 8H, <i>H</i><sub>piperazine</sub>), 2.85 (dd, <i>J</i> = 15.6/7.7 Hz, 1H, 4-<i>H</i>), 2.99 (dd, <i>J</i> = 15.6/2.9 Hz, 1H, 4-<i>H</i>), 5.29 (dd, <i>J</i> = 7.9/3.1 Hz, 1H, 3-<i>H</i>), 7.07–7.14 (m, 2H, 5-<i>H</i>, 8-<i>H</i>), 7.14–7.22 (m, 2H, 6-<i>H</i>, 7-<i>H</i>). A signal for the OH proton is not observed in the spectrum. <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ (ppm) = 24.0 (1C, <i>C</i>-5′), 24.2 (1C, <i>C</i>-3′), 26.0 (2C, <i>C</i>-2<sub>cyclohexyl</sub>, <i>C</i>-6<sub>cyclohexyl</sub>), 26.4 (1C, <i>C</i>-4<sub>cyclohexyl</sub>), 29.01 (1C, <i>C</i>-3<sub>cyclohexyl</sub> or <i>C</i>-5<sub>cyclohexyl</sub>), 29.03 (1C, <i>C</i>-3<sub>cyclohexyl</sub> or <i>C</i>-5<sub>cyclohexyl</sub>), 36.2 (1C, <i>C</i>-2′), 37.0 (1C, <i>C</i>-4), 38.9 (1C, <i>C</i>-6′), 49.4 (2C, <i>C</i>-2<sub>piperazine</sub> and <i>C</i>-6<sub>piperazine</sub> or <i>C</i>-3<sub>piperazine</sub> and <i>C</i>-5<sub>piperazine</sub>), 49.5 (2C, <i>C</i>-2<sub>piperazine</sub> and <i>C</i>-6<sub>piperazine</sub> or <i>C</i>-3<sub>piperazine</sub> and <i>C</i>-5<sub>piperazine</sub>), 63.1 (1C, <i>C</i>-4′), 63.8 (1C, <i>C</i>-1<sub>cyclohexyl</sub>), 76.8 (1C, <i>C</i>-1), 89.5 (1C, <i>C</i>-3), 124.7 (1C, <i>C</i>-8), 126.6 (1C, <i>C</i>-7), 126.8 (1C, <i>C</i>-6), 129.4 (1C, <i>C</i>-5), 131.6 (1C, <i>C</i>-4a), 141.5 (1C, <i>C</i>-8a). FT-IR (neat): ν [cm<sup>–1</sup>] = 3352 (O–H), 2928 (C–H<sub>alkyl</sub>), 1454 (C═C<sub>arom</sub>). Purity (HPLC): 97.7%, <i>t</i><sub>R</sub> = 12.7 min.</div></div><div id="sec7_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35">7.2.8.  <i>trans</i>-4′-(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)-3,4-dihydro-spiro[[2]benzopyran-1,1′-cyclohexan]-3-ol (<b>10e</b>)</h4><div class="NLM_p last">A solution of acetal <b>6e</b> (154 mg, 0.36 mmol) and 0.2 M HCl (9 mL, 1.8 mmol, 5 equiv) in THF (10 mL) was stirred at rt for 3 d. 1 M NaOH (5 mL) was added, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (4 × 10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 2 cm, <i>l</i> = 19 cm, <i>V</i> = 10 mL, cyclohexane/ethyl acetate 80:20 + 1% <i>N</i>,<i>N</i>-dimethylethanamine → cyclohexane/ethyl acetate 50:50 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). Colorless solid, mp 174 °C, yield 127 mg (86%). C<sub>25</sub>H<sub>31</sub>NO<sub>4</sub> (409.5 g/mol). <i>R<sub>f</sub></i> = 0.31 (cyclohexane/ethyl acetate 50:50 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 410.2294 (calcd 410.2326 for C<sub>25</sub>H<sub>32</sub>NO<sub>4</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) = 1.46 (dq, <i>J</i> = 12.9/2.9 Hz, 1H, 2′-<i>H</i><sub>equ</sub>), 1.72 (dq, <i>J</i> = 13.2/2.8 Hz, 1H, 6′-<i>H</i><sub>equ</sub>), 1.84–1.91 (m, 1H, 6′-<i>H</i><sub>ax</sub>), 1.91–1.99 (m, 4H, 3′-<i>H</i>, 5′-<i>H</i>), 2.17 (ddd, <i>J</i> = 12.9/10.6/6.4 Hz, 1H, 2′-<i>H</i><sub>ax</sub>), 2.36 (quint, <i>J</i> = 3.0 Hz, 1H, 4′-<i>H</i><sub>equ</sub>), 2.68 (dd, <i>J</i> = 15.7/8.2 Hz, 1H, 4-<i>H</i>), 2.71–2.76 (m, 2H, 3-<i>H</i><sub>isoquinoline</sub>), 2.76–2.80 (m, 2H, 4-<i>H</i><sub>isoquinoline</sub>), 2.82 (dd, <i>J</i> = 15.7/2.8 Hz, 1H, 4-<i>H</i>), 3.61 (s, 2H, 1-<i>H</i><sub>isoquinoline</sub>), 3.70 (s, 3H, 7-OC<i>H</i><sub>3</sub>), 3.73 (s, 3H, 6-OC<i>H</i><sub>3</sub>), 5.11 (ddd, <i>J</i> = 8.6/5.9/2.9 Hz, 1H, 3-<i>H</i>), 6.41 (d, <i>J</i> = 5.9 Hz, 1H, O<i>H</i>), 6.70 (s, 1H, 5-<i>H</i><sub>isoquinoline</sub>), 6.70 (s, 1H, 8-<i>H</i><sub>isoquinoline</sub>), 7.00 (dd, <i>J</i> = 7.5/1.6 Hz, 1H, 8-<i>H</i>), 7.06 (dd, <i>J</i> = 6.1/1.6 Hz, 1H, 5-<i>H</i>), 7.09–7.15 (m, 2H, 6-<i>H</i>, 7-<i>H</i>). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) = 23.8 (1C, <i>C</i>-3′), 23.9 (1C, <i>C</i>-5′), 28.7 (1C, <i>C</i>-4<sub>isoquinoline</sub>), 30.3 (1C, <i>C</i>-6′), 33.7 (1C, <i>C</i>-2′), 36.8 (1C, <i>C</i>-4), 47.0 (1C, <i>C</i>-3<sub>isoquinoline</sub>), 52.9 (1C, <i>C</i>-1<sub>isoquinoline</sub>), 55.4 (1C, 7-O<i>C</i>H<sub>3</sub>), 55.5 (1C, 6-O<i>C</i>H<sub>3</sub>), 56.6 (1C, <i>C</i>-4′), 76.3 (1C, <i>C</i>-1), 88.3 (1C, <i>C</i>-3), 110.3 (1C, C-8<sub>isoquinoline</sub>), 111.6 (1C, C-5<sub>isoquinoline</sub>), 124.5 (1C, <i>C</i>-8), 126.11 (1C, <i>C</i>-6), 126.14 (1C, <i>C</i>-7), 126.2 (1C, C-4a<sub>isoquinoline</sub>), 127.1 (1C, C-8a<sub>isoquinoline</sub>), 128.9 (1C, <i>C</i>-5), 132.1 (1C, <i>C</i>-4a), 142.5 (1C, <i>C</i>-8a), 146.9 (1C, C-7<sub>isoquinoline</sub>), 147.1 (1C, C-6<sub>isoquinoline</sub>). FT-IR (neat): ν [cm<sup>–1</sup>] = 3360 (O–H), 2928, 2882, 2808 (C–H<sub>alkyl</sub>), 1520, 1454 (C═C<sub>arom</sub>). Purity (HPLC): 95.4%, <i>t</i><sub>R</sub> = 15.2 min.</div></div><div id="sec7_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36">7.2.9.  <i>cis</i>-4′-(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)-3,4-dihydro-spiro[[2]benzopyran-1,1′-cyclohexan]-3-ol (<b>10f</b>)</h4><div class="NLM_p last">A solution of acetal <b>6f</b> (97 mg, 0.23 mmol) and 0.2 M HCl (6 mL, 1.2 mmol, 5.2 equiv) in THF (10 mL) was stirred at rt for 3 d. 1 M NaOH (5 mL) was added, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (4 × 10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 2 cm, <i>l</i> = 19 cm, <i>V</i> = 10 mL, cyclohexane/ethyl acetate 50:50 + 1% <i>N</i>,<i>N</i>-dimethylethanamine → ethyl acetate + 1% <i>N</i>,<i>N</i>-dimethylethanamine). Pale yellow solid, mp 202 °C, yield 69 mg (74%). C<sub>25</sub>H<sub>31</sub>NO<sub>4</sub> (409.5 g/mol). <i>R<sub>f</sub></i> = 0.06 (cyclohexane/ethyl acetate 50:50 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 410.2278 (calcd 410.2326 for C<sub>25</sub>H<sub>32</sub>NO<sub>4</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) = 1.59 (td, <i>J</i> = 13.6/3.8 Hz, 1H, 2′-<i>H</i><sub>ax</sub>), 1.61–1.68 (m, 2H, 3′-<i>H</i>, 5′-<i>H</i>), 1.74–1.78 (m, 1H, 6′-<i>H</i>), 1.80–1.94 (m, 3H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>), 2.02 (dq, <i>J</i> = 13.7/3.2 Hz, 1H, 2′-<i>H</i><sub>equ</sub>), 2.58–2.64 (m, 1H, 4′-<i>H</i><sub>ax</sub>), 2.64–2.70 (m, 3H, 4-<i>H</i>, 4-<i>H</i><sub>isoquinoline</sub>), 2.75 (t, <i>J</i> = 5.8 Hz, 2H, 3-<i>H</i><sub>isoquinoline</sub>), 2.81 (dd, <i>J</i> = 15.8/2.9 Hz, 1H, 4-<i>H</i>), 3.64 (s, 2H, 1-<i>H</i><sub>isoquinoline</sub>), 3.68 (s, 6H, 6-OC<i>H</i><sub>3</sub>, 7-OC<i>H</i><sub>3</sub>), 5.09 (ddd, <i>J</i> = 8.6/5.9/2.9 Hz, 1H, 3-<i>H</i>), 6.41 (d, <i>J</i> = 5.9 Hz, 1H, O<i>H</i>), 6.62 (s, 2H, 5-<i>H</i><sub>isoquinoline</sub>, 8-<i>H</i><sub>isoquinoline</sub>), 7.05 (dd, <i>J</i> = 7.5/1.5 Hz, 1H, 5-<i>H</i>), 7.11 (td, <i>J</i> = 7.3/1.5 Hz, 1H, 6-<i>H</i>), 7.14 (td, <i>J</i> = 7.5/1.7 Hz, 1H, 7-<i>H</i>), 7.20 (dd, <i>J</i> = 7.7/1.5 Hz, 1H, 8-<i>H</i>). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) = 23.2 (1C, <i>C</i>-3′ or <i>C</i>-5′), 23.3 (1C, <i>C</i>-3′ or <i>C</i>-5′), 29.1 (1C, C-4<sub>isoquinoline</sub>), 35.2 (1C, <i>C</i>-2′), 36.7 (1C, <i>C</i>-4), 38.3 (1C, <i>C</i>-6′), 46.9 (1C, C-3<sub>isoquinoline</sub>), 50.7 (1C, C-1<sub>isoquinoline</sub>), 55.48 (1C, 6-O<i>C</i>H<sub>3</sub> or 7-O<i>C</i>H<sub>3</sub>), 55.52 (1C, 6-O<i>C</i>H<sub>3</sub> or 7-O<i>C</i>H<sub>3</sub>), 61.6 (1C, <i>C</i>-4′), 75.6 (1C, <i>C</i>-1), 88.2 (1C, <i>C</i>-3), 110.2 (1C, C-8<sub>isoquinoline</sub>), 111.8 (1C, C-5<sub>isoquinoline</sub>), 124.6 (1C, <i>C</i>-8), 126.1 (1C, <i>C</i>-7), 126.2 (1C, <i>C</i>-6), 126.3 (1C, C-4a<sub>isoquinoline</sub>), 127.4 (1C, C-8a<sub>isoquinoline</sub>), 129.0 (1C, <i>C</i>-5), 132.2 (1C, <i>C</i>-4a), 142.0 (1C, <i>C</i>-8a), 146.8 (1C, <i>C</i>-6<sub>isoquinoline</sub> or <i>C</i>-7<sub>isoquinoline</sub>), 147.0 (1C, <i>C</i>-6<sub>isoquinoline</sub> or <i>C</i>-7<sub>isoquinoline</sub>). FT-IR (neat): ν [cm<sup>–1</sup>] = 3102 (O–H), 2931, 2939 (C–H<sub>alkyl</sub>), 1516, 1466 (C═C<sub>arom</sub>). Purity (HPLC): 97.9%, <i>t</i><sub>R</sub> = 15.7 min.</div></div><div id="sec7_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37">7.2.10.  Ethyl <i>trans</i>-2-{4′-[(2,4-Dimethylbenzyl)amino]-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-3-yl}acetate (<b>11a</b>)</h4><div class="NLM_p last">A solution of lactol <b>10a</b> (154 mg, 0.44 mmol) and (ethoxycarbonylmethylene)triphenylphosphorane (308 mg, 0.89 mmol, 2.0 equiv) in toluene (25 mL) was heated to reflux under N<sub>2</sub> atmosphere for 5 d. After cooling to rt, the mixture was concentrated in vacuo and the residue was purified by fc (<i>d</i> = 3 cm, <i>l</i> = 20 cm, <i>V</i> = 20 mL, cyclohexane/ethyl acetate 95:5 + 2% <i>N</i>,<i>N</i>-dimethylethanamine). Yellow oil, yield 72 mg (39%). C<sub>27</sub>H<sub>35</sub>NO<sub>3</sub> (421.6 g/mol). <i>R<sub>f</sub></i> = 0.14 (cyclohexane/ethyl acetate 90:10 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 422.2688 (calcd 422.2690 for C<sub>27</sub>H<sub>36</sub>NO<sub>3</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.30 (t, <i>J</i> = 7.1 Hz, 3H, OCH<sub>2</sub>C<i>H</i><sub>3</sub>), 1.45–1.52 (m, 1H, 2′-<i>H</i>), 1.55–1.70 (m, 2H, 3′-<i>H,</i> 5′-<i>H</i>), 1.81–1.92 (m, 2H, 5′-<i>H,</i> 6′-<i>H</i>), 1.94–2.05 (m, 2H, 3′-<i>H,</i> 6′-<i>H</i>), 2.28–2.38 (m, 1H, 2′-<i>H</i>), 2.32 (s, 3H, 4–C<i>H</i><sub>3</sub>), 2.41 (s, 3H, 2–C<i>H</i><sub>3</sub>), 2.56–2.68 (m, 2H, C<i>H</i><sub>2</sub>CO<sub>2</sub>Et), 2.68–2.80 (m, 2H, 4-<i>H</i>), 2.96–3.00 (m, 1H, 4′-<i>H</i><sub>equ</sub>), 3.74 (s, 2H, ArC<i>H</i><sub>2</sub>NH), 4.11–4.29 (m, 3H, 3-<i>H</i>, OC<i>H</i><sub>2</sub>CH<sub>3</sub>), 6.98–7.06 (m, 3H, 5-<i>H</i><sub>,</sub> 3-<i>H</i><sub>benzyl,</sub> 5-<i>H</i><sub>benzyl</sub>), 7.09–7.15 (m, 1H, 6-<i>H</i>), 7.15–7.21 (m, 2H, 7-<i>H</i><sub>,</sub> 8-<i>H</i>), 7.21–7.26 (m, 1H, 6–C<i>H</i><sub>benzyl</sub>). A signal for the NH proton is not observed in the spectrum. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 14.4 (1C, OCH<sub>2</sub><i>C</i>H<sub>3</sub>), 19.2 (1C, 2-<i>C</i>H<sub>3</sub>), 21.1 (1C, 4-<i>C</i>H<sub>3</sub>), 26.0 (2C, <i>C</i>-3′, <i>C</i>-5′), 29.3 (1C, <i>C</i>-6′), 33.5 (1C, <i>C</i>-2′), 35.3 (1C, <i>C</i>-4), 41.8 (1C, <i>C</i>H<sub>2</sub>CO<sub>2</sub>Et), 49.9 (1C, Ar<i>C</i>H<sub>2</sub>NH), 51.5 (1C, <i>C</i>-4′), 60.7 (1C, O<i>C</i>H<sub>2</sub>CH<sub>3</sub>), 65.3 (1C, <i>C</i>-3), 76.4 (1C, <i>C</i>-1), 125.6 (1C, <i>C</i>-8), 126.1 (1C, <i>C</i>-6), 126.4 (1C, <i>C</i>-7), 126.7 (1C, <i>C</i>-5<sub>benzyl</sub>), 128.7 (1C, <i>C</i>-5), 129.1 (1C, <i>C</i>-6<sub>benzyl</sub>), 131.3 (1C, <i>C</i>-3<sub>benzyl</sub>), 132.9 (1C, <i>C</i>-4a), 136.3 (1C, <i>C</i>-1<sub>benzyl</sub>), 136.7 (1C, <i>C</i>-2<sub>benzyl</sub>), 136.8 (1C, <i>C</i>-4<sub>benzyl</sub>), 143.1 (1C, <i>C</i>-8a), 171.7 (1C, <i>C</i>═O). FT-IR (neat): ν [cm<sup>–1</sup>] = 3063 (N–H), 2955, 2924 (C–H<sub>alkyl</sub>), 1732 (C═O), 1450, 1369 (C═C<sub>arom</sub>). Purity (HPLC): 98.1%, <i>t</i><sub>R</sub> = 21.8 min.</div></div><div id="sec7_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38">7.2.11.  Ethyl <i>cis</i>-2-{4′-[(2,4-Dimethylbenzyl)amino]-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-3-yl}acetate (<b>11b</b>)</h4><div class="NLM_p last">A solution of lactol <b>10b</b> (164 mg, 0.47 mmol) and (ethoxycarbonylmethylene)triphenylphosphorane (330 mg, 0.95 mmol, 2.0 equiv) in toluene (30 mL) was heated to reflux under N<sub>2</sub> atmosphere for 3 d. After cooling to rt, the mixture was concentrated in vacuo and the residue was purified by fc (<i>d</i> = 3 cm, <i>l</i> = 20 cm, <i>V</i> = 20 mL, cyclohexane/ethyl acetate 80:20 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). Yellow oil, yield 156 mg (79%). C<sub>27</sub>H<sub>35</sub>NO<sub>3</sub> (421.6 g/mol). <i>R<sub>f</sub></i> = 0.18 (cyclohexane/ethyl acetate 80:20 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 422.2690 (calcd 422.2690 for C<sub>27</sub>H<sub>36</sub>NO<sub>3</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.29 (t, <i>J</i> = 7.1 Hz, 3H, OCH<sub>2</sub>C<i>H</i><sub>3</sub>), 1.54–1.60 (m, 2H, 2′-<i>H</i>, 3′-<i>H</i>), 1.66–1.75 (m, 1H, 5′-<i>H</i>), 1.77–1.93 (m, 4H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>), 2.21 (dt, <i>J</i> = 10.7/2.9 Hz, 1H, 2′-<i>H</i>), 2.30 (s, 3H, 4–C<i>H</i><sub>3</sub>), 2.34 (s, 3H, 2–C<i>H</i><sub>3</sub>), 2.58 (dd, <i>J</i> = 15.0/5.0 Hz, 1H, C<i>H</i><sub>2</sub>CO<sub>2</sub>Et), 2.63–2.80 (m, 4H, 4-<i>H</i>, 4′-<i>H</i><sub>ax</sub>, C<i>H</i><sub>2</sub>CO<sub>2</sub>Et), 3.80 (s, 2H, ArC<i>H</i><sub>2</sub>NH), 4.14–4.27 (m, 3H, 3-<i>H</i>, OC<i>H</i><sub>2</sub>CH<sub>3</sub>), 6.97–7.00 (m, 2H, 3-<i>H</i><sub>benzyl</sub>, 5-<i>H</i><sub>benzyl</sub>), 7.06 (dd, <i>J</i> = 7.5/1.3 Hz, 1H, 5-<i>H</i>), 7.09 (dd, <i>J</i> = 7.7/1.4 Hz, 1H, 8-<i>H</i>), 7.13 (td, <i>J</i> = 7.4/1.4 Hz, 1H, 6-<i>H</i>), 7.16–7.20 (m, 1H, 7-<i>H</i>), 7.21 (d, <i>J</i> = 7.9 Hz, 1H, 6-<i>H</i><sub>benzyl</sub>). A signal for the NH proton is not observed in the spectrum. <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ (ppm) = 14.4 (1C, OCH<sub>2</sub><i>C</i>H<sub>3</sub>), 19.1 (1C, 2-<i>C</i>H<sub>3</sub>), 21.1 (1C, 4-<i>C</i>H<sub>3</sub>), 28.6 (2C, <i>C</i>-3′, <i>C</i>-5′), 34.3 (1C, <i>C</i>-2′), 35.2 (1C, <i>C</i>-4), 38.5 (1C, <i>C</i>-6′), 41.6 (1C, <i>C</i>H<sub>2</sub>CO<sub>2</sub>Et), 48.4 (1C, Ar<i>C</i>H<sub>2</sub>NH), 56.4 (1C, <i>C</i>-4′), 60.8 (1C, O<i>C</i>H<sub>2</sub>CH<sub>3</sub>), 65.3 (1C, <i>C</i>-3), 75.7 (1C, <i>C</i>-1), 125.1 (1C, <i>C</i>-8), 126.2 (1C, <i>C</i>-6), 126.3 (1C, <i>C</i>-7), 126.7 (1C, <i>C</i>-5<sub>benzyl</sub>), 128.7 (1C, <i>C</i>-6<sub>benzyl</sub>), 128.9 (1C, <i>C</i>-5), 131.3 (1C, <i>C</i>-3<sub>benzyl</sub>), 133.3 (1C, <i>C</i>-4a), 135.6 (1C, <i>C</i>-1<sub>benzyl</sub>), 136.3 (1C, <i>C</i>-2<sub>benzyl</sub>), 136.6 (1C, <i>C</i>-4<sub>benzyl</sub>), 142.3 (1C, <i>C</i>-8a), 171.6 (1C, <i>C</i>═O). FT-IR (neat): ν [cm<sup>–1</sup>] = 3063 (N–H), 2924 (C–H<sub>alkyl</sub>), 1732 (C═O), 1447, 1373 (C═C<sub>arom</sub>). Purity (HPLC): 95.2%, <i>t</i><sub>R</sub> = 21.8 min.</div></div><div id="sec7_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39">7.2.12.  Ethyl <i>trans</i>-2-{4′-(4-Cyclohexylpiperazin-1-yl)-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-3-yl}acetate (<b>11c</b>)</h4><div class="NLM_p last">A solution of lactol <b>10c</b> (120 mg, 0.31 mmol) and (ethoxycarbonylmethylene)triphenylphosphorane (216 mg, 0.62 mmol, 2.0 equiv) in toluene (10 mL) was heated to reflux under N<sub>2</sub> atmosphere for 5 d. After cooling to rt, the mixture was concentrated in vacuo and the residue was purified by fc (<i>d</i> = 2.5 cm, <i>l</i> = 20 cm, <i>V</i> = 10 mL, cyclohexane/ethyl acetate 80:20 + 2% <i>N</i>,<i>N</i>-dimethylethanamine). Yellow solid, mp 135 °C, yield 73 mg (52%). C<sub>28</sub>H<sub>42</sub>N<sub>2</sub>O<sub>3</sub> (454.7 g/mol). <i>R<sub>f</sub></i> = 0.18 (cyclohexane/ethyl acetate 80:20 + 2% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 455.3303 (calcd 455.3268 for C<sub>28</sub>H<sub>43</sub>N<sub>2</sub>O<sub>3</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.07–1.19 (m, 1H, 4-<i>H</i><sub>cyclohexyl</sub>), 1.19–1.34 (m, 7H, OCH<sub>2</sub>C<i>H</i><sub>3</sub>, 2-<i>H</i><sub>cyclohexyl</sub>, 3-<i>H</i><sub>cyclohexyl</sub>, 5-<i>H</i><sub>cyclohexyl</sub>, 6-<i>H</i><sub>cyclohexyl</sub>), 1.38–1.45 (m, 1H, 2′-<i>H</i>), 1.60–1.69 (m, 1H, 4-<i>H</i><sub>cyclohexyl</sub>), 1.70–1.93 (m, 8H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>, 2-<i>H</i><sub>cyclohexyl</sub>, 6-<i>H</i><sub>cyclohexyl</sub>), 1.93–2.04 (m, 2H, 3-<i>H</i><sub>cyclohexyl</sub>, 5-<i>H</i><sub>cyclohexyl</sub>), 2.16–2.23 (m, 2H, 2′-<i>H</i>, 4′-<i>H</i><sub>eq</sub>), 2.23–2.33 (m, 1H, 1-<i>H</i><sub>cyclohexyl</sub>), 2.47–2.79 (m, 12H, 4-<i>H</i>, C<i>H</i><sub>2</sub>CO<sub>2</sub>Et, H<sub>piperazine</sub>), 4.09–4.28 (m, 3H, 3-<i>H</i>, OC<i>H</i><sub>2</sub>CH<sub>3</sub>), 7.04 (d, <i>J</i> = 7.3 Hz, 1H, 5-<i>H</i>), 7.09–7.15 (m, 1H, 6-<i>H</i>), 7.15–7.23 (m, 2H, 7-<i>H</i>, 8-<i>H</i>). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 14.4 (1C, OCH<sub>2</sub><i>C</i>H<sub>3</sub>), 23.86 (1C, <i>C</i>-3′), 23.91 (1C, <i>C</i>-5′), 26.0 (2C, <i>C</i>-2<sub>cyclohexyl</sub>, <i>C</i>-6<sub>cyclohexyl</sub>), 26.4 (1C, <i>C</i>-4<sub>cyclohexyl</sub>), 29.2 (2C, <i>C</i>-3<sub>cyclohexyl</sub>, <i>C</i>-5<sub>cyclohexyl</sub>), 29.6 (1C, <i>C</i>-6′), 34.0 (1C, <i>C</i>-2′), 35.3 (1C, <i>C</i>H<sub>2</sub>CO<sub>2</sub>Et), 41.7 (1C, <i>C</i>-4), 49.9 (2C, <i>C</i>-2<sub>piperazine</sub> and <i>C</i>-6<sub>piperazine</sub> or <i>C</i>-3<sub>piperazine</sub> and <i>C</i>-5<sub>piperazine</sub>), 50.5 (2C, <i>C</i>-2<sub>piperazine</sub> and <i>C</i>-6<sub>piperazine</sub> or <i>C</i>-3<sub>piperazine</sub> and <i>C</i>-5<sub>piperazine</sub>), 57.5 (1C, <i>C</i>-4′), 60.7 (1C, O<i>C</i>H<sub>2</sub>CH<sub>3</sub>), 63.8 (1C, <i>C</i>-1<sub>cyclohexyl</sub>), 65.4 (1C, <i>C</i>-3), 76.5 (1C, <i>C</i>-1), 125.6 (1C, <i>C</i>-8), 126.1 (1C, <i>C</i>-6), 126.3 (1C, <i>C</i>-7), 128.7 (1C, <i>C</i>-5), 133.0 (1C, <i>C</i>-4a), 143.2 (1C, <i>C</i>-8a), 171.7 (1C, <i>C</i>═O). FT-IR (neat): ν [cm<sup>–1</sup>] = 2928, 2805 (C–H<sub>alkyl</sub>), 1736 (C═O), 1450 (C═C<sub>arom</sub>). Purity (HPLC): 97.5%, <i>t</i><sub>R</sub> = 16.8 min.</div></div><div id="sec7_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40">7.2.13.  Ethyl <i>cis</i>-2-{4′-(4-Cyclohexylpiperazin-1-yl)-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-3-yl}acetate (<b>11d</b>)</h4><div class="NLM_p last">A solution of lactol <b>10d</b> (174 mg, 0.45 mmol) and (ethoxycarbonylmethylene)triphenylphosphorane (326 mg, 0.94 mmol, 2.1 equiv) in toluene (20 mL) was heated to reflux under N<sub>2</sub> atmosphere for 4 d. After cooling to rt, the mixture was concentrated in vacuo and the residue was purified twice by fc (<i>d</i> = 3 cm, <i>l</i> = 20 cm, <i>V</i> = 10 mL, cyclohexane/ethyl acetate 66:33 + 2% <i>N</i>,<i>N</i>-dimethylethanamine; <i>d</i> = 2 cm, <i>l</i> = 21 cm, <i>V</i> = 10 mL, cyclohexane/ethyl acetate 80:20 + 2% <i>N</i>,<i>N</i>-dimethylethanamine). Yellow solid, mp 117 °C, yield 182 mg (89%). C<sub>28</sub>H<sub>42</sub>N<sub>2</sub>O<sub>3</sub> (454.7 g/mol). <i>R<sub>f</sub></i> = 0.17 (cyclohexane/ethyl acetate 66:33 + 2% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 455.3256 (calcd 455.3268 for C<sub>28</sub>H<sub>43</sub>N<sub>2</sub>O<sub>3</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.05–1.15 (m, 1H, 4-<i>H</i><sub>cyclohexyl</sub>), 1.16–1.26 (m, 4H, 2-<i>H</i><sub>cyclohexyl</sub>, 3-<i>H</i><sub>cyclohexyl</sub>, 5-<i>H</i><sub>cyclohexyl</sub>, 6-<i>H</i><sub>cyclohexyl</sub>), 1.28 (t, <i>J</i> = 7.2 Hz, 3H, OCH<sub>2</sub>C<i>H</i><sub>3</sub>), 1.51–1.58 (m, 1H, 2′-<i>H</i>), 1.59–1.65 (m, 1H, 4-<i>H</i><sub>cyclohexyl</sub>), 1.65–1.75 (m, 3H, 3′-<i>H</i>, 5′-<i>H</i>), 1.75–1.88 (m, 5H, 5′-<i>H</i>, 6′-<i>H</i>, 2-<i>H</i><sub>cyclohexyl</sub>, 6-<i>H</i><sub>cyclohexyl</sub>), 1.88–1.95 (m, 2H, 3-<i>H</i><sub>cyclohexyl</sub>, 5-<i>H</i><sub>cyclohexyl</sub>), 2.20–2.28 (m, 2H, 2′-<i>H</i>, 1-<i>H</i><sub>cyclohexyl</sub>), 2.38–2.47 (m, 1H, 4′-<i>H</i><sub>ax</sub>), 2.57 (dd, <i>J</i> = 15.0/4.7 Hz, 1H, C<i>H</i><sub>2</sub>CO<sub>2</sub>Et), 2.60–2.70 (m, 9H, C<i>H</i><sub>2</sub>CO<sub>2</sub>Et, <i>H</i><sub>piperazine</sub>), 2.70–2.77 (m, 2H, 4-<i>H</i>), 4.12–4.25 (m, 3H, 3-<i>H</i>, OC<i>H</i><sub>2</sub>CH<sub>3</sub>), 7.05 (d, <i>J</i> = 7.5 Hz, 1H, 5-<i>H</i>), 7.09 (d, <i>J</i> = 7.7 Hz, 1H, 8-<i>H</i>), 7.12 (td, <i>J</i> = 7.4/1.4 Hz, 1H, 6-<i>H</i>), 7.17 (t, <i>J</i> = 7.7 Hz, 1H, 7-<i>H</i>). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ (ppm) = 14.4 (1C, OCH<sub>2</sub><i>C</i>H<sub>3</sub>), 23.7 (1C, <i>C</i>-5′), 23.8 (1C, <i>C</i>-3′), 26.1 (2C, <i>C</i>-2<sub>cyclohexyl</sub>, <i>C</i>-6<sub>cyclohexyl</sub>), 26.4 (1C, <i>C</i>-4<sub>cyclohexyl</sub>), 29.1 (2C, <i>C</i>-3<sub>cyclohexyl</sub>, <i>C</i>-5<sub>cyclohexyl</sub>), 34.9 (1C, <i>C</i>-2′), 35.2 (1C, <i>C</i>-4), 39.1 (1C, <i>C</i>-6′), 41.6 (1C, <i>C</i>H<sub>2</sub>CO<sub>2</sub>Et), 49.4 (2C, <i>C</i>-2<sub>piperazine</sub> and <i>C</i>-6<sub>piperazine</sub> or <i>C</i>-3<sub>piperazine</sub> and <i>C</i>-5<sub>piperazine</sub>), 49.5 (2C, <i>C</i>-2<sub>piperazine</sub> and <i>C</i>-6<sub>piperazine</sub> or <i>C</i>-3<sub>piperazine</sub> and <i>C</i>-5<sub>piperazine</sub>), 60.7 (1C, O<i>C</i>H<sub>2</sub>CH<sub>3</sub>), 63.2 (1C, <i>C</i>-4′), 63.8 (1C, <i>C</i>-1<sub>cyclohexyl</sub>), 65.3 (1C, <i>C</i>-3), 75.6 (1C, <i>C</i>-1), 125.1 (1C, <i>C</i>-8), 126.2 (1C, <i>C</i>-6), 126.3 (1C, <i>C</i>-7), 128.9 (1C, <i>C</i>-5), 133.2 (1C, <i>C</i>-4a), 142.2 (1C, <i>C</i>-8a), 171.5 (1C, C = O). FT-IR (neat): ν [cm<sup>–1</sup>] = 2978, 2928, 2855 (C–H<sub>alkyl</sub>), 1728 (C = O), 1450 (C═C<sub>arom</sub>). Purity (HPLC): 97.2%, <i>t</i><sub>R</sub> = 16.4 min.</div></div><div id="sec7_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41">7.2.14.  Ethyl <i>trans</i>-2-{4′-(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-3-yl}acetate (<b>11e</b>)</h4><div class="NLM_p last">A solution of lactol <b>10e</b> (160 mg, 0.39 mmol) and (ethoxycarbonylmethylene)triphenylphosphorane (272 mg, 0.78 mmol, 2.0 equiv) in toluene (12 mL) was heated to reflux under N<sub>2</sub> atmosphere for 4 d. After cooling to rt, the mixture was concentrated in vacuo and the residue was purified by fc (<i>d</i> = 3 cm, <i>l</i> = 19 cm, <i>V</i> = 20 mL, cyclohexane/ethyl acetate 90:10 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). Yellow oil, yield 175 mg (94%). C<sub>29</sub>H<sub>37</sub>NO<sub>5</sub> (479.6 g/mol). <i>R<sub>f</sub></i> = 0.31 (cyclohexane/ethyl acetate 80:20 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 480.2755 (calcd 480.2744 for C<sub>29</sub>H<sub>38</sub>NO<sub>5</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.31 (t, <i>J</i> = 7.2 Hz, 3H, OCH<sub>2</sub>C<i>H</i><sub>3</sub>), 1.43–1.51 (m, 1H, 2′-<i>H</i>), 1.76–2.04 (m, 6H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>), 2.30 (dt, <i>J</i> = 14.0/8.7 Hz, 1H, 2′-<i>H</i>), 2.36–2.41 (m, 1H, 4′-<i>H</i><sub>equ</sub>), 2.56–2.68 (m, 2H, C<i>H</i><sub>2</sub>CO<sub>2</sub>Et), 2.69–2.76 (m, 2H, 4-<i>H</i>), 2.76–2.81 (m, 2H, 3-<i>H</i><sub>isoquinoline</sub>), 2.82–2.90 (m, 2H, 4-H<sub>isoquinoline</sub>), 3.66 (s, 2H, 1-H<sub>isoquinoline</sub>), 3.86 (s, 3H, 7-OC<i>H</i><sub>3</sub>), 3.88 (s, 3H, 6-OC<i>H</i><sub>3</sub>), 4.11–4.23 (m, 2H, OC<i>H</i><sub>2</sub>CH<sub>3</sub>), 4.23–4.31 (m, 1H, 3-<i>H</i>), 6.59 (s, 1H, 8-<i>H</i><sub>isoquinoline</sub>), 6.65 (s, 1H, 5-<i>H</i><sub>isoquinoline</sub>), 7.03 (d, <i>J</i> = 6.7 Hz, 1H, 5-<i>H</i>), 7.07–7.17 (m, 3H, 6-<i>H</i>, 7-<i>H</i>, 8-<i>H</i>). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 14.5 (1C, OCH<sub>2</sub><i>C</i>H<sub>3</sub>), 24.3 (2C, <i>C</i>-3′, <i>C</i>-5′), 29.4 (1C, <i>C</i>-4<sub>isoquinoline</sub>), 29.6 (1C, <i>C</i>-6′), 34.0 (1C, <i>C</i>-2′), 35.3 (1C, <i>C</i>-4), 41.8 (1C, <i>C</i>H<sub>2</sub>CO<sub>2</sub>Et), 47.5 (1C, <i>C</i>-3<sub>isoquinoline</sub>), 53.5 (1C, <i>C</i>-1<sub>isoquinoline</sub>), 56.1 (2C, 6-O<i>C</i>H<sub>3</sub>, 7-O<i>C</i>H<sub>3</sub>), 57.2 (1C, <i>C</i>-4′), 60.7 (1C, O<i>C</i>H<sub>2</sub>CH<sub>3</sub>), 65.4 (1C, <i>C</i>-3), 76.6 (1C, <i>C</i>-1), 109.9 (1C, <i>C</i>-8<sub>isoquinoline</sub>), 111.3 (1C, <i>C</i>-5<sub>isoquinoline</sub>), 125.8 (1C, <i>C</i>-6 or <i>C</i>-8), 126.1 (1C, <i>C</i>-6 or <i>C</i>-8), 126.3 (1C, <i>C</i>-7), 127.1 (1C, <i>C</i>-4a<sub>isoquinoline</sub>), 127.8 (1C, <i>C</i>-8a<sub>isoquinoline</sub>), 128.6 (1C, <i>C</i>-5), 132.9 (1C, <i>C</i>-4a), 143.0 (1C, <i>C</i>-8a), 147.4 (1C, <i>C</i>-7<sub>isoquinoline</sub>), 147.5 (1C, <i>C</i>-6<sub>isoquinoline</sub>), 171.7 (1C, <i>C</i>═O). FT-IR (neat): ν [cm<sup>–1</sup>] = 2967, 2920 (C–H<sub>alkyl</sub>), 1736 (C═O), 1520, 1454 (C═C<sub>arom</sub>). Purity (HPLC): 98.4%, <i>t</i><sub>R</sub> = 20.0 min.</div></div><div id="sec7_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42">7.2.15.  Ethyl <i>cis</i>-2-{4′-(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-3-yl}acetate (<b>11f</b>)</h4><div class="NLM_p last">A solution of lactol <b>10f</b> (175 mg, 0.43 mmol) and (ethoxycarbonylmethylene)triphenylphosphorane (305 mg, 0.88 mmol, 2.1 equiv) in toluene (12 mL) was heated to reflux under N<sub>2</sub> atmosphere for 5 d. After cooling to rt, the mixture was concentrated in vacuo and the residue was purified by fc (<i>d</i> = 3 cm, <i>l</i> = 19 cm, <i>V</i> = 20 mL, cyclohexane/ethyl acetate 80:20 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). Yellow oil, yield 157 mg (77%). C<sub>29</sub>H<sub>37</sub>NO<sub>5</sub> (479.6 g/mol). <i>R<sub>f</sub></i> = 0.09 (cyclohexane/ethyl acetate 80:20 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 480.2752 (calcd 480.2744 for C<sub>29</sub>H<sub>38</sub>NO<sub>5</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.31 (t, <i>J</i> = 7.1 Hz, 3H, OCH<sub>2</sub>C<i>H</i><sub>3</sub>), 1.55–1.65 (m, 1H, 2′-<i>H</i><sub>ax</sub>), 1.73–1.99 (m, 6H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>), 2.28 (dq, <i>J</i> = 14.2/3.1 Hz, 1H, 2′-<i>H</i><sub>equ</sub>), 2.61 (dd, <i>J</i> = 15.1/4.6 Hz, 1H, C<i>H</i><sub>2</sub>CO<sub>2</sub>Et), 2.65–2.79 (m, 4H, 4-<i>H</i>, 4′-<i>H</i><sub>ax</sub>, C<i>H</i><sub>2</sub>CO<sub>2</sub>Et), 2.79–2.92 (m, 4H, 3-<i>H</i><sub>isoquinoline</sub>, 4-<i>H</i><sub>isoquinoline</sub>), 3.77 (s, 2H, 1-<i>H</i><sub>isoquinoline</sub>), 3.84 (s, 3H, 6-OC<i>H</i><sub>3</sub> or 7-OC<i>H</i><sub>3</sub>), 3.84 (s, 3H, 6-OC<i>H</i><sub>3</sub> or 7-OC<i>H</i><sub>3</sub>), 4.16–4.23 (m, 2H, OC<i>H</i><sub>2</sub>CH<sub>3</sub>), 4.23–4.31 (m, 1H, 3-<i>H</i>), 6.53 (s, 1H, 8-<i>H</i><sub>isoquinoline</sub>), 6.59 (s, 1H, 5-<i>H</i><sub>isoquinoline</sub>), 7.07 (d, <i>J</i> = 7.1 Hz, 1H, 5-<i>H</i>), 7.10–7.13 (m, 1H, 8-<i>H</i>), 7.13–7.16 (m, 1H, 6-<i>H</i>), 7.16–7.22 (m, 1H, 7-<i>H</i>). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 14.4 (1C, OCH<sub>2</sub><i>C</i>H<sub>3</sub>), 23.3 (1C, <i>C</i>-3′ or <i>C</i>-5′), 23.6 (1C, <i>C</i>-3′ or <i>C</i>-5′), 29.4 (1C, <i>C</i>-4<sub>isoquinoline</sub>), 34.9 (1C, <i>C</i>-2′), 35.2 (1C, <i>C</i>-4), 39.1 (1C, <i>C</i>-6′), 41.7 (1C, <i>C</i>H<sub>2</sub>CO<sub>2</sub>Et), 46.9 (1C, <i>C</i>-3<sub>isoquinoline</sub>), 51.4 (1C, <i>C</i>-1<sub>isoquinoline</sub>), 56.06 (1C, 6-O<i>C</i>H<sub>3</sub> or 7-O<i>C</i>H<sub>3</sub>), 56.08 (1C, 6-O<i>C</i>H<sub>3</sub> or 7-O<i>C</i>H<sub>3</sub>), 60.7 (1C, O<i>C</i>H<sub>2</sub>CH<sub>3</sub>), 62.7 (1C, <i>C</i>-4′), 65.3 (1C, <i>C</i>-3), 75.6 (1C, <i>C</i>-1), 109.8 (1C, <i>C</i>-8<sub>isoquinoline</sub>), 111.6 (1C, <i>C</i>-5<sub>isoquinoline</sub>), 125.1 (1C, <i>C</i>-8), 126.3 (1C, <i>C</i>-6), 126.4 (1C, <i>C</i>-7), 126.7 (1C, <i>C</i>-4a<sub>isoquinoline</sub>), 127.3 (1C, <i>C</i>-8a<sub>isoquinoline</sub>), 128.9 (1C, <i>C</i>-5), 133.2 (1C, <i>C</i>-4a), 142.1 (1C, <i>C</i>-8a), 147.3 (1C, <i>C</i>-7<sub>isoquinoline</sub>), 147.6 (1C, <i>C</i>-6<sub>isoquinoline</sub>), 171.6 (1C, <i>C</i>═O). FT-IR (neat): ν [cm<sup>–1</sup>] = 2928 (C–H<sub>alkyl</sub>), 1732 (C═O), 1516, 1450 (C═C<sub>arom</sub>). Purity (HPLC): 96.0%, <i>t</i><sub>R</sub> = 20.1 min.</div></div><div id="sec7_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43">7.2.16.  <i>trans</i>-2-{4′-[(2,4-Dimethylbenzyl)amino]-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-3-yl}ethanol (<b>12a</b>)</h4><div class="NLM_p last">A solution of LiAlH<sub>4</sub> (22 mg, 0.59 mmol, 3.1 equiv) in THF (5 mL) was added slowly to a solution of ester <b>11a</b> (82 mg, 0.19 mmol) in Et<sub>2</sub>O (10 mL) at −20 °C under N<sub>2</sub> atmosphere. After stirring for 4 h, H<sub>2</sub>O (10 mL) was added, the precipitate was filtered off, and the aqueous layer was extracted with ethyl acetate (3 × 10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo and the residue was purified by fc (<i>d</i> = 1.5 cm, <i>l</i> = 18 cm, <i>V</i> = 5 mL, cyclohexane/ethyl acetate 90:10 + 1% <i>N</i>,<i>N</i>-dimethylethanamine → 70:30 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). Yellow oil, yield 58 mg (79%). C<sub>25</sub>H<sub>33</sub>NO<sub>2</sub> (379.5 g/mol). <i>R<sub>f</sub></i> = 0.11 (cyclohexane/ethyl acetate 80:20 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 380.2568 (calcd 380.2584 for C<sub>25</sub>H<sub>34</sub>NO<sub>2</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.49–1.56 (m, 1H, 2′-<i>H</i>), 1.64–1.78 (m, 2H, 3′-<i>H</i>, 5′-<i>H</i>), 1.85–1.98 (m, 5H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>, C<i>H</i><sub>2</sub>CH<sub>2</sub>OH), 2.00–2.10 (m, 1H, 6′-<i>H</i>), 2.32 (s, 3H, 4–C<i>H</i><sub>3</sub>), 2.34–2.44 (m, 1H, 2′-<i>H</i>), 2.41 (s, 3H, 4–C<i>H</i><sub>3</sub>), 2.61 (dd, <i>J</i> = 15.8/2.7 Hz, 1H, 4-<i>H</i>), 2.84 (dd, <i>J</i> = 15.7/11.4 Hz, 1H, 4-<i>H</i>), 3.01–3.10 (m, 1H, 4′-<i>H</i><sub>eq</sub>), 3.75 (s, 2H, ArC<i>H</i><sub>2</sub>NH), 3.86–3.93 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>OH), 4.00–4.06 (m, 1H, 3-<i>H</i>), 6.99–7.03 (m, 2H, 3-<i>H</i><sub>benzyl</sub>, 5-<i>H</i><sub>benzyl</sub>), 7.05 (d, <i>J</i> = 7.6 Hz, 1H, 5-<i>H</i>), 7.11–7.15 (m, 1H, 6-<i>H</i>), 7.15–7.20 (m, 2H, 7-<i>H</i>, 8-<i>H</i>), 7.22–7.26 (m, 1H, 6-<i>H</i><sub>benzyl</sub>). Signals for the NH and OH protons are not observed in the spectrum. <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ (ppm) = 19.2 (1C, 2-<i>C</i>H<sub>3</sub>), 21.2 (1C, 4-<i>C</i>H<sub>3</sub>), 26.3 (2C, <i>C</i>-3′, <i>C</i>-5′), 29.3 (1C, <i>C</i>-6′), 33.4 (1C, <i>C</i>-2′), 35.5 (1C, <i>C</i>-4), 38.0 (1C, <i>C</i>H<sub>2</sub>CH<sub>2</sub>OH), 49.9 (1C, Ar<i>C</i>H<sub>2</sub>NH), 51.2 (1C, <i>C</i>-4′), 61.5 (1C, CH<sub>2</sub><i>C</i>H<sub>2</sub>OH), 68.5 (1C, <i>C</i>-3), 76.7 (1C, <i>C</i>-1), 125.7 (1C, <i>C</i>-8), 126.2 (1C, <i>C</i>-6), 126.3 (1C, <i>C</i>-7), 126.7 (1C, <i>C</i>-5<sub>benzyl</sub>), 128.7 (1C, <i>C</i>-5), 129.1 (1C, <i>C</i>-6<sub>benzyl</sub>), 131.3 (1C, <i>C</i>-3<sub>benzyl</sub>), 133.0 (1C, <i>C</i>-4a), 136.1 (1C, <i>C</i>-1<sub>benzyl</sub>), 136.7 (1C, <i>C</i>-2<sub>benzyl</sub>), 136.9 (1C, <i>C</i>-4<sub>benzyl</sub>), 142.8 (1C, <i>C</i>-8a). FT-IR (neat): ν [cm<sup>–1</sup>] = 3426 (O–H/N–H), 2920 (C–H<sub>alkyl</sub>), 1435, 1373 (C═C<sub>arom</sub>), 1061 (C–O). Purity (HPLC): 98.2%, <i>t</i><sub>R</sub> = 18.3 min.</div></div><div id="sec7_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44">7.2.17.  <i>cis</i>-2-{4′-[(2,4-Dimethylbenzyl)amino]-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-3-yl}ethanol (<b>12b</b>)</h4><div class="NLM_p last">LiAlH<sub>4</sub> (55 mg, 1.44 mmol, 2.9 equiv) was added slowly to a solution of ester <b>11b</b> (211 mg, 0.50 mmol) in Et<sub>2</sub>O (10 mL) at −20 °C under N<sub>2</sub> atmosphere. After stirring for 2 h, H<sub>2</sub>O (10 mL) was added, the precipitate was filtered off, and the aqueous layer was extracted with ethyl acetate (3 × 10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 3 cm, <i>l</i> = 16 cm, <i>V</i> = 20 mL, cyclohexane/ethyl acetate 10:20 + 1% <i>N</i>,<i>N</i>-dimethylethanamine → ethyl acetate + 1% <i>N</i>,<i>N</i>-dimethylethanamine). Pale yellow solid, mp 89 °C, yield 157 mg (82%). C<sub>25</sub>H<sub>33</sub>NO<sub>2</sub> (379.5 g/mol). <i>R<sub>f</sub></i> = 0.06 (cyclohexane/ethyl acetate 50:50 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 380.2568 (calcd 380.2568 for C<sub>25</sub>H<sub>34</sub>NO<sub>2</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.53–1.66 (m, 3H, 2′-<i>H</i>, 3′-<i>H</i>, 5′-<i>H</i>), 1.80–1.85 (m, 1H, 6′-<i>H</i>), 1.85–1.99 (m, 5H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>, C<i>H</i><sub>2</sub>CH<sub>2</sub>OH), 2.20 (dt, <i>J</i> = 10.8/3.0 Hz, 1H, 2′-<i>H</i>), 2.30 (s, 3H, 4-C<i>H</i><sub>3</sub>), 2.34 (s, 3H, 2-C<i>H</i><sub>3</sub>), 2.63 (dd, <i>J</i> = 15.9/2.7 Hz, 1H, 4-<i>H</i>), 2.65–2.71 (m, 1H, 4′-<i>H</i><sub>ax</sub>), 2.82 (dd, <i>J</i> = 15.9/11.1 Hz, 1H, 4-<i>H</i>), 3.81 (s, 2H, ArC<i>H</i><sub>2</sub>NH), 3.86–3.95 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>OH), 4.01 (ddt, <i>J</i> = 11.4/8.6/3.1 Hz, 1H, 3-<i>H</i>), 6.97–7.01 (m, 2H, 3-<i>H</i><sub>benzyl</sub>, 5-<i>H</i><sub>benzyl</sub>), 7.05–7.11 (m, 2H, 5-<i>H</i>, 8-<i>H</i>), 7.14 (td, <i>J</i> = 7.4/1.5 Hz, 1H, 6-<i>H</i>), 7.17 (t, <i>J</i> = 7.5 Hz, 1H, 7-<i>H</i>), 7.21 (d, <i>J</i> = 8.2 Hz, 1H, 6-<i>H</i><sub>benzyl</sub>). Signals for the NH and OH protons are not observed in the spectrum. <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ (ppm) = 19.1 (1C, 2-<i>C</i>H<sub>3</sub>), 21.1 (1C, 4-<i>C</i>H<sub>3</sub>), 29.0 (1C, C-3′ or C-5′), 29.1 (1C, C-3′ or C-5′), 34.4 (1C, <i>C</i>-2′), 35.5 (1C, <i>C</i>-4), 38.1 (1C, <i>C</i>H<sub>2</sub>CH<sub>2</sub>OH), 38.4 (1C, <i>C</i>-6′), 48.4 (1C, Ar<i>C</i>H<sub>2</sub>NH), 56.0 (1C, <i>C</i>-4′), 60.8 (1C, CH<sub>2</sub><i>C</i>H<sub>2</sub>OH), 67.6 (1C, <i>C</i>-3), 75.8 (1C, <i>C</i>-1), 125.1 (1C, <i>C</i>-8), 126.26 (1C, <i>C</i>-6 or <i>C</i>-7), 126.27 (1C, <i>C</i>-6 or <i>C</i>-7), 126.7 (1C, <i>C</i>-5<sub>benzyl</sub>), 128.6 (1C, <i>C</i>-6<sub>benzyl</sub>), 128.9 (1C, <i>C</i>-5), 131.3 (1C, <i>C</i>-3<sub>benzyl</sub>), 133.5 (1C, <i>C</i>-4a), 135.6 (1C, <i>C</i>-1<sub>benzyl</sub>), 136.3 (1C, <i>C</i>-2<sub>benzyl</sub>), 136.6 (1C, <i>C</i>-4<sub>benzyl</sub>), 142.1 (1C, <i>C</i>-8a). FT-IR (neat): ν [cm<sup>–1</sup>] = 3364 (O–H/N–H), 2924 (C–H<sub>alkyl</sub>), 1454 (C═C<sub>arom</sub>), 1061 (C–O). Purity (HPLC): 99.8%, <i>t</i><sub>R</sub> = 18.7 min.</div></div><div id="sec7_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45">7.2.18.  <i>trans</i>-2-{4′-(4-Cyclohexylpiperazin-1-yl)-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-3-yl}ethanol (<b>12c</b>)</h4><div class="NLM_p last">A solution of LiAlH<sub>4</sub> (15 mg, 0.38 mmol, 2.9 equiv) in THF (2 mL) was added slowly to a solution of ester <b>11c</b> (60 mg, 0.13 mmol) in Et<sub>2</sub>O (5 mL) at −20 °C under N<sub>2</sub> atmosphere. After stirring for 5 h, H<sub>2</sub>O (8 mL) was added, the precipitate was filtered off, and the aqueous layer was extracted with ethyl acetate (3 × 10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 1.5 cm, <i>l</i> = 18 cm, <i>V</i> = 10 mL, cyclohexane/ethyl acetate 50:50 + 2% <i>N</i>,<i>N</i>-dimethylethanamine). Colorless solid, mp 185 °C, yield 45 mg (85%). C<sub>26</sub>H<sub>40</sub>N<sub>2</sub>O<sub>2</sub> (412.6 g/mol). <i>R<sub>f</sub></i> = 0.11 (cyclohexane/ethyl acetate 50:50 + 2% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 413.3154 (calcd 413.3163 for C<sub>26</sub>H<sub>41</sub>N<sub>2</sub>O<sub>2</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.08–1.18 (m, 1H, 4-<i>H</i><sub>cyclohexyl</sub>), 1.19–1.31 (m, 4H, 2-<i>H</i><sub>cyclohexyl</sub>, 3-<i>H</i><sub>cyclohexyl</sub>, 5-<i>H</i><sub>cyclohexyl</sub>, 6-<i>H</i><sub>cyclohexyl</sub>), 1.45 (dq, <i>J</i> = 13.3/3.0 Hz, 1H, 2′-<i>H</i><sub>equ</sub>), 1.61–1.68 (m, 1H, 4-<i>H</i><sub>cyclohexyl</sub>), 1.70–1.78 (m, 2H, 3′-<i>H</i>, 5′-<i>H</i>), 1.78–1.86 (m, 3H, 6′-<i>H</i>, 2-<i>H</i><sub>cyclohexyl</sub>, 6-<i>H</i><sub>cyclohexyl</sub>), 1.86–2.02 (m, 7H, C<i>H</i><sub>2</sub>CH<sub>2</sub>OH, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>, 3-<i>H</i><sub>cyclohexyl</sub>, 5-<i>H</i><sub>cyclohexyl</sub>), 2.20–2.31 (m, 3H, 2′-<i>H</i><sub>ax</sub>, 4′-<i>H</i><sub>equ</sub>, 1-<i>H</i><sub>cyclohexyl</sub>), 2.40–2.77 (broad signal, 8H, 4-<i>H</i>, <i>H</i><sub>piperazine</sub>), 2.83 (dd, <i>J</i> = 15.8/11.1 Hz, 1H, 4-<i>H</i>), 2.86–2.93 (broad signal, 1H, H<sub>piperazine</sub>), 3.86–3.93 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>OH), 4.02 (ddt, <i>J</i> = 11.6/8.6/3.1 Hz, 1H, 3-<i>H</i>), 7.04 (d, <i>J</i> = 7.5 Hz, 1H, 5-<i>H</i>), 7.13 (td, <i>J</i> = 7.2/1.7 Hz, 1H, 6-<i>H</i>), 7.15–7.22 (m, 2H, 7-<i>H</i>, 8-<i>H</i>). A signal for the OH proton is not observed in the spectrum. <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ (ppm) = 24.2 (1C, <i>C</i>-3′ or <i>C</i>-5′), 24.3 (1C, <i>C</i>-3′ or <i>C</i>-5′), 26.0 (2C, <i>C</i>-2<sub>cyclohexyl</sub>, <i>C</i>-6<sub>cyclohexyl</sub>), 26.4 (1C, <i>C</i>-4<sub>cyclohexyl</sub>), 29.2 (2C, <i>C</i>-3<sub>cyclohexyl</sub>, <i>C</i>-5<sub>cyclohexyl</sub>), 29.7 (1C, <i>C</i>-6′), 34.0 (1C, <i>C</i>-2′), 35.6 (1C, <i>C</i>-4), 38.0 (1C, <i>C</i>H<sub>2</sub>CH<sub>2</sub>OH), 49.9 (2C, <i>C</i>-2<sub>piperazine</sub> and <i>C</i>-6<sub>piperazine</sub> or <i>C</i>-3<sub>piperazine</sub> and <i>C</i>-5<sub>piperazine</sub>), 50.5 (2C, <i>C</i>-2<sub>piperazine</sub> and <i>C</i>-6<sub>piperazine</sub> or <i>C</i>-3<sub>piperazine</sub> and <i>C</i>-5<sub>piperazine</sub>), 57.3 (1C, <i>C</i>-4′), 61.4 (1C, CH<sub>2</sub><i>C</i>H<sub>2</sub>OH), 63.7 (1C, <i>C</i>-1<sub>cyclohexyl</sub>), 68.4 (1C, <i>C</i>-3), 76.8 (1C, <i>C</i>-1), 125.6 (1C, <i>C</i>-8), 126.1 (1C, <i>C</i>-6), 126.3 (1C, <i>C</i>-7), 128.6 (1C, <i>C</i>-5), 133.2 (1C, <i>C</i>-4a), 143.0 (1C, <i>C</i>-8a). FT-IR (neat): ν [cm<sup>–1</sup>] = 3198 (O–H), 2978, 2932, 2816 (C–H<sub>alkyl</sub>), 1450 (C═C<sub>arom</sub>). Purity (HPLC, method 1): 99.5%, <i>t</i><sub>R</sub> = 14.0 min.</div></div><div id="sec7_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46">7.2.19.  <i>cis</i>-2-{4′-(4-Cyclohexylpiperazin-1-yl)-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-3-yl}ethanol (<b>12d</b>)</h4><div class="NLM_p last">A solution of LiAlH<sub>4</sub> (30 mg, 0.79 mmol, 2.8 equiv) in THF (2 mL) was added slowly to a solution of ester <b>11d</b> (125 mg, 0.28 mmol) in Et<sub>2</sub>O (6 mL) at −20 °C under N<sub>2</sub> atmosphere. After stirring for 4 h, H<sub>2</sub>O (15 mL) was added, the precipitate was filtered off, and the aqueous layer was extracted with ethyl acetate (3 × 15 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo and the residue was purified twice by fc (<i>d</i> = 2 cm, <i>l</i> = 17 cm, <i>V</i> = 10 mL, cyclohexane/ethyl acetate 33:66 + 2% <i>N</i>,<i>N</i>-dimethylethanamine → ethyl acetate + 2% <i>N</i>,<i>N</i>-dimethylethanamine; <i>d</i> = 1.5 cm, <i>l</i> = 10 cm, <i>V</i> = 3 mL, cyclohexane/ethyl acetate 66:33 + 2% <i>N</i>,<i>N</i>-dimethylethanamine → 33:66 + 2% <i>N</i>,<i>N</i>-dimethylethanamine). Colorless solid, mp 128 °C, yield 94 mg (82%). C<sub>26</sub>H<sub>40</sub>N<sub>2</sub>O<sub>2</sub> (412.6 g/mol). <i>R<sub>f</sub></i> = 0.08 (cyclohexane/ethyl acetate 33:66 + 2% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 413.3137 (calcd 413.3163 for C<sub>26</sub>H<sub>41</sub>N<sub>2</sub>O<sub>2</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.04–1.16 (m, 1H, 4-<i>H</i><sub>cyclohexyl</sub>), 1.17–1.31 (m, 4H, 2-<i>H</i><sub>cyclohexyl</sub>, 3-<i>H</i><sub>cyclohexyl</sub>, 5-<i>H</i><sub>cyclohexyl</sub>, 6-<i>H</i><sub>cyclohexyl</sub>), 1.53–1.68 (m, 2H, 2′-<i>H</i>, 4-<i>H</i><sub>cyclohexyl</sub>), 1.67–1.85 (m, 6H, 3′-<i>H</i>, 5′-<i>H</i>, 2-<i>H</i><sub>cyclohexyl</sub>, 6-<i>H</i><sub>cyclohexyl</sub>), 1.85–1.98 (m, 6H, C<i>H</i><sub>2</sub>CH<sub>2</sub>OH, 6′-<i>H</i>, 3-<i>H</i><sub>cyclohexyl</sub>, 5-<i>H</i><sub>cyclohexyl</sub>), 2.19–2.30 (m, 2H, 2′-<i>H</i>, 1-<i>H</i><sub>cyclohexyl</sub>), 2.48 (tt, <i>J</i> = 11.3/3.8 Hz, 1H, 4′-<i>H</i><sub>ax</sub>), 2.62 (dd, <i>J</i> = 16.0/2.8 Hz, 1H, 4-<i>H</i>), 2.65–2.76 (broad signal, 8H, <i>H</i><sub>piperazine</sub>), 2.81 (dd, <i>J</i> = 15.9/11.1 Hz, 1H, 4-<i>H</i>), 3.87–3.92 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>OH), 3.96–4.05 (m, 1H, 3-<i>H</i>), 7.05 (d, <i>J</i> = 6.8 Hz, 1H, 5-<i>H</i>), 7.09 (dd, <i>J</i> = 7.3/1.8 Hz, 1H, 8-<i>H</i>), 7.11–7.20 (m, 2H, 6-<i>H</i>, 7-<i>H</i>). A signal for the OH proton is not observed in the spectrum. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 23.8 (1C, <i>C</i>-3′ or <i>C</i>-5′), 23.8 (1C, <i>C</i>-3′ or <i>C</i>-5′), 26.0 (2C, <i>C</i>-2<sub>cyclohexyl</sub>, <i>C</i>-6<sub>cyclohexyl</sub>), 26.4 (1C, <i>C</i>-4<sub>cyclohexyl</sub>), 29.06 (1C, <i>C</i>-3<sub>cyclohexyl</sub> or <i>C</i>-5<sub>cyclohexyl</sub>), 29.07 (1C, <i>C</i>-3<sub>cyclohexyl</sub> or <i>C</i>-5<sub>cyclohexyl</sub>), 34.9 (1C, <i>C</i>-2′), 35.5 (1C, <i>C</i>-4), 38.1 (1C, <i>C</i>H<sub>2</sub>CH<sub>2</sub>OH), 38.8 (1C, <i>C</i>-6′), 49.3 (2C, <i>C</i>-2<sub>piperazine</sub> and <i>C</i>-6<sub>piperazine</sub> or <i>C</i>-3<sub>piperazine</sub> and <i>C</i>-5<sub>piperazine</sub>), 49.4 (2C, <i>C</i>-2<sub>piperazine</sub> and <i>C</i>-6<sub>piperazine</sub> or <i>C</i>-3<sub>piperazine</sub> and <i>C</i>-5<sub>piperazine</sub>), 61.1 (1C, CH<sub>2</sub><i>C</i>H<sub>2</sub>OH), 63.0 (1C, <i>C</i>-4′), 63.8 (1C, <i>C</i>-1<sub>cyclohexyl</sub>), 68.1 (1C, <i>C</i>-3), 75.8 (1C, <i>C</i>-1), 125.1 (1C, <i>C</i>-8), 126.30 (1C, <i>C</i>-6 or <i>C</i>-7), 126.32 (1C, <i>C</i>-6 or <i>C</i>-7), 128.9 (1C, <i>C</i>-5), 133.4 (1C, <i>C</i>-4a), 141.9 (1C, <i>C</i>-8a). FT-IR (neat): ν [cm<sup>–1</sup>] = 3225 (O–H), 2970, 2928, 2851 (C–H<sub>alkyl</sub>), 1447 (C═C<sub>arom</sub>). Purity (HPLC, method 1): 99.2%, <i>t</i><sub>R</sub> = 13.5 min.</div></div><div id="sec7_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47">7.2.20.  <i>trans</i>-2-{4′-(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-3-yl}ethanol (<b>12e</b>)</h4><div class="NLM_p last">LiAlH<sub>4</sub> (36 mg, 0.93 mmol, 2.7 equiv) was added slowly to a solution of ester <b>11e</b> (163 mg, 0.34 mmol) in Et<sub>2</sub>O (9 mL) at −20 °C under N<sub>2</sub> atmosphere. After stirring for 3 h, H<sub>2</sub>O (10 mL) was added, the precipitate was filtered off and the aqueous layer was extracted with ethyl acetate (3 × 10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 3 cm, <i>l</i> = 17 cm, <i>V</i> = 20 mL, cyclohexane/ethyl acetate 66:33 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). Pale yellow solid, mp 160 °C, yield 105 mg (71%). C<sub>27</sub>H<sub>35</sub>NO<sub>4</sub> (437.6 g/mol). <i>R<sub>f</sub></i> = 0.23 (cyclohexane/ethyl acetate 66:33 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 438.2686 (calcd 438.2639 for C<sub>27</sub>H<sub>36</sub>NO<sub>4</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.48–1.55 (m, 1H, 2′-<i>H</i>), 1.80–2.09 (m, 8H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>, C<i>H</i><sub>2</sub>CH<sub>2</sub>OH), 2.28–2.38 (m, 1H, 2′-<i>H</i>), 2.40–2.52 (m, 1H, 4′-<i>H</i><sub>equ</sub>), 2.62 (dd, <i>J</i> = 15.9/2.6 Hz, 1H, 4-<i>H</i>), 2.75–2.93 (m, 5H, 4-<i>H</i>, 3-<i>H</i><sub>isoquinoline</sub>, 4-<i>H</i><sub>isoquinoline</sub>), 3.62–3.72 (m, 2H, 1-<i>H</i><sub>isoquinoline</sub>), 3.86 (s, 3H, 7-OC<i>H</i><sub>3</sub>), 3.88 (s, 3H, 6-OC<i>H</i><sub>3</sub>), 3.89–3.95 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>OH), 4.04 (ddt, <i>J</i> = 11.0/8.2/2.9 Hz, 1H, 3-<i>H</i>), 6.59 (s, 1H, 8-<i>H</i><sub>isoquinoline</sub>), 6.65 (s, 1H, 5-<i>H</i><sub>isoquinoline</sub>), 7.03 (d, <i>J</i> = 7.7 Hz, 1H, 5-<i>H</i>), 7.09–7.17 (m, 3H, 6-<i>H</i>, 7-<i>H</i>, 8-<i>H</i>). A signal for the OH proton is not observed in the spectrum. <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ (ppm) = 24.6 (2C, <i>C</i>-3′, <i>C</i>-5′), 29.4 (1C, <i>C</i>-4<sub>isoquinoline</sub>), 29.7 (1C, <i>C</i>-6′), 33.9 (1C, <i>C</i>-2′), 35.6 (1C, <i>C</i>-4), 38.0 (1C, <i>C</i>H<sub>2</sub>CH<sub>2</sub>OH), 47.4 (1C, <i>C</i>-3<sub>isoquinoline</sub>), 53.5 (1C, <i>C</i>-1<sub>isoquinoline</sub>), 56.1 (2C, 6-O<i>C</i>H<sub>3</sub>, 7-O<i>C</i>H<sub>3</sub>), 57.0 (1C, <i>C</i>-4′), 61.4 (1C, CH<sub>2</sub><i>C</i>H<sub>2</sub>OH), 68.5 (1C, <i>C</i>-3), 76.9 (1C, <i>C</i>-1), 109.9 (1C, <i>C</i>-8<sub>isoquinoline</sub>), 111.3 (1C, <i>C</i>-5<sub>isoquinoline</sub>), 125.9 (1C, <i>C</i>-6 or <i>C</i>-8), 126.2 (1C, <i>C</i>-6 or <i>C</i>-8), 126.3 (1C, <i>C</i>-7), 127.0 (1C, <i>C</i>-4a<sub>isoquinoline</sub>), 127.6 (1C, <i>C</i>-8a<sub>isoquinoline</sub>), 128.5 (1C, <i>C</i>-5), 133.0 (1C, <i>C</i>-4a), 142.7 (1C, <i>C</i>-8a), 147.4 (1C, <i>C</i>-7<sub>isoquinoline</sub>), 147.6 (1C, <i>C</i>-6<sub>isoquinoline</sub>). FT-IR (neat): ν [cm<sup>–1</sup>] = 3437 (O–H), 2920 (C–H<sub>alkyl</sub>), 1516, 1450 (C═C<sub>arom</sub>). Purity (HPLC): 96.1%, <i>t</i><sub>R</sub> = 16.4 min.</div></div><div id="sec7_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48">7.2.21.  <i>cis</i>-2-{4′-(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-3-yl}ethanol (<b>12f</b>)</h4><div class="NLM_p last">A solution of LiAlH<sub>4</sub> (32 mg, 0.85 mmol, 2.9 equiv) in THF (5 mL) was added slowly to a solution of ester <b>11f</b> (137 mg, 0.29 mmol) in Et<sub>2</sub>O (9 mL) at −20 °C under N<sub>2</sub> atmosphere. After stirring for 3.5 h, H<sub>2</sub>O (10 mL) was added, the precipitate was filtered off, and the aqueous layer was extracted with ethyl acetate (4 × 10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 2 cm, <i>l</i> = 18 cm, <i>V</i> = 10 mL, cyclohexane/ethyl acetate 50:50 + 1% <i>N</i>,<i>N</i>-dimethylethanamine → ethyl acetate + 1% <i>N</i>,<i>N</i>-dimethylethanamine). Yellow solid, mp 148 °C, yield 88 mg (69%). C<sub>27</sub>H<sub>35</sub>NO<sub>4</sub> (437.6 g/mol). <i>R<sub>f</sub></i> = 0.06 (cyclohexane/ethyl acetate 50:50 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 438.2673 (calcd 438.2639 for C<sub>27</sub>H<sub>36</sub>NO<sub>4</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.60–1.70 (m, 1H, 2′-<i>H</i>), 1.81–1.90 (m, 4H, 3′-<i>H</i>, 5′-<i>H</i>), 1.90–2.03 (m, 4H, 6′-<i>H</i>, C<i>H</i><sub>2</sub>CH<sub>2</sub>OH), 2.25–2.33 (m, 1H, 2′-<i>H</i>), 2.64 (dd, <i>J</i> = 15.9/2.6 Hz, 1H, 4-<i>H</i>), 2.70–2.79 (m, 2H, 4′-<i>H</i><sub>ax</sub>), 2.80–2.97 (m, 5H, 4-<i>H</i>, 3-<i>H</i><sub>isoquinoline</sub>, 4-<i>H</i><sub>isoquinoline</sub>), 3.81 (s, 2H, 1-<i>H</i><sub>isoquinoline</sub>), 3.84 (s, 6H, 6-OC<i>H</i><sub>3</sub>, 7-OC<i>H</i><sub>3</sub>), 3.90–4.00 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>OH), 4.00–4.09 (m, 1H, 3-<i>H</i>), 6.55 (s, 1H, 8-<i>H</i><sub>isoquinoline</sub>), 6.60 (s, 1H, 5-<i>H</i><sub>isoquinoline</sub>), 7.07 (d, <i>J</i> = 7.3 Hz, 1H 5-<i>H</i>), 7.10–7.22 (m, 3H, 6-<i>H</i>, 7-<i>H</i>, 8-<i>H</i>). A signal for the OH proton is not observed in the spectrum. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 23.7 (1C, <i>C</i>-5′), 23.8 (1C, <i>C</i>-3′), 29.4 (1C, <i>C</i>-4<sub>isoquinoline</sub>), 35.0 (1C, <i>C</i>-2′), 35.5 (1C, <i>C</i>-4), 38.1 (1C, <i>C</i>H<sub>2</sub>CH<sub>2</sub>OH), 39.0 (1C, <i>C</i>-6′), 46.9 (1C, <i>C</i>-3<sub>isoquinoline</sub>), 51.5 (1C, <i>C</i>-1<sub>isoquinoline</sub>), 56.06 (1C, 6-O<i>C</i>H<sub>3</sub> or 7-O<i>C</i>H<sub>3</sub>), 56.14 (1C, 6-O<i>C</i>H<sub>3</sub> or 7-O<i>C</i>H<sub>3</sub>), 61.2 (1C, CH<sub>2</sub><i>C</i>H<sub>2</sub>OH), 62.7 (1C, <i>C</i>-4′), 68.3 (1C, <i>C</i>-3), 75.9 (1C, <i>C</i>-1), 109.8 (1C, <i>C</i>-8<sub>isoquinoline</sub>), 111.6 (1C, <i>C</i>-5<sub>isoquinoline</sub>), 125.1 (1C, <i>C</i>-8), 126.3 (1C, <i>C</i>-6 or <i>C</i>-7), 126.4 (1C, <i>C</i>-6 or <i>C</i>-7), 126.6 (1C, <i>C</i>-4a<sub>isoquinoline</sub>), 127.0 (1C, <i>C</i>-8a<sub>isoquinoline</sub>), 128.9 (1C, <i>C</i>-5), 133.4 (1C, <i>C</i>-4a), 141.8 (1C, <i>C</i>-8a), 147.4 (1C, <i>C</i>-7<sub>isoquinoline</sub>), 147.6 (1C, <i>C</i>-6<sub>isoquinoline</sub>). FT-IR (neat): ν [cm<sup>–1</sup>] = 3179 (O–H), 2943, 2920, 2851 (C–H<sub>alkyl</sub>), 1516, 1443 (C═C<sub>arom</sub>). Purity (HPLC): 96.3%, <i>t</i><sub>R</sub> = 16.7 min.</div></div><div id="sec7_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49">7.2.22.  <i>trans</i>-<i>N</i>-(2,4-Dimethylbenzyl)-3-(2-fluoroethyl)-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-4′-amine (<b>13a</b>)</h4><div class="NLM_p last">A solution of alcohol <b>12a</b> (36 mg, 0.09 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (4 mL) was added dropwise to a solution of DAST (0.03 mL, 0.23 mmol, 2.6 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) under N<sub>2</sub> atmosphere at −78 °C. After 90 min, the mixture was warmed to rt and stirred for 20 h. 1 M NaOH (3 mL) was added, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (4 × 5 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 1 cm, <i>l</i> = 18 cm, <i>V</i> = 5 mL, cyclohexane/ethyl acetate 90:10 + 1% <i>N</i>,<i>N</i>-dimethylethanamine → 80:20 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). Pale yellow solid, mp 67 °C, yield 24 mg (67%). C<sub>25</sub>H<sub>32</sub>FNO (381.5 g/mol). <i>R<sub>f</sub></i> = 0.56 (cyclohexane/ethyl acetate 80:20 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 382.2541 (calcd 382.2541 for C<sub>25</sub>H<sub>33</sub>FNO<sub>2</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.50 (dq, <i>J</i> = 13.4/3.0 Hz, 1H, 2′-<i>H</i>), 1.60–1.72 (m, 2H, 3′-<i>H</i>, 5′-<i>H</i>), 1.81–1.94 (m, 3H, 5′-<i>H</i>, 6′-<i>H</i>, C<i>H</i><sub>2</sub>CH<sub>2</sub>F), 1.94–2.18 (m, 3H, 3′-<i>H</i>, 6′-<i>H</i>, C<i>H</i><sub>2</sub>CH<sub>2</sub>F), 2.31–2.41 (m, 1H, 2′-<i>H</i>), 2.33 (s, 3H, 4–C<i>H</i><sub>3</sub>), 2.43 (s, 3H, 2–C<i>H</i><sub>3</sub>), 2.66 (dd, <i>J</i> = 15.8/3.1 Hz, 1H, 4-<i>H</i>), 2.75 (dd, <i>J</i> = 15.8/10.7 Hz, 1H, 4-<i>H</i>), 3.02 (quint, <i>J</i> = 3.0 Hz, 1H, 4′-<i>H</i><sub>equ</sub>), 3.75 (s, 2H, ArC<i>H</i><sub>2</sub>NH), 3.97 (ddt, <i>J</i> = 10.6/9.3/3.3 Hz, 1H, 3-<i>H</i>), 4.60 (ddd, <i>J</i> = 9.0/5.7/4.3 Hz, 0.5H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 4.72 (m, 2 × 0.5H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 4.84 (td, <i>J</i> = 9.0/4.5 Hz, 0.5H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 6.99–7.04 (m, 2H, 3-<i>H</i><sub>benzyl</sub>, 5-<i>H</i><sub>benzyl</sub>), 7.06 (m, 1H, 5-<i>H</i>), 7.10–7.16 (m, 1H, 6-<i>H</i>), 7.16–7.20 (m, 2H, 7-<i>H</i>, 8-<i>H</i>), 7.24 (d, <i>J</i> = 7.5 Hz, 1H, 6-<i>H</i><sub>benzyl</sub>). A signal for the NH proton is not observed in the spectrum. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 19.1 (1C, 2-<i>C</i>H<sub>3</sub>), 21.2 (1C, 4-<i>C</i>H<sub>3</sub>), 26.1 (1C, <i>C</i>-3′), 26.3 (1C, <i>C</i>-5′), 29.3 (1C, <i>C</i>-6′), 33.6 (1C, <i>C</i>-2′), 35.8 (1C, <i>C</i>-4), 37.1 (d, <i>J</i> = 19.4 Hz, 1C, <i>C</i>H<sub>2</sub>CH<sub>2</sub>F), 49.9 (1C, Ar<i>C</i>H<sub>2</sub>NH), 51.4 (1C, <i>C</i>-4′), 63.7 (d, <i>J</i> = 5.0 Hz, 1C, <i>C</i>-3), 76.1 (1C, <i>C</i>-1), 81.1 (d, <i>J</i> = 163.7 Hz, 1C, CH<sub>2</sub><i>C</i>H<sub>2</sub>F), 125.6 (1C, <i>C</i>-8), 126.0 (1C, <i>C</i>-6), 126.3 (1C, <i>C</i>-7), 126.7 (1C, <i>C</i>-5<sub>benzyl</sub>), 128.7 (1C, <i>C</i>-5), 129.0 (1C, <i>C</i>-6<sub>benzyl</sub>), 131.3 (1C, <i>C</i>-3<sub>benzyl</sub>), 133.3 (1C, <i>C</i>-4a), 136.2 (1C, <i>C</i>-1<sub>benzyl</sub>), 136.69 (1C, <i>C</i>-2<sub>benzyl</sub>), 136.73 (1C, <i>C</i>-4<sub>benzyl</sub>), 143.3 (1C, <i>C</i>-8a). FT-IR (neat): ν [cm<sup>–1</sup>] = 3306 (N–H), 2947, 2924 (C–H<sub>alkyl</sub>), 1447 (C═C<sub>arom</sub>). Purity (HPLC): 98.1%, <i>t</i><sub>R</sub> = 21.4 min.</div></div><div id="sec7_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50">7.2.23.  <i>cis</i>-<i>N</i>-(2,4-Dimethylbenzyl)-3-(2-fluoroethyl)-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-4′-amine (<b>13b</b>)</h4><div class="NLM_p last">A solution of alcohol <b>12b</b> (70 mg, 0.18 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (6 mL) was added dropwise to a solution of DAST (0.07 mL, 0.53 mmol, 2.9 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) under N<sub>2</sub> atmosphere at −78 °C. After 90 min, the mixture was warmed to rt and stirred for 20 h. 1 M NaOH (5 mL) was added, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (4 × 8 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified twice by fc (<i>d</i> = 2 cm, <i>l</i> = 18 cm, <i>V</i> = 10 mL, cyclohexane/ethyl acetate 90:10 + 1% <i>N</i>,<i>N</i>-dimethylethanamine; <i>d</i> = 1.5 cm, <i>l</i> = 23 cm, <i>V</i> = 5 mL, cyclohexane/ethyl acetate 80:20 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). Colorless oil, yield 15 mg (22%). C<sub>25</sub>H<sub>32</sub>FNO (381.5 g/mol). <i>R<sub>f</sub></i> = 0.40 (cyclohexane/ethyl acetate 50:50 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 382.2526 (calcd 382.2541 for C<sub>25</sub>H<sub>33</sub>FNO<sub>2</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.51–1.63 (m, 2H, 2′-<i>H</i>, 3′-<i>H</i>), 1.66–1.94 (m, 5H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>), 1.94–2.15 (m, 2H, C<i>H</i><sub>2</sub>CH<sub>2</sub>F), 2.15–2.22 (m, 1H, 2′-<i>H</i>), 2.31 (s, 3H, 4–C<i>H</i><sub>3</sub>), 2.35 (s, 3H, 2–C<i>H</i><sub>3</sub>), 2.63–2.71 (m, 2H, 4′-<i>H</i><sub>ax</sub>, 4-<i>H</i>), 2.76 (dd, <i>J</i> = 15.8/10.8 Hz, 1H, 4-<i>H</i>), 3.82 (s, 2H, ArC<i>H</i><sub>2</sub>NH), 3.95 (ddt, <i>J</i> = 10.7/9.0/3.4 Hz, 1H, 3-<i>H</i>), 4.65 (dddd, <i>J</i> = 46.8/9.4/5.4/4.4 Hz, 1H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 4.76 (dtd, <i>J</i> = 47.5/9.0/4.4 Hz, 1H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 6.97–7.03 (m, 2H, 3-<i>H</i><sub>benzyl</sub>, 5-<i>H</i><sub>benzyl</sub>), 7.05–7.11 (m, 2H, 5-<i>H</i>, 8-<i>H</i>), 7.11–7.18 (m, 2H, 6-<i>H</i>, 7-<i>H</i>), 7.18–7.24 (m, 1H, 6-<i>H</i><sub>benzyl</sub>). A signal for the NH proton is not observed in the spectrum. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 19.1 (1C, 2-<i>C</i>H<sub>3</sub>), 21.1 (1C, 4-<i>C</i>H<sub>3</sub>), 28.89 (1C, <i>C</i>-3′), 28.94 (1C, <i>C</i>-5′), 34.2 (1C, <i>C</i>-2′), 35.7 (1C, <i>C</i>-4), 37.0 (d, <i>J</i> = 19.4 Hz, 1C, <i>C</i>H<sub>2</sub>CH<sub>2</sub>F), 38.6 (1C, <i>C</i>-6′), 48.5 (1C, Ar<i>C</i>H<sub>2</sub>NH), 56.3 (1C, <i>C</i>-4′), 64.0 (d, <i>J</i> = 4.9 Hz, 1C, <i>C</i>-3), 75.4 (1C, <i>C</i>-1), 81.1 (d, <i>J</i> = 163.6 Hz, 1C, CH<sub>2</sub><i>C</i>H<sub>2</sub>F), 125.1 (1C, <i>C</i>-8), 126.2 (1C, <i>C</i>-6 or <i>C</i>-7), 126.3 (1C, <i>C</i>-6 or <i>C</i>-7), 126.7 (1C, <i>C</i>-5<sub>benzyl</sub>), 128.7 (1C, <i>C</i>-6<sub>benzyl</sub>), 128.9 (1C, <i>C</i>-5), 131.3 (1C, <i>C</i>-3<sub>benzyl</sub>), 133.7 (1C, <i>C</i>-4a), 135.6 (1C, <i>C</i>-1<sub>benzyl</sub>), 136.3 (1C, <i>C</i>-2<sub>benzyl</sub>), 136.7 (1C, <i>C</i>-4<sub>benzyl</sub>), 142.5 (1C, <i>C</i>-8a). FT-IR (neat): ν [cm<sup>–1</sup>] = 3017 (N–H), 2924, 2855 (C–H<sub>alkyl</sub>), 1447 (C═C<sub>arom</sub>). Purity (HPLC): 97.4%, <i>t</i><sub>R</sub> = 21.4 min.</div></div><div id="sec7_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51">7.2.24.  <i>trans</i>-1-Cyclohexyl-4-[3-(2-fluoroethyl)-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-4′-yl]piperazine (<b>13c</b>)</h4><div class="NLM_p last">A solution of alcohol <b>12c</b> (35 mg, 0.09 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (4 mL) was added dropwise to a solution of DAST (0.03 mL, 0.23 mmol, 2.6 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) under N<sub>2</sub> atmosphere at −78 °C. After 1 h, the mixture was warmed to rt and stirred for 23 h. 1 M NaOH (3 mL) was added, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (4 × 5 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 1 cm, <i>l</i> = 18 cm, <i>V</i> = 5 mL, cyclohexane/ethyl acetate 66:33 + 2% <i>N</i>,<i>N</i>-dimethylethanamine). Colorless solid, mp 167 °C, yield 24 mg (67%). C<sub>26</sub>H<sub>39</sub>FN<sub>2</sub>O (414.6 g/mol). <i>R<sub>f</sub></i> = 0.35 (cyclohexane/ethyl acetate 66:33 + 2% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 415.3103 (calcd 415.3119 for C<sub>26</sub>H<sub>40</sub>FN<sub>2</sub>O<sub>2</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.07–1.20 (m, 1H, 4-<i>H</i><sub>cyclohexyl</sub>), 1.20–1.34 (m, 4H, 2-<i>H</i><sub>cyclohexyl</sub>, 3-<i>H</i><sub>cyclohexyl</sub>, 5-<i>H</i><sub>cyclohexyl</sub>, 6-<i>H</i><sub>cyclohexyl</sub>), 1.38–1.46 (m, 1H, 2′-<i>H</i>), 1.61–1.68 (m, 1H, 4-<i>H</i><sub>cyclohexyl</sub>), 1.69–1.92 (m, 8H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>, 2-<i>H</i><sub>cyclohexyl</sub>, 6-<i>H</i><sub>cyclohexyl</sub>), 1.92–2.15 (m, 4H, C<i>H</i><sub>2</sub>CH<sub>2</sub>F, 3-<i>H</i><sub>cyclohexyl</sub>, 5-<i>H</i><sub>cyclohexyl</sub>), 2.20–2.34 (m, 3H, 2′-<i>H</i>, 4′-<i>H</i><sub>equ</sub>, 1-<i>H</i><sub>cyclohexyl</sub>), 2.48–2.80 (m, 10H, 4-<i>H</i>, <i>H</i><sub>pperazine</sub>), 3.95 (ddt, <i>J</i> = 10.6/9.3/3.3 Hz, 1H, 3-<i>H</i>), 4.59 (ddd, <i>J</i> = 9.4/5.6/4.3 Hz, 0.5H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 4.67–4.74 (m, 2 × 0.5H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 4.83 (td, <i>J</i> = 9.0/4.4 Hz, 0.5H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 7.05 (d, <i>J</i> = 7.5 Hz, 1H, 5-<i>H</i>), 7.12 (td, <i>J</i> = 6.9/6.1/2.3 Hz, 1H, 6-<i>H</i>), 7.15–7.22 (m, 2H, 7-<i>H</i>, 8-<i>H</i>). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 24.0 (1C, <i>C</i>-3′ or <i>C</i>-5′), 24.1 (1C, <i>C</i>-3′ or <i>C</i>-5′), 26.0 (2C, <i>C</i>-2<sub>cyclohexyl</sub>, <i>C</i>-6<sub>cyclohexyl</sub>), 26.4 (1C, <i>C</i>-4<sub>cyclohexyl</sub>), 29.1 (2C, <i>C</i>-3<sub>cyclohexyl</sub>, <i>C</i>-5<sub>cyclohexyl</sub>), 29.6 (1C, <i>C</i>-6′), 34.1 (1C, <i>C</i>-2′), 35.9 (1C, <i>C</i>-4), 37.1 (d, <i>J</i> = 19.4 Hz, 1C, <i>C</i>H<sub>2</sub>CH<sub>2</sub>F), 49.9 (2C, <i>C</i>-2<sub>piperazine</sub> and <i>C</i>-6<sub>piperazine</sub> or <i>C</i>-3<sub>piperazine</sub> and <i>C</i>-5<sub>piperazine</sub>), 50.5 (2C, <i>C</i>-2<sub>piperazine</sub> and <i>C</i>-6<sub>piperazine</sub> or <i>C</i>-3<sub>piperazine</sub> and <i>C</i>-5<sub>piperazine</sub>), 57.5 (1C, <i>C</i>-4′), 63.8 (1C, <i>C</i>-1<sub>cyclohexyl</sub>), 63.9 (d, <i>J</i> = 5.0 Hz, 1C, <i>C</i>-3), 76.2 (1C, <i>C</i>-1), 81.1 (d, <i>J</i> = 163.6 Hz, 1C, CH<sub>2</sub><i>C</i>H<sub>2</sub>F), 125.6 (1C, <i>C</i>-8), 126.0 (1C, <i>C</i>-6), 126.2 (1C, <i>C</i>-7), 128.7 (1C, <i>C</i>-5), 133.4 (1C, <i>C</i>-4a), 143.4 (1C, <i>C</i>-8a). FT-IR (neat): ν [cm<sup>–1</sup>] = 2916, 2851, 2801 (C–H<sub>alkyl</sub>), 1451 (C═C<sub>arom</sub>). Purity (HPLC): 93.6%, <i>t</i><sub>R</sub> = 16.6 min.</div></div><div id="sec7_2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52">7.2.25.  <i>cis</i>-1-Cyclohexyl-4-[3-(2-fluoroethyl)-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-4′-yl]piperazine (<b>13d</b>)</h4><div class="NLM_p last">A solution of alcohol <b>12d</b> (64 mg, 0.15 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was added dropwise to a solution of DAST (0.05 mL, 0.38 mmol, 2.5 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) under N<sub>2</sub> atmosphere at −78 °C. After 1 h, the mixture was warmed to rt and stirred for 20 h. 1 M NaOH (4 mL) was added, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (4 × 5 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 2 cm, <i>l</i> = 15 cm, <i>V</i> = 10 mL, cyclohexane/ethyl acetate 66:33 + 2% <i>N</i>,<i>N</i>-dimethylethanamine; <i>d</i> = 1.5 cm, <i>l</i> = 20 cm, <i>V</i> = 5 mL, cyclohexane/ethyl acetate 95:5 + 1% <i>N</i>,<i>N</i>-dimethylethanamine → 80:20 + 1% <i>N</i>,<i>N</i>-dimethylethanamine; <i>d</i> = 2 cm, <i>l</i> = 16 cm, <i>V</i> = 5 mL, cyclohexane/ethyl acetate 90:10 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). Yellow solid, mp 152 °C, yield 9 mg (13%). C<sub>26</sub>H<sub>39</sub>FN<sub>2</sub>O (414.6 g/mol). <i>R<sub>f</sub></i> = 0.17 (cyclohexane/ethyl acetate 66:33 + 2% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 415.3155 (calcd 415.3119 for C<sub>26</sub>H<sub>40</sub>FN<sub>2</sub>O<sub>2</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.04–1.17 (m, 1H, 4-<i>H</i><sub>cyclohexyl</sub>), 1.17–1.32 (m, 4H, 2-<i>H</i><sub>cyclohexyl</sub>, 3-<i>H</i><sub>cyclohexyl</sub>, 5-<i>H</i><sub>cyclohexyl</sub>, 6-<i>H</i><sub>cyclohexyl</sub>), 1.51–1.60 (m, 1H, 2′-<i>H</i>), 1.60–1.71 (m, 1H, 4-<i>H</i><sub>cyclohexyl</sub>), 1.71–1.90 (m, 8H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>, 2-<i>H</i><sub>cyclohexyl</sub>, 6-<i>H</i><sub>cyclohexyl</sub>), 1.90–2.14 (m, 4H, C<i>H</i><sub>2</sub>CH<sub>2</sub>F, 3-<i>H</i><sub>cyclohexyl</sub>, 5-<i>H</i><sub>cyclohexyl</sub>), 2.16–2.25 (m, 1H, 2′-<i>H</i>), 2.25–2.34 (m, 1H, 1-<i>H</i><sub>cyclohexyl</sub>), 2.42–2.52 (m, 1H, 4′-<i>H</i><sub>ax</sub>), 2.60–2.85 (m, 10H, 4-<i>H</i>, <i>H</i><sub>piperazine</sub>), 3.94 (ddt, <i>J</i> = 10.3/8.9/3.4 Hz, 1H, 3-<i>H</i>), 4.58 (ddd, <i>J</i> = 8.9/5.6/4.5 Hz, 0.5H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 4.66–4.73 (m, 2 × 0.5H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 4.82 (td, <i>J</i> = 9.1/4.4 Hz, 0.5H CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 7.06 (d, <i>J</i> = 7.4 Hz, 1H, 5-<i>H</i>), 7.08–7.11 (m, 1H, 8-<i>H</i>), 7.11–7.15 (m, 1H, 6-<i>H</i>), 7.15–7.20 (m, 1H, 7-<i>H</i>). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 23.7 (1C, <i>C</i>-5′), 23.9 (1C, <i>C</i>-3′), 26.0 (2C, <i>C</i>-2<sub>cyclohexyl</sub>, <i>C</i>-6<sub>cyclohexyl</sub>), 26.4 (1C, <i>C</i>-4<sub>cyclohexyl</sub>), 29.0 (2C, <i>C</i>-3<sub>cyclohexyl</sub>, <i>C</i>-5<sub>cyclohexyl</sub>), 34.8 (1C, <i>C</i>-2′), 35.7 (1C, <i>C</i>-4), 37.0 (d, <i>J</i> = 19.3 Hz, 1C, <i>C</i>H<sub>2</sub>CH<sub>2</sub>F), 39.0 (1C, <i>C</i>-6′), 49.3 (4C, <i>C</i><sub>piperazine</sub>), 63.2 (1C, <i>C</i>-4′), 63.8 (1C, <i>C</i>-1<sub>cyclohexyl</sub>), 64.0 (d, <i>J</i> = 4.9 Hz, 1C, <i>C</i>-3), 75.3 (1C, <i>C</i>-1), 81.1 (d, <i>J</i> = 163.8 Hz, 1C, CH<sub>2</sub><i>C</i>H<sub>2</sub>F), 125.1 (1C, <i>C</i>-8), 126.2 (1C, <i>C</i>-6 or <i>C</i>-7), 126.3 (1C, <i>C</i>-6 or <i>C</i>-7), 128.9 (1C, <i>C</i>-5), 133.6 (1C, <i>C</i>-4a), 142.3 (1C, <i>C</i>-8a). FT-IR (neat): ν [cm<sup>–1</sup>] = 2924, 2851, 2824 (C–H<sub>alkyl</sub>), 1450 (C═C<sub>arom</sub>). Purity (HPLC): 94.2%, <i>t</i><sub>R</sub> = 15.5 min.</div></div><div id="sec7_2_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53">7.2.26.  <i>trans</i>-6,7-Dimethoxy-2-[3-(2-fluoroethyl)-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-4′-yl]-1,2,3,4-tetrahydroisoquinoline (<b>13e</b>)</h4><div class="NLM_p last">A solution of alcohol <b>12e</b> (62 mg, 0.14 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (6 mL) was added dropwise to a solution of DAST (0.06 mL, 0.45 mmol, 3.2 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (8 mL) under N<sub>2</sub> atmosphere at −78 °C. After 1.5 h, the mixture was warmed to rt and stirred for 21 h. 1 M NaOH (5 mL) was added, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (4 × 8 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified twice by fc (<i>d</i> = 1.5 cm, <i>l</i> = 22 cm, <i>V</i> = 5 mL, cyclohexane/ethyl acetate 80:20 + 1% <i>N</i>,<i>N</i>-dimethylethanamine; <i>d</i> = 1.5 cm, <i>l</i> = 23 cm, <i>V</i> = 5 mL, cyclohexane/ethyl acetate 90:10 + 2% <i>N</i>,<i>N</i>-dimethylethanamine). Colorless solid, mp 125 °C, yield 15 mg (21%). C<sub>27</sub>H<sub>34</sub>FNO<sub>3</sub> (439.6 g/mol). <i>R<sub>f</sub></i> = 0.23 (cyclohexane/ethyl acetate 80:20 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 440.2627 (calcd 440.2595 for C<sub>27</sub>H<sub>35</sub>FNO<sub>3</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.44–1.52 (m, 1H, 2′-<i>H</i>), 1.77–2.19 (m, 8H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>, C<i>H</i><sub>2</sub>CH<sub>2</sub>F), 2.26–2.40 (m, 1H, 2′-<i>H</i>), 2.40–2.47 (m, 1H, 4′-<i>H</i><sub>equ</sub>), 2.65 (dd, <i>J</i> = 15.9/3.0 Hz, 1H, 4-<i>H</i>), 2.73 (dd, <i>J</i> = 15.9/5.1 Hz, 1H, 4-<i>H</i>), 2.77–2.83 (m, 2H, 3-<i>H</i><sub>isoquinoline</sub>), 2.83–2.91 (m, 2H, 4-<i>H</i><sub>isoquinoline</sub>), 3.68 (s, 2H, 1-<i>H</i><sub>isoquinoline</sub>), 3.86 (s, 3H, 7-OC<i>H</i><sub>3</sub>), 3.88 (s, 3H, 6-OC<i>H</i><sub>3</sub>), 3.91–4.06 (m, 1H, 3-<i>H</i>), 4.61 (dt, <i>J</i> = 9.3/5.0 Hz, 0.5H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 4.69–4.78 (m, 2 × 0.5H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 4.85 (td, <i>J</i> = 8.8/4.3 Hz, 0.5H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 6.60 (s, 1H, 8-<i>H</i><sub>isoquinoline</sub>), 6.66 (s, 1H, 5-<i>H</i><sub>isoquinoline</sub>), 7.04 (d, <i>J</i> = 6.6 Hz, 1H, 5-<i>H</i>), 7.07–7.17 (m, 3H, 6-<i>H</i>, 7-<i>H</i>, 8-<i>H</i>). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 24.4 (1C, <i>C</i>-3′), 24.6 (1C, <i>C</i>-5′), 29.4 (1C, <i>C</i>-4<sub>isoquinoline</sub>), 29.6 (1C, <i>C</i>-6′), 34.1 (1C, <i>C</i>-2′), 35.9 (1C, <i>C</i>-4), 37.1 (d, <i>J</i> = 19.3 Hz, 1C, <i>C</i>H<sub>2</sub>CH<sub>2</sub>F), 47.5 (1C, <i>C</i>-3<sub>isoquinoline</sub>), 53.5 (1C, <i>C</i>-1<sub>isoquinoline</sub>), 56.1 (2C, 6-O<i>C</i>H<sub>3</sub>, 7-O<i>C</i>H<sub>3</sub>), 57.2 (1C, <i>C</i>-4′), 63.9 (d, <i>J</i> = 4.7 Hz, 1C, <i>C</i>-3), 76.3 (1C, <i>C</i>-1), 81.1 (d, <i>J</i> = 163.7 Hz, 1C, CH<sub>2</sub><i>C</i>H<sub>2</sub>F), 109.9 (1C, <i>C</i>-8<sub>isoquinoline</sub>), 111.3 (1C, <i>C</i>-5<sub>isoquinoline</sub>), 125.8 (1C, <i>C</i>-6 or <i>C</i>-8), 126.0 (1C, <i>C</i>-6 or <i>C</i>-8), 126.3 (1C, <i>C</i>-7), 127.0 (1C, <i>C</i>-8a<sub>isoquinoline</sub>), 127.7 (1C, <i>C</i>-4a<sub>isoquinoline</sub>), 128.6 (1C, <i>C</i>-5), 133.3 (1C, <i>C</i>-4a), 143.2 (1C, <i>C</i>-8a), 147.4 (1C, <i>C</i>-7<sub>isoquinoline</sub>), 147.5 (1C, <i>C</i>-6<sub>isoquinoline</sub>). FT-IR (neat): ν [cm<sup>–1</sup>] = 2951, 2932, 2781 (C–H<sub>alkyl</sub>), 1520, 1462, 1447 (C═C<sub>arom</sub>). Purity (HPLC, method 1): 93.2%, <i>t</i><sub>R</sub> = 19.7 min.</div></div><div id="sec7_2_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54">7.2.27.  <i>cis</i>-6,7-Dimethoxy-2-[3-(2-fluoroethyl)-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-4′-yl]-1,2,3,4-tetrahydroisoquinoline (<b>13f</b>)</h4><div class="NLM_p last">A solution of alcohol <b>12f</b> (67 mg, 0.15 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (8 mL) was added dropwise to a solution of DAST (0.06 mL, 0.45 mmol, 3.0 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (6 mL) under N<sub>2</sub> atmosphere at −78 °C. After 1 h, the mixture was warmed to rt and stirred for 20 h. 1 M NaOH (5 mL) was added, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (4 × 6 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified twice by fc (<i>d</i> = 1.5 cm, <i>l</i> = 23 cm, <i>V</i> = 5 mL, cyclohexane/ethyl acetate 66:33 + 1% <i>N</i>,<i>N</i>-dimethylethanamine; <i>d</i> = 1.5 cm, <i>l</i> = 23 cm, <i>V</i> = 5 mL, cyclohexane/ethyl acetate 80:20 + 2% <i>N</i>,<i>N</i>-dimethylethanamine). Colorless solid, mp 136 °C, yield 18 mg (27%). C<sub>27</sub>H<sub>34</sub>FNO<sub>3</sub> (439.6 g/mol). <i>R<sub>f</sub></i> = 0.31 (cyclohexane/ethyl acetate 50:50 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 440.2613 (calcd 440.2595 for C<sub>27</sub>H<sub>35</sub>FNO<sub>3</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.56–1.68 (m, 1H, 2′-<i>H</i>), 1.74–2.15 (m, 8H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>, C<i>H</i><sub>2</sub>CH<sub>2</sub>F), 2.22–2.29 (m, 1H, 2′-<i>H</i>), 2.63–2.82 (m, 3H, 4-<i>H</i>, 4′-<i>H</i><sub>ax</sub>), 2.82–2.99 (m, 4H, 3-<i>H</i><sub>isoquinoline</sub>, 4-<i>H</i><sub>isoquinoline</sub>), 3.82 (s, 2H, 1-<i>H</i><sub>isoquinoline</sub>), 3.85 (s, 6H, 6-OC<i>H</i><sub>3</sub>, 7-OC<i>H</i><sub>3</sub>), 3.91–4.04 (m, 1H, 3-<i>H</i>), 4.69 (dddd, <i>J</i> = 46.7/9.2/5.3/4.4 Hz, 1H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 4.82 (dtd, <i>J</i> = 47.4/9.1/4.3 Hz, 1H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 6.55 (s, 1H, 8-<i>H</i><sub>isoquinoline</sub>), 6.60 (s, 1H, 5-<i>H</i><sub>isoquinoline</sub>), 7.06–7.10 (m, 1H, 5-<i>H</i>), 7.10–7.22 (m, 3H, 6-<i>H</i>, 7-<i>H</i>, 8-<i>H</i>). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 23.8 (2C, <i>C</i>-3′, <i>C</i>-5′), 29.1 (1C, C-4<sub>isoquinoline</sub>), 34.8 (1C, <i>C</i>-2′), 35.7 (1C, <i>C</i>-4), 37.1 (d, <i>J</i> = 19.3 Hz, 1C, <i>C</i>H<sub>2</sub>CH<sub>2</sub>F), 39.1 (1C, <i>C</i>-6′), 47.0 (1C, C-3<sub>isoquinoline</sub>), 51.5 (1C, C-1<sub>isoquinoline</sub>), 56.07 (1C, 6-O<i>C</i>H<sub>3</sub> or 7-O<i>C</i>H<sub>3</sub>), 56.12 (1C, 6-O<i>C</i>H<sub>3</sub> or 7-O<i>C</i>H<sub>3</sub>), 62.7 (1C, <i>C</i>-4′), 64.0 (d, <i>J</i> = 4.7 Hz, 1C, <i>C</i>-3), 75.2 (1C, <i>C</i>-1), 81.2 (d, <i>J</i> = 164.0 Hz, 1C, CH<sub>2</sub><i>C</i>H<sub>2</sub>F), 109.8 (1C, C-8<sub>isoquinoline</sub>), 111.6 (1C, C-5<sub>isoquinoline</sub>), 125.1 (1C, <i>C</i>-8), 126.29 (1C, <i>C</i>-6 or <i>C</i>-7), 126.32 (1C, <i>C</i>-6 or <i>C</i>-7), 126.5 (1C, C-4a<sub>isoquinoline</sub>), 126.8 (1C, C-8a<sub>isoquinoline</sub>), 128.9 (1C, <i>C</i>-5), 133.6 (1C, <i>C</i>-4a), 142.2 (1C, <i>C</i>-8a), 147.4 (1C, C-7<sub>isoquinoline</sub>), 147.7 (1C, C-6<sub>isoquinoline</sub>). FT-IR (neat): ν [cm<sup>–1</sup>] = 2978, 2920 (C–H<sub>alkyl</sub>), 1512, 1462, 1443 (C═C<sub>arom</sub>). Purity (HPLC): 97.8%, <i>t</i><sub>R</sub> = 19.7 min.</div></div><div id="sec7_2_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55">7.2.28.  3-[1-(4-Fluorophenyl)indol-3-yl]propanoic Acid (<b>15</b>)</h4><div class="NLM_p last">A solution of 4-bromofluorobenzene (0.26 mL, 2.38 mmol), 3-(indol-3-yl)propionic acid (<b>14</b>, 500 mg, 2.64 mmol, 1.1 equiv), CuI (320 mg, 1.68 mmol, 0.7 equiv), and Cs<sub>2</sub>CO<sub>3</sub> (2.58 g, 7.93 mmol, 3.3 equiv) in DMF (20 mL) was heated to reflux for 2 d under N<sub>2</sub> atmosphere. After cooling to rt, ethyl acetate (100 mL) was added and the mixture was washed with 0.1 M HCl (2 × 80 mL). The aqueous layer was extracted with ethyl acetate (3 × 60 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 4 cm, <i>l</i> = 18 cm, <i>V</i> = 30 mL, cyclohexane/ethyl acetate 80:20 + 1% HCOOH). Brownish solid, mp 140 °C, yield 586 mg (78%). C<sub>17</sub>H<sub>14</sub>FNO<sub>2</sub> (283.3 g/mol). <i>R<sub>f</sub></i> = 0.69 (cyclohexane/ethyl acetate 50:50 + 1% HCOOH). HR-MS (APCI): <i>m</i>/<i>z</i> = 283.1077 (calcd 283.1081 for C<sub>17</sub>H<sub>15</sub>FNO<sub>2</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ (ppm) = 2.83 (t, <i>J</i> = 7.6 Hz, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CO), 3.17 (t, <i>J</i> = 7.6 Hz, 2H, C<i>H</i><sub>2</sub>CH<sub>2</sub>CO), 7.13 (s, 1H, 2-<i>H</i>), 7.17–7.22 (m, 3H, 5-<i>H</i>, 3-<i>H</i><sub>phenyl</sub>, 5-<i>H</i><sub>phenyl</sub>), 7.22–7.25 (m, 1H, 6-<i>H</i>), 7.41–7.44 (m, 2H, 2-<i>H</i><sub>phenyl</sub>, 6-<i>H</i><sub>phenyl</sub>), 7.44–7.47 (m, 1H, 7-<i>H</i>), 7.64–7.66 (m, 1H, 4-<i>H</i>). A signal for the COOH proton is not observed in the spectrum. <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ (ppm) = 20.4 (1C, <i>C</i>H<sub>2</sub>CH<sub>2</sub>CO), 34.5 (1C, CH<sub>2</sub><i>C</i>H<sub>2</sub>CO), 110.4 (1C, <i>C</i>-7), 115.8 (1C, <i>C</i>-3), 116.6 (d, <i>J</i> = 22.8 Hz, 2C, <i>C</i>-3<sub>phenyl</sub>, <i>C</i>-5<sub>phenyl</sub>), 119.2 (1C, <i>C</i>-4), 120.2 (1C, <i>C</i>-5), 122.9 (1C, <i>C</i>-6), 125.5 (1C, <i>C</i>-2), 126.1 (d, <i>J</i> = 8.1 Hz, 2C, <i>C</i>-2<sub>phenyl</sub>, <i>C</i>-6<sub>phenyl</sub>), 128.5 (1C, <i>C</i>-3a), 135.9 (d, <i>J</i> = 3.0 Hz, 1C, <i>C</i>-1<sub>phenyl</sub>), 136.5 (1C, <i>C</i>-7a), 161.1 (d, <i>J</i> = 246.2 Hz, 1C, <i>C</i>-4<sub>phenyl</sub>), 178.8 (1C, <i>C</i>═O). FT-IR (neat): ν [cm<sup>–1</sup>] = 3051 (COOH), 2978, 2909 (C–H<sub>alkyl</sub>), 1717 (C═O), 1512, 1458, 1450 (C═C<sub>arom</sub>). Purity (HPLC): 99.4%, <i>t</i><sub>R</sub> = 21.2 min.</div></div><div id="sec7_2_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56">7.2.29.  3-[1-(4-Fluorophenyl)indol-3-yl]propanamide (<b>16</b>)</h4><div class="NLM_p last">Et<sub>3</sub>N (1.0 mL, 7.2 mmol, 3.7 equiv) and ethyl chloroformate (0.28 mL, 2.94 mmol, 1.5 equiv) were added to a solution of <b>15</b> (548 mg, 1.93 mmol) in THF (10 mL) at 0 °C under N<sub>2</sub> atmosphere. After 1 h, NH<sub>3</sub> (0.5 M in THF, 20.0 mL, 10.0 mmol, 5.2 equiv) was added and the mixture was stirred for 2 h. The precipitate was filtered off, and the filtrate was concentrated in vacuo. H<sub>2</sub>O (50 mL) was added, and the aqueous phase was extracted with EtOAc (4 × 50 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. Brownish solid, mp 123 °C, yield 532 mg (97%). C<sub>17</sub>H<sub>15</sub>FN<sub>2</sub>O (282.3 g/mol). <i>R<sub>f</sub></i> = 0.22 (cyclohexane/ethyl acetate 50:50 + 1% HCOOH). HR-MS (APCI): <i>m</i>/<i>z</i> = 189.1012 (calcd 189.1022 for C<sub>17</sub>H<sub>16</sub>FN<sub>2</sub>O [MH<sup>+</sup>]). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 2.68 (t, <i>J</i> = 7.4 Hz, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CO), 3.17 (t, <i>J</i> = 7.2 Hz, 2H, C<i>H</i><sub>2</sub>CH<sub>2</sub>CO), 5.49 (s, 1H, CON<i>H</i><sub>2</sub>), 5.66 (s, 1H, CON<i>H</i><sub>2</sub>), 7.14 (s, 1H, 2-<i>H</i>), 7.15–7.21 (m, 3H, 5-<i>H</i>, 3-<i>H</i><sub>phenyl</sub>, 5-<i>H</i><sub>phenyl</sub>), 7.21–7.26 (m, 1H, 6-<i>H</i>), 7.39–7.44 (m, 2H, 2-<i>H</i><sub>phenyl</sub>, 6-<i>H</i><sub>phenyl</sub>), 7.44–7.48 (m, 1H, 7-<i>H</i>), 7.63–7.68 (m, 1H, 4-<i>H</i>). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 21.0 (1C, <i>C</i>H<sub>2</sub>CH<sub>2</sub>CO), 36.4 (1C, CH<sub>2</sub><i>C</i>H<sub>2</sub>CO), 110.5 (1C, <i>C</i>-7), 116.0 (1C, <i>C</i>-3), 116.6 (d, <i>J</i> = 22.9 Hz, 2C, <i>C</i>-3<sub>phenyl</sub>, <i>C</i>-5<sub>phenyl</sub>), 119.2 (1C, <i>C</i>-4), 120.2 (1C, <i>C</i>-5), 122.8 (1C, <i>C</i>-6), 125.7 (1C, <i>C</i>-2), 126.0 (d, <i>J</i> = 8.4 Hz, 2C, <i>C</i>-2<sub>phenyl</sub>, <i>C</i>-6<sub>phenyl</sub>), 128.5 (1C, <i>C</i>-3a), 135.9 (d, <i>J</i> = 3.0 Hz, 1C, <i>C</i>-1<sub>phenyl</sub>), 136.5 (1C, <i>C</i>-7a), 161.1 (d, <i>J</i> = 246.1 Hz, 1C, <i>C</i>-4<sub>phenyl</sub>), 175.3 (1C, <i>C</i>═O). FT-IR (neat): ν [cm<sup>–1</sup>] = 3395, 3206 (N–H), 2963, 2920 (C–H<sub>alkyl</sub>), 1654 (C═O), 1508, 1454 (C═C<sub>arom</sub>). Purity (HPLC): 93.2%, <i>t</i><sub>R</sub> = 19.8 min.</div></div><div id="sec7_2_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57">7.2.30.  3-[1-(4-Fluorophenyl)indol-3-yl]propan-1-amine (<b>17</b>)</h4><div class="NLM_p last">LiAlH<sub>4</sub> (150 mg, 3.94 mmol, 3.4 equiv) was added to a solution of amide <b>16</b> (329 mg, 1.17 mmol) in THF (25 mL) at 0 °C under N<sub>2</sub> atmosphere. The mixture was heated to reflux for 2 h. After cooling to rt, H<sub>2</sub>O (15 mL) was added, the precipitate was filtered off, and the aqueous phase was extracted with CH<sub>2</sub>Cl<sub>2</sub> (4 × 20 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 4 cm, <i>l</i> = 18 cm, <i>V</i> = 30 mL, CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH 95:5 + 3% NH<sub>3</sub> (25%)). Yellow oil, yield 200 mg (64%). C<sub>17</sub>H<sub>17</sub>FN<sub>2</sub> (268.3 g/mol). <i>R<sub>f</sub></i> = 0.13 (CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH 95:5 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 269.1464 (calcd 269.1449 for C<sub>17</sub>H<sub>18</sub>FN<sub>2</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.93 (quint, <i>J</i> = 7.5 Hz, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>NH<sub>2</sub>), 2.80–2.90 (m, 4H, C<i>H</i><sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>NH<sub>2</sub>), 7.09 (s, 1H, 2-<i>H</i>), 7.14–7.25 (m, 4H, 5-<i>H</i>, 6-<i>H</i>, 3-<i>H</i><sub>phenyl</sub>, 5-<i>H</i><sub>phenyl</sub>), 7.39–7.47 (m, 3H, 7-<i>H</i>, 2-<i>H</i><sub>phenyl</sub>, 6-<i>H</i><sub>phenyl</sub>), 7.64–7.67 (m, 1H, 4-<i>H</i>). A signal for the NH<sub>2</sub> protons is not observed in the spectrum. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 22.5 (1C, <i>C</i>H<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NH<sub>2</sub>), 33.9 (1C, CH<sub>2</sub><i>C</i>H<sub>2</sub>CH<sub>2</sub>NH<sub>2</sub>), 42.1 (1C, CH<sub>2</sub>CH<sub>2</sub><i>C</i>H<sub>2</sub>NH<sub>2</sub>), 110.3 (1C, <i>C</i>-7), 116.5 (d, <i>J</i> = 22.8 Hz, 2C, <i>C</i>-3<sub>phenyl</sub>, <i>C</i>-5<sub>phenyl</sub>), 117.5 (1C, <i>C</i>-3), 119.4 (1C, <i>C</i>-4), 120.0 (1C, <i>C</i>-5), 122.7 (1C, <i>C</i>-6), 125.2 (1C, <i>C</i>-2), 126.0 (d, <i>J</i> = 8.4 Hz, 2C, <i>C</i>-2<sub>phenyl</sub>, <i>C</i>-6<sub>phenyl</sub>), 129.0 (1C, <i>C</i>-3a), 136.1 (d, <i>J</i> = 3.0 Hz, 1C, <i>C</i>-1<sub>phenyl</sub>), 136.5 (1C, <i>C</i>-7a), 161.0 (d, <i>J</i> = 246.0 Hz, 1C, <i>C</i>-4<sub>phenyl</sub>). FT-IR (neat): ν [cm<sup>–1</sup>] = 3051 (N–H), 2924, 2851 (C–H<sub>alkyl</sub>), 1508, 1458 (C═C<sub>arom</sub>). Purity (HPLC): 94.7%, <i>t</i><sub>R</sub> = 17.9 min.</div></div><div id="sec7_2_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58">7.2.31.  <i>trans</i>-<i>N</i>-{3-[1-(4-Fluorophenyl)(indol-3-yl)]propyl}-3-methoxy-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-4′-amine (<b>18a</b>) and <i>cis</i>-<i>N</i>-{3-[1-(4-Fluorophenyl)(indol-3-yl)]propyl}-3-methoxy-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-4′-amine (<b>18b</b>)</h4><div class="NLM_p">A solution of ketone <b>5</b> (164 mg, 0.67 mmol), amine <b>17</b> (265 mg, 0.67 mmol, 1.5 equiv), and acetic acid (45 μL, 0.79 mmol, 1.2 equiv) in THF (20 mL) was stirred under N<sub>2</sub> atmosphere at rt. After 2.5 h, NaBH(OAc)<sub>3</sub> (252 mg, 1.19 mmol, 1.8 equiv) was added and the mixture was stirred for 17 h at rt. 1 M NaOH (10 mL) was added, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (4 × 20 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 3 cm, <i>l</i> = 19 cm, <i>V</i> = 20 mL, CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH 98:2 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). <b>18a</b> was eluted first and <b>18b</b> afterward.</div><div id="sec7_2_31_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> <i>trans-</i><b>18a</b></h5><div class="NLM_p last">Yellow oil, yield 99 mg (30%). C<sub>32</sub>H<sub>35</sub>FN<sub>2</sub>O<sub>2</sub> (498.6 g/mol). <i>R<sub>f</sub></i> = 0.51 (CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH 95:5 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 499.2770 (calcd 499.2755 for C<sub>32</sub>H<sub>36</sub>FN<sub>2</sub>O<sub>2</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ (ppm) = 1.55 (dq, <i>J</i> = 12.5/2.7 Hz, 1H, 2′-<i>H</i><sub>equ</sub>), 1.68–1.73 (m, 2H, 3′-<i>H</i>, 5′-<i>H</i>), 1.80 (ddt, <i>J</i> = 14.3/4.6/2.8 Hz, 1H, 6′-<i>H</i><sub>equ</sub>), 1.87 (td, <i>J</i> = 13.9/3.7 Hz, 1H, 6′-<i>H</i><sub>ax</sub>), 2.00–2.04 (m, 1H, 5′-<i>H</i>), 2.04–2.13 (m, 3H, 3′-<i>H</i>, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>NH), 2.13–2.19 (m, 1H, 2′-<i>H</i><sub>ax</sub>), 2.76–2.82 (m, 3H, 4-<i>H</i>, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>NH), 2.90 (dd, <i>J</i> = 15.7/2.9 Hz, 1H, 4-<i>H</i>), 2.91–2.96 (m, 3H, 4′-<i>H</i><sub>equ</sub>, C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NH), 3.53 (s, 3H, OC<i>H</i><sub>3</sub>), 4.88 (dd, <i>J</i> = 7.6/3.1 Hz, 1H, 3-<i>H</i>), 7.06 (d, <i>J</i> = 7.0 Hz, 1H, 5-<i>H</i>), 7.11–7.17 (m, 3H, 6-<i>H</i>, 7-<i>H</i>, 5-<i>H</i><sub>indole</sub>), 7.20 (ddd, <i>J</i> = 8.2/6.9/1.2 Hz, 1H, 6-<i>H</i><sub>indole</sub>), 7.26–7.30 (m, 3H, 2-<i>H</i><sub>indole</sub>, 3-<i>H</i><sub>phenyl</sub>, 5-<i>H</i><sub>phenyl</sub>), 7.32 (dd, <i>J</i> = 7.3/1.7 Hz, 1H, 8-<i>H</i>), 7.46 (d, <i>J</i> = 8.2 Hz, 1H, 7-<i>H</i><sub>indole</sub>), 7.50–7.54 (m, 2H, 2-<i>H</i><sub>phenyl</sub>, 6-<i>H</i><sub>phenyl</sub>), 7.69 (d, <i>J</i> = 7.7 Hz, 1H, 4-<i>H</i><sub>indole</sub>). A signal for the NH proton is not observed in the spectrum. <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ (ppm) = 24.0 (1C, <i>C</i>H<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NH), 26.1 (1C, <i>C</i>-3′), 26.3 (1C, <i>C</i>-5′), 30.7 (1C, CH<sub>2</sub><i>C</i>H<sub>2</sub>CH<sub>2</sub>NH), 31.5 (1C, <i>C</i>-6′), 34.1 (1C, <i>C</i>-2′), 36.2 (1C, <i>C</i>-4), 48.6 (1C, CH<sub>2</sub>CH<sub>2</sub><i>C</i>H<sub>2</sub>NH), 52.5 (1C, <i>C</i>-4′), 56.3 (1C, O<i>C</i>H<sub>3</sub>), 78.0 (1C, <i>C</i>-1), 97.8 (1C, <i>C</i>-3), 111.1 (1C, <i>C</i>-7<sub>indole</sub>), 117.4 (d, <i>J</i> = 23.1 Hz, 2C, <i>C</i>-3<sub>phenyl</sub>, <i>C</i>-5<sub>phenyl</sub>), 118.5 (1C, <i>C</i>-3<sub>indole</sub>), 120.2 (1C, <i>C</i>-4<sub>indole</sub>), 120.9 (1C, <i>C</i>-5<sub>indole</sub>), 123.6 (1C, <i>C</i>-6<sub>indole</sub>), 126.1 (1C, <i>C</i>-8), 126.4 (1C, <i>C</i>-2<sub>indole</sub>), 127.0 (d, <i>J</i> = 8.3 Hz, 2C, <i>C</i>-2<sub>phenyl</sub>, <i>C</i>-6<sub>phenyl</sub>), 127.5 (1C, <i>C</i>-7), 127.6 (1C, <i>C</i>-6), 130.0 (1C, <i>C</i>-5), 130.3 (1C, <i>C</i>-3a<sub>indole</sub>), 132.4 (1C, <i>C</i>-4a), 137.5 (d, <i>J</i> = 3.1 Hz, 1C, <i>C</i>-1<sub>phenyl</sub>), 137.8 (1C, <i>C</i>-7a<sub>indole</sub>), 143.4 (1C, <i>C</i>-8a), 162.2 (d, <i>J</i> = 244.0 Hz, 1C, <i>C</i>-4<sub>phenyl</sub>). FT-IR (neat): ν [cm<sup>–1</sup>] = 3318 (N–H), 2928, 2808 (C–H<sub>alkyl</sub>), 1508, 1458 (C═C<sub>arom</sub>). Purity (HPLC): 97.4%, <i>t</i><sub>R</sub> = 23.0 min.</div></div><div id="sec7_2_31_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> <i>cis-</i><b>18b</b></h5><div class="NLM_p last">Yellow solid, mp 118 °C, yield 138 mg (42%). C<sub>32</sub>H<sub>35</sub>FN<sub>2</sub>O<sub>2</sub> (498.6 g/mol). <i>R<sub>f</sub></i> = 0.49 (CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH 95:5 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 499.2769 (calcd 499.2755 for C<sub>32</sub>H<sub>36</sub>FN<sub>2</sub>O<sub>2</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ (ppm) = 1.62–1.72 (m, 2H, 2′-<i>H</i>, 3′-<i>H</i>), 1.72–1.86 (m, 4H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>), 1.94 (td, <i>J</i> = 13.7/4.1 Hz, 1H, 6′-<i>H</i>), 1.99–2.10 (m, 3H, 2′-<i>H</i>, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>NH), 2.71 (tt, <i>J</i> = 11.0/3.9 Hz, 1H, 4′-<i>H</i><sub>ax</sub>), 2.78 (dd, <i>J</i> = 15.6/7.5 Hz, 1H, 4-<i>H</i>), 2.81–2.85 (m, 2H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>NH), 2.88–2.93 (m, 3H, 4-<i>H</i>, C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NH), 3.53 (s, 3H, OCH<sub>3</sub>), 4.86–4.89 (m, 1H, 3-<i>H</i>), 7.05–7.08 (m, 1H, 5-<i>H</i>), 7.12–7.17 (m, 4H, 6-<i>H</i>, 7-<i>H</i>, 8-<i>H</i>, 5-<i>H</i><sub>indole</sub>), 7.17–7.21 (m, 1H, 6-<i>H</i><sub>indole</sub>), 7.25–7.30 (m, 3H, 2-<i>H</i><sub>indole</sub>, 3-<i>H</i><sub>phenyl</sub>, 5-<i>H</i><sub>phenyl</sub>), 7.46 (dt, <i>J</i> = 8.2/1.0 Hz, 1H, 7-<i>H</i><sub>indole</sub>), 7.49–7.55 (m, 2H, 2-<i>H</i><sub>phenyl</sub>, 6-<i>H</i><sub>phenyl</sub>), 7.67 (dt, <i>J</i> = 8.0/1.0 Hz, 1H, 4-<i>H</i><sub>indole</sub>). A signal for the NH proton is not observed in the spectrum. <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ (ppm) = 23.8 (1C, <i>C</i>H<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NH), 28.6 (1C, <i>C</i>-3′ or <i>C</i>-5′), 28.7 (1C, <i>C</i>-3′ or <i>C</i>-5′), 30.6 (1C, CH<sub>2</sub><i>C</i>H<sub>2</sub>CH<sub>2</sub>NH), 36.1 (1C, <i>C</i>-4), 36.4 (1C, <i>C</i>-2′), 38.9 (1C, <i>C</i>-6′), 47.3 (1C, CH<sub>2</sub>CH<sub>2</sub><i>C</i>H<sub>2</sub>NH), 56.4 (1C, O<i>C</i>H<sub>3</sub>), 57.3 (1C, <i>C</i>-4′), 77.3 (1C, <i>C</i>-1), 97.8 (1C, <i>C</i>-3), 111.1 (1C, <i>C</i>-7<sub>indole</sub>), 117.4 (d, <i>J</i> = 23.0 Hz, 2C, <i>C</i>-3<sub>phenyl</sub>, <i>C</i>-5<sub>phenyl</sub>), 118.3 (1C, <i>C</i>-3<sub>indole</sub>), 120.2 (1C, <i>C</i>-4<sub>indole</sub>), 120.9 (1C, <i>C</i>-5<sub>indole</sub>), 123.6 (1C, <i>C</i>-6<sub>indole</sub>), 125.6 (1C, <i>C</i>-6 or <i>C</i>-8), 126.4 (1C, <i>C</i>-2<sub>indole</sub>), 126.9 (d, <i>J</i> = 8.6 Hz, 2C, <i>C</i>-2<sub>phenyl</sub>, <i>C</i>-6<sub>phenyl</sub>), 127.5 (1C, <i>C</i>-7), 127.7 (1C, <i>C</i>-6 or <i>C</i>-8), 130.1 (1C, <i>C</i>-5), 130.3 (1C, <i>C</i>-3a<sub>indole</sub>), 132.6 (1C, <i>C</i>-4a), 137.5 (d, <i>J</i> = 3.2 Hz, 1C, <i>C</i>-1<sub>phenyl</sub>), 137.7 (1C, <i>C</i>-7a<sub>indole</sub>), 142.5 (1C, <i>C</i>-8a), 162.2 (d, <i>J</i> = 244.4 Hz, 1C, <i>C</i>-4<sub>phenyl</sub>). FT-IR (neat): ν [cm<sup>–1</sup>] = 3318 (N–H), 2928, 2851 (C–H<sub>alkyl</sub>), 1508, 1458 (C═C<sub>arom</sub>). Purity (HPLC): 98.3%, <i>t</i><sub>R</sub> = 23.0 min.</div></div></div><div id="sec7_2_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61">7.2.32.  3-Hydroxy-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-4′-one (<b>19</b>)</h4><div class="NLM_p last">A solution of acetal <b>5</b> (502 mg, 2.04 mmol) and 0.2 M HCl (50 mL, 10.0 mmol, 5 equiv) in THF (50 mL) was stirred at rt for 3 d. 1 M NaOH (25 mL) was added, and the aqueous layer was extracted with Et<sub>2</sub>O (3 × 30 mL) and CH<sub>2</sub>Cl<sub>2</sub> (1 × 30 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 3 cm, <i>l</i> = 18 cm, <i>V</i> = 20 mL, cyclohexane/ethyl acetate 67:33 → cyclohexane/ethyl acetate 1:1). Colorless solid, mp 169 °C, yield 448 mg (95%). C<sub>14</sub>H<sub>16</sub>O<sub>3</sub> (232.3 g/mol). <i>R<sub>f</sub></i> = 0.14 (cyclohexane/ethyl acetate 67:33). HR-MS (APCI): <i>m</i>/<i>z</i> = 215.1067 (calcd 215.1067 for C<sub>14</sub>H<sub>15</sub>O<sub>2</sub> [M-H<sub>2</sub>O+H<sup>+</sup>]). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) = 1.94–2.03 (m, 1H, 2′-<i>H</i>), 2.07–2.14 (m, 3H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>), 2.14–2.25 (m, 1H, 6′-<i>H</i>), 2.37 (td, <i>J</i> = 13.4/4.9 Hz, 1H, 2′-<i>H</i>), 2.69–2.82 (m, 3H, 4-<i>H</i>, 3′-<i>H</i>, 5′-<i>H</i>), 2.89 (dd, <i>J</i> = 15.8/3.0 Hz, 1H, 4-<i>H</i>), 5.24 (ddd, <i>J</i> = 7.3/5.3/3.0 Hz, 1H, 3-<i>H</i>), 6.56 (d, <i>J</i> = 5.3 Hz, 1H, 3-O<i>H</i>), 7.06–7.12 (m, 1H, 5-<i>H</i>), 7.12–7.18 (m, 2H, 6-<i>H</i>, 7-<i>H</i>), 7.22–7.28 (m, 1H, 8-<i>H</i>). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) = 35.3 (1C, <i>C</i>-6′), 36.3 (1C, <i>C</i>-4), 36.9 (1C, <i>C</i>-3′ or <i>C</i>-5′), 37.0 (1C, <i>C</i>-3′ or <i>C</i>-5′), 37.9 (1C, <i>C</i>-2′), 74.7 (1C, <i>C</i>-1), 88.7 (1C, <i>C</i>-3), 124.4 (1C, <i>C</i>-8), 126.2 (1C, <i>C</i>-7), 126.6 (1C, <i>C</i>-6), 129.1 (1C; <i>C</i>-5), 132.1 (1C, <i>C</i>-4a), 140.4 (1C, <i>C</i>-8a), 210.3 (1C, <i>C</i>-4′). FT-IR (neat): ν [cm<sup>–1</sup>] = 3283 (O–H), 2916, 2851 (C–H<sub>alkyl</sub>), 1686 (C═O), 1450, 1439, 1412 (C═C<sub>arom</sub>). Purity (HPLC): 96.4%, <i>t</i><sub>R</sub> = 14.8 min.</div></div><div id="sec7_2_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62">7.2.33.  Ethyl 2-(4′-Oxo-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-3-yl)acetate (<b>20</b>)</h4><div class="NLM_p last">A solution of lactol <b>19</b> (100 mg, 0.43 mmol), (ethoxycarbonylmethylene)triphenylphosphorane (211 mg, 0.60 mmol, 1.4 equiv) and Cs<sub>2</sub>CO<sub>3</sub> (141 mg, 0.43 mmol, 1.0 equiv) in toluene (15 mL) was heated to reflux under N<sub>2</sub> atmosphere for 2 d. After cooling to rt, H<sub>2</sub>O (10 mL) was added and the aqueous layer was extracted with Et<sub>2</sub>O (3 × 30 mL). The combined organic layers were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 2 cm, <i>l</i> = 20 cm, <i>V</i> = 10 mL, cyclohexane/ethyl acetate 90:10 → 80:20). Colorless solid, mp 83 °C, yield 81 mg (63%). C<sub>18</sub>H<sub>22</sub>O<sub>4</sub> (302.4 g/mol). <i>R<sub>f</sub></i> = 0.50 (cyclohexane/ethyl acetate 67:33). HR-MS (APCI): <i>m</i>/<i>z</i> = 303.1563 (calcd 303.1591 for C<sub>18</sub>H<sub>23</sub>O<sub>4</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.27 (t, <i>J</i> = 7.2 Hz, 3H, OCH<sub>2</sub>C<i>H</i><sub>3</sub>), 2.03 (td, <i>J</i> = 14.1/4.8 Hz, 1H, 2′-<i>H</i>), 2.06–2.12 (m, 1H, 6′-<i>H</i>), 2.22–2.36 (m, 3H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>), 2.48–2.54 (m, 1H, 2′-<i>H</i>), 2.63–2.73 (m, 2H, C<i>H</i><sub>2</sub>CO<sub>2</sub>Et), 2.76 (dd, <i>J</i> = 15.8/3.0 Hz, 1H, 4-<i>H</i>), 2.79–2.93 (m, 3H, 4-<i>H</i>, 3′-<i>H</i>, 5′-<i>H</i>), 4.11–4.24 (m, 2H, OC<i>H</i><sub>2</sub>CH<sub>3</sub>), 4.35–4.41 (m, 1H, 3-<i>H</i>), 7.07 (dd, <i>J</i> = 7.4/1.7 Hz, 1H, 8-<i>H</i>), 7.10–7.12 (m, 1H, 5-<i>H</i>), 7.16–7.22 (m, 2H, 6-<i>H</i>, 7-<i>H</i>). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ (ppm) = 14.4 (1C, OCH<sub>2</sub><i>C</i>H<sub>3</sub>), 35.0 (1C, <i>C</i>-4), 35.3 (1C, <i>C</i>-2′), 37.3 (1C, <i>C</i>-3′), 37.4 (1C, <i>C</i>-5′), 39.3 (1C, <i>C</i>-6′), 41.4 (1C, <i>C</i>H<sub>2</sub>CO<sub>2</sub>Et), 60.9 (1C, OCH<sub>2</sub><i>C</i>H<sub>3</sub>), 65.8 (1C, <i>C</i>-3), 75.0 (1C, <i>C</i>-1), 124.8 (1C, <i>C</i>-8), 126.7 (1C, <i>C</i>-7), 126.8 (1C, <i>C</i>-6), 129.1 (1C, <i>C</i>-5), 133.0 (1C, <i>C</i>-4a), 140.2 (1C, <i>C</i>-8a), 171.5 (1C, <i>C</i>═O), 212.2 (1C, <i>C</i>-4′). FT-IR (neat): ν [cm<sup>–1</sup>] = 2978, 2905 (C–H<sub>alkyl</sub>), 1724 (C═O<sub>ester</sub>), 1697 (C═O<sub>ketone</sub>), 1435, 1408 (C═C<sub>arom</sub>). Purity (HPLC): 96.0%, <i>t</i><sub>R</sub> = 21.0 min.</div></div><div id="sec7_2_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63">7.2.34.  Ethyl 2-(3,4-Dihydrodispiro[[2]benzopyran-1,1′-cyclohexan-4′,2″-[1,3]dioxolan]-3-yl)acetate (<b>21</b>)</h4><div class="NLM_p last">A solution of ester <b>20</b> (1.37 g, 4.52 mmol), ethylene glycol (6 mL, 107 mmol, 24 equiv), trimethyl orthoformate (3 mL, 27.4 mmol, 6 equiv), and <i>p</i>-toluenesulfonic acid (174 mg, 0.91 mmol, 0.2 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (100 mL) was stirred at rt for 24 h. The mixture was washed with saturated Na<sub>2</sub>CO<sub>3</sub> solution (2 × 60 mL) and brine (1 × 60 mL). The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. Yellow oil, yield 1.55 g (99%). C<sub>20</sub>H<sub>26</sub>O<sub>5</sub> (346.4 g/mol). <i>R<sub>f</sub></i> = 0.28 (CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH 99:1). HR-MS (APCI): <i>m</i>/<i>z</i> = 347.1873 (calcd 347.1853 for C<sub>20</sub>H<sub>27</sub>O<sub>5</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.30 (t, <i>J</i> = 7.2 Hz, 3H, OCH<sub>2</sub>C<i>H</i><sub>3</sub>), 1.55–1.64 (m, 2H, 3′-<i>H</i>, 5′-<i>H</i>), 1.71–1.76 (m, 1H, 6′-<i>H</i>), 1.86 (td, <i>J</i> = 13.9/3.7 Hz, 1H, 2′-<i>H</i>), 1.94 (td, <i>J</i> = 13.9/3.4 Hz, 1H, 3′-<i>H</i>), 2.04–2.12 (m, 1H, 5′-<i>H</i>), 2.14–2.21 (m, 2H, 2′-<i>H</i>, 6′-<i>H</i>), 2.58 (dd, <i>J</i> = 15.1/4.5 Hz, 1H, C<i>H</i><sub>2</sub>CO<sub>2</sub>Et), 2.66 (dd, <i>J</i> = 14.8/8.3 Hz, 1H, C<i>H</i><sub>2</sub>CO<sub>2</sub>Et), 2.71–2.80 (m, 2H, 4-<i>H</i>), 3.98 (s, 4H, OC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>O), 4.13–4.27 (m, 3H, 3-<i>H</i>, OC<i>H</i><sub>2</sub>CH<sub>3</sub>), 7.06 (d, <i>J</i> = 7.3 Hz, 1H, 5-<i>H</i>), 7.12–7.15 (m, 1H, 6-<i>H</i>), 7.16–7.20 (m, 2H, 7-<i>H</i>, 8-<i>H</i>). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ (ppm) = 14.4 (1C, OCH<sub>2</sub><i>C</i>H<sub>3</sub>), 30.46 (1C, <i>C</i>-3′), 30.50 (1C, <i>C</i>-5′), 32.9 (1C, <i>C</i>-2′), 35.2 (1C, <i>C</i>-4), 37.2 (1C, <i>C</i>-6′), 41.6 (1C, <i>C</i>H<sub>2</sub>CO<sub>2</sub>Et), 60.8 (1C, O<i>C</i>H<sub>2</sub>CH<sub>3</sub>), 64.3 (1C, O<i>C</i>H<sub>2</sub>CH<sub>2</sub>O), 64.4 (1C, OCH<sub>2</sub><i>C</i>H<sub>2</sub>O), 65.5 (1C, <i>C</i>-3), 75.4 (1C, <i>C</i>-1), 108.8 (1C, <i>C</i>-4′), 125.3 (1C, <i>C</i>-8), 126.3 (1C, <i>C</i>-6), 126.4 (1C, <i>C</i>-7), 128.8 (1C, <i>C</i>-5), 133.1 (1C, <i>C</i>-4a), 141.8 (1C, <i>C</i>-8a), 171.6 (1C, <i>C</i>═O). FT-IR (neat): ν [cm<sup>–1</sup>] = 2978, 2928, 2889 (C–H<sub>alkyl</sub>), 1728 (C═O), 1435, 1369 (C═C<sub>arom</sub>). Purity (HPLC): 90.0%, <i>t</i><sub>R</sub> = 22.4 min.</div></div><div id="sec7_2_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64">7.2.35.  2-(3,4-Dihydrodispiro[[2]benzopyran-1,1′-cyclohexan-4′,2″-[1,3]dioxolan]-3-yl)ethanol (<b>22</b>)</h4><div class="NLM_p last">LiAlH<sub>4</sub> (494 mg, 12.99 mmol, 2.9 equiv) was added slowly to a solution of ester <b>21</b> (1.54 g, 4.46 mmol) in Et<sub>2</sub>O (30 mL) at −20 °C under N<sub>2</sub> atmosphere. After stirring for 2 h, H<sub>2</sub>O (50 mL) was added, the precipitate was filtered off, and the aqueous layer was extracted with ethyl acetate (3 × 50 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 5 cm, <i>l</i> = 18 cm, <i>V</i> = 50 mL, cyclohexane/ethyl acetate 50:50). Colorless oil, yield 1.10 g (81%). C<sub>18</sub>H<sub>24</sub>O<sub>4</sub> (304.4 g/mol). <i>R<sub>f</sub></i> = 0.19 (cyclohexane/ethyl acetate 50:50). HR-MS (APCI): <i>m</i>/<i>z</i> = 305.1736 (calcd 305.1747 for C<sub>18</sub>H<sub>25</sub>O<sub>4</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.61–1.71 (m, 2H, 3′-<i>H</i>, 5′-<i>H</i>), 1.76–1.81 (m, 1H, 2′-<i>H</i>), 1.85–1.99 (m, 4H, 5′-<i>H</i>, 6′-<i>H</i>, C<i>H</i><sub>2</sub>CH<sub>2</sub>OH), 2.00–2.06 (m, 1H, 3′-<i>H</i>), 2.14–2.19 (m, 1H, 6′-<i>H</i>), 2.22 (td, <i>J</i> = 13.8/4.3 Hz, 1H, 2′-<i>H</i>), 2.64 (dd, <i>J</i> = 15.9/2.7 Hz, 1H, 4-<i>H</i>), 2.82 (dd, <i>J</i> = 15.6/11.2 Hz, 1H, 4-<i>H</i>), 3.85–3.95 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>OH), 4.00 (s, 4H, OC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>O), 4.00–4.04 (m, 1H, 3-<i>H</i>), 7.06 (d, <i>J</i> = 7.6 Hz, 1H, 5-<i>H</i>), 7.10–7.16 (m, 1H, 6-<i>H</i>), 7.17–7.19 (m, 2H, 7-<i>H</i>, 8-<i>H</i>). A signal for the OH proton is not observed in the spectrum. <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ (ppm) = 30.7 (1C, <i>C</i>-3′ or <i>C</i>-5′), 30.8 (1C, <i>C</i>-3′ or <i>C</i>-5′), 33.0 (1C,<i>C</i>-6′), 35.4 (1C, <i>C</i>-4), 37.1 (1C, <i>C</i>-2′), 38.2 (1C, <i>C</i>H<sub>2</sub>CH<sub>2</sub>OH), 60.6 (1C, CH<sub>2</sub><i>C</i>H<sub>2</sub>OH), 64.4 (1C, O<i>C</i>H<sub>2</sub>CH<sub>2</sub>O), 64.5 (1C, OCH<sub>2</sub><i>C</i>H<sub>2</sub>O), 67.3 (1C, <i>C</i>-3), 75.4 (1C, <i>C</i>-1), 108.5 (1C, <i>C</i>-4′), 125.3 (1C, <i>C</i>-8), 126.30 (1C, <i>C</i>-7), 126.33 (1C, <i>C</i>-6), 128.9 (1C, <i>C</i>-5), 133.5 (1C, <i>C</i>-4a), 141.7 (1C, <i>C</i>-8a). FT-IR (neat): ν [cm<sup>–1</sup>] = 3421 (O–H), 2928, 2886 (C–H<sub>alkyl</sub>), 1508, 1435 (C═C<sub>arom</sub>). Purity (HPLC): 95.4%, <i>t</i><sub>R</sub> = 18.0 min.</div></div><div id="sec7_2_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65">7.2.36.  3-(2-Fluoroethyl)-3,4-dihydrodispiro[[2]benzopyran-1,1′-cyclohexan-4′,2″-[1,3]dioxolan] (<b>23</b>)</h4><div class="NLM_p last">A solution of alcohol <b>22</b> (55 mg, 0.18 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added dropwise to a solution of DAST (0.05 mL, 0.38 mmol, 2.1 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) under N<sub>2</sub> atmosphere at −78 °C. After 1 h, the mixture was warmed to rt and stirred for 18 h. H<sub>2</sub>O (10 mL) was added, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (4 × 10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 1.5 cm, <i>l</i> = 19 cm, <i>V</i> = 5 mL, cyclohexane/ethyl acetate 90:10). Yellow oil, yield 27 mg (49%). C<sub>18</sub>H<sub>23</sub>FO<sub>3</sub> (306.4 g/mol). <i>R<sub>f</sub></i> = 0.66 (cyclohexane/ethyl acetate 67:33). HR-MS (APCI): <i>m</i>/<i>z</i> = 307.1690 (calcd 307.1704 for C<sub>18</sub>H<sub>24</sub>FO<sub>3</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.61–1.69 (m, 2H, 3′-<i>H</i>, 5′-<i>H</i>), 1.77 (ddt, <i>J</i> = 13.2/3.8/2.8 Hz, 1H, 2′-<i>H</i><sub>equ</sub>), 1.84–1.99 (m, 3H, 5′-<i>H</i>, 6′-<i>H</i>, C<i>H</i><sub>2</sub>CH<sub>2</sub>F), 2.04–2.18 (m, 3H, 3′-<i>H</i>, 6′-<i>H</i>, C<i>H</i><sub>2</sub>CH<sub>2</sub>F), 2.22 (td, <i>J</i> = 13.6/4.0 Hz, 1H, 2′-<i>H</i><sub>ax</sub>), 2.67 (dd, <i>J</i> = 15.8/2.8 Hz, 1H, 4-<i>H</i>), 2.76 (dd, <i>J</i> = 15.8/10.7 Hz, 1H, 4-<i>H</i>), 3.96 (ddt, <i>J</i> = 11.0/9.1/3.2 Hz, 1H, 3-<i>H</i>), 4.00 (s, 4H, OC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>O), 4.63 (dddd, <i>J</i> = 46.8/9.5/5.5/4.3 Hz, 1H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 4.76 (dtd, <i>J</i> = 47.6/9.4/4.1 Hz, 1H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 7.05–7.09 (m, 1H, 5-<i>H</i>), 7.11–7.17 (m, 1H, 6-<i>H</i>), 7.17–7.22 (m, 2H, 7-<i>H</i>, 8-<i>H</i>). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ (ppm) = 30.6 (1C, <i>C</i>-3′), 30.7 (1C, <i>C</i>-5′), 32.9 (1C, <i>C</i>-6′), 35.7 (1C, <i>C</i>-4), 37.0 (d, <i>J</i> = 19.3 Hz, 1C, <i>C</i>H<sub>2</sub>CH<sub>2</sub>F), 37.3 (1C, <i>C</i>-2′), 64.0 (d, <i>J</i> = 4.7 Hz, 1C, <i>C</i>-3), 64.4 (1C, O<i>C</i>H<sub>2</sub>CH<sub>2</sub>O), 64.5 (1C, OCH<sub>2</sub><i>C</i>H<sub>2</sub>O), 75.1 (1C, <i>C</i>-1), 81.0 (d, <i>J</i> = 163.4 Hz, 1C, CH<sub>2</sub><i>C</i>H<sub>2</sub>F), 108.7 (1C, <i>C</i>-4′), 125.3 (1C, <i>C</i>-8), 126.29 (1C, <i>C</i>-7), 126.32 (1C, <i>C</i>-6), 128.9 (1C, <i>C</i>-5), 133.5 (1C, <i>C</i>-4a), 142.0 (1C, <i>C</i>-8a). FT-IR (neat): ν [cm<sup>–1</sup>] = 2967, 2928, 2855 (C–H<sub>alkyl</sub>), 1489, 1439 (C═C<sub>arom</sub>). Purity (HPLC): 95.8%, <i>t</i><sub>R</sub> = 22.4 min.</div></div><div id="sec7_2_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66">7.2.37.  3-(2-Fluoroethyl)-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-4′-one (<b>24</b>)</h4><div class="NLM_p last">A solution of ketal <b>23</b> (694 mg, 2.27 mmol) and 2 M HCl (20 mL, 40.0 mmol, 17.6 equiv) in Et<sub>2</sub>O (50 mL) was heated to reflux for 3 d. After cooling to rt, H<sub>2</sub>O (20 mL) was added and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 30 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 4 cm, <i>l</i> = 18 cm, <i>V</i> = 30 mL, cyclohexane/ethyl acetate 90:10). Colorless solid, mp 105 °C, yield 566 mg (95%). C<sub>16</sub>H<sub>19</sub>FO<sub>2</sub> (262.3 g/mol). <i>R<sub>f</sub></i> = 0.39 (cyclohexane/ethyl acetate 80:20). HR-MS (APCI): <i>m</i>/<i>z</i> = 263.1459 (calcd 263.1442 for C<sub>16</sub>H<sub>20</sub>FO<sub>2</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.89–1.98 (m, 1H, C<i>H</i><sub>2</sub>CH<sub>2</sub>F), 1.98–2.07 (m, 1H, 2′-<i>H</i>), 2.07–2.23 (m, 2H, 6′-<i>H</i>, C<i>H</i><sub>2</sub>CH<sub>2</sub>F), 2.27–2.40 (m, 3H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>), 2.43–2.51 (m, 1H, 2′-<i>H</i>), 2.67–2.79 (m, 2H, 4-<i>H</i>, 3′-<i>H</i>), 2.83 (dd, <i>J</i> = 16.0/10.9 Hz, 1H, 4-<i>H</i>), 2.88–2.99 (m, 1H, 5′-<i>H</i>), 4.09 (ddt, <i>J</i> = 10.6/9.1/3.4 Hz, 1H, 3-<i>H</i>), 4.59 (ddd, <i>J</i> = 9.3/5.2/4.3 Hz, 0.5H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 4.70 (td, <i>J</i> = 9.6/4.4 Hz, 2 × 0.5H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 4.82 (td, <i>J</i> = 9.3/3.9 Hz, 0.5H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 7.05–7.10 (m, 1H, 8-<i>H</i>), 7.10–7.15 (m, 1H, 5-<i>H</i>), 7.15–7.23 (m, 2H, 6-<i>H</i>, 7-<i>H</i>). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 35.3 (1C, C-2′), 35.6 (1C, <i>C</i>-4), 36.9 (d, <i>J</i> = 19.2 Hz, 1C, <i>C</i>H<sub>2</sub>CH<sub>2</sub>F), 37.3 (1C, <i>C</i>-3′), 37.5 (1C, <i>C</i>-5′), 39.3 (1C, <i>C</i>-6′), 64.6 (d, <i>J</i> = 4.3 Hz, 1C, <i>C</i>-3), 74.7 (1C, <i>C</i>-1), 80.6 (d, <i>J</i> = 164.5 Hz, 1C, CH<sub>2</sub><i>C</i>H<sub>2</sub>F), 124.7 (1C, <i>C</i>-8), 126.6 (1C, <i>C</i>-7), 126.8 (1C, <i>C</i>-6), 129.2 (1C, <i>C</i>-5), 133.4 (1C, <i>C</i>-4a), 140.4 (1C, <i>C</i>-8a), 211.9 (1C, <i>C</i>═O). FT-IR (neat): ν [cm<sup>–1</sup>] = 2932, 2897 (C–H<sub>alkyl</sub>), 1705 (C═O), 1493, 1439 (C═C<sub>arom</sub>). Purity (HPLC): 97.0%, <i>t</i><sub>R</sub> = 20.9 min.</div></div><div id="sec7_2_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67">7.2.38.  <i>trans</i>-3-Methoxy-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-4′-amine (<b>25a</b>)</h4><div class="NLM_p last">A solution of amine <b>4a</b> (274 mg, 0.81 mmol) and 10% Pd/C (36 mg, 0.03 mmol, 4 mol %) in CH<sub>3</sub>OH (20 mL) was stirred at rt for 20 h under H<sub>2</sub> atmosphere. The mixture was filtered through Celite, washed with CH<sub>2</sub>Cl<sub>2</sub> (150 mL), concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 2 cm, <i>l</i> = 20 cm, <i>V</i> = 10 mL, CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH 95:5 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). Pale yellow solid, mp 94 °C, yield 143 mg (72%). C<sub>15</sub>H<sub>21</sub>NO<sub>2</sub> (247.3 g/mol). <i>R<sub>f</sub></i> = 0.09 (cyclohexane/ethyl acetate 67:33 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 248.1648 (calcd 248.1645 for C<sub>15</sub>H<sub>22</sub>NO<sub>2</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ (ppm) = 1.58–1.63 (m, 3H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>), 1.84–1.89 (m, 1H, 2′-<i>H</i>), 1.98 (td, <i>J</i> = 14.1/3.8 Hz, 1H, 2′-<i>H</i>), 2.11–2.20 (m, 1H, 3′-<i>H</i>), 2.20–2.30 (m, 2H, 5′-<i>H</i>, 6′-<i>H</i>), 2.80 (dd, <i>J</i> = 15.6/7.6 Hz, 1H, 4-<i>H</i>), 2.92 (dd, <i>J</i> = 15.6/3.1 Hz, 1H, 4-<i>H</i>), 3.26 (quint, <i>J</i> = 3.2 Hz, 1H, 4′-<i>H</i><sub>equ</sub>), 3.55 (s, 3H, OC<i>H</i><sub>3</sub>), 4.91 (dd, <i>J</i> = 7.6/3.1 Hz, 1H, 3-<i>H</i>), 7.08 (d, <i>J</i> = 7.5 Hz, 1H, 5-<i>H</i>), 7.15 (td, <i>J</i> = 7.4/1.3 Hz, 1H, 6-<i>H</i>), 7.18–7.22 (m, 1H, 7-<i>H</i>), 7.38 (dd, <i>J</i> = 7.7/1.3 Hz, 1H, 8-<i>H</i>). A signal for the NH<sub>2</sub> protons is not observed in the spectrum. <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ (ppm) = 28.8 (1C, <i>C</i>-5′), 29.0 (1C, <i>C</i>-3′), 31.0 (1C, <i>C</i>-2′), 33.6 (1C, <i>C</i>-6′), 36.2 (1C, <i>C</i>-4), 45.6 (1C, <i>C</i>-4′), 56.3 (1C, O<i>C</i>H<sub>3</sub>), 78.0 (1C, <i>C</i>-1), 97.8 (1C, <i>C</i>-3), 126.1 (1C, <i>C</i>-8), 127.5 (1C, <i>C</i>-7), 127.6 (1C, <i>C</i>-6), 130.0, (1C, <i>C</i>-5) 132.4 (1C, <i>C</i>-4a), 143.4 (1C, <i>C</i>-8a). FT-IR (neat): ν [cm<sup>–1</sup>] = 3360 (N–H), 2947, 2870 (C–H<sub>alkyl</sub>), 1562, 1447, 1431 (C═C<sub>arom</sub>). Purity (HPLC): 96.4%, <i>t</i><sub>R</sub> = 13.3 min.</div></div><div id="sec7_2_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68">7.2.39.  <i>cis</i>-3-Methoxy-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-4′-amine (<b>25b</b>)</h4><div class="NLM_p last">A solution of amine <b>4b</b> (326 mg, 0.97 mmol) and 10% Pd/C (41 mg, 0.04 mmol, 4 mol %) in CH<sub>3</sub>OH (20 mL) was stirred at rt for 19 h under H<sub>2</sub> atmosphere. The mixture was filtered through Celite, washed with CH<sub>2</sub>Cl<sub>2</sub> (150 mL), concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 2 cm, <i>l</i> = 20 cm, <i>V</i> = 10 mL, CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH 97:3 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). Pale yellow solid, mp 114 °C, yield 202 mg (89%). C<sub>15</sub>H<sub>21</sub>NO<sub>2</sub> (247.3 g/mol). <i>R<sub>f</sub></i> = 0.17 (CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH 95:5 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 248.1626 (calcd 248.1645 for C<sub>15</sub>H<sub>22</sub>NO<sub>2</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ (ppm) = 1.72–1.94 (m, 6H, 2′-<i>H</i><sub>ax</sub>, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>), 1.99–2.07 (m, 1H, 6′-<i>H</i>), 2.11 (dq, <i>J</i> = 14.0/3.0 Hz, 1H, 2′-<i>H</i><sub>equ</sub>), 2.80 (dd, <i>J</i> = 15.7/7.3 Hz, 1H, 4-<i>H</i>), 2.92 (dd, <i>J</i> = 15.8/3.1 Hz, 1H, 4-<i>H</i>), 3.01–3.08 (m, 1H, 4′-<i>H</i><sub>ax</sub>), 3.56 (s, 3H, OC<i>H</i><sub>3</sub>), 4.91 (dd, <i>J</i> = 7.4/3.1 Hz, 1H, 3-<i>H</i>), 7.08 (d, <i>J</i> = 7.6 Hz, 1H, 5-<i>H</i>), 7.13–7.20 (m, 3H, 6-<i>H</i>, 7-<i>H</i>, 8-<i>H</i>). A signal for the NH<sub>2</sub> protons is not observed in the spectrum. <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ (ppm) = 29.9 (1C, <i>C</i>-3′ or <i>C</i>-5′), 30.0 (1C, <i>C</i>-3′ or <i>C</i>-5′), 36.1 (1C, <i>C</i>-4), 36.3 (1C, <i>C</i>-2′), 38.7 (1C, <i>C</i>-6′), 50.7 (1C, <i>C</i>-4′), 56.4 (1C, O<i>C</i>H<sub>3</sub>), 76.7 (1C, <i>C</i>-1), 97.9 (1C, <i>C</i>-3), 125.6 (1C, <i>C</i>-8), 127.6 (1C, <i>C</i>-7), 127.8 (1C, <i>C</i>-6), 130.2 (1C, <i>C</i>-5), 132.6 (1C, <i>C</i>-4a), 142.2 (1C, <i>C</i>-8a). FT-IR (neat): ν [cm<sup>–1</sup>] = 3445, 3352 (N–H), 2928, 2859 (C–H<sub>alkyl</sub>), 1574, 1443, 1385 (C═C<sub>arom</sub>). Purity (HPLC, method 1): 98.6%, <i>t</i><sub>R</sub> = 13.4 min.</div></div><div id="sec7_2_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69">7.2.40.  <i>trans</i>-3-Methoxy-<i>N</i>-(6,7,8,9-tetrahydro-5<i>H</i>-benzo[7]annulen-7-yl)-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-4′-amine (<b>27a</b>)</h4><div class="NLM_p last">A solution of ketone <b>26</b> (52 mg, 0.32 mmol), amine <b>25a</b> (77 mg, 0.31 mmol, 1.0 equiv), and acetic acid (18 μL, 0.32 mmol, 1.0 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was stirred under N<sub>2</sub> atmosphere at rt. After 30 min, NaBH(OAc)<sub>3</sub> (119 mg, 0.56 mmol, 1.8 equiv) was added and the mixture was stirred for 3 h at rt. 1 M NaOH (15 mL) was added, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 20 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 2.5 cm, <i>l</i> = 20 cm, <i>V</i> = 10 mL, cyclohexane/ethyl acetate 80:20 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). Colorless oil, yield 58 mg (48%). C<sub>26</sub>H<sub>33</sub>NO<sub>2</sub> (391.6 g/mol). <i>R<sub>f</sub></i> = 0.32 (cyclohexane/ethyl acetate 50:50 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 392.2599 (calcd 392.2584 for C<sub>26</sub>H<sub>34</sub>NO<sub>2</sub> [MH<sup>+</sup>]). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ (ppm) = 1.25–1.37 (m, 2H, 6-<i>H</i><sub>benzannulene</sub>, 8-<i>H</i><sub>benzannulene</sub>), 1.64 (dt, <i>J</i> = 12.6/3.0 Hz, 1H, 2′-<i>H</i>), 1.71–1.78 (m, 2H, 3′-<i>H</i>, 5′-<i>H</i>), 1.85–1.92 (m, 1H, 6′-<i>H</i>), 1.96 (td, <i>J</i> = 13.5/3.6 Hz, 1H, 6′-<i>H</i>), 2.06–2.29 (m, 5H, 2′-<i>H</i>, 3′-<i>H</i>, 5′-<i>H</i>, 6-<i>H</i><sub>benzannulene</sub>, 8-<i>H</i><sub>benzannulene</sub>), 2.78–2.87 (m, 5H, 4-H, 5-<i>H</i><sub>benzannulene</sub>, 9-<i>H</i><sub>benzannulene</sub>), 2.89–2.98 (m, 2H, 4-<i>H</i>, 7-<i>H</i><sub>benzannulene</sub>), 3.18 (quint, <i>J</i> = 3.1 Hz, 1H, 4′-<i>H</i><sub>equ</sub>), 3.58 (s, 3H, OC<i>H</i><sub>3</sub>), 4.93 (dd, <i>J</i> = 7.5/3.2 Hz, 1H, 3-<i>H</i>), 7.08–7.14 (m, 5H, 5-<i>H</i>, 1-<i>H</i><sub>benzannulene</sub>, 2-<i>H</i><sub>benzannulene</sub>, 3-<i>H</i><sub>benzannulene</sub>, 4-<i>H</i><sub>benzannulene</sub>), 7.17 (td, <i>J</i> = 7.4/1.4 Hz, 1H, 6-<i>H</i>), 7.22 (td, <i>J</i> = 7.5/1.6 Hz, 1H, 7-<i>H</i>), 7.35 (dd, <i>J</i> = 7.7/1.4 Hz, 1H, 8-<i>H</i>). A signal for the NH proton is not observed in the spectrum. <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ (ppm) = 26.6 (1C, <i>C</i>-3′), 26.8 (1C, <i>C</i>-5′), 31.6 (1C, <i>C</i>-6′), 33.5 (2C, <i>C</i>-5<sub>benzannulene</sub>, <i>C</i>-9<sub>benzannulene</sub>), 34.2 (1C, <i>C</i>-2‘), 35.7 (2C, <i>C</i>-6<sub>benzannulene</sub>, <i>C</i>-8<sub>benzannulene</sub>), 36.2 (1C, <i>C</i>-4), 48.5 (1C, <i>C</i>-4‘), 56.3 (1C, O<i>C</i>H<sub>3</sub>), 60.0 (1C, C-7<sub>benzannulene</sub>), 78.0 (1C, <i>C</i>-1), 97.8 (1C, <i>C</i>-3), 126.0 (1C, <i>C</i>-8), 127.3 (2C, <i>C</i>-2<sub>benzannulene</sub>, <i>C</i>-3<sub>benzannulene</sub>), 127.5 (1C, <i>C</i>-7), 127.6 (1C, <i>C</i>-6), 129.8 (2C, <i>C</i>-1<sub>benzannulene</sub>, <i>C</i>-4<sub>benzannulene</sub>), 130.0 (1C, <i>C</i>-5), 132.4 (1C, <i>C</i>-4a), 143.4 (1C, <i>C</i>-8a), 143.7 (2C, <i>C</i>-4a<sub>benzannulene</sub>, <i>C</i>-9a<sub>benzannulene</sub>). FT-IR (neat): ν [cm<sup>–1</sup>] = 3314 (N–H), 2924, 2843 (C–H<sub>alkyl</sub>), 1489, 1443 (C═C<sub>arom</sub>). Purity (HPLC, method 1): 99.1%, <i>t</i><sub>R</sub> = 20.0 min.</div></div><div id="sec7_2_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70">7.2.41.  <i>cis</i>-3-Methoxy-<i>N</i>-(6,7,8,9-tetrahydro-5<i>H</i>-benzo[7]annulen-7-yl)-3,4-dihydrospiro([2]benzopyran-1,1′-cyclohexan)-4′-amine (<b>27b</b>)</h4><div class="NLM_p last">A solution of ketone <b>26</b> (50.0 mg, 0.31 mmol, 1.0 equiv), amine <b>25b</b> (77.0 mg, 0.31 mmol, 1.0 equiv), and NaBH(OAc)<sub>3</sub> (132 mg, 0.62 mmol, 2.0 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (4 mL) was stirred for 12 h at rt. A saturated solution of NaHCO<sub>3</sub> (10 mL) and CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was added, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 2 cm, <i>l</i> = 25 cm, <i>V</i> = 7 mL, cyclohexane:ethyl acetate = 20:80 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). Colorless solid, mp 132 °C, yield 34 mg (28%). C<sub>26</sub>H<sub>33</sub>NO<sub>2</sub> (391.6). <i>R<sub>f</sub></i> = 0.36 (cyclohexane/ethyl acetate = 1:9 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 392.2572 (calcd 392.2584 for C<sub>26</sub>H<sub>34</sub>NO<sub>2</sub> [M + H]<sup>+</sup>). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ [ppm] = 1.18–1.26 (m, 2H, 6-<i>H</i><sub>benzannulene</sub>, 8-<i>H</i><sub>benzannulene</sub>), 1.66–1.80 (m, 3H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>), 1.82–1.89 (m, 3H, 2′-<i>H</i>, 3′-<i>H</i>, 5′-<i>H</i>), 2.01 (dt, <i>J</i> = 13.6/4.2 Hz, 1H, 2′-<i>H</i>), 2.10 (dt, <i>J</i> = 10.5/3.0 Hz, 1H, 6′-<i>H</i>), 2.16–2.23 (m, 2H, 6-<i>H</i><sub>benzannulene</sub>, 8-<i>H</i><sub>benzannulene</sub>), 2.77–2.89 (m, 6H, 5-<i>H</i><sub>benzannulene</sub>, 9-<i>H</i><sub>benzannulene</sub>, 4′-<i>H</i><sub>ax</sub>, 4-<i>H</i>), 2.91 (dd, <i>J</i> = 15.6/3.0 Hz, 1H, 4-<i>H</i>), 3.01 (tt, <i>J</i> = 10.6/3.5 Hz, 1H, 7-<i>H</i><sub>benzannulene</sub>), 3.57 (s, 3H, OC<i>H</i><sub>3</sub>), 4.90 (dd, <i>J</i> = 7.5/3.1 Hz, 1H, 3-<i>H</i>), 7.05–7.10 (m, 5H, 5-<i>H</i>, 1-<i>H</i><sub>benzannulene</sub>, 2-<i>H</i><sub>benzannulene</sub>, 3-<i>H</i><sub>benzannulene</sub>, 4-<i>H</i><sub>benzannulene</sub>), 7.13–7.20 (m, 3H, 6-<i>H</i>, 7-<i>H</i>, 8-<i>H</i>). A signal for the NH proton is not observed in the spectrum. <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ [ppm] = 29.5 (1C, <i>C</i>-3′), 29.7 (1C, <i>C</i>-5′), 33.4 (2C, <i>C</i>-5<sub>benzannulene</sub>, <i>C</i>-9<sub>benzannulene</sub>), 35.51 (1C, <i>C</i>-6<sub>benzannulene</sub> or <i>C</i>-8<sub>benzannulene</sub>), 35.53 (1C, <i>C</i>-6<sub>benzannulene</sub> or <i>C</i>-8<sub>benzannulene</sub>), 36.2 (1C, <i>C</i>-4), 36.8 (1C, <i>C</i>-6‘), 39.3 (1C, <i>C</i>-2′), 53.5 (1C, <i>C</i>-4′). 56.5 (1C, O<i>C</i>H<sub>3</sub>), 59.0 (1C, <i>C</i>-7<sub>benzannulene</sub>), 77.6 (1C, <i>C</i>-1), 97.8 (1C, <i>C</i>-3), 125.7 (1C, <i>C</i>-8), 127.3 (2C, <i>C</i>-2<sub>benzannulene</sub>, <i>C</i>-3<sub>benzannulene</sub>), 127.5 (1C, <i>C</i>-6), 127.6 (1C, <i>C</i>-7), 129.8 (2C, <i>C</i>-1<sub>benzannulene</sub>, <i>C</i>-4<sub>benzannulene</sub>), 130.1 (1C, <i>C</i>-5), 132.6 (1C, <i>C</i>-4a), 142.8 (1C, <i>C</i>-8a), 143.6 (2C, <i>C</i>-4a<sub>benzannulene</sub>, <i>C</i>-9a<sub>benzannulene</sub>). FT-IR (neat): ν̃ [cm<sup>–1</sup>] = 3024, 2924 (C–H), 1489, 1443 (C═C). Purity (HPLC): 95.3%, <i>t</i><sub>R</sub> = 19.9 min.</div></div><div id="sec7_2_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71">7.2.42.  <i>trans</i>-<i>N</i>-Benzyl-3-(2-fluoroethyl)-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-4′-amine (<b>28a</b>) and <i>cis</i>-<i>N</i>-Benzyl-3-(2-fluoroethyl)-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-4′-amine (<b>28b</b>)</h4><div class="NLM_p">A solution of ketone <b>24</b> (248 mg, 0.94 mmol), benzylamine (distilled, 0.16 mL, 1.47 mmol, 1.6 equiv), acetic acid (59 μL, 1.04 mmol, 1.1 equiv), and NaBH(OAc)<sub>3</sub> (366 mg, 1.73 mmol, 1.8 equiv) in THF (20 mL) was stirred under N<sub>2</sub> atmosphere at rt. After 3 h, 1 M NaOH (15 mL) was added and the aqueous layer was extracted with Et<sub>2</sub>O (3 × 25 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 4 cm, <i>l</i> = 16 cm, <i>V</i> = 20 mL, cyclohexane/ethyl acetate 80:20 + 1% <i>N</i>,<i>N</i>-dimethylethanamine → 67:33 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). <b>28a</b> was eluted first and <b>28b</b> afterward.</div><div id="sec7_2_42_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i72" class="anchor-spacer"></div><h5 class="article-section__title" id="_i72"> <i>trans</i>-<b>28a</b></h5><div class="NLM_p last">Colorless oil, yield 148 mg (45%). C<sub>23</sub>H<sub>28</sub>FNO (353.8 g/mol). <i>R<sub>f</sub></i> = 0.57 (cyclohexane/ethyl acetate 67:33 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 354.2224 (calcd 354.2228 for C<sub>23</sub>H<sub>29</sub>FNO [MH<sup>+</sup>]). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ (ppm) = 1.45 (dq, <i>J</i> = 13.6/3.2 Hz, 1H, 2′-<i>H</i><sub>equ</sub>), 1.64–1.73 (m, 2H, 3′-<i>H</i>, 5′-<i>H</i>), 1.82–1.96 (m, 4H, 5′-<i>H</i>, 6′-<i>H</i>, C<i>H</i><sub>2</sub>CH<sub>2</sub>F), 2.00–2.11 (m, 2H, 3′-<i>H</i>, C<i>H</i><sub>2</sub>CH<sub>2</sub>F), 2.29 (td, <i>J</i> = 13.7/4.0 Hz, 1H, 2′-<i>H</i><sub>ax</sub>), 2.65–2.69 (m, 2H, 4-<i>H</i>), 2.92 (quint, <i>J</i> = 3.2 Hz, 1H, 4′-<i>H</i><sub>equ</sub>), 3.82 (s, 2H, ArC<i>H</i><sub>2</sub>NH), 3.94 (tdd, <i>J</i> = 8.8/5.3/3.5 Hz, 1H, 3-<i>H</i>), 4.61 (dddd, <i>J</i> = 47.0/9.2/5.5/4.8 Hz, 1H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 4.72 (dtd, <i>J</i> = 47.7/9.0/4.4 Hz, 1H CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 7.05 (d, <i>J</i> = 7.5 Hz, 1H, 5-<i>H</i>), 7.10 (td, <i>J</i> = 7.4/1.3 Hz, 1H, 6-<i>H</i>), 7.16 (t, <i>J</i> = 7.7 Hz, 1H, 7-<i>H</i>), 7.24–7.29 (m, 1H, 4-<i>H</i><sub>benzyl</sub>), 7.33–7.38 (m, 3H, 8-<i>H</i>, 3-<i>H</i><sub>benzyl</sub>, 5-<i>H</i><sub>benzyl</sub>), 7.39–7.43 (m, 2H, 2-<i>H</i><sub>benzyl</sub>, 6-<i>H</i><sub>benzyl</sub>). A signal for the NH proton is not observed in the spectrum. <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ (ppm) = 26.1 (1C, <i>C</i>-3′), 26.2 (1C, <i>C</i>-5′), 30.0 (1C, <i>C</i>-6′), 34.4 (1C, <i>C</i>-2′), 36.6 (1C, <i>C</i>-4), 38.1 (d, <i>J</i> = 19.6 Hz, 1C, <i>C</i>H<sub>2</sub>CH<sub>2</sub>F), 51.3 (1C, <i>C</i>-4′), 52.3 (1C, Ar<i>C</i>H<sub>2</sub>NH), 65.1 (d, <i>J</i> = 5.0 Hz, 1C, <i>C</i>-3), 76.9 (1C, <i>C</i>-1), 81.7 (d, <i>J</i> = 163.2 Hz, 1C, CH<sub>2</sub><i>C</i>H<sub>2</sub>F), 126.5 (1C, <i>C</i>-8), 127.0 (1C, <i>C</i>-6), 127.2 (1C, <i>C</i>-7), 128.0 (1C, <i>C</i>-4<sub>benzyl</sub>), 129.4 (2C, <i>C</i>-3<sub>benzyl</sub>, <i>C</i>-5<sub>benzyl</sub>), 129.6 (3C, <i>C</i>-5, <i>C</i>-2<sub>benzyl</sub>, <i>C</i>-6<sub>benzyl</sub>), 134.3 (1C, <i>C</i>-4a), 141.3 (1C, <i>C</i>-1<sub>benzyl</sub>), 144.2 (1C, <i>C</i>-8a). FT-IR (neat): ν [cm<sup>–1</sup>] = 3317 (N–H), 2978, 2924, 2893 (C–H<sub>alkyl</sub>), 1489, 1450 (C═C<sub>arom</sub>). Purity (HPLC, method 1): 98.8%, <i>t</i><sub>R</sub> = 19.2 min.</div></div><div id="sec7_2_42_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i73" class="anchor-spacer"></div><h5 class="article-section__title" id="_i73"> <i>cis</i>-<b>28b</b></h5><div class="NLM_p last">Colorless oil, yield 150 mg (45%). C<sub>23</sub>H<sub>28</sub>FNO (353.8 g/mol). <i>R<sub>f</sub></i> = 0.22 (cyclohexane/ethyl acetate 67:33 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 354.2221 (calcd 354.2228 for C<sub>23</sub>H<sub>29</sub>FNO [MH<sup>+</sup>]). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ (ppm) = 1.56–1.69 (m, 2H, 2′-<i>H</i>, 3′-<i>H</i>), 1.70–1.79 (m, 1H, 6′-<i>H</i>), 1.80–2.02 (m, 5H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>, C<i>H</i><sub>2</sub>CH<sub>2</sub>F), 2.03–2.13 (m, 1H, C<i>H</i><sub>2</sub>CH<sub>2</sub>F), 2.13–2.20 (m, 1H, 2′-<i>H</i>), 2.64–2.77 (m, 3H, 4-<i>H</i>, 4′-<i>H</i><sub>ax</sub>), 3.86 (s, 2H, ArC<i>H</i><sub>2</sub>NH), 3.96 (tdd, <i>J</i> = 8.9/5.6/3.5 Hz, 1H, 3-<i>H</i>), 4.67 (dddd, <i>J</i> = 46.9/10.1/6.0/4.5 Hz, 1H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 4.83 (dtd, <i>J</i> = 47.8/9.2/4.7 Hz, 1H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 7.06–7.10 (m, 1H, 5-<i>H</i>), 7.10–7.19 (m, 3H, 6-<i>H</i>, 7-<i>H</i>, 8-<i>H</i>), 7.26–7.32 (m, 1H, 4-<i>H</i><sub>benzyl</sub>), 7.34–7.43 (m, 4H, 2-<i>H</i><sub>benzyl</sub>, 3-<i>H</i><sub>benzyl</sub>, 5-<i>H</i><sub>benzyl</sub>, 6-<i>H</i><sub>benzyl</sub>). A signal for the NH proton is not observed in the spectrum. <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ (ppm) = 28.7 (1C, <i>C</i>-5′), 28.8 (1C, <i>C</i>-3′), 34.8 (1C, <i>C</i>-2′), 36.6 (1C, <i>C</i>-4), 38.1 (d, <i>J</i> = 19.5 Hz, 1C, <i>C</i>H<sub>2</sub>CH<sub>2</sub>F), 39.3 (1C, <i>C</i>-6′), 51.5 (1C, Ar<i>C</i>H<sub>2</sub>NH), 56.4 (1C, <i>C</i>-4′), 65.2 (d, <i>J</i> = 5.3 Hz, 1C, <i>C</i>-3), 76.4 (1C, <i>C</i>-1), 81.8 (d, <i>J</i> = 162.6 Hz, 1C, CH<sub>2</sub><i>C</i>H<sub>2</sub>F), 126.1 (1C, <i>C</i>-8), 127.1 (1C, <i>C</i>-6 or <i>C</i>-7), 127.2 (1C, <i>C</i>-6 or <i>C</i>-7), 128.1 (1C, <i>C</i>-4<sub>benzyl</sub>), 129.52 (2C, <i>C</i>-2<sub>benzyl</sub> and <i>C</i>-6<sub>benzyl</sub> or <i>C</i>-3<sub>benzyl</sub> and <i>C</i>-5<sub>benzyl</sub>), 129.53 (2C, <i>C</i>-2<sub>benzyl</sub> and <i>C</i>-6<sub>benzyl</sub> or <i>C</i>-3<sub>benzyl</sub> and <i>C</i>-5<sub>benzyl</sub>), 129.7 (1C, <i>C</i>-5), 134.7 (1C, <i>C</i>-4a), 140.9 (1C, <i>C</i>-1<sub>benzyl</sub>), 143.4 (1C, <i>C</i>-8a). FT-IR (neat): ν [cm<sup>–1</sup>] = 3059 (N–H), 2924, 2855 (C–H<sub>alkyl</sub>), 1489, 1450 (C═C<sub>arom</sub>). Purity (HPLC): 98.2%, <i>t</i><sub>R</sub> = 19.2 min.</div></div></div><div id="sec7_2_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74">7.2.43.  <i>trans</i>-3-(2-Fluoroethyl)-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-4′-amine (<b>29a</b>)</h4><div class="NLM_p last">A solution of amine <b>28a</b> (118 mg, 0.33 mmol), ammonium formate (102 mg, 1.61 mmol, 4.9 equiv), and 10% Pd/C (15 mg, 0.01 mmol, 4 mol %) in CH<sub>3</sub>OH (15 mL) was heated to reflux for 2 h under N<sub>2</sub> atmosphere. After cooling to rt, the mixture was filtered through Celite, washed with CH<sub>2</sub>Cl<sub>2</sub> (100 mL), and concentrated in vacuo. 0.1 M NaOH (60 mL) was added, and the aqueous phase was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 50 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. Yellow oil, yield 83 mg (96%). C<sub>16</sub>H<sub>22</sub>FNO (263.4 g/mol). <i>R<sub>f</sub></i> = 0.06 (cyclohexane/ethyl acetate 67:33 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 264.1753 (calcd 264.1758 for C<sub>16</sub>H<sub>23</sub>FNO [MH<sup>+</sup>]). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.43–1.57 (m, 3H, 2′-<i>H</i>, 3′-<i>H</i>, 5′-<i>H</i>), 1.83–2.01 (m, 4H, 5′-<i>H</i>, 6′-<i>H</i>, C<i>H</i><sub>2</sub>CH<sub>2</sub>F), 2.02–2.16 (m, 2H, 3′-H, C<i>H</i><sub>2</sub>CH<sub>2</sub>F), 2.31 (td, <i>J</i> = 13.5/4.2 Hz, 1H, 2′-<i>H</i>), 2.66 (dd, <i>J</i> = 15.8/3.2 Hz, 1H, 4-<i>H</i>), 2.74 (dd, <i>J</i> = 15.9/10.6 Hz, 1H, 4-<i>H</i>), 3.32–3.37 (m, 1H, 4′-<i>H</i><sub>equ</sub>), 3.95 (ddt, <i>J</i> = 10.6/9.3/3.4 Hz, 1H, 3-<i>H</i>), 4.58 (ddd, <i>J</i> = 9.1/5.7/4.3 Hz, 0.5H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 4.67–4.73 (m, 2 × 0.5H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 4.82 (td, <i>J</i> = 9.1/4.4 Hz, 0.5H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 7.04–7.08 (m, 1H, 5-<i>H</i>), 7.13 (td, <i>J</i> = 7.3/1.6 Hz, 1H, 6-<i>H</i>), 7.16–7.21 (m, 1H, 7-<i>H</i>), 7.23 (dd, <i>J</i> = 7.7/1.7 Hz, 1H, 8-<i>H</i>). A signal for the NH<sub>2</sub> protons is not observed in the spectrum. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 28.4 (1C, <i>C</i>-3′), 28.5 (1C, <i>C</i>-5′), 28.6 (1C, <i>C</i>-6′), 32.8 (1C, <i>C</i>-2′), 35.8 (1C, <i>C</i>-4), 37.1 (d, <i>J</i> = 19.4 Hz, 1C, <i>C</i>H<sub>2</sub>CH<sub>2</sub>F), 44.5 (1C, <i>C</i>-4′), 63.8 (d, <i>J</i> = 5.0 Hz, 1C, <i>C</i>-3), 75.8 (1C, <i>C</i>-1), 81.0 (d, <i>J</i> = 163.7 Hz, 1C, CH<sub>2</sub><i>C</i>H<sub>2</sub>F), 125.5 (1C, <i>C</i>-8), 126.2 (1C, <i>C</i>-6), 126.3 (1C, <i>C</i>-7), 128.8 (1C, <i>C</i>-5), 133.3 (1C, <i>C</i>-4a), 143.1 (1C, <i>C</i>-8a). FT-IR (neat): ν [cm<sup>–1</sup>] = 3372 (N–H), 2920, 2851 (C–H<sub>alkyl</sub>), 1489, 1439 (C═C<sub>arom</sub>). Purity (HPLC): 94.4%, <i>t</i><sub>R</sub> = 15.6 min.</div></div><div id="sec7_2_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75">7.2.44.  <i>cis</i>-3-(2-Fluoroethyl)-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-4′-amine (<b>29b</b>)</h4><div class="NLM_p last">A solution of amine <b>28b</b> (137 mg, 0.39 mmol), ammonium formate (125 mg, 1.99 mmol, 5.1 equiv), and 10% Pd/C (17 mg, 0.02 mmol, 4 mol %) in CH<sub>3</sub>OH (15 mL) was heated to reflux for 4.5 h under N<sub>2</sub> atmosphere. After cooling to rt, the mixture was filtered through Celite, washed with CH<sub>2</sub>Cl<sub>2</sub> (100 mL), and concentrated in vacuo. 0.1 M NaOH (60 mL) was added, and the aqueous phase was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 50 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. Yellow oil, yield 90 mg (88%). C<sub>16</sub>H<sub>22</sub>FNO (263.4 g/mol). <i>R<sub>f</sub></i> = 0.06 (cyclohexane/ethyl acetate 67:33 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 264.1748 (calcd 264.1758 for C<sub>16</sub>H<sub>23</sub>FNO [MH<sup>+</sup>]). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.45–1.60 (m, 2H, 2′-<i>H</i>, 3′-<i>H</i>), 1.60–1.81 (m, 4H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>), 1.85–2.12 (m, 3H, 6′-H, C<i>H</i><sub>2</sub>CH<sub>2</sub>F), 2.12–2.19 (m, 1H, 2′-<i>H</i>), 2.66 (dd, <i>J</i> = 15.8/3.1 Hz, 1H, 4-<i>H</i>), 2.75 (dd, <i>J</i> = 15.8/10.7 Hz, 1H, 4-<i>H</i>), 2.82 (tt, <i>J</i> = 11.3/10.6/4.6 Hz, 1H, 4′-<i>H</i><sub>ax</sub>), 3.94 (ddt, <i>J</i> = 10.6/9.1/3.4 Hz, 1H, 3-<i>H</i>), 4.59 (ddd, <i>J</i> = 9.0/5.6/4.4 Hz, 0.5H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 4.68–4.76 (m, 2 × 0.5H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 4.84 (td, <i>J</i> = 9.0/4.4 Hz, 0.5H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 7.04–7.12 (m, 2H, 5-<i>H</i>, 8-<i>H</i>), 7.12–7.20 (m, 2H, 6-<i>H</i>, 7-<i>H</i>). A signal for the NH<sub>2</sub> protons is not observed in the spectrum. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 32.1 (1C, <i>C</i>-5′), 32.2 (1C, <i>C</i>-3′), 34.4 (1C, <i>C</i>-2′), 35.7 (1C, <i>C</i>-4), 37.1 (d, <i>J</i> = 19.4 Hz, 1C, <i>C</i>H<sub>2</sub>CH<sub>2</sub>F), 38.7 (1C, <i>C</i>-6′), 50.4 (1C, <i>C</i>-4′), 64.0 (d, <i>J</i> = 4.9 Hz, 1C, <i>C</i>-3), 74.9 (1C, <i>C</i>-1), 81.1 (d, <i>J</i> = 163.7 Hz, 1C, CH<sub>2</sub><i>C</i>H<sub>2</sub>F), 125.1 (1C, <i>C</i>-8), 126.2 (1C, <i>C</i>-6 or <i>C</i>-7), 126.3 (1C, <i>C</i>-6 or <i>C</i>-7), 128.9 (1C, <i>C</i>-5), 133.6 (1C, <i>C</i>-4a), 142.4 (1C, <i>C</i>-8a). FT-IR (neat): ν [cm<sup>–1</sup>] = 3356 (N–H), 2924, 2855 (C–H<sub>alkyl</sub>), 1516, 1447 (C═C<sub>arom</sub>). Purity (HPLC): 96.0%, <i>t</i><sub>R</sub> = 15.2 min.</div></div><div id="sec7_2_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76">7.2.45.  <i>trans</i>-3-(2-Fluoroethyl)-<i>N</i>-(6,7,8,9-tetrahydro-5<i>H</i>-benzo[7]annulen-7-yl)-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-4′-amine (<b>30a</b>)</h4><div class="NLM_p last">A solution of ketone <b>26</b> (25 mg, 0.16 mmol), amine <b>29a</b> (42 mg, 0.16 mmol, 1.0 equiv), acetic acid (10 μL, 0.18 mmol, 1.1 equiv), and NaBH(OAc)<sub>3</sub> (62 mg, 0.29 mmol, 1.8 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) was stirred under N<sub>2</sub> atmosphere at rt. After 21 h, 1 M NaOH (3 mL) was added and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 2 cm, <i>l</i> = 19 cm, <i>V</i> = 10 mL, cyclohexane/ethyl acetate 90:10 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). Colorless oil, yield 50 mg (76%). C<sub>27</sub>H<sub>34</sub>FNO (407.6 g/mol). <i>R<sub>f</sub></i> = 0.34 (cyclohexane/ethyl acetate 67:33 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 408.2668 (calcd 408.2697 for C<sub>27</sub>H<sub>35</sub>FNO [MH<sup>+</sup>]). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.22–1.39 (m, 2H, 6-<i>H</i><sub>benzannulene</sub>, 8-<i>H</i><sub>benzannulene</sub>), 1.46–1.53 (m, 1H, 2′-<i>H</i>), 1.53–1.65 (m, 2H, 3′-<i>H</i>, 5′-<i>H</i>), 1.81–2.14 (m, 6H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>, C<i>H</i><sub>2</sub>CH<sub>2</sub>F), 2.14–2.24 (m, 2H, 6-<i>H</i><sub>benzannulene</sub>, 8-<i>H</i><sub>benzannulene</sub>), 2.30 (td, <i>J</i> = 13.3/3.6 Hz, 1H, 2′-<i>H</i>), 2.65 (dd, <i>J</i> = 16.2/3.1 Hz, 1H, 4-<i>H</i>), 2.69–2.80 (m, 3H, 4-<i>H</i>, 5-<i>H</i><sub>benzannulene</sub>, 9-<i>H</i><sub>benzannulene</sub>), 2.80–2.89 (m, 3H, 5-<i>H</i><sub>benzannulene</sub>, 7-<i>H</i><sub>benzannulene</sub>, 9-<i>H</i><sub>benzannulene</sub>), 3.13–3.19 (m, 1H, 4′-<i>H</i><sub>equ</sub>), 3.96 (ddt, <i>J</i> = 10.6/9.2/3.3 Hz, 1H, 3-<i>H</i>), 4.60 (dddd, <i>J</i> = 49.9/9.0/5.7/4.3 Hz, 1H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 4.78 (dtd, <i>J</i> = 47.4/9.1/4.4 Hz, 1H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 7.06 (d, <i>J</i> = 7.3 Hz, 1H, 5-<i>H</i>), 7.09–7.16 (m, 5H, 6-<i>H</i>, 1-<i>H</i><sub>benzannulene</sub>, 2-<i>H</i><sub>benzannulene</sub>, 3-<i>H</i><sub>benzannulene</sub>, 4-<i>H</i><sub>benzannulene</sub>), 7.16–7.22 (m, 2H, 7-<i>H</i>, 8-<i>H</i>). A signal for the NH proton is not observed in the spectrum. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 26.4 (1C, <i>C</i>-3′), 26.6 (1C, <i>C</i>-5′), 29.2 (1C, <i>C</i>-6′), 32.7 (2C, <i>C</i>-5<sub>benzannulene</sub>, <i>C</i>-9<sub>benzannulene</sub>), 33.5 (1C, <i>C</i>-2′), 35.4 (2C, <i>C</i>-6<sub>benzannulene</sub>, <i>C</i>-8<sub>benzannulene</sub>), 35.8 (1C, <i>C</i>-4), 37.1 (d, <i>J</i> = 19.3 Hz, 1C, <i>C</i>H<sub>2</sub>CH<sub>2</sub>F), 47.4 (1C, <i>C</i>-4′), 58.2 (1C, <i>C</i>-7<sub>benzannulene</sub>), 63.8 (d, <i>J</i> = 5.1 Hz, 1C, <i>C</i>-3), 76.0 (1C, <i>C</i>-1), 81.1 (d, <i>J</i> = 163.7 Hz, 1C, CH<sub>2</sub><i>C</i>H<sub>2</sub>F), 125.5 (1C, <i>C</i>-8), 126.1 (1C, <i>C</i>-6), 126.3 (3C, <i>C</i>-7, <i>C</i>-2<sub>benzannulene</sub>, <i>C</i>-3<sub>benzannulene</sub>), 128.7 (1C, <i>C</i>-5), 129.0 (2C, <i>C</i>-1<sub>benzannulene</sub>, <i>C</i>-4<sub>benzannulene</sub>), 133.3 (1C, <i>C</i>-4a), 142.8 (2C, <i>C</i>-4a<sub>benzannulene</sub>, <i>C</i>-9a<sub>benzannulene</sub>), 143.3 (1C, <i>C</i>-8a). FT-IR (neat): ν [cm<sup>–1</sup>] = 3318 (N–H), 2924, 2843 (C–H<sub>alkyl</sub>), 1489, 1450 (C═C<sub>arom</sub>). Purity (HPLC): 96.8%, <i>t</i><sub>R</sub> = 21.3 min.</div></div><div id="sec7_2_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77">7.2.46.  <i>trans</i>-3-(2-Fluoroethyl)-<i>N</i>-(6,7,8,9-tetrahydro-5<i>H</i>-benzo[7]annulen-7-yl)-3,4-dihydrospiro[[2]benzopyran-1,1′-cyclohexan]-4′-amine (<b>30b</b>)</h4><div class="NLM_p last">A solution of ketone <b>26</b> (25 mg, 0.15 mmol), amine <b>29b</b> (43 mg, 0.16 mmol, 1.1 equiv), acetic acid (10 μL, 0.18 mmol, 1.1 equiv), and NaBH(OAc)<sub>3</sub> (59 mg, 0.28 mmol, 1.9 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) was stirred under N<sub>2</sub> atmosphere at rt. After 22 h, 1 M NaOH (5 mL) was added and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue was purified by fc (<i>d</i> = 2 cm, <i>l</i> = 20 cm, <i>V</i> = 10 mL, cyclohexane/ethyl acetate 80:20 + 1% <i>N</i>,<i>N</i>-dimethylethanamine → 67:33 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). Colorless oil, yield 49 mg (81%). C<sub>27</sub>H<sub>34</sub>FNO (407.6 g/mol). <i>R<sub>f</sub></i> = 0.47 (cyclohexane/ethyl acetate 50:50 + 1% <i>N</i>,<i>N</i>-dimethylethanamine). HR-MS (APCI): <i>m</i>/<i>z</i> = 408.2656 (calcd 408.2697 for C<sub>27</sub>H<sub>35</sub>FNO [MH<sup>+</sup>]). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) = 1.28–1.39 (m, 2H, 6-<i>H</i><sub>benzannulene</sub>, 8-<i>H</i><sub>benzannulene</sub>), 1.44–1.55 (m, 1H, 3′-<i>H</i>), 1.60 (td, <i>J</i> = 13.7/3.2 Hz, 1H, 2′-<i>H</i>), 1.65–1.75 (m, 1H, 5′-<i>H</i>), 1.75–1.85 (m, 3H, 3′-<i>H</i>, 5′-<i>H</i>, 6′-<i>H</i>), 1.85–2.10 (m, 3H, 6′-H, C<i>H</i><sub>2</sub>CH<sub>2</sub>F), 2.10–2.23 (m, 3H, 2′-<i>H</i>, 6-<i>H</i><sub>benzannulene</sub>, 8-<i>H</i><sub>benzannulene</sub>), 2.66 (dd, <i>J</i> = 15.8/3.0 Hz, 1H, 4-<i>H</i>), 2.70–2.88 (m, 6H, 4-<i>H</i>, 4′-<i>H</i><sub>ax</sub>, 5-<i>H</i><sub>benzannulene</sub>, 9-<i>H</i><sub>benzannulene</sub>), 2.92–3.02 (m, 1H, 7-<i>H</i><sub>benzannulene</sub>), 3.95 (ddt, <i>J</i> = 11.7/8.8/3.4 Hz, 1H, 3-<i>H</i>), 4.65 (ddt, <i>J</i> = 46.7/9.0/5.5/4.5 Hz, 1H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 4.85 (dtd, <i>J</i> = 47.5/9.0/4.4 Hz, 1H, CH<sub>2</sub>C<i>H</i><sub>2</sub>F), 7.07 (d, <i>J</i> = 7.3 Hz, 1H, 5-<i>H</i>), 7.09–7.16 (m, 6H, 6-<i>H</i>, 8-<i>H</i>, 1-<i>H</i><sub>benzannulene</sub>, 2-<i>H</i><sub>benzannulene</sub>, 3-<i>H</i><sub>benzannulene</sub>, 4-<i>H</i><sub>benzannulene</sub>), 7.16–7.22 (m, 1H, 7-<i>H</i>). A signal for the NH proton is not observed in the spectrum. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) = 29.6 (1C, <i>C</i>-3′ or <i>C</i>-5′), 29.7 (1C, <i>C</i>-3′ or <i>C</i>-5′), 32.6 (2C, <i>C</i>-5<sub>benzannulen</sub>, <i>C</i>-9<sub>benzannulen</sub>), 34.5 (1C, <i>C</i>-2′), 35.2 (2C, <i>C</i>-6<sub>benzannulen</sub>, <i>C</i>-8<sub>benzannulen</sub>), 35.7 (1C, <i>C</i>-4), 37.0 (d, <i>J</i> = 19.3 Hz, 1C, <i>C</i>H<sub>2</sub>CH<sub>2</sub>F), 38.9 (1C, <i>C</i>-6′), 53.3 (1C, <i>C</i>-4′), 58.0 (1C, <i>C</i>-7<sub>benzannulen</sub>), 64.1 (d, <i>J</i> = 4.8 Hz, 1C, <i>C</i>-3), 75.4 (1C, <i>C</i>-1), 81.1 (d, <i>J</i> = 163.6 Hz, 1C, CH<sub>2</sub><i>C</i>H<sub>2</sub>F), 125.1 (1C, <i>C</i>-8), 126.2 (1C, <i>C</i>-6 or <i>C</i>-7), 126.27 (1C, <i>C</i>-6 or <i>C</i>-7), 126.32 (2C, <i>C</i>-2<sub>benzannulen</sub>, <i>C</i>-3<sub>benzannulen</sub>), 128.9 (1C, <i>C</i>-5), 129.0 (2C, <i>C</i>-1<sub>benzannulen</sub>, <i>C</i>-4<sub>benzannulen</sub>), 133.7 (1C, <i>C</i>-4a), 142.5 (1C, <i>C</i>-8a), 142.7 (2C, <i>C</i>-4a<sub>benzannulen</sub>, <i>C</i>-9a<sub>benzannulen</sub>). FT-IR (neat): ν [cm<sup>–1</sup>] = 3059 (N–H), 2924, 2847 (C–H<sub>alkyl</sub>), 1489, 1447 (C═C<sub>arom</sub>). Purity (HPLC): 98.8%, <i>t</i><sub>R</sub> = 21.4 min.</div></div></div><div id="sec7_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78">7.3.  X-ray Diffraction</h3><div class="NLM_p">For compound <i>trans</i><b>-6e</b> data sets were collected with an APEX II CCD diffractometer. For compound <i>cis</i><b>-6f</b> data sets were collected with a D8 Venture Dual Source 100 CMOS diffractometer. Programs used were the following: data collection, APEX3 V2016.1-0 (Bruker AXS Inc., 2016);<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> cell refinement, SAINT V8.37A (Bruker AXS Inc., 2015);<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> data reduction, SAINT V8.37A (Bruker AXS Inc., 2015);<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> absorption correction, SADABS V2014/7 (Bruker AXS Inc., 2014);<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> structure solution, SHELXT-2015 (Sheldrick, 2015);<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> structure refinement, SHELXL-2015 (Sheldrick, 2015);<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> graphics, XP (Bruker AXS, 1998).<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a><i>R</i>-values are given for observed reflections, and wR2 values are given for all reflections.</div><div id="sec7_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79">7.3.1.  X-ray Crystal Structure Analysis of <i>trans</i>-<b>6e</b> (dan8992)</h4><div class="NLM_p last">A colorless prism-like specimen of C<sub>26</sub>H<sub>33</sub>NO<sub>4</sub>, approximate dimensions 0.200 mm × 0.200 mm × 0.230 mm, was used for the X-ray crystallographic analysis. The X-ray intensity data were measured. A total of 1635 frames were collected. The total exposure time was 24.64 h. The frames were integrated with the Bruker SAINT software package using a wide-frame algorithm. The integration of the data using a monoclinic unit cell yielded a total of 34 283 reflections to a maximum θ angle of 66.67° (0.84 Å resolution), of which 3931 were independent (average redundancy 8.721, completeness = 99.9%, <i>R</i><sub>int</sub> = 4.32%, <i>R</i><sub>sig</sub> = 2.24%) and 3521 (89.57%) were greater than 2σ(<i>F</i><sup>2</sup>). The final cell constants of <i>a</i> = 13.7232(4) Å, <i>b</i> = 6.5580(2) Å, <i>c</i> = 24.7015(7) Å, β = 93.5540(10)°, volume = 2218.78(11) Å<sup>3</sup>, are based upon the refinement of the <i>XYZ</i> centroids of 9967 reflections above 20 σ(<i>I</i>) with 7.186° < 2θ < 133.1°. Data were corrected for absorption effects using the multiscan method (SADABS). The ratio of minimum to maximum apparent transmission was 0.889. The calculated minimum and maximum transmission coefficients (based on crystal size) are 0.8600 and 0.8770. The structure was solved and refined using the Bruker SHELXTL Software Package, using the space group <i>P</i>2<sub>1/<i>n</i></sub>, with <i>Z</i> = 4 for the formula unit, C<sub>26</sub>H<sub>33</sub>NO<sub>4</sub>. The final anisotropic full-matrix least-squares refinement on <i>F</i><sup>2</sup> with 283 variables converged at R1 = 3.88%, for the observed data and wR2 = 9.74% for all data. The goodness-of-fit was 1.043. The largest peak in the final difference electron density synthesis was 0.342 e<sup>–</sup>/Å<sup>3</sup> and the largest hole was −0.203 e<sup>–</sup>/Å<sup>3</sup> with an rms deviation of 0.040 e<sup>–</sup>/Å<sup>3</sup>. On the basis of the final model, the calculated density was 1.268 g/cm<sup>3</sup> and <i>F</i>(000) was 912 e<sup>–</sup>. CCDC number: 1855388.</div></div><div id="sec7_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80">7.3.2.  X-ray Crystal Structure Analysis of <i>cis</i>-<b>6f</b> (dan8995)</h4><div class="NLM_p last">A colorless plate-like specimen of C<sub>26</sub>H<sub>33</sub>NO<sub>4</sub>, approximate dimensions 0.094 mm × 0.279 mm × 0.327 mm, was used for the X-ray crystallographic analysis. The X-ray intensity data were measured. A total of 1121 frames were collected. The total exposure time was 16.57 h. The frames were integrated with the Bruker SAINT software package using a wide-frame algorithm. The integration of the data using a monoclinic unit cell yielded a total of 24 421 reflections to a maximum θ angle of 68.34° (0.83 Å resolution), of which 4026 were independent (average redundancy 6.066, completeness = 99.5%, <i>R</i><sub>int</sub> = 3.12%, <i>R</i><sub>sig</sub> = 2.26%) and 3798 (94.34%) were greater than 2σ(<i>F</i><sup>2</sup>). The final cell constants of <i>a</i> = 21.9660(9) Å, <i>b</i> = 6.2458(3) Å, <i>c</i> = 32.4538(13) Å, β = 99.1270(10)°, volume = 4396.1(3) Å<sup>3</sup>, are based upon the refinement of the <i>XYZ</i>-centroids of 9316 reflections above 20 σ(<i>I</i>) with 5.516° < 2θ < 136.6°. Data were corrected for absorption effects using the multiscan method (SADABS). The ratio of minimum to maximum apparent transmission was 0.893. The calculated minimum and maximum transmission coefficients (based on crystal size) are 0.8080 and 0.9390. The structure was solved and refined using the Bruker SHELXTL Software Package, using the space group <i>C</i>2/<i>c</i>, with <i>Z</i> = 8 for the formula unit, C<sub>26</sub>H<sub>33</sub>NO<sub>4</sub>. The final anisotropic full-matrix least-squares refinement on <i>F</i><sup>2</sup> with 283 variables converged at R1 = 3.56%, for the observed data and wR2 = 8.99% for all data. The goodness-of-fit was 1.055. The largest peak in the final difference electron density synthesis was 0.267 e<sup>–</sup>/Å<sup>3</sup>, and the largest hole was −0.215 e<sup>–</sup>/Å<sup>3</sup> with an rms deviation of 0.046 e<sup>–</sup>/Å<sup>3</sup>. On the basis of the final model, the calculated density was 1.280 g/cm<sup>3</sup> and <i>F</i>(000) was 1824 e<sup>–</sup>. CCDC number: 1855389.</div></div></div><div id="sec7_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81">7.4.  In Vitro Studies</h3><div id="sec7_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82">7.4.1.  Receptor Binding Studies</h4><div id="sec7_4_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i83" class="anchor-spacer"></div><h5 class="article-section__title" id="_i83">7.4.1.1.  Materials</h5><div class="NLM_p">Guinea pig brains and rat livers were commercially available (Harlan-Winkelmann, Borchen, Germany). Homogenizers: Elvehjem Potter (B. Braun Biotech International, Melsungen, Germany) and Soniprep 150, MSE, London, U.K.). Centrifuges: cooling centrifuge Eppendorf 5424R (Eppendorf, Hamburg, Germany) and high-speed cooling centrifuge model Sorvall RC-5C plus (Thermo Fisher Scientific, Langenselbold, Germany). Multiplates: standard 96-well multiplates (Diagonal, Muenster, Germany). Shaker: self-made device with adjustable temperature and tumbling speed (scientific workshop of the institute). Harvester: MicroBeta FilterMate 96 harvester. Filter: Printed Filtermat types A and B. Scintillator: Meltilex (type A or B) solid state scintillator. Scintillation analyzer: MicroBeta Trilux (all PerkinElmer LAS, Rodgau-Jügesheim, Germany).</div><div class="NLM_p">7.4.1.1.1. Preparation of Membrane Homogenates from Guinea Pig Brain. Five guinea pig brains were homogenized with the potter (500–800 rpm, 10 up and down strokes) in 6 volumes of cold 0.32 M sucrose. The suspension was centrifuged at 1200<i>g</i> for 10 min at 4 °C. The supernatant was separated and centrifuged at 23 500<i>g</i> for 20 min at 4 °C. The pellet was resuspended in 5–6 volumes of buffer (50 mM Tris, pH 7.4) and centrifuged again at 23 500<i>g</i> (20 min, 4 °C). This procedure was repeated twice. The final pellet was resuspended in 5–6 volumes of buffer and frozen (−80 °C) in 1.5 mL portions containing about 1.5 mg protein/mL.</div><div class="NLM_p last">7.4.1.1.2. Preparation of Membrane Homogenates from Rat Live. Two rat livers were cut into small pieces and homogenized with the potter (500–800 rpm, 10 up and down strokes) in 6 volumes of cold 0.32 M sucrose. The suspension was centrifuged at 1200<i>g</i> for 10 min at 4 °C. The supernatant was separated and centrifuged at 31 000<i>g</i> for 20 min at 4 °C. The pellet was resuspended in 5–6 volumes of buffer (50 mM Tris, pH 8.0) and incubated at rt for 30 min. After the incubation, the suspension was centrifuged again at 31 000<i>g</i> for 20 min at 4 °C. The final pellet was resuspended in 5–6 volumes of buffer and stored at −80 °C in 1.5 mL portions containing about 2 mg of protein/mL.</div></div><div id="sec7_4_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i84" class="anchor-spacer"></div><h5 class="article-section__title" id="_i84">7.4.1.2.  Protein Determination</h5><div class="NLM_p last">The protein concentration was determined by the method of Bradford,<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> modified by Stoscheck.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> The Bradford solution was prepared by dissolving 5 mg of Coomassie Brilliant Blue G 250 in 2.5 mL of EtOH (95%, v/v). 10 mL of deionized H<sub>2</sub>O and 5 mL of phosphoric acid (85%, m/v) were added to this solution, and the mixture was stirred and filled to a total volume of 50 mL with deionized water. The calibration was carried out using bovine serum albumin as a standard in nine concentrations (0.1, 0.2, 0.4, 0.6, 0.8, 1.0, 1.5, 2.0, and 4.0 mg/mL). In a 96-well standard multiplate, an amount of 10 μL of the calibration solution or 10 μL of the membrane receptor preparation was mixed with 190 μL of the Bradford solution, respectively. After 5 min, the UV absorption of the protein–dye complex at λ = 595 nm was measured with a plate reader (Tecan Genios, Tecan, Crailsheim, Germany).</div></div><div id="sec7_4_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i85" class="anchor-spacer"></div><h5 class="article-section__title" id="_i85">7.4.1.3.  General Procedures for Binding Assays</h5><div class="NLM_p last">The test compound solutions were prepared by dissolving approximately 10 μmol (usually 2–4 mg) of test compound in DMSO so that a 10 mM stock solution was obtained. To obtain the required test solutions for the assay, the DMSO stock solution was diluted with the respective assay buffer. The filtermats were presoaked in 0.5% aqueous polyethylenimine solution for 2 h at rt before use. All binding experiments were carried out in duplicate in the 96-well multiplates. The concentrations given are the final concentration in the assay. Generally, the assays were performed by addition of 50 μL of the respective assay buffer, 50 μL of test compound solution in various concentrations (10<sup>–5</sup>, 10<sup>–6</sup>, 10<sup>–7</sup>, 10<sup>–8</sup>, 10<sup>–9</sup>, and 10<sup>–10</sup> mol/L), 50 μL of the corresponding radioligand solution, and 50 μL of the respective receptor preparation into each well of the multiplate (total volume 200 μL). The receptor preparation was always added last. During the incubation, the multiplates were shaken at a speed of 500–600 rpm at the specified temperature. Unless otherwise noted, the assays were terminated after 120 min by rapid filtration using the harvester. During the filtration, each well was washed five times with 300 μL of water. Subsequently, the filtermats were dried at 95 °C. The solid scintillator was melted on the dried filtermats at a temperature of 95 °C for 5 min. After solidifying of the scintillator at rt, the trapped radioactivity in the filtermats was measured with the scintillation analyzer. Each position on the filtermat corresponding to one well of the multiplate was measured for 5 min with the [<sup>3</sup>H]-counting protocol. The overall counting efficiency was 20%. The IC<sub>50</sub> values were calculated with the program GraphPad Prism 3.0 (GraphPad Software, San Diego, CA, USA) by nonlinear regression analysis. Subsequently, the IC<sub>50</sub> values were transformed into <i>K</i><sub>i</sub> values using the equation of Cheng and Prusoff.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> The <i>K</i><sub>i</sub> values are given as mean value ± SEM from three independent experiments.</div></div><div id="sec7_4_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i86" class="anchor-spacer"></div><h5 class="article-section__title" id="_i86">7.4.1.4.  σ<sub>1</sub> Receptor Affinity</h5><div class="NLM_p last">The assay was performed with the radioligand [<sup>3</sup>H]-(+)-pentazocine (22.0 Ci/mmol; PerkinElmer). The thawed membrane preparation of guinea pig brain cortex (about 100 μg of the protein) was incubated with various concentrations of test compounds, 2 nM [<sup>3</sup>H]-(+)-pentazocine, and Tris buffer (50 mM, pH 7.4) at 37 °C. The nonspecific binding was determined with 10 μM unlabeled (+)-pentazocine. The <i>K</i><sub>d</sub> value of (+)-pentazocine is 2.9 nM.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></div></div><div id="sec7_4_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i87" class="anchor-spacer"></div><h5 class="article-section__title" id="_i87">7.4.1.5.  σ<sub>2</sub> receptor affinity</h5><div class="NLM_p last">The assay was performed with the radioligand [<sup>3</sup>H]di-<i>o</i>-tolylguanidine (specific activity 50 Ci/mmol; ARC, St. Louis, MO, USA). The thawed rat liver membrane preparation (about 100 μg protein) was incubated with various concentrations of the test compound, 3 nM [<sup>3</sup>H]di-<i>o</i>-tolylguanidine and buffer containing (+)-pentazocine (500 nM (+)-pentazocine in Tris buffer (50 mM TRIS, pH 8.0)) at rt. The nonspecific binding was determined with 10 μM nonlabeled di-<i>o</i>-tolylguanidine. The <i>K</i><sub>d</sub> value of di-<i>o</i>-tolylguanidine is 17.9 nM.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div></div></div></div><div id="sec7_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88">7.5.  Pain Behavioral Studies</h3><div class="NLM_p">To evaluate the effect of drugs on mechanical allodynia induced by capsaicin, a previously described experimental procedure was used.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The compound under study or its solvent (HPMC) was administered sc to female CD-1 mice (Charles River, Barcelona, Spain) 30 min before the intraplantar (ipl) administration of 20 μL capsaicin (1 μg in 1% DMSO). 15 min after the ipl administration of capsaicin, a mechanical punctate stimulation (0.5 g force) was applied with an electronic von Frey device (Dynamic Plantar Aesthesiometer, Ugo Basile, Comerio, Italy) at least 5 mm from the site of injection toward the toes (area of secondary mechanical hypersensitivity), and the paw withdrawal latency time was automatically recorded. Each mouse was tested in three trials at 30 s intervals, and the mean of the three measurements was calculated. A cutoff time of 50 s was used in each trial.</div><div class="NLM_p">In the experiments to elucidate the influence of σ<sub>1</sub> receptors on the antiallodynic effect of compound tested, the σ<sub>1</sub> receptor agonist PRE-084 (compound <b>35</b>) was administered sc. Five minutes before the sc administration of the compound tested and 30 min later (i.e.. 35 min after compound <b>35</b> administration) capsaicin was ipl injected and the above-mentioned procedures were performed to measure mechanical allodynia.</div><div class="NLM_p">Animal care was provided in accordance with institutional (Research Ethics Committee of the University of Granada, Granada, Spain), regional (Junta de Andalucía, Spain), and international standards (European Communities Council Directive 2010/63). The protocol of the experiments was approved by Junta de Andalucia (License 04/09/2017/113). The degree of effect on capsaicin-induced mechanical allodynia was calculated as % antiallodynic effect = [(LTD – LTS)/(CT – LTS)] × 100 where LTD is the latency time for paw withdrawal in drug-treated animals, LTS is the latency time in solvent-treated animals (mean value 12.03 s), and CT is the cutoff time (50 s).The statistical significance of differences between values obtained in the different experimental groups was analyzed with one-way analysis of variance (ANOVA) followed by the Bonferroni test. The differences between mean values were considered statistically significant when the value of <i>P</i> was below 0.05.</div><div class="NLM_p last">All animal experiments performed in the manuscript were conducted in compliance with institutional guidelines. License number: 04/09/2017/113.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i89"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01183" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08113" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08113" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01183" class="ext-link">10.1021/acs.jmedchem.8b01183</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Purity data of all compounds, <sup>1</sup>H and <sup>13</sup>C NMR spectra, HPLC chromatograms (purity), and experimental details of in vitro assays (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01183/suppl_file/jm8b01183_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">checkCIF/PLATON report (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01183/suppl_file/jm8b01183_si_002.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01183/suppl_file/jm8b01183_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01183/suppl_file/jm8b01183_si_001.pdf">jm8b01183_si_001.pdf (5.15 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01183/suppl_file/jm8b01183_si_002.pdf">jm8b01183_si_002.pdf (313.3 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01183/suppl_file/jm8b01183_si_003.csv">jm8b01183_si_003.csv (3.64 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01183" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13876" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13876" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bernhard Wünsch</span> - <span class="hlFld-Affiliation affiliation">Institut
für Pharmazeutische und Medizinische Chemie der Universität
Münster, Corrensstraße
48, D-48149 Münster, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Cells-in-Motion
Cluster of Excellence (EXC 1003-CiM), Westfälische
Wilhelms-Universität Münster, 48149 Münster, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9030-8417" title="Orcid link">http://orcid.org/0000-0002-9030-8417</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#572022323924343f1722393e7a3a22323924233225793332"><span class="__cf_email__" data-cfemail="ee999b8b809d8d86ae9b8087c3839b8b809d9a8b9cc08a8b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Melanie Bergkemper</span> - <span class="hlFld-Affiliation affiliation">Institut
für Pharmazeutische und Medizinische Chemie der Universität
Münster, Corrensstraße
48, D-48149 Münster, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elisabeth Kronenberg</span> - <span class="hlFld-Affiliation affiliation">Institut
für Pharmazeutische und Medizinische Chemie der Universität
Münster, Corrensstraße
48, D-48149 Münster, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simone Thum</span> - <span class="hlFld-Affiliation affiliation">Institut
für Pharmazeutische und Medizinische Chemie der Universität
Münster, Corrensstraße
48, D-48149 Münster, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frederik Börgel</span> - <span class="hlFld-Affiliation affiliation">Institut
für Pharmazeutische und Medizinische Chemie der Universität
Münster, Corrensstraße
48, D-48149 Münster, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Constantin Daniliuc</span> - <span class="hlFld-Affiliation affiliation">Organisch-Chemisches
Institut der Westfälischen Wilhelms-Universität Münster, Corrensstraße 40, D-48149 Münster, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dirk Schepmann</span> - <span class="hlFld-Affiliation affiliation">Institut
für Pharmazeutische und Medizinische Chemie der Universität
Münster, Corrensstraße
48, D-48149 Münster, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francisco Rafael Nieto</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Institute of Neuroscience, School of Medicine
and Biomedical Research Center, University
of Granada, Avenida de la Investigación 11, 18016 Granada, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Brust</span> - <span class="hlFld-Affiliation affiliation">Institut
für Radiopharmazeutische Krebsforschung, Forschungsstelle Leipzig, Helmholtz-Zentrum Dresden-Rossendorf, Permoserstraße 15, 04318 Leipzig, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5555-7058" title="Orcid link">http://orcid.org/0000-0001-5555-7058</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raquel F. Reinoso</span> - <span class="hlFld-Affiliation affiliation">Esteve
Pharmaceuticals S.A, Baldiri Reixach 4-8, 08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Inés Alvarez</span> - <span class="hlFld-Affiliation affiliation">Esteve
Pharmaceuticals S.A, Baldiri Reixach 4-8, 08028 Barcelona, Spain</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i90">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26072" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26072" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the Deutsche Forschungsgemeinschaft (DFG) and the Cells-in-motion Cluster of Excellence (EXC, 1300-CiM), University of Münster, Germany.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">APCI</td><td class="NLM_def"><p class="first last">atmospheric pressure chemical ionization</p></td></tr><tr><td class="NLM_term"><i>d</i></td><td class="NLM_def"><p class="first last">diameter of the column</p></td></tr><tr><td class="NLM_term">DAST</td><td class="NLM_def"><p class="first last">diethylaminosulfur trifluoride</p></td></tr><tr><td class="NLM_term">DOR</td><td class="NLM_def"><p class="first last">δ opioid receptor</p></td></tr><tr><td class="NLM_term">DTG</td><td class="NLM_def"><p class="first last">1,3-di(<i>o</i>-tolyl)guanidine</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">endoplasmic reticulum</p></td></tr><tr><td class="NLM_term">fc</td><td class="NLM_def"><p class="first last">flash column chromatography</p></td></tr><tr><td class="NLM_term">HPMC</td><td class="NLM_def"><p class="first last">hydroxypropylmethylcellulose</p></td></tr><tr><td class="NLM_term">IP3</td><td class="NLM_def"><p class="first last">inositol trisphosphate</p></td></tr><tr><td class="NLM_term">ipl</td><td class="NLM_def"><p class="first last">intraplantar</p></td></tr><tr><td class="NLM_term">KOR</td><td class="NLM_def"><p class="first last">κ opioid receptor</p></td></tr><tr><td class="NLM_term"><i>l</i></td><td class="NLM_def"><p class="first last">length of the stationary phase</p></td></tr><tr><td class="NLM_term">MAM</td><td class="NLM_def"><p class="first last">mitochondrion-associated endoplasmic reticulum membranes</p></td></tr><tr><td class="NLM_term">MOR</td><td class="NLM_def"><p class="first last">μ opioid receptor</p></td></tr><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mammalian target of rapamycine</p></td></tr><tr><td class="NLM_term">NET</td><td class="NLM_def"><p class="first last">norepinephrine transporter</p></td></tr><tr><td class="NLM_term">NMDA</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate</p></td></tr><tr><td class="NLM_term">PCP</td><td class="NLM_def"><p class="first last">phencyclidine</p></td></tr><tr><td class="NLM_term">p-TsOH</td><td class="NLM_def"><p class="first last"><i>p</i>-toluenesulfonic acid</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">TRIS</td><td class="NLM_def"><p class="first last">tris(hydroxymethyl)aminomethane</p></td></tr><tr><td class="NLM_term"><i>V</i></td><td class="NLM_def"><p class="first last">fraction size</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i92">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52366" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52366" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 67 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eades, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huppler, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, P. E.</span></span> <span> </span><span class="NLM_article-title">The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>197</i></span>,  <span class="NLM_fpage">517</span>– <span class="NLM_lpage">532</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=945347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaE28XltlOhurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=1976&pages=517-532&author=W.+R.+Martinauthor=C.+G.+Eadesauthor=J.+A.+Thompsonauthor=R.+E.+Hupplerauthor=P.+E.+Gilbert&title=The+effects+of+morphine-+and+nalorphine-like+drugs+in+the+nondependent+and+morphine-dependent+chronic+spinal+dog"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog</span></div><div class="casAuthors">Martin, W. R.; Eades, C. G.; Thompson, J. A.; Huppler, R. E.; Gilbert, P. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">517-32</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Three different syndromes produced by congeners of morphine sulfate (I sulfate) [64-31-3] were identified in the nondependent chronic spinal dog.  These syndromes were attributed to interaction of agonists with three distinguishable receptors (μ, κ and σ).  I was the prototype agonist for the μ receptor, ketocyclazocine lactate [59985-33-0] for the κ receptor and SKF-10,047 lactate [59985-34-1] for the σ receptor.  The I syndrome (μ) in the dog was characterized by miosis, bradycardia, hypothermia, a general depression of the nociceptive responses and indifferences to environmental stimuli.  Ketocyclazocine (κ) constricted pupils, depressed the flexor reflex and produced sedation but did not markedly alter pulse rate or the skin twitch reflex.  SKF-10,047 (σ) caused mydriasis, tachypnea, tachycardia and mania.  The effects of these three drugs was antagonized by the pure antagonist naltrexone-HCl, indicating that they are agonists.  Further, chronic administration of I, ketocyclazocine and SKF-10,047 induced tolerance to their agonistic effects.  I suppressed abstinence in I-dependent dogs while ketocyclazocine did not.  Ketocyclazocine at best pptd. only a liminal abstinence syndrome in the I-dependent dog, indicating that it had little affinity for the I receptor.  Ketocyclazocine thus appears to be a selective agonist at the κ receptor.  Buprenorphine-HCl [53152-21-9] was a partial agonist of the μ type which both suppressed and pptd. abstinence in the I-dependent dog while I and d-propoxyphene-HCl [1639-60-7] were stronger agonists.  Apomorphine-HCl [314-19-2] and SKF-10,047 produced similar pharmacol. effects suggesting that σ activity may involve a dopaminergic mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6rgyf41iRTbVg90H21EOLACvtfcHk0lhpyC1l9fXHBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XltlOhurw%253D&md5=ca7c637f336ac9ecc2c3bb040dbcdbee</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DW.%2BR.%26aulast%3DEades%26aufirst%3DC.%2BG.%26aulast%3DThompson%26aufirst%3DJ.%2BA.%26aulast%3DHuppler%26aufirst%3DR.%2BE.%26aulast%3DGilbert%26aufirst%3DP.%2BE.%26atitle%3DThe%2520effects%2520of%2520morphine-%2520and%2520nalorphine-like%2520drugs%2520in%2520the%2520nondependent%2520and%2520morphine-dependent%2520chronic%2520spinal%2520dog%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1976%26volume%3D197%26spage%3D517%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tam, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, L.</span></span> <span> </span><span class="NLM_article-title">Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">5618</span>– <span class="NLM_lpage">5621</span>, <span class="refDoi"> DOI: 10.1073/pnas.81.17.5618</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1073%2Fpnas.81.17.5618" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=6147851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaL2cXmtVCiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1984&pages=5618-5621&author=S.+W.+Tamauthor=L.+Cook&title=Sigma+opiates+and+certain+antipsychotic+drugs+mutually+inhibit+%28%2B%29-%5B3H%5D+SKF+10%2C047+and+%5B3H%5Dhaloperidol+binding+in+guinea+pig+brain+membranes&doi=10.1073%2Fpnas.81.17.5618"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">σ Opiates and certain antipsychotic drugs mutually inhibit (+)-[3H]SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes</span></div><div class="casAuthors">Tam, S. William; Cook, Leonard</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5618-21</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The relationship between binding of antipsychotic drugs and σ psychotomimetic opiates to binding sites for the σ agonist 3H-labeled (+)-SKF 10,047  [58640-82-7] and to dopamine D2 sites was investigated.  In guinea pig brain membranes, (+)-[3H]SKF 10,047 bound to a single class of sites with a Kd of 4 × 10-8M and a Bmax of 333 fmol/mg of protein.  This binding was different from μ, κ, or δ opiate receptor binding.  It was inhibited by opiates that produce psychotomimetic activities but not by opiates that lack such activities.  Some antipsychotic drugs inhibited (+)-[3H]SKF 10,047 binding with high to moderate affinities in the following order of potency: haloperidol  [52-86-8] > perphenazine  [58-39-9] > fluphenazine  [69-23-8] > acetophenazine  [2751-68-0] > trifluoperazine  [117-89-5] > molindone  [7416-34-4] ≥ pimozide  [2062-78-4] ≥ thioridazine  [50-52-2] ≥ chlorpromazine  [50-53-3] ≥ triflupromazine  [146-54-3].  However, there were other antipsychotic drugs such as spiperone  [749-02-0] and clozapine  [5786-21-0] that showed low affinity for the (+)-[3H]SKF 10,047 binding sites.  Affinities of antipsychotic drugs for (+)-[3H]SKF 10,047 binding sites did not correlate with those for [3H]spiperone (dopamine D2) sites.  [3H]-Haloperidol binding in whole brain membranes was also inhibited by the σ opiates pentazocine  [359-83-1], cyclazocine  [3572-80-3], and (+)-SKF 10,047.  In the striatum, about half of the saturable [3H]haloperidol binding was to [3H]spiperone (D2) sites and the other half was to sites similar to (+)-[3H]SKF 10,047 binding sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3J2yT0mD-vLVg90H21EOLACvtfcHk0lisoP3IeEjtsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXmtVCiu7w%253D&md5=bdb8459ffe1755e96b9cba9d63186817</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1073%2Fpnas.81.17.5618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.81.17.5618%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DS.%2BW.%26aulast%3DCook%26aufirst%3DL.%26atitle%3DSigma%2520opiates%2520and%2520certain%2520antipsychotic%2520drugs%2520mutually%2520inhibit%2520%2528%252B%2529-%255B3H%255D%2520SKF%252010%252C047%2520and%2520%255B3H%255Dhaloperidol%2520binding%2520in%2520guinea%2520pig%2520brain%2520membranes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1984%26volume%3D81%26spage%3D5618%26epage%3D5621%26doi%3D10.1073%2Fpnas.81.17.5618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tam, S. W.</span></span> <span> </span><span class="NLM_article-title">Naloxone-inaccessible sigma receptor in rat central nervous system</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">6703</span>– <span class="NLM_lpage">6707</span>, <span class="refDoi"> DOI: 10.1073/pnas.80.21.6703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1073%2Fpnas.80.21.6703" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1983&pages=6703-6707&author=S.+W.+Tam&title=Naloxone-inaccessible+sigma+receptor+in+rat+central+nervous+system&doi=10.1073%2Fpnas.80.21.6703"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1073%2Fpnas.80.21.6703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.80.21.6703%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DS.%2BW.%26atitle%3DNaloxone-inaccessible%2520sigma%2520receptor%2520in%2520rat%2520central%2520nervous%2520system%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1983%26volume%3D80%26spage%3D6703%26epage%3D6707%26doi%3D10.1073%2Fpnas.80.21.6703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellewell, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGarry, K. A.</span></span> <span> </span><span class="NLM_article-title">Evidence for a multi-site model of the rat brain sigma receptor</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>163</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">318</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(89)90200-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2F0014-2999%2889%2990200-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=2542066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaL1MXktlGru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=1989&pages=309-318&author=W.+D.+Bowenauthor=S.+B.+Hellewellauthor=K.+A.+McGarry&title=Evidence+for+a+multi-site+model+of+the+rat+brain+sigma+receptor&doi=10.1016%2F0014-2999%2889%2990200-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for a multi-site model of the rat brain σ receptor</span></div><div class="casAuthors">Bowen, Wayne D.; Hellewell, Susan B.; McGarry, Kelly A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">309-18</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">UV irradn. of rat brain membranes at 254 nm, a treatment which modifies UV absorbing residues in proteins, decreased binding of both (+)-3-[3H](3-hydroxyphenyl)-N-(1-propyl)piperidine ([3H](+)-3-PPP) and 1,3-di-o-[3H]tolylguanidine ([3H]DTG) to σ receptors.  For [3H](+)-3-PPP, this was due to a decreased Bmax.  In contrast, irradn. markedly increased binding of (+)-N-[3H]allylnormetazocine ([3H](+)-SKF 10,047) due to a decrease in the Kd.  Both unlabeled DTG and haloperidol were competitive inhibitors of [3H](+)-3-PPP binding to untreated membranes, causing an increase in the Kd and no change in the Bmax.  The benzomorphans, (+)-SKF 10,047 and (+)-pentazocine, were uncompetitive inhibitors, causing a decrease in both the Kd and Bmax for [3H](+)-3-PPP.  Finally, the ability of DTG and (+)-3-PPP to inhibit binding of [3H](+)-SKF 10,047 was markedly reduced by UV irradn., whereas irradn. had little effect on the potency of unlabeled (+)-SKF 10,047 and (+)-pentazocine.  These data suggest that σ-related (+)-benzomorphans and non-benzomorphans interact either with distinct, allosterically coupled sites on the same σ receptor macromol. or with different populations of σ receptor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpz--JsUNQSebVg90H21EOLACvtfcHk0lisoP3IeEjtsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXktlGru70%253D&md5=f738cac19d6abf591fcf96d03f66687d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2889%2990200-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252889%252990200-8%26sid%3Dliteratum%253Aachs%26aulast%3DBowen%26aufirst%3DW.%2BD.%26aulast%3DHellewell%26aufirst%3DS.%2BB.%26aulast%3DMcGarry%26aufirst%3DK.%2BA.%26atitle%3DEvidence%2520for%2520a%2520multi-site%2520model%2520of%2520the%2520rat%2520brain%2520sigma%2520receptor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1989%26volume%3D163%26spage%3D309%26epage%3D318%26doi%3D10.1016%2F0014-2999%2889%2990200-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quirion, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itzhak, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junien, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musacchio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothman, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsung-Ping, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, D. P.</span></span> <span> </span><span class="NLM_article-title">A proposal for the classification of sigma binding sites</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1016/0165-6147(92)90030-A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2F0165-6147%2892%2990030-A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1315463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A280%3ADyaK383ksFGrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1992&pages=85-86&author=R.+Quirionauthor=W.+D.+Bowenauthor=Y.+Itzhakauthor=J.+L.+Junienauthor=J.+Musacchioauthor=R.+B.+Rothmanauthor=S.+Tsung-Pingauthor=S.+W.+Tamauthor=D.+P.+Taylor&title=A+proposal+for+the+classification+of+sigma+binding+sites&doi=10.1016%2F0165-6147%2892%2990030-A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A proposal for the classification of sigma binding sites</span></div><div class="casAuthors">Quirion R; Bowen W D; Itzhak Y; Junien J L; Musacchio J M; Rothman R B; Su T P; Tam S W; Taylor D P</div><div class="citationInfo"><span class="NLM_cas:title">Trends in pharmacological sciences</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">85-6</span>
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9QiJWG_oOy3p3bfzSLaX5fW6udTcc2ean9CSdcB83Lrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK383ksFGrsQ%253D%253D&md5=bdbde1d04c3c3e627e4ff512102ddf5d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2892%2990030-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252892%252990030-A%26sid%3Dliteratum%253Aachs%26aulast%3DQuirion%26aufirst%3DR.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26aulast%3DItzhak%26aufirst%3DY.%26aulast%3DJunien%26aufirst%3DJ.%2BL.%26aulast%3DMusacchio%26aufirst%3DJ.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DTsung-Ping%26aufirst%3DS.%26aulast%3DTam%26aufirst%3DS.%2BW.%26aulast%3DTaylor%26aufirst%3DD.%2BP.%26atitle%3DA%2520proposal%2520for%2520the%2520classification%2520of%2520sigma%2520binding%2520sites%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1992%26volume%3D13%26spage%3D85%26epage%3D86%26doi%3D10.1016%2F0165-6147%2892%2990030-A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Privat, A.</span></span> <span> </span><span class="NLM_article-title">Modulation by neurosteroids of the in vivo (+)-[3H]SKF-10,047 binding to sigma 1 receptors in the mouse forebrain</span>. <i>J. Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">734</span>– <span class="NLM_lpage">743</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1097-4547(19961215)46:6<734::AID-JNR10>3.0.CO;2-U</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1002%2F%28SICI%291097-4547%2819961215%2946%3A6%3C734%3A%3AAID-JNR10%3E3.0.CO%3B2-U" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=8978508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaK28Xns1ekurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1996&pages=734-743&author=T.+Mauriceauthor=F.+J.+Romanauthor=A.+Privat&title=Modulation+by+neurosteroids+of+the+in+vivo+%28%2B%29-%5B3H%5DSKF-10%2C047+binding+to+sigma+1+receptors+in+the+mouse+forebrain&doi=10.1002%2F%28SICI%291097-4547%2819961215%2946%3A6%3C734%3A%3AAID-JNR10%3E3.0.CO%3B2-U"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation by neurosteroids of the in vivo (+)-[3H]SKF-10,047 binding to σ1 receptors in the mouse forebrain</span></div><div class="casAuthors">Maurice, Tangui; Roman, Francois J.; Privat, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">734-743</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss</span>)
        </div><div class="casAbstract">Recent reports suggest an interaction between neuro-(active)steroids and sigma1 (σ1) receptors, affecting biochem. parameters as well as physiol. responses mediated by σ1 ligands in the rodent brain.  In this study, the authors examd. the modulation by neurosteroids of the haloperidol-sensitive in vivo (+)-[3H]SKF-10,047 binding to σ1 sites in the mouse hippocampus and cortex.  Progesterone (PROG; 2-40 mg/kg), pregnenolone sulfate (PREGS; 10-40 mg/kg), and dehydroepiandrosterone sulfate (DHEAS); 10-40 mg/kg were administered systemically 10 min before the radioactive tracer.  The total amt. of (+)-[3H]SKF-10,047 bound in each structure was significantly affected by PROG and PREGS only at the highest dose tested and was unaffected by DHEAS.  However, bound to free (B/F) radioactivity ratios were highly significantly decreased by 30-40% in each structure by PROG and PREGS.  DHEAS, at 40 mg/kg, induced a significant 20% decrease in the hippocampus.  Furthermore, the in vivo (+)-[3H]SKF-10,047 binding parameters were diminished in pregnant female mice compared to non-pregnant or male mice.  These results confirm the in vitro binding results, bring a direct in vivo demonstration of the interaction between neurosteroids and σ1 receptors, and show that physiol. modulations of the steroidal concns. affect the σ1 systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpryJS-9i3X0LVg90H21EOLACvtfcHk0lisCHik_EfUKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xns1ekurc%253D&md5=1034f429f7a7d34decb83db0060d2b22</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-4547%2819961215%2946%3A6%3C734%3A%3AAID-JNR10%3E3.0.CO%3B2-U&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-4547%252819961215%252946%253A6%253C734%253A%253AAID-JNR10%253E3.0.CO%253B2-U%26sid%3Dliteratum%253Aachs%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DRoman%26aufirst%3DF.%2BJ.%26aulast%3DPrivat%26aufirst%3DA.%26atitle%3DModulation%2520by%2520neurosteroids%2520of%2520the%2520in%2520vivo%2520%2528%252B%2529-%255B3H%255DSKF-10%252C047%2520binding%2520to%2520sigma%25201%2520receptors%2520in%2520the%2520mouse%2520forebrain%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D1996%26volume%3D46%26spage%3D734%26epage%3D743%26doi%3D10.1002%2F%28SICI%291097-4547%2819961215%2946%3A6%3C734%3A%3AAID-JNR10%3E3.0.CO%3B2-U" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junien, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Privat, A.</span></span> <span> </span><span class="NLM_article-title">Dehydroepiandrosterone sulfate attenuates dizocilpine-induced learning impairment in mice via sigma 1-receptors</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">164</span>, <span class="refDoi"> DOI: 10.1016/S0166-4328(97)86061-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2FS0166-4328%2897%2986061-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1997&pages=159-164&author=T.+Mauriceauthor=J.+L.+Junienauthor=A.+Privat&title=Dehydroepiandrosterone+sulfate+attenuates+dizocilpine-induced+learning+impairment+in+mice+via+sigma+1-receptors&doi=10.1016%2FS0166-4328%2897%2986061-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0166-4328%2897%2986061-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-4328%252897%252986061-5%26sid%3Dliteratum%253Aachs%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DJunien%26aufirst%3DJ.%2BL.%26aulast%3DPrivat%26aufirst%3DA.%26atitle%3DDehydroepiandrosterone%2520sulfate%2520attenuates%2520dizocilpine-induced%2520learning%2520impairment%2520in%2520mice%2520via%2520sigma%25201-receptors%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D1997%26volume%3D83%26spage%3D159%26epage%3D164%26doi%3D10.1016%2FS0166-4328%2897%2986061-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romieu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Fardon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span> <span> </span><span class="NLM_article-title">Sigma 1 receptor-related neuroactive steroids modulate cocaine-induced reward</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3572</span>– <span class="NLM_lpage">3576</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.23-09-03572.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1523%2FJNEUROSCI.23-09-03572.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=12736327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslGntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=3572-3576&author=P.+Romieuauthor=R.+Martin-Fardonauthor=W.+D.+Bowenauthor=T.+Maurice&title=Sigma+1+receptor-related+neuroactive+steroids+modulate+cocaine-induced+reward&doi=10.1523%2FJNEUROSCI.23-09-03572.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">σ1 Receptor-related neuroactive steroids modulate cocaine-induced reward</span></div><div class="casAuthors">Romieu, Pascal; Martin-Fardon, Remi; Bowen, Wayne D.; Maurice, Tangui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3572-3576</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The σ1 receptor is critically involved in the rewarding effect of cocaine, as measured using the conditioned place preference (CPP) procedure in mice.  Neuroactive steroids exert rapid neuromodulatory effects in the brain by interacting with GABAA, NMDA, and σ1 receptors.  At the σ1 receptor level, 3β-hydroxy-5-androsten-17-one [dehydroepiandrosterone (DHEA)] and 3β-hydroxy-5-pregnen-20-one (pregnenolone) act as agonists, whereas 4-pregnene-3,20-dione (progesterone) is an efficient antagonist.  The present study sought to investigate the action of neuroactive steroids in acquisition of cocaine-induced CPP in C57BL/6 mice.  None of these steroids induced CPP alone.  However, pretreatment with DHEA or pregnenolone (5-20 mg/kg, s.c.) during conditioning with cocaine (10 mg/kg, i.p.) increased the conditioned score.  On the contrary, pretreatment with either progesterone (10 or 20 mg/kg, s.c.) or finasteride (25 mg/kg, twice a day), a 5α-reductase inhibitor, blocked acquisition of cocaine (20 mg/kg)-induced CPP.  A crossed pharmacol. was obsd. between steroids and σ1 ligands.  The σ1 antagonist N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(dimethylamino)ethylamine blocked cocaine-induced CPP and its potentiation by DHEA or pregnenolone.  Progesterone blocked cocaine-induced CPP and its potentiation by the σ1 agonist igmesine.  These results showed that neuroactive steroids play a role in cocaine-induced appetence, through their interaction with the σ1 receptor.  Therefore, neuroendocrine control of cocaine addiction may not involve solely glucocorticoids.  The importance of neuroactive steroids as factors of individual vulnerability to drug addiction should, thus, be considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGZv5oasaAH7Vg90H21EOLACvtfcHk0lisCHik_EfUKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslGntbw%253D&md5=4f45c1ac0e562d735fb69c91aff38ed3</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.23-09-03572.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.23-09-03572.2003%26sid%3Dliteratum%253Aachs%26aulast%3DRomieu%26aufirst%3DP.%26aulast%3DMartin-Fardon%26aufirst%3DR.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26aulast%3DMaurice%26aufirst%3DT.%26atitle%3DSigma%25201%2520receptor-related%2520neuroactive%2520steroids%2520modulate%2520cocaine-induced%2520reward%26jtitle%3DJ.%2520Neurosci.%26date%3D2003%26volume%3D23%26spage%3D3572%26epage%3D3576%26doi%3D10.1523%2FJNEUROSCI.23-09-03572.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fontanilla, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johannessen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajipour, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozzi, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruoho, A. E.</span></span> <span> </span><span class="NLM_article-title">The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>323</i></span>,  <span class="NLM_fpage">934</span>– <span class="NLM_lpage">937</span>, <span class="refDoi"> DOI: 10.1126/science.1166127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1126%2Fscience.1166127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=19213917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhslSgsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2009&pages=934-937&author=D.+Fontanillaauthor=M.+Johannessenauthor=A.+R.+Hajipourauthor=N.+V.+Cozziauthor=M.+B.+Jacksonauthor=A.+E.+Ruoho&title=The+hallucinogen+N%2CN-dimethyltryptamine+%28DMT%29+is+an+endogenous+sigma-1+receptor+regulator&doi=10.1126%2Fscience.1166127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator</span></div><div class="casAuthors">Fontanilla, Dominique; Johannessen, Molly; Hajipour, Abdol R.; Cozzi, Nicholas V.; Jackson, Meyer B.; Ruoho, Arnold E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">5916</span>),
    <span class="NLM_cas:pages">934-937</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The sigma-1 receptor is widely distributed in the central nervous system and periphery.  Originally mischaracterized as an opioid receptor, the sigma-1 receptor binds a vast no. of synthetic compds. but does not bind opioid peptides; it is currently considered an orphan receptor.  The sigma-1 receptor pharmacophore includes an alkylamine core, also found in the endogenous compd. N,N-dimethyltryptamine (DMT).  DMT acts as a hallucinogen, but its receptor target has been unclear.  DMT bound to sigma-1 receptors and inhibited voltage-gated sodium ion (Na+) channels in both native cardiac myocytes and heterologous cells that express sigma-1 receptors.  DMT induced hypermobility in wild-type mice but not in sigma-1 receptor knockout mice.  These biochem., physiol., and behavioral expts. indicate that DMT is an endogenous agonist for the sigma-1 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAp8p0wmc1wLVg90H21EOLACvtfcHk0ljmZVt4m8YK4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhslSgsbw%253D&md5=480f24607d42dbe5c5fcd9cdc8ee5e5c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.1166127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1166127%26sid%3Dliteratum%253Aachs%26aulast%3DFontanilla%26aufirst%3DD.%26aulast%3DJohannessen%26aufirst%3DM.%26aulast%3DHajipour%26aufirst%3DA.%2BR.%26aulast%3DCozzi%26aufirst%3DN.%2BV.%26aulast%3DJackson%26aufirst%3DM.%2BB.%26aulast%3DRuoho%26aufirst%3DA.%2BE.%26atitle%3DThe%2520hallucinogen%2520N%252CN-dimethyltryptamine%2520%2528DMT%2529%2520is%2520an%2520endogenous%2520sigma-1%2520receptor%2520regulator%26jtitle%3DScience%26date%3D2009%26volume%3D323%26spage%3D934%26epage%3D937%26doi%3D10.1126%2Fscience.1166127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruoho, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, U. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontanilla, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mavlyutov, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajipour, A. R.</span></span> <span> </span><span class="NLM_article-title">The ligand binding region of the sigma-1 receptor: studies utilizing photoaffinity probes, sphingosine and N-alkylamines</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">920</span>– <span class="NLM_lpage">929</span>, <span class="refDoi"> DOI: 10.2174/138161212799436584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.2174%2F138161212799436584" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=920-929&author=A.+E.+Ruohoauthor=U.+B.+Chuauthor=S.+Ramachandranauthor=D.+Fontanillaauthor=T.+Mavlyutovauthor=A.+R.+Hajipour&title=The+ligand+binding+region+of+the+sigma-1+receptor%3A+studies+utilizing+photoaffinity+probes%2C+sphingosine+and+N-alkylamines&doi=10.2174%2F138161212799436584"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F138161212799436584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212799436584%26sid%3Dliteratum%253Aachs%26aulast%3DRuoho%26aufirst%3DA.%2BE.%26aulast%3DChu%26aufirst%3DU.%2BB.%26aulast%3DRamachandran%26aufirst%3DS.%26aulast%3DFontanilla%26aufirst%3DD.%26aulast%3DMavlyutov%26aufirst%3DT.%26aulast%3DHajipour%26aufirst%3DA.%2BR.%26atitle%3DThe%2520ligand%2520binding%2520region%2520of%2520the%2520sigma-1%2520receptor%253A%2520studies%2520utilizing%2520photoaffinity%2520probes%252C%2520sphingosine%2520and%2520N-alkylamines%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2012%26volume%3D18%26spage%3D920%26epage%3D929%26doi%3D10.2174%2F138161212799436584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moebius, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flandorfer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knaus, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Striessnig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glossmann, H.</span></span> <span> </span><span class="NLM_article-title">Purification, molecular cloning, and expression of the mammalian sigma1-binding site</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">8072</span>– <span class="NLM_lpage">8077</span>, <span class="refDoi"> DOI: 10.1073/pnas.93.15.8072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1073%2Fpnas.93.15.8072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=8755605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaK28XksFSqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=8072-8077&author=M.+Hannerauthor=F.+F.+Moebiusauthor=A.+Flandorferauthor=H.+G.+Knausauthor=J.+Striessnigauthor=E.+Kempnerauthor=H.+Glossmann&title=Purification%2C+molecular+cloning%2C+and+expression+of+the+mammalian+sigma1-binding+site&doi=10.1073%2Fpnas.93.15.8072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Purification, molecular cloning, and expression of the mammalian sigma1-binding site</span></div><div class="casAuthors">Hanner, Markus; Moebius, Fabian F.; Flandorfer, Astrid; Knaus, Hans-Guenther; Striessnig, Joerg; Kempner, Ellis; Glossman, Hartmut</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">8072-8077</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Sigma-ligands comprise several chem. unrelated drugs such as haloperidol, pentazocine, and ditolylguanidine, which bind to a family of low mol. mass proteins in the endoplasmic reticulum.  These so-called sigma-receptors are believed to mediate various pharmacol. effects of sigma-ligands by as yet unknown mechanisms.  Based on their opposite enantioselectivity for benzomorphans and different mol. masses, two subtypes are differentiated.  We purified the sigma1-binding site as a single 30-kDa protein from guinea pig liver employing the benzomorphan (+)[3H]pentazocine and the aryladize (-)[3H]azidopamil as specific probes.  The purified (+)[3H]pentazocine-binding protein retained its high affinity for haloperidol, pentazocine, and ditolylguanidine.  Partial amino acid sequence obtained after trypsinolysis revealed no homol. to known proteins.  Radiation inactivation of the pentazocine-labeled sigma1-binding site yielded a mol. mass of 24 kDa.  The corresponding cDNA was cloned using degenerate oligonucleotides and cDNA library screening.  Its open reading frame encoded a 25.3-kDa protein with at least one putative transmembrane segment.  The protein expressed in yeast cells transformed with the cDNA showed the pharmacol. characteristics of the brain and liver sigma1-binding site.  The deduced amino acid sequence was structurally unrelated to known mammalian proteins but it shared homol. with fungal proteins involved in sterol synthesis.  Northern blots showed high densities of the sigma1-binding site mRNA in sterol-producing tissues.  This is also in agreement with the known ability of sigma1-binding sites to interact with steroids, such as progesterone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3kp2l6ZPKdrVg90H21EOLACvtfcHk0ljmZVt4m8YK4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XksFSqsr8%253D&md5=01c7d3bbab83dd5d18531845213bf267</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.15.8072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.15.8072%26sid%3Dliteratum%253Aachs%26aulast%3DHanner%26aufirst%3DM.%26aulast%3DMoebius%26aufirst%3DF.%2BF.%26aulast%3DFlandorfer%26aufirst%3DA.%26aulast%3DKnaus%26aufirst%3DH.%2BG.%26aulast%3DStriessnig%26aufirst%3DJ.%26aulast%3DKempner%26aufirst%3DE.%26aulast%3DGlossmann%26aufirst%3DH.%26atitle%3DPurification%252C%2520molecular%2520cloning%252C%2520and%2520expression%2520of%2520the%2520mammalian%2520sigma1-binding%2520site%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26spage%3D8072%26epage%3D8077%26doi%3D10.1073%2Fpnas.93.15.8072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leibach, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganapathy, V.</span></span> <span> </span><span class="NLM_article-title">Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 sigma receptor</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>241</i></span>,  <span class="NLM_fpage">535</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1997.7840</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1006%2Fbbrc.1997.7840" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=241&publication_year=1997&pages=535-540&author=P.+Sethauthor=F.+H.+Leibachauthor=V.+Ganapathy&title=Cloning+and+structural+analysis+of+the+cDNA+and+the+gene+encoding+the+murine+type+1+sigma+receptor&doi=10.1006%2Fbbrc.1997.7840"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1997.7840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1997.7840%26sid%3Dliteratum%253Aachs%26aulast%3DSeth%26aufirst%3DP.%26aulast%3DLeibach%26aufirst%3DF.%2BH.%26aulast%3DGanapathy%26aufirst%3DV.%26atitle%3DCloning%2520and%2520structural%2520analysis%2520of%2520the%2520cDNA%2520and%2520the%2520gene%2520encoding%2520the%2520murine%2520type%25201%2520sigma%2520receptor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1997%26volume%3D241%26spage%3D535%26epage%3D540%26doi%3D10.1006%2Fbbrc.1997.7840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kekuda, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leibach, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganapathy, V.</span></span> <span> </span><span class="NLM_article-title">Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1)</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>229</i></span>,  <span class="NLM_fpage">553</span>– <span class="NLM_lpage">558</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1996.1842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1006%2Fbbrc.1996.1842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=8954936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaK28Xns1ehtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=1996&pages=553-558&author=R.+Kekudaauthor=P.+D.+Prasadauthor=Y.+J.+Feiauthor=F.+H.+Leibachauthor=V.+Ganapathy&title=Cloning+and+functional+expression+of+the+human+type+1+sigma+receptor+%28hSigmaR1%29&doi=10.1006%2Fbbrc.1996.1842"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1)</span></div><div class="casAuthors">Kekuda, Ramesh; Prasad, Puttur D.; Fei, You-Jun; Leibach, Frederich H.; Ganapathy, Vadivel</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">229</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">553-558</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">We have isolated a cDNA clone from a human placental choriocarcinoma cell (JAR) cDNA library which codes for a functional type 1 sigma receptor.  An RT-PCR product obtained from guinea pig kidney mRNA using primers specific for the guineas pig sigma receptor cDNA was used to screen the cDNA library.  The hSigmaR1 cDNA predicts a protein of 223 amino acids with a single putative transmembrane domain.  The amino acid sequence exhibits 93% identity with the guinea pig sigma receptor.  When functionally expressed in HeLa cells, the hSigmaR1 cDNA enhances the binding of [3H]-haloperidol, a sigma receptor ligand, to the HeLa cell membranes.  The inhibitor specificity of the cloned hSigmaR1 indicates that it is the type 1 sigma receptor.  Several human tissues, including placenta, liver, and brain, and several human cell lines express the SigmaR1 mRNA (1.7 kb) to a variable extent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSSxDn_6je4bVg90H21EOLACvtfcHk0ljDQikMR7igyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xns1ehtrw%253D&md5=8a128351bb8a55e5b3fc3dd31d879b90</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1996.1842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1996.1842%26sid%3Dliteratum%253Aachs%26aulast%3DKekuda%26aufirst%3DR.%26aulast%3DPrasad%26aufirst%3DP.%2BD.%26aulast%3DFei%26aufirst%3DY.%2BJ.%26aulast%3DLeibach%26aufirst%3DF.%2BH.%26aulast%3DGanapathy%26aufirst%3DV.%26atitle%3DCloning%2520and%2520functional%2520expression%2520of%2520the%2520human%2520type%25201%2520sigma%2520receptor%2520%2528hSigmaR1%2529%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1996%26volume%3D229%26spage%3D553%26epage%3D558%26doi%3D10.1006%2Fbbrc.1996.1842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hellewell, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feinstein, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orringer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, W. D.</span></span> <span> </span><span class="NLM_article-title">Rat liver and kidney contain high densities of σ1 and σ2 receptors: characterization by ligand binding and photoaffinity labeling</span>. <i>Eur. J. Pharmacol., Mol. Pharmacol. Sect.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>268</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1016/0922-4106(94)90115-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2F0922-4106%2894%2990115-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=7925616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaK2cXkslelsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1994&pages=9-18&author=S.+B.+Hellewellauthor=A.+Bruceauthor=G.+Feinsteinauthor=J.+Orringerauthor=W.+Williamsauthor=W.+D.+Bowen&title=Rat+liver+and+kidney+contain+high+densities+of+%CF%831+and+%CF%832+receptors%3A+characterization+by+ligand+binding+and+photoaffinity+labeling&doi=10.1016%2F0922-4106%2894%2990115-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Rat liver and kidney contain high densities of σ1 and σ2 receptors: characterization by ligand binding and photoaffinity labeling</span></div><div class="casAuthors">Hellewell, Susan B.; Bruce, Ashley; Feinstein, Glen; Orringer, Jeffrey; Williams, Wanda; Bowen, Wayne D.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology, Molecular Pharmacology Section</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-18</span>CODEN:
                <span class="NLM_cas:coden">EJPPET</span>;
        ISSN:<span class="NLM_cas:issn">0922-4106</span>.
    </div><div class="casAbstract">Rat liver and kidney were investigated for the presence of sigma (σ) receptor subtypes by radioligand binding with three highly selective σ probes and by photoaffinity labeling using [3H]azido-di-o-tolylguanidine ([3H]azido-DTG). [3H](+)-Pentazocine, a highly selective σ1 probe, bound to sites in liver membranes with Kd = 7.5 nM and Bmax = 2929 fmol/mg protein. [3H](+)-Pentazocine binding sites in kidney had Kd = 23.3 nM and Bmax = 229 fmol/mg protein. [3H]1,3-Di-o-tolylguanidine ([3H]DTG) and [3H](+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine ([3H](+)-3-PPP) label both σ1 and σ2 receptor.  Parameters for [3H]DTG in the liver were Kd = 17.9 nM and Bmax = 11,895 fmol/mg protein.  Similar parameters were obsd. for [3H](+)-3-PPP, Kd = 51.9 nM and Bmax = 11 070 fmol/mg protein. [3H]DTG bound to rat kidney with Kd = 45.8 nM and Bmax = 1190 fmol/mg protein.  The observation that either [3H]DTG or [3H](+)-3-PPP and [3H](+)-3-PPP labeled a higher no. of sites relative to [3H](+)-pentazocine suggested that liver and kidney contain both subtypes of σ receptor.  This was confirmed by competition studies vs. [3H](+)-pentazocine and [3H]DTG (in the presence of dextrallorphan to mask σ1 sites).  In both tissues, [3H](+)-pentazocine labeled sites with high affinity for haloperidol and enantioselectivity for (+)-benzomorphans over (-)-benzomorphans. [3H]DTG + dextrallorphan labeled sites in both tissues which also had high affinity for haloperidol, but which had the characteristic σ2 property of low affinity for (+)-benzomorphans and enantioselectivity for (-)-benzomorphans over the corresponding (+)-isomer.  Similar results were obtained with [3H](+)-3-PPP + dextrallorphan.  Several novel aryl diamines, such as 1S,2R-cis-N-[2-(3,4-dichlorophenyl)ethyl]- N-methyl-2-(1-pyrrolidinyl)cyclohexylamine (BD737) and N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylamine (BD1008), bound to both sites with high affinity.  Photoaffinity labeling with 10 nM [3H]azido-DTG resulted in specific labeling of polypeptides of 25 kDa and 21.5 kDa.  Dextrallorphan (100 nM or 500 nM) completely blocked labeling of the 25 kDa polypeptide, but had no effect on labeling of the lower mol. wt. protein. (+)-10,11-Dihydro-5-methyl-5H-dibenzo[a,d]cyclohepten-5,10-imine ((+)-MK-801) had no effect on labeling of either polypeptide.  These data are consistent with the notion that the 25 kDa and 21.5 kDa proteins represent σ1 and σ2 receptors, resp.  Thus, rat liver and kidney contain high densities of σ1 and σ2 receptors, with σ2 sites comprising 75-80% of the total σ population.  The high d. of σ receptor subtypes may indicate important functions in hepatic and renal tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOgAMHz8C8c7Vg90H21EOLACvtfcHk0ljDQikMR7igyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkslelsbc%253D&md5=aeefd275781454593365b4b0d127a8a6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2F0922-4106%2894%2990115-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0922-4106%252894%252990115-5%26sid%3Dliteratum%253Aachs%26aulast%3DHellewell%26aufirst%3DS.%2BB.%26aulast%3DBruce%26aufirst%3DA.%26aulast%3DFeinstein%26aufirst%3DG.%26aulast%3DOrringer%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DW.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3DRat%2520liver%2520and%2520kidney%2520contain%2520high%2520densities%2520of%2520%25CF%25831%2520and%2520%25CF%25832%2520receptors%253A%2520characterization%2520by%2520ligand%2520binding%2520and%2520photoaffinity%2520labeling%26jtitle%3DEur.%2520J.%2520Pharmacol.%252C%2520Mol.%2520Pharmacol.%2520Sect.%26date%3D1994%26volume%3D268%26spage%3D9%26epage%3D18%26doi%3D10.1016%2F0922-4106%2894%2990115-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurpinar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manglik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the human σ1 receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>532</i></span>,  <span class="NLM_fpage">527</span>– <span class="NLM_lpage">530</span>, <span class="refDoi"> DOI: 10.1038/nature17391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1038%2Fnature17391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=27042935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlsl2gt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=532&publication_year=2016&pages=527-530&author=H.+R.+Schmidtauthor=S.+Zhengauthor=E.+Gurpinarauthor=A.+Koehlauthor=A.+Manglikauthor=A.+C.+Kruse&title=Crystal+structure+of+the+human+%CF%831+receptor&doi=10.1038%2Fnature17391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the human σ1 receptor</span></div><div class="casAuthors">Schmidt, Hayden R.; Zheng, Sanduo; Gurpinar, Esin; Koehl, Antoine; Manglik, Aashish; Kruse, Andrew C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">532</span>
        (<span class="NLM_cas:issue">7600</span>),
    <span class="NLM_cas:pages">527-530</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The human σ1 receptor is an enigmatic endoplasmic reticulum (ER)-resident transmembrane protein implicated in a variety of disorders including depression, drug addiction, and neuropathic pain.  Recently, an addnl. connection to amyotrophic lateral sclerosis has emerged from studies of human genetics and mouse models.  Unlike many transmembrane receptors that belong to large, extensively studied families such as G-protein-coupled receptors or ligand-gated ion channels, the σ1 receptor is an evolutionary isolate with no discernible similarity to any other human protein.  Despite its increasingly clear importance in human physiol. and disease, the mol. architecture of the σ1 receptor and its regulation by drug-like compds. remain poorly defined.  Here, the authors report crystal structures of the human σ1 receptor in complex with 2 chem. divergent ligands, PD 144418 and 4-(N-benzylpiperidin-4-yl)-4-iodobenzamide (4-IBP).  The structures revealed a trimeric architecture with a single transmembrane domain in each protomer.  The C-terminal domain of the receptor showed an extensive flat, hydrophobic membrane-proximal surface, suggesting an intimate assocn. with the cytosolic surface of the ER membrane in cells.  This domain included a cupin-like β-barrel with the ligand-binding site buried at its center.  This large, hydrophobic ligand-binding cavity showed remarkable plasticity in ligand recognition, binding the 2 ligands in similar positions despite dissimilar chem. structures.  Taken together, these results revealed the overall architecture, oligomerization state, and mol. basis for ligand recognition by this important but poorly understood protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokQBAf03Pml7Vg90H21EOLACvtfcHk0lgjSljVIOsylg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlsl2gt7o%253D&md5=fb6df7814060fbd05ba41261ad1061f5</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature17391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature17391%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DH.%2BR.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DGurpinar%26aufirst%3DE.%26aulast%3DKoehl%26aufirst%3DA.%26aulast%3DManglik%26aufirst%3DA.%26aulast%3DKruse%26aufirst%3DA.%2BC.%26atitle%3DCrystal%2520structure%2520of%2520the%2520human%2520%25CF%25831%2520receptor%26jtitle%3DNature%26date%3D2016%26volume%3D532%26spage%3D527%26epage%3D530%26doi%3D10.1038%2Fnature17391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, T.-P.</span></span> <span> </span><span class="NLM_article-title">Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">596</span>– <span class="NLM_lpage">610</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.08.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2Fj.cell.2007.08.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=17981125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWitrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=596-610&author=T.+Hayashiauthor=T.-P.+Su&title=Sigma-1+receptor+chaperones+at+the+ER-mitochondrion+interface+regulate+Ca%282%2B%29+signaling+and+cell+survival&doi=10.1016%2Fj.cell.2007.08.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca2+ signaling and cell survival</span></div><div class="casAuthors">Hayashi, Teruo; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">596-610</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Communication between the endoplasmic reticulum (ER) and mitochondrion is important for bioenergetics and cellular survival.  The ER supplies Ca2+ directly to mitochondria via inositol 1,4,5-trisphosphate receptors (IP3Rs) at close contacts between the two organelles referred to as mitochondrion-assocd. ER membrane (MAM).  We found here that the ER protein sigma-1 receptor (Sig-1R), which is implicated in neuroprotection, carcinogenesis, and neuroplasticity, is a Ca2+-sensitive and ligand-operated receptor chaperone at MAM.  Normally, Sig-1Rs form a complex at MAM with another chaperone, BiP.  Upon ER Ca2+ depletion or via ligand stimulation, Sig-1Rs dissoc. from BiP, leading to a prolonged Ca2+ signaling into mitochondria via IP3Rs.  Sig-1Rs can translocate under chronic ER stress.  Increasing Sig-1Rs in cells counteracts ER stress response, whereas decreasing them enhances apoptosis.  These results reveal that the orchestrated ER chaperone machinery at MAM, by sensing ER Ca2+ concns., regulates ER-mitochondrial interorganellar Ca2+ signaling and cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFqHhdVumdO7Vg90H21EOLACvtfcHk0lgjSljVIOsylg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWitrzK&md5=7bb4e806d7ad895f9ed1a8c4f7eb7f6c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.08.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.08.036%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.-P.%26atitle%3DSigma-1%2520receptor%2520chaperones%2520at%2520the%2520ER-mitochondrion%2520interface%2520regulate%2520Ca%25282%252B%2529%2520signaling%2520and%2520cell%2520survival%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D596%26epage%3D610%26doi%3D10.1016%2Fj.cell.2007.08.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weissman, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedreen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">London, E. D.</span></span> <span> </span><span class="NLM_article-title">Sigma receptors in post-mortem human brains</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>247</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">33</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=2845055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaL1cXmt1agtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=247&publication_year=1988&pages=29-33&author=A.+D.+Weissmanauthor=T.+P.+Suauthor=J.+C.+Hedreenauthor=E.+D.+London&title=Sigma+receptors+in+post-mortem+human+brains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma receptors in post-mortem human brains</span></div><div class="casAuthors">Weissman, Arthur D.; Su, Tsung Ping; Hedreen, John C.; London, Edythe D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">247</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-33</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The pharmacol. profile and regional distribution of σ-receptors in human autopsy brains were detd. with [3H]haloperidol as the ligand, in the presence of 50 nM spiperone to block binding to D2 dopamine sites.  Specific binding in the cerebellum was to a single and saturable class of receptors with Kd 0.95 nM and max. binding = 358 fmol/mg protein.  Inhibition studies of the nondopamine [3H]haloperiodol binding site in human cerebellar membranes revealed stereospecific binding and a pharmacol. profile similar to that of specific σ-binding sites characterized in rodent brains with [3H]haloperiodol, N-[3H]allylnormetazocine, and di-o-[3H]tolylguanidine as radioligands.  The densities of σ-sites in the brain were highest in the cerebellum, nucleus accumbens, and cerebral cortex.  A post-mortem simulation study was performed with guinea pig brains due to the concern that σ-receptors might deteriorate in the human brain before assay.  However, this site was remarkably stable and insensitive to long periods of cooling or freezing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMrj71ILka9rVg90H21EOLACvtfcHk0lgjSljVIOsylg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXmt1agtL4%253D&md5=551fd162f7aba3ebe2c8d08bc7c629d6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeissman%26aufirst%3DA.%2BD.%26aulast%3DSu%26aufirst%3DT.%2BP.%26aulast%3DHedreen%26aufirst%3DJ.%2BC.%26aulast%3DLondon%26aufirst%3DE.%2BD.%26atitle%3DSigma%2520receptors%2520in%2520post-mortem%2520human%2520brains%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1988%26volume%3D247%26spage%3D29%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Samovilova, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagornaya, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinogradov, V. A.</span></span> <span> </span><span class="NLM_article-title">(+)-[3H]SKF 10,047 sites in rat liver</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>147</i></span>,  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">264</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(88)90784-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2F0014-2999%2888%2990784-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=3366176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaL1cXhvVSnsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=1988&pages=259-264&author=N.+N.+Samovilovaauthor=L.+V.+Nagornayaauthor=V.+A.+Vinogradov&title=%28%2B%29-%5B3H%5DSKF+10%2C047+sites+in+rat+liver&doi=10.1016%2F0014-2999%2888%2990784-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">(+)-[3H]SK & F 10,047 binding sites in rat liver</span></div><div class="casAuthors">Samovilova, N. N.; Nagornaya, L. V.; Vinogradov, V. A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">259-64</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Stereospecific binding sites for (+)-[3H]SKF 10,047 were demonstrated in rat liver.  These binding sites are σ-opioid receptors, and this was confirmed by their binding properties: reversibility, saturability, stereospecificity, effects of ions and various pharmacol. drugs on (+)-[3H]SKF 10,047 binding.  Apparently, (+)-[3H]SKF 10,047 binding sites in liver and brain are a part of novel sigmergic regulatory system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFdpImXhfaEbVg90H21EOLACvtfcHk0lgjSljVIOsylg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhvVSnsbo%253D&md5=1c9d70a805fba66cec42147d8cfc109c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2888%2990784-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252888%252990784-4%26sid%3Dliteratum%253Aachs%26aulast%3DSamovilova%26aufirst%3DN.%2BN.%26aulast%3DNagornaya%26aufirst%3DL.%2BV.%26aulast%3DVinogradov%26aufirst%3DV.%2BA.%26atitle%3D%2528%252B%2529-%255B3H%255DSKF%252010%252C047%2520sites%2520in%2520rat%2520liver%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1988%26volume%3D147%26spage%3D259%26epage%3D264%26doi%3D10.1016%2F0014-2999%2888%2990784-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ela, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eilam, Y.</span></span> <span> </span><span class="NLM_article-title">Sigma receptor ligands modulate contractility, Ca++ influx and beating rate in cultured cardiac myocytes</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>269</i></span>,  <span class="NLM_fpage">1300</span>– <span class="NLM_lpage">1309</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=8014874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaK2cXkslelu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=1300-1309&author=C.+Elaauthor=J.+Bargauthor=Z.+Vogelauthor=Y.+Hasinauthor=Y.+Eilam&title=Sigma+receptor+ligands+modulate+contractility%2C+Ca%2B%2B+influx+and+beating+rate+in+cultured+cardiac+myocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma receptor ligands modulate contractility, Ca++ influx and beating rate in cultured cardiac myocytes</span></div><div class="casAuthors">Ela, Catherine; Barg, Jacob; Vogel, Zvi; Hasin, Yonathan; Eilam, Yael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1300-9</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Specific binding of [3H]-1,3-di-o-tolylguanidine (DTG) and (+)-[3H]-(3-hydroxyphenyl)-N-(1-propyl)-piperidine [(+)-3-PPP] to membranes of cultured cardiac myocytes from neonatal rats revealed the presence of sigma receptors on these cells.  Exposure of cultured cardiomyocytes to nanomolar concns. of (+)-3-PPP, (+)-pentazocine and haloperidol induced specific patterns of changes in contractility of elec. paced cultures.  The amplitude of systolic cell-motion (ASM) decreased by 10 to 25% 1 to 2 min after drug addn., then transiently increased (3-10 min) and finally decreased to about 75% of control level.  Fluorescence measurements on indo-1 loaded cardiomyocytes revealed drug-induced changes in the size of the concn. of free cytosolic calcium ([Ca++]i)-transients, similar to the changes obsd. in ASM.  These changes appear to be mediated by corresponding changes in the rates of 45Ca++ influx which increased 2 to 7 min after the addn. of (+)-3-PPP and decrease to 50% of the control level thereafter.  Preincubation with thapsigargin, which depletes the sarcoplasmic reticulum-Ca++ stores, did not affect the pattern of changes in ASM, induced by the subsequent addn. of (+)-3-PPP.  This indicates that the changes in [Ca++]i are not mediated by sarcoplasmic reticulum-Ca++ transport systems.  Exposure to sigma ligands did not affect the apparent sensitivity of the myofilaments to Ca++, as indicated by the relationships between changes in ASM and in [Ca++]i-transients.  Cultures which were not paced, contracted spontaneously at a const. rhythm.  Sigma receptor ligands caused changes in beating frequencies which were followed by irregular contractions.  The present work suggests that sigma receptors may have an important role in regulating contractility, beating rates, and Ca++ fluxes in cardiac myocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVM-XyqI5Y9rVg90H21EOLACvtfcHk0liBCGvkVcgtww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkslelu7s%253D&md5=a5623b7000ad4089ca80f168f5f619a9</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEla%26aufirst%3DC.%26aulast%3DBarg%26aufirst%3DJ.%26aulast%3DVogel%26aufirst%3DZ.%26aulast%3DHasin%26aufirst%3DY.%26aulast%3DEilam%26aufirst%3DY.%26atitle%3DSigma%2520receptor%2520ligands%2520modulate%2520contractility%252C%2520Ca%252B%252B%2520influx%2520and%2520beating%2520rate%2520in%2520cultured%2520cardiac%2520myocytes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1994%26volume%3D269%26spage%3D1300%26epage%3D1309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morin-Surun, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denavit-Saubié, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baulieu, E.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monnet, F. P.</span></span> <span> </span><span class="NLM_article-title">Intracellular σ1 receptor modulates phospholipase C and protein kinase C activities in the brainstem</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">8196</span>– <span class="NLM_lpage">8199</span>, <span class="refDoi"> DOI: 10.1073/pnas.96.14.8196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1073%2Fpnas.96.14.8196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10393971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaK1MXltVOrsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=8196-8199&author=M.+P.+Morin-Surunauthor=T.+Collinauthor=M.+Denavit-Saubi%C3%A9author=E.-E.+Baulieuauthor=F.+P.+Monnet&title=Intracellular+%CF%831+receptor+modulates+phospholipase+C+and+protein+kinase+C+activities+in+the+brainstem&doi=10.1073%2Fpnas.96.14.8196"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular σ1 receptor modulates phospholipase C and protein kinase C activities in the brainstem</span></div><div class="casAuthors">Morin-Surun, M. P.; Collin, T.; Denavit-Saubie, M.; Baulieu, E.-E.; Monnet, F. P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">8196-8199</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Most physiol. effects of σ1 receptor ligands are sensitive to pertussis toxin, suggesting a coupling with cell membrane-bound G proteins.  However, the cloning of the σ1 receptor has allowed the identification of an intracellular protein anchored on the endoplasmic reticulum.  Here, we show, using the isolated adult guinea pig brainstem prepn., that activation of the σ1 receptor results in its translocation from the cytosol to the vicinity of the cell membrane and induces a robust and rapid decrease in hypoglossal activity, which is mediated by phospholipase C.  The subsequent activation of protein kinase C β1 and β2 isoforms and the phosphorylation of a protein of the same mol. wt. as the cloned σ1 receptor lead to a desensitization of the σ1 motor response.  Our results indicate that the intracellular σ1 receptor regulates several components implicated in plasma membrane-bound signal transduction.  This might be an example of a mechanism by which an intracellular receptor modulates metabotropic responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEDyEaAzNqjbVg90H21EOLACvtfcHk0liBCGvkVcgtww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltVOrsLY%253D&md5=0e7890bbd263ddb3368d6ab32799769f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.14.8196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.14.8196%26sid%3Dliteratum%253Aachs%26aulast%3DMorin-Surun%26aufirst%3DM.%2BP.%26aulast%3DCollin%26aufirst%3DT.%26aulast%3DDenavit-Saubi%25C3%25A9%26aufirst%3DM.%26aulast%3DBaulieu%26aufirst%3DE.-E.%26aulast%3DMonnet%26aufirst%3DF.%2BP.%26atitle%3DIntracellular%2520%25CF%25831%2520receptor%2520modulates%2520phospholipase%2520C%2520and%2520protein%2520kinase%2520C%2520activities%2520in%2520the%2520brainstem%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D8196%26epage%3D8199%26doi%3D10.1073%2Fpnas.96.14.8196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, T.-P.</span></span> <span> </span><span class="NLM_article-title">Intracellular dynamics of sigma-1 receptors (sigma(1) binding sites) in NG108–15 cells</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>306</i></span>,  <span class="NLM_fpage">726</span>– <span class="NLM_lpage">733</span>, <span class="refDoi"> DOI: 10.1124/jpet.103.051292</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1124%2Fjpet.103.051292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=12730356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlslGlu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2003&pages=726-733&author=T.+Hayashiauthor=T.-P.+Su&title=Intracellular+dynamics+of+sigma-1+receptors+%28sigma%281%29+binding+sites%29+in+NG108%E2%80%9315+cells&doi=10.1124%2Fjpet.103.051292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular dynamics of σ-1 receptors (σ1 binding sites) in NG108-15 cells</span></div><div class="casAuthors">Hayashi, Teruo; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">306</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">726-733</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The σ-1 receptors bind diverse kinds of psychoactive compds., including cocaine, and translocate upon stimulation by these compds.  However, the exact intracellular localization and dynamics of σ-1 receptors have been unclear.  We recently found that σ-1 receptors specifically localize on cholesterol-enriched loci on the endoplasmic reticulum (ER) membrane that function as neutral lipid storage sites (i.e., ER lipid droplets or ER-LDs) from which neutral lipids bud out to form cytosolic lipid droplets.  By combining immunocytochem. and real-time monitoring of enhanced yellow fluorescent protein (EYFP)-tagged σ-1 receptors (Sig-1R-EYFP) in living cells, we characterized the σ-1 receptor translocation in this study.  (+)-Pentazocine, a selective σ-1 receptor agonist, causes a significant decrease of σ-1 receptors in ER-LDs and a diffused distribution of σ-1 receptors over the entire endoplasmic reticulum reticular network in NG108-15 cells.  In the presence of σ-1 receptor agonists, Sig-1R-EYFP move out from ER-LDs and slide along the endoplasmic reticulum network toward nuclear envelope and the tip of neurites.  Fluorescence recovery after photo-bleaching anal. demonstrates that Sig-1R-EYFP on endoplasmic reticulum reticular network are highly mobile compared with those in ER-LDs.  A sucrose gradient fractionation study shows that (+)-pentazocine shifts σ-1 receptors from ER-LD membranes to higher d. membranes.  These results indicate that σ-1 receptors localize on ER-LDs and upon stimulation translocate on continuous endoplasmic reticulum reticular network toward peripheries of cells.  Because σ-1 receptors specifically target ER lipid storage sites and compartmentalize neutral lipids therein, these results suggest that σ-1 receptors' dynamic translocation might affect lipid transport and distribution in neuronal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokTnv4NnuBm7Vg90H21EOLACvtfcHk0liBCGvkVcgtww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlslGlu7g%253D&md5=8fac13ecd5adc16fddf5440fc6d098f7</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.051292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.051292%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.-P.%26atitle%3DIntracellular%2520dynamics%2520of%2520sigma-1%2520receptors%2520%2528sigma%25281%2529%2520binding%2520sites%2529%2520in%2520NG108%25E2%2580%259315%2520cells%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D306%26spage%3D726%26epage%3D733%26doi%3D10.1124%2Fjpet.103.051292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, T.-P.</span></span> <span> </span><span class="NLM_article-title">Sigma-1 Receptor Chaperones and Diseases</span>. <i>Cent. Nerv. Syst. Agents Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.2174/1871524910909030184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.2174%2F1871524910909030184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=20021352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWnt7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=184-189&author=S.-Y.+Tsaiauthor=T.+Hayashiauthor=T.+Moriauthor=T.-P.+Su&title=Sigma-1+Receptor+Chaperones+and+Diseases&doi=10.2174%2F1871524910909030184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptor chaperones and diseases</span></div><div class="casAuthors">Tsai, Shang-Yi; Hayashi, Teruo; Mori, Tomohisa; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Central Nervous System Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">184-189</span>CODEN:
                <span class="NLM_cas:coden">CNSAC3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5249</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Chaperones are proteins that assist the correct folding of other protein clients either when the clients are being synthesized or at their functional localities.  Chaperones are responsible for certain diseases.  The sigma-1 receptor is recently identified as a receptor chaperone whose activity can be activated/deactivated by specific ligands.  Under physiol. conditions, the sigma-1 receptor chaperones the functional IP3 receptor at the endoplasmic reticulum and mitochondrion interface to ensure proper Ca2+ signaling from endoplasmic reticulum into mitochondrion.  However, under pathol. conditions whereby cells encounter enormous stress that results in the endoplasmic reticulum losing its global Ca2+ homeostasis, the sigma-1 receptor translocates and counteracts the arising apoptosis.  Thus, the sigma-1 receptor is a receptor chaperone essential for the metabotropic receptor signaling and for the survival against cellular stress.  The sigma-1 receptor has been implicated in many diseases including addiction, pain, depression, stroke, and cancer.  Whether the chaperone activity of the sigma-1 receptor attributes to those diseases awaits further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBHVqBwWpruLVg90H21EOLACvtfcHk0lhvzAunBbDffA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWnt7rM&md5=2a24b524318a17026caadb8e64e908c6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F1871524910909030184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871524910909030184%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DS.-Y.%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.-P.%26atitle%3DSigma-1%2520Receptor%2520Chaperones%2520and%2520Diseases%26jtitle%3DCent.%2520Nerv.%2520Syst.%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D184%26epage%3D189%26doi%3D10.2174%2F1871524910909030184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuevas, J.</span></span> <span> </span><span class="NLM_article-title">Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons</span>. <i>J. Neurophysiol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">2867</span>– <span class="NLM_lpage">2879</span>, <span class="refDoi"> DOI: 10.1152/jn.2002.87.6.2867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1152%2Fjn.2002.87.6.2867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=12037190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BD38XltFSks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2002&pages=2867-2879&author=H.+Zhangauthor=J.+Cuevas&title=Sigma+receptors+inhibit+high-voltage-activated+calcium+channels+in+rat+sympathetic+and+parasympathetic+neurons&doi=10.1152%2Fjn.2002.87.6.2867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons</span></div><div class="casAuthors">Zhang, Hongling; Cuevas, Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurophysiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2867-2879</span>CODEN:
                <span class="NLM_cas:coden">JONEA4</span>;
        ISSN:<span class="NLM_cas:issn">0022-3077</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">Studies on the expression and cellular function of sigma receptors in autonomic neurons were conducted in neonatal rat intracardiac and superior cervical (SCG) ganglia.  Individual neurons from SCG and intracardiac ganglia were shown to express transcripts encoding the sigma-1 receptor using single-cell RT-PCR techniques.  The relationship between sigma receptors and calcium channels was studied in isolated neurons of these ganglia under voltage-clamp mode using the perforated-patch configuration of the whole cell patch-clamp recording technique.  Bath application of sigma receptor agonists was shown to rapidly depress peak calcium channel currents in a reversible manner in both SCG and intracardiac ganglion neurons.  The inhibition of barium (IBa) currents was dose-dependent, and half-maximal inhibitory concn. (IC50) values for haloperidol, ibogaine, (+)-pentazocine, and 1,3-Di-O-tolylguanidine (DTG) were 6, 31, 61, and 133 μM, resp.  The rank order potency of haloperidol > ibogaine > (+)-pentazocine > DTG is consistent with the effects on calcium channels being mediated by a sigma-2 receptor.  Preincubation of neurons with the irreversible sigma receptor antagonist, metaphit, blocked DTG-mediated inhibition of Ca2+ channel currents.  Maximum inhibition of calcium channel currents was ≥95%, suggesting that sigma receptors block all calcium channel subtypes found on the cell body of these neurons, which includes N-, L-, P/Q-, and R-type calcium channels.  In addn. to depressing peak Ca2+ channel current, sigma receptors altered the biophys. properties of these channels.  Following sigma receptor activation, Ca2+ channel inactivation rate was accelerated, and the voltage dependence of both steady-state inactivation and activation shifted toward more neg. potentials.  Expts. on the signal transduction cascade coupling sigma receptors and Ca2+ channels demonstrated that neither cell dialysis nor intracellular application of 100 μM guanosine 5'-O-(2-thiodiphosphate) trilithium salt (GDP-β-S) abolished the modulation of IBa by sigma receptor agonists.  These data suggest that neither a diffusible cytosolic second messenger nor a G protein is involved in this pathway.  Activation of sigma receptors on sympathetic and parasympathetic neurons is likely to modulate cell-to-cell signaling in autonomic ganglia and thus the regulation of cardiac function by the peripheral nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8TEGVj60pJLVg90H21EOLACvtfcHk0lhvzAunBbDffA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltFSks74%253D&md5=7d0aebce61514d66065e60dda149e038</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1152%2Fjn.2002.87.6.2867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fjn.2002.87.6.2867%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DCuevas%26aufirst%3DJ.%26atitle%3DSigma%2520receptors%2520inhibit%2520high-voltage-activated%2520calcium%2520channels%2520in%2520rat%2520sympathetic%2520and%2520parasympathetic%2520neurons%26jtitle%3DJ.%2520Neurophysiol.%26date%3D2002%26volume%3D87%26spage%3D2867%26epage%3D2879%26doi%3D10.1152%2Fjn.2002.87.6.2867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soriani, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foll, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monnet, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaudry, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cazin, L.</span></span> <span> </span><span class="NLM_article-title">A-Current down-modulated by sigma receptor in frog pituitary melanotrope cells through a G protein-dependent pathway</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">328</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10087020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaK1MXit1KhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1999&pages=321-328&author=O.+Sorianiauthor=F.+L.+Follauthor=F.+Romanauthor=F.+P.+Monnetauthor=H.+Vaudryauthor=L.+Cazin&title=A-Current+down-modulated+by+sigma+receptor+in+frog+pituitary+melanotrope+cells+through+a+G+protein-dependent+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A-current down-modulated by σ receptor in frog pituitary melanotrope cells through a G protein-dependent pathway</span></div><div class="casAuthors">Soriani, Olivier; Le Foll, Frank; Roman, Francois; Monnet, Francois P.; Vaudry, Hubert; Cazin, Lionel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">321-328</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Gramicidin perforated patch-clamp recordings were used to study the effects of 2 σ 1 receptor ligands, (+)-N-cyclopropylmethyl-N-methyl-1,4-diphenyl-1-ethyl-but-3-en-1-ylaminehydrochloride (JO 1784) and (+)-pentazocine, on the transient outward potassium current (IA) in cultured frog melanotrope cells.  (+)-Pentazocine reversibly decreased the current amplitude in a dose-dependent manner.  The effects of (+)-pentazocine were mimicked by JO 1784 and were markedly reduced by the σ 1 receptor antagonist, N,N-dipropyl-2-[4-methoxy-3-2(2-phenylethoxy)phenyl]-ethylamine monohydrochloride (NE 100).  Inactivation rate of IA was best fitted with a double exponential function, yielding time consts. of 23.7 and 112.5 ms.  (+)-Pentazocine (20 μM) accelerated the current decay, decreasing the time consts. to 10.7 and 59 ms, resp.  Current-voltage expts. revealed that (+)-pentazocine (20 μM) did neither modify the open-state I/V curves nor the voltage dependence of IA.  However, (+)-pentazocine (20 μM) shifted the steady-state inactivation curve toward more neg. potentials and increased the time const. of the time-dependent removal of inactivation.  In whole-cell expts., internal dialysis of guanosine-5'-O-(3-thiophosphate) (100 μM) irreversibly prolonged the response to (+)-pentazocine.  In addn., cholera toxin pretreatment (1 μg/mL; 12 h) suppressed the inhibition of IA by (+)-pentazocine (20 μM).  It is concluded that in frog melanotrope cells, a cholera toxin-sensitive, G protein-dependent inhibition of IA through a σ 1 receptor activation, at least partially, underlies the excitatory effect of σ ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBI9uiiiXYGbVg90H21EOLACvtfcHk0lhvzAunBbDffA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXit1KhtrY%253D&md5=f04b547693f49eacc5997bd756519634</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoriani%26aufirst%3DO.%26aulast%3DFoll%26aufirst%3DF.%2BL.%26aulast%3DRoman%26aufirst%3DF.%26aulast%3DMonnet%26aufirst%3DF.%2BP.%26aulast%3DVaudry%26aufirst%3DH.%26aulast%3DCazin%26aufirst%3DL.%26atitle%3DA-Current%2520down-modulated%2520by%2520sigma%2520receptor%2520in%2520frog%2520pituitary%2520melanotrope%2520cells%2520through%2520a%2520G%2520protein-dependent%2520pathway%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D289%26spage%3D321%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soriani, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Foll, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaudry, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cazin, L.</span></span> <span> </span><span class="NLM_article-title">The sigma-ligand (+)-pentazocine depresses M current and enhances calcium conductances in frog melanotrophs</span>. <i>Am. J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>277</i></span>,  <span class="NLM_fpage">E73</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1152/ajpendo.1999.277.1.E73</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1152%2Fajpendo.1999.277.1.E73" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=1999&pages=E73-80&author=O.+Sorianiauthor=F.+Le+Follauthor=L.+Galasauthor=F.+Romanauthor=H.+Vaudryauthor=L.+Cazin&title=The+sigma-ligand+%28%2B%29-pentazocine+depresses+M+current+and+enhances+calcium+conductances+in+frog+melanotrophs&doi=10.1152%2Fajpendo.1999.277.1.E73"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1152%2Fajpendo.1999.277.1.E73&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpendo.1999.277.1.E73%26sid%3Dliteratum%253Aachs%26aulast%3DSoriani%26aufirst%3DO.%26aulast%3DLe%2BFoll%26aufirst%3DF.%26aulast%3DGalas%26aufirst%3DL.%26aulast%3DRoman%26aufirst%3DF.%26aulast%3DVaudry%26aufirst%3DH.%26aulast%3DCazin%26aufirst%3DL.%26atitle%3DThe%2520sigma-ligand%2520%2528%252B%2529-pentazocine%2520depresses%2520M%2520current%2520and%2520enhances%2520calcium%2520conductances%2520in%2520frog%2520melanotrophs%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D1999%26volume%3D277%26spage%3DE73%26epage%3D80%26doi%3D10.1152%2Fajpendo.1999.277.1.E73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, D.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, P.</span></span> <span> </span><span class="NLM_article-title">Neurosteroid dehydroepiandrosterone sulphate inhibits persistent sodium currents in rat medial prefrontal cortex via activation of sigma-1 receptors</span>. <i>Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>210</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1016/j.expneurol.2007.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2Fj.expneurol.2007.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=18035354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVWis7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=2008&pages=128-136&author=Z.-X.+Chengauthor=D.-M.+Lanauthor=P.-Y.+Wuauthor=Y.-H.+Zhuauthor=Y.+Dongauthor=L.+Maauthor=P.+Zheng&title=Neurosteroid+dehydroepiandrosterone+sulphate+inhibits+persistent+sodium+currents+in+rat+medial+prefrontal+cortex+via+activation+of+sigma-1+receptors&doi=10.1016%2Fj.expneurol.2007.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Neurosteroid dehydroepiandrosterone sulphate inhibits persistent sodium currents in rat medial prefrontal cortex via activation of sigma-1 receptors</span></div><div class="casAuthors">Cheng, Zheng-Xiang; Lan, Dan-Mei; Wu, Pei-Ying; Zhu, Yan-Hua; Dong, Yi; Ma, Lan; Zheng, Ping</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">210</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">128-136</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Dehydroepiandrosterone sulfate is one of the most important neurosteroids.  In the present paper, we studied the effect of dehydroepiandrosterone sulfate on persistent sodium currents and its mechanism and functional consequence with whole-cell patch clamp recording method combined with a pharmacol. approach in the rat medial prefrontal cortex slices.  The results showed that dehydroepiandrosterone sulfate inhibited the amplitude of persistent sodium currents and the inhibitory effect was significant at 0.1 μM, reached max. at 1 μM and decreased with the increase in the concns. of above 1 μM.  The effect of dehydroepiandrosterone sulfate on persistent sodium currents was canceled by the Gi protein inhibitor and the protein kinase C inhibitor, but not by the protein kinase A inhibitor.  The effect of dehydroepiandrosterone sulfate on persistent sodium currents was also canceled by the sigma-1 receptor blockers and the sigma-1 receptor agonist could mimic the effect of dehydroepiandrosterone sulfate.  Dehydroepiandrosterone sulfate had no significant influence on neuronal excitability but could significantly inhibit chem. inhibition of mitochondria-evoked increase in persistent sodium currents.  These results suggest that dehydroepiandrosterone sulfate inhibits persistent sodium currents via the activation of sigma-1 receptors-Gi protein-protein kinase C-coupled signaling pathway, and the main functional consequence of this effect of DHEAS is presumably to protect neurons under ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo69uQz-5-SLVg90H21EOLACvtfcHk0lhzr4NN448o2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVWis7o%253D&md5=c79ecd56505459124cca3431353b9b1e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2007.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2007.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DZ.-X.%26aulast%3DLan%26aufirst%3DD.-M.%26aulast%3DWu%26aufirst%3DP.-Y.%26aulast%3DZhu%26aufirst%3DY.-H.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DP.%26atitle%3DNeurosteroid%2520dehydroepiandrosterone%2520sulphate%2520inhibits%2520persistent%2520sodium%2520currents%2520in%2520rat%2520medial%2520prefrontal%2520cortex%2520via%2520activation%2520of%2520sigma-1%2520receptors%26jtitle%3DExp.%2520Neurol.%26date%3D2008%26volume%3D210%26spage%3D128%26epage%3D136%26doi%3D10.1016%2Fj.expneurol.2007.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Renaudo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">L’Hoste, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guizouarn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borgèse, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soriani, O.</span></span> <span> </span><span class="NLM_article-title">Cancer cell cycle modulated by a functional coupling between sigma-1 receptors and Cl- channels</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">2259</span>– <span class="NLM_lpage">2267</span>, <span class="refDoi"> DOI: 10.1074/jbc.M607915200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1074%2Fjbc.M607915200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=2259-2267&author=A.+Renaudoauthor=S.+L%E2%80%99Hosteauthor=H.+Guizouarnauthor=F.+Borg%C3%A8seauthor=O.+Soriani&title=Cancer+cell+cycle+modulated+by+a+functional+coupling+between+sigma-1+receptors+and+Cl-+channels&doi=10.1074%2Fjbc.M607915200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M607915200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M607915200%26sid%3Dliteratum%253Aachs%26aulast%3DRenaudo%26aufirst%3DA.%26aulast%3DL%25E2%2580%2599Hoste%26aufirst%3DS.%26aulast%3DGuizouarn%26aufirst%3DH.%26aulast%3DBorg%25C3%25A8se%26aufirst%3DF.%26aulast%3DSoriani%26aufirst%3DO.%26atitle%3DCancer%2520cell%2520cycle%2520modulated%2520by%2520a%2520functional%2520coupling%2520between%2520sigma-1%2520receptors%2520and%2520Cl-%2520channels%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D2259%26epage%3D2267%26doi%3D10.1074%2Fjbc.M607915200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romieu, P.</span></span> <span> </span><span class="NLM_article-title">Involvement of the sigma1 receptor in the appetitive effects of cocaine</span>. <i>Pharmacopsychiatry</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">Suppl. 3</span>),  <span class="NLM_fpage">198</span>– <span class="NLM_lpage">207</span>, <span class="refDoi"> DOI: 10.1055/s-2004-832678</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1055%2Fs-2004-832678" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2004&pages=198-207&issue=Suppl.+3&author=T.+Mauriceauthor=P.+Romieu&title=Involvement+of+the+sigma1+receptor+in+the+appetitive+effects+of+cocaine&doi=10.1055%2Fs-2004-832678"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1055%2Fs-2004-832678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2004-832678%26sid%3Dliteratum%253Aachs%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DRomieu%26aufirst%3DP.%26atitle%3DInvolvement%2520of%2520the%2520sigma1%2520receptor%2520in%2520the%2520appetitive%2520effects%2520of%2520cocaine%26jtitle%3DPharmacopsychiatry%26date%3D2004%26volume%3D37%26issue%3DSuppl.%25203%26spage%3D198%26epage%3D207%26doi%3D10.1055%2Fs-2004-832678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.-Y.</span></span> <span> </span><span class="NLM_article-title">Roles of sigma-1 receptors in Alzheimer’s disease</span>. <i>Int. J. Clin. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">4808</span>– <span class="NLM_lpage">4820</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=26131055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A280%3ADC%252BC2MbptFynsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=4808-4820&author=J.-L.+Jinauthor=M.+Fangauthor=Y.-X.+Zhaoauthor=X.-Y.+Liu&title=Roles+of+sigma-1+receptors+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of sigma-1 receptors in Alzheimer's disease</span></div><div class="casAuthors">Jin Jia-Li; Fang Min; Zhao Yan-Xin; Liu Xue-Yuan</div><div class="citationInfo"><span class="NLM_cas:title">International journal of clinical and experimental medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">4808-20</span>
        ISSN:<span class="NLM_cas:issn">1940-5901</span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the leading cause of senile dementia all over the world.  Still no existing drugs can effectively reverse the cognitive impairment.  However, Sigma-1 (σ-1) receptors have been long implicated in multiple neurological and psychiatric conditions over these years.  In this review, we discuss the current understanding of σ-1 receptor functions.  Through regulation of lipid rafts, secretases, kinases, neuroceptors and ion channels, σ-1 receptors can influence cellular signal transduction, TCA cycle, oxidative stress, neuron plasticity and neurotransmitter release etc.  Based on this, we suggest the key cellular mechanisms linking σ-1 receptor to Alzheimer's disease.  Besides, we detail the evidences showing that σ-1 receptors agonists, being the promising compounds for treatment of cognitive dysfunction, exhibit robust neuroprotection and anti-amnesia effect against Aβ neurotoxicity in the progress of Alzheimer's disease.  The evidence comes from animal models, preclinical studies in humans and full clinical trials.  In addition, the questions to be solved regarding this receptor are also presented.  When concerned with NMDAR, σ-1 receptor activation may result in two totally different influences on AD.  Utilization of σ-1 agents early in AD remains an overlooked therapeutic opportunity.  This article may pave the way for further studies about sigma-1 receptor on Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQtgNNdI_x_xG52AMpI4GK2fW6udTcc2eaHlhzO3roDR7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MbptFynsQ%253D%253D&md5=9a885f6b442e658b1037e96c4fabdfa1</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DJ.-L.%26aulast%3DFang%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DY.-X.%26aulast%3DLiu%26aufirst%3DX.-Y.%26atitle%3DRoles%2520of%2520sigma-1%2520receptors%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Med.%26date%3D2015%26volume%3D8%26spage%3D4808%26epage%3D4820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhir, A.</span></span> <span> </span><span class="NLM_article-title">sigma-1 receptors in major depression and anxiety</span>. <i>Expert Rev. Neurother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1021</span>– <span class="NLM_lpage">1034</span>, <span class="refDoi"> DOI: 10.1586/ern.09.40</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1586%2Fern.09.40" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=19589051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1egtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=1021-1034&author=S.+K.+Kulkarniauthor=A.+Dhir&title=sigma-1+receptors+in+major+depression+and+anxiety&doi=10.1586%2Fern.09.40"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">σ-1 receptors in major depression and anxiety</span></div><div class="casAuthors">Kulkarni, Shrinivas K.; Dhir, Ashish</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1021-1034</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Major depression and anxiety are two of the major psychiatric disorders that have some overlapping pathophysiologies, the most significant being the dysfunction in the monoaminergic, GABAergic and glutamatergic systems.  A large no. of drugs that alter these neurotransmitter levels/systems are effective in the treatment of major depression and anxiety.  However, full remission of the clin. symptoms has not been achieved, perhaps owing to the complex pathophysiol. of the diseases.  Thus, the search for newer targets and target-specific drugs continues.  Recently, the role of σ-receptors, particularly the σ-1 receptor subtype, has been identified as a target for the pathophysiol. of neuropsychiatric disorders, and σ-1 receptor modulators are considered to be the drugs of the future for the treatment of major depression and anxiety.  The present review attempts to discuss the role of σ-1 receptors in the pathophysiol. of major depression and anxiety and also tries to position the use of its receptor modulators in the treatment of these two major disorders.  The role of σ-1 receptors in the mechanism of antidepressant action of venlafaxine, bupropion, neurosteroids and one of the herbal antidepressants, berberine, is reviewed.  Although, σ-1 receptor modulators may be future therapeutic options, either as individual agents or adjuvants in the treatment of mental disorders, the topic needs further preclin. and clin. exploration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSBtnV2P59xLVg90H21EOLACvtfcHk0lg8LDk6BoJ8bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1egtL0%253D&md5=a26dd8928fbbb21fa2f137c4b6b4bc29</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1586%2Fern.09.40&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fern.09.40%26sid%3Dliteratum%253Aachs%26aulast%3DKulkarni%26aufirst%3DS.%2BK.%26aulast%3DDhir%26aufirst%3DA.%26atitle%3Dsigma-1%2520receptors%2520in%2520major%2520depression%2520and%2520anxiety%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2009%26volume%3D9%26spage%3D1021%26epage%3D1034%26doi%3D10.1586%2Fern.09.40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niitsu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, K.</span></span> <span> </span><span class="NLM_article-title">Sigma-1 receptor agonists as therapeutic drugs for cognitive impairment in neuropsychiatric diseases</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">875</span>– <span class="NLM_lpage">883</span>, <span class="refDoi"> DOI: 10.2174/138161212799436476</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.2174%2F138161212799436476" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=22288409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvVSqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=875-883&author=T.+Niitsuauthor=M.+Iyoauthor=K.+Hashimoto&title=Sigma-1+receptor+agonists+as+therapeutic+drugs+for+cognitive+impairment+in+neuropsychiatric+diseases&doi=10.2174%2F138161212799436476"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptor agonists as therapeutic drugs for cognitive impairment in neuropsychiatric diseases</span></div><div class="casAuthors">Niitsu, Tomihisa; Iyo, Masaomi; Hashimoto, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">875-883</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cognitive impairment is a core feature of patients with neuropsychiatric diseases such as schizophrenia and psychotic depression.  The drugs currently used to treat cognitive impairment have significant limitations, ensuring that the search for more effective therapies remains active.  Endoplasmic reticulum protein sigma-1 receptors are unique binding sites in the brain that exert a potent effect on multiple neurotransmitter systems.  Accumulating evidence suggests that sigma-1 receptors play a role in both the pathophysiol. of neuropsychiatric diseases, and the mechanistic action of some therapeutic drugs, such as the selective serotonin reuptake inhibitors (SSRIs), donepezil and neurosteroids.  Among SSRIs, fluvoxamine, a potent sigma-1 receptor agonist, has the highest affinity at sigma-1 receptors.  Sigma-1 receptor agonists greatly potentiate nerve-growth factor (NGF)-induced neurite outgrowth in PC12 cells, an effect that is antagonized by treatment with the selective sigma-1 receptor antagonist NE-100.  Furthermore, phencyclidine (PCP)-induced cognitive impairment, assocd. with animal models of schizophrenia is significantly improved by sub-chronic administration of sigma-1 receptor agonists such as fluvoxamine, SA4503 (cutamesine) and donepezil.  This effect is antagonized by co-administration of NE-100.  A positron emission tomog. (PET) study using the specific sigma-1 receptor ligand [11C]SA4503 demonstrates that fluvoxamine and donepezil bind to sigma-1 receptors in the healthy human brain.  In clin. studies, some sigma-1 receptor agonists, including fluvoxamine, donepezil and neurosteroids, improve cognitive impairment and clin. symptoms in neuropsychiatric diseases.  In this article, we review the recent findings on sigma-1 receptor agonists as potential therapeutic drugs for the treatment of cognitive impairment in schizophrenia and psychotic depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbtEOCYECSSbVg90H21EOLACvtfcHk0lg8LDk6BoJ8bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvVSqt7o%253D&md5=b64d4ca448cf6d78910df4944255686e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F138161212799436476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212799436476%26sid%3Dliteratum%253Aachs%26aulast%3DNiitsu%26aufirst%3DT.%26aulast%3DIyo%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DK.%26atitle%3DSigma-1%2520receptor%2520agonists%2520as%2520therapeutic%2520drugs%2520for%2520cognitive%2520impairment%2520in%2520neuropsychiatric%2520diseases%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2012%26volume%3D18%26spage%3D875%26epage%3D883%26doi%3D10.2174%2F138161212799436476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zamanillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. M.</span></span> <span> </span><span class="NLM_article-title">Sigma 1 receptor: a new therapeutic target for pain</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>716</i></span>,  <span class="NLM_fpage">78</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2013.01.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2Fj.ejphar.2013.01.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=23500210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt12ju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=716&publication_year=2013&pages=78-93&author=D.+Zamanilloauthor=L.+Romeroauthor=M.+Merlosauthor=J.+M.+Vela&title=Sigma+1+receptor%3A+a+new+therapeutic+target+for+pain&doi=10.1016%2Fj.ejphar.2013.01.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma 1 receptor: A new therapeutic target for pain</span></div><div class="casAuthors">Zamanillo, Daniel; Romero, Luz; Merlos, Manuel; Vela, Jose Miguel</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">716</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">78-93</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sigma 1 receptor (σ1 receptor) is a unique ligand-regulated mol. chaperone located mainly in the endoplasmic reticulum and the plasma membrane. σ1 receptor is activated under stress or pathol. conditions and interacts with several neurotransmitter receptors and ion channels to modulate their function.  The effects reported preclinically with σ1 receptor ligands are consistent with a role for σ1 receptor in central sensitization and pain hypersensitivity and suggest a potential therapeutic use of σ1 receptor antagonists for the management of neuropathic pain as monotherapy.  Moreover, data support their use in opioid adjuvant therapy: combination of σ1 receptor antagonists and opioids results in potentiation of opioid analgesia, without significant increases in opioid-related unwanted effects.  Results from clin. trials using selective σ1 receptor antagonists in several pain conditions are eagerly awaited to ascertain the potential of σ1 receptor modulation in pain therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZl3UX9-U94rVg90H21EOLACvtfcHk0lg8LDk6BoJ8bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt12ju70%253D&md5=7eba2c57ef558fbc50fb90d7067ab2e8</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2013.01.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2013.01.068%26sid%3Dliteratum%253Aachs%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3DSigma%25201%2520receptor%253A%2520a%2520new%2520therapeutic%2520target%2520for%2520pain%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D716%26spage%3D78%26epage%3D93%26doi%3D10.1016%2Fj.ejphar.2013.01.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finnerup, N. B.</span></span> <span> </span><span class="NLM_article-title">Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">924</span>– <span class="NLM_lpage">935</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(14)70102-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2FS1474-4422%2814%2970102-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=25142459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A280%3ADC%252BC2M7mvVOguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=924-935&author=T.+S.+Jensenauthor=N.+B.+Finnerup&title=Allodynia+and+hyperalgesia+in+neuropathic+pain%3A+clinical+manifestations+and+mechanisms&doi=10.1016%2FS1474-4422%2814%2970102-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms</span></div><div class="casAuthors">Jensen Troels S; Finnerup Nanna B</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">924-35</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Allodynia (pain due to a stimulus that does not usually provoke pain) and hyperalgesia (increased pain from a stimulus that usually provokes pain) are prominent symptoms in patients with neuropathic pain.  Both are seen in various peripheral neuropathies and central pain disorders, and affect 15-50% of patients with neuropathic pain.  Allodynia and hyperalgesia are classified according to the sensory modality (touch, pressure, pinprick, cold, and heat) that is used to elicit the sensation.  Peripheral sensitisation and maladaptive central changes contribute to the generation and maintenance of these reactions, with separate mechanisms in different subtypes of allodynia and hyperalgesia.  Pain intensity and relief are important measures in clinical pain studies, but might be insufficient to capture the complexity of the pain experience.  Better understanding of allodynia and hyperalgesia might provide clues to the underlying pathophysiology of neuropathic pain and, as such, they represent new or additional endpoints in pain trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTMEle2RONFvZPq5LRczm8ffW6udTcc2eZ5PoyMJD_Tk7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7mvVOguw%253D%253D&md5=0a472896d219627cee6a4db77ade7d09</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2814%2970102-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252814%252970102-4%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DT.%2BS.%26aulast%3DFinnerup%26aufirst%3DN.%2BB.%26atitle%3DAllodynia%2520and%2520hyperalgesia%2520in%2520neuropathic%2520pain%253A%2520clinical%2520manifestations%2520and%2520mechanisms%26jtitle%3DLancet%2520Neurol.%26date%3D2014%26volume%3D13%26spage%3D924%26epage%3D935%26doi%3D10.1016%2FS1474-4422%2814%2970102-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Entrena, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobos, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieto, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cendán, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gris, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">del Pozo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamanillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J. M.</span></span> <span> </span><span class="NLM_article-title">Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: studies with selective sigma-1 ligands and sigma-1 knockout mice</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">252</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1016/j.pain.2009.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2Fj.pain.2009.03.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=19375855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BD1MXls1Ortr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2009&pages=252-261&author=J.+M.+Entrenaauthor=E.+J.+Cobosauthor=F.+R.+Nietoauthor=C.+M.+Cend%C3%A1nauthor=G.+Grisauthor=E.+del+Pozoauthor=D.+Zamanilloauthor=J.+M.+Baeyens&title=Sigma-1+receptors+are+essential+for+capsaicin-induced+mechanical+hypersensitivity%3A+studies+with+selective+sigma-1+ligands+and+sigma-1+knockout+mice&doi=10.1016%2Fj.pain.2009.03.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: Studies with selective sigma-1 ligands and sigma-1 knockout mice</span></div><div class="casAuthors">Entrena, Jose Manuel; Cobos, Enrique Jose; Nieto, Francisco Rafael; Cendan, Cruz Miguel; Gris, Georgia; Del Pozo, Esperanza; Zamanillo, Daniel; Baeyens, Jose Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">252-261</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We evaluated the role of σ1 receptors on capsaicin-induced mech. hypersensitivity and on nociceptive pain induced by punctate mech. stimuli, using wild-type and σ1 receptor knockout (σ1-KO) mice and selective σ1 receptor-acting drugs.  Mutation in σ1-KO mice was confirmed by PCR anal. of genomic DNA and, at the protein level, by [3H](+)-pentazocine binding assays.  Both wild-type and σ1-KO mice not treated with capsaicin showed similar responses to different intensities of mech. stimuli (0.05-8 g force), ranging from innocuous to noxious, applied to the hind paw.  This indicates that σ1 gene inactivation does not modify the perception of punctate mech. stimuli.  The intraplantar (i.pl.) administration of capsaicin induced dose-dependent mech. allodynia in wild-type mice (markedly reducing both the threshold force necessary to induce paw withdrawal and the latency to paw withdrawal induced by a given force).  In contrast, capsaicin was completely unable to induce mech. hypersensitivity in σ1-KO mice.  The high-affinity and selective σ1 antagonists BD-1063, BD-1047 and NE-100, administered s.c. dose-dependently inhibited mech. allodynia induced by capsaicin (1 μg,i.pl.), yielding ED50 (mg/kg) values of 15.80 ± 0.93, 29.31 ± 1.65 and 40.74 ± 7.20, resp.  The effects of the σ1 antagonists were reversed by the σ1 agonist PRE-084 (32 mg/kg, s.c.).  None of the drugs tested modified the responses induced by a painful mech. punctate stimulus (4 g force) in nonsensitized animals.  These results suggest that σ1 receptors are essential for capsaicin-induced mech. hypersensitivity, but are not involved in mech. nociceptive pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxwYUgwwMlprVg90H21EOLACvtfcHk0lhsoQFGoa6l6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXls1Ortr0%253D&md5=e51c7b76ea146ba992c7d1768e1da9a3</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2009.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2009.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DNieto%26aufirst%3DF.%2BR.%26aulast%3DCend%25C3%25A1n%26aufirst%3DC.%2BM.%26aulast%3DGris%26aufirst%3DG.%26aulast%3Ddel%2BPozo%26aufirst%3DE.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DSigma-1%2520receptors%2520are%2520essential%2520for%2520capsaicin-induced%2520mechanical%2520hypersensitivity%253A%2520studies%2520with%2520selective%2520sigma-1%2520ligands%2520and%2520sigma-1%2520knockout%2520mice%26jtitle%3DPain%26date%3D2009%26volume%3D143%26spage%3D252%26epage%3D261%26doi%3D10.1016%2Fj.pain.2009.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Díaz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuberes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berrocal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contijoch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christmann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Port, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holenz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laggner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serafini, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgueño, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamanillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almansa, C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of the 1-arylpyrazole class of σ(1) receptor antagonists: identification of 4-{2–5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxyethyl}morpholine (S1RA, E-52862)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8211</span>– <span class="NLM_lpage">8224</span>, <span class="refDoi"> DOI: 10.1021/jm3007323</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3007323" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8211-8224&author=J.+L.+D%C3%ADazauthor=R.+Cuberesauthor=J.+Berrocalauthor=M.+Contijochauthor=U.+Christmannauthor=A.+Fern%C3%A1ndezauthor=A.+Portauthor=J.+Holenzauthor=H.+Buschmannauthor=C.+Laggnerauthor=M.+T.+Serafiniauthor=J.+Burgue%C3%B1oauthor=D.+Zamanilloauthor=M.+Merlosauthor=J.+M.+Velaauthor=C.+Almansa&title=Synthesis+and+biological+evaluation+of+the+1-arylpyrazole+class+of+%CF%83%281%29+receptor+antagonists%3A+identification+of+4-%7B2%E2%80%935-methyl-1-%28naphthalen-2-yl%29-1H-pyrazol-3-yloxyethyl%7Dmorpholine+%28S1RA%2C+E-52862%29&doi=10.1021%2Fjm3007323"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm3007323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3007323%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25ADaz%26aufirst%3DJ.%2BL.%26aulast%3DCuberes%26aufirst%3DR.%26aulast%3DBerrocal%26aufirst%3DJ.%26aulast%3DContijoch%26aufirst%3DM.%26aulast%3DChristmann%26aufirst%3DU.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DPort%26aufirst%3DA.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DBuschmann%26aufirst%3DH.%26aulast%3DLaggner%26aufirst%3DC.%26aulast%3DSerafini%26aufirst%3DM.%2BT.%26aulast%3DBurgue%25C3%25B1o%26aufirst%3DJ.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520the%25201-arylpyrazole%2520class%2520of%2520%25CF%2583%25281%2529%2520receptor%2520antagonists%253A%2520identification%2520of%25204-%257B2%25E2%2580%25935-methyl-1-%2528naphthalen-2-yl%2529-1H-pyrazol-3-yloxyethyl%257Dmorpholine%2520%2528S1RA%252C%2520E-52862%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8211%26epage%3D8224%26doi%3D10.1021%2Fjm3007323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahn, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span> <span> </span><span class="NLM_article-title">Identification of the gene that codes for the σ2 receptor</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">7160</span>– <span class="NLM_lpage">7165</span>, <span class="refDoi"> DOI: 10.1073/pnas.1705154114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1073%2Fpnas.1705154114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=28559337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovVSisrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=7160-7165&author=A.+Alonauthor=H.+R.+Schmidtauthor=M.+D.+Woodauthor=J.+J.+Sahnauthor=S.+F.+Martinauthor=A.+C.+Kruse&title=Identification+of+the+gene+that+codes+for+the+%CF%832+receptor&doi=10.1073%2Fpnas.1705154114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the gene that codes for the σ2 receptor</span></div><div class="casAuthors">Alon, Assaf; Schmidt, Hayden R.; Wood, Michael D.; Sahn, James J.; Martin, Stephen F.; Kruse, Andrew C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">7160-7165</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The σ2 receptor is an enigmatic protein that has attracted significant attention because of its involvement in diseases as diverse as cancer and neurol. disorders.  Unlike virtually all other receptors of medical interest, it has eluded mol. cloning since its discovery, and the gene that codes for the receptor remains unknown, precluding the use of modern biol. methods to study its function.  Using a chem. biol. approach, we purified the σ2 receptor from tissue, revealing its identity as TMEM97, an endoplasmic reticulum-resident transmembrane protein that regulates the sterol transporter NPC1.  We show that TMEM97 possesses the full suite of mol. properties that define the σ2 receptor, and we identify Asp29 and Asp56 as essential for ligand recognition.  Cloning the σ2 receptor resolves a longstanding mystery and will enable therapeutic targeting of this potential drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsoAS9Q6KtY7Vg90H21EOLACvtfcHk0lhsoQFGoa6l6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXovVSisrw%253D&md5=71d3c246ebe6ac84c33980b97cb9889c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1705154114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1705154114%26sid%3Dliteratum%253Aachs%26aulast%3DAlon%26aufirst%3DA.%26aulast%3DSchmidt%26aufirst%3DH.%2BR.%26aulast%3DWood%26aufirst%3DM.%2BD.%26aulast%3DSahn%26aufirst%3DJ.%2BJ.%26aulast%3DMartin%26aufirst%3DS.%2BF.%26aulast%3DKruse%26aufirst%3DA.%2BC.%26atitle%3DIdentification%2520of%2520the%2520gene%2520that%2520codes%2520for%2520the%2520%25CF%25832%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26spage%3D7160%26epage%3D7165%26doi%3D10.1073%2Fpnas.1705154114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, F. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, B. de</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, K. C.</span></span> <span> </span><span class="NLM_article-title">Sigma receptors: biology and function</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">402</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1990&pages=355-402&author=J.+M.+Walkerauthor=W.+D.+Bowenauthor=F.+O.+Walkerauthor=R.+R.+Matsumotoauthor=B.+de+Costaauthor=K.+C.+Rice&title=Sigma+receptors%3A+biology+and+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DJ.%2BM.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26aulast%3DWalker%26aufirst%3DF.%2BO.%26aulast%3DMatsumoto%26aufirst%3DR.%2BR.%26aulast%3DCosta%26aufirst%3DB.%2Bde%26aulast%3DRice%26aufirst%3DK.%2BC.%26atitle%3DSigma%2520receptors%253A%2520biology%2520and%2520function%26jtitle%3DPharmacol.%2520Rev.%26date%3D1990%26volume%3D42%26spage%3D355%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, W. D.</span></span> <span> </span><span class="NLM_article-title">Sigma receptors: recent advances and new clinical potentials</span>. <i>Pharm. Acta Helv.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1016/S0031-6865(99)00034-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2FS0031-6865%2899%2900034-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=211-218&author=W.+D.+Bowen&title=Sigma+receptors%3A+recent+advances+and+new+clinical+potentials&doi=10.1016%2FS0031-6865%2899%2900034-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0031-6865%2899%2900034-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0031-6865%252899%252900034-5%26sid%3Dliteratum%253Aachs%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3DSigma%2520receptors%253A%2520recent%2520advances%2520and%2520new%2520clinical%2520potentials%26jtitle%3DPharm.%2520Acta%2520Helv.%26date%3D2000%26volume%3D74%26spage%3D211%26epage%3D218%26doi%3D10.1016%2FS0031-6865%2899%2900034-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vilner, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, W. D.</span></span> <span> </span><span class="NLM_article-title">Modulation of cellular calcium by sigma-2 receptors: release from intracellular stores in human SK-N-SH neuroblastoma cells</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">900</span>– <span class="NLM_lpage">911</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10688603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhslWktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2000&pages=900-911&author=B.+J.+Vilnerauthor=W.+D.+Bowen&title=Modulation+of+cellular+calcium+by+sigma-2+receptors%3A+release+from+intracellular+stores+in+human+SK-N-SH+neuroblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of cellular calcium by sigma-2 receptors: release from intracellular stores in human SK-N-SH neuroblastoma cells</span></div><div class="casAuthors">Vilner, Bertold J.; Bowen, Wayne D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">900-911</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Human SK-N-SH neuroblastoma cells expressed sigma-1 and sigma-2 receptors with similar pharmacol. profiles to those of rodent-derived tissues, although sigma-2 receptors exhibited some affinity differences that might suggest heterogeneity or species differences.  Structurally diverse sigma ligands produced two types of increases in intracellular (cytosolic) Ca2+ concn. ([Ca2+]i) in these cells.  CB-64D, CB-64L, JL-II-147, BD737, LR172, BD1008, haloperidol, reduced haloperidol, and ibogaine all produced an immediate, dose-dependent, and transient rise in [Ca2+]i.  Sigma-inactive compds. structurally similar to the most active sigma ligands and ligands for several neurotransmitter receptors produced little or no effect.  The high activity of CB-64D and ibogaine (sigma-2-selective ligands) compared with the low activity of (+)-pentazocine and other (+)-benzomorphans (sigma-1-selective ligands), in addn. to enantioselectivity for CB-64D over CB-64L, strongly indicated mediation by sigma-2 receptors.  The effect of CB-64D and BD737 was blocked by the sigma antagonists BD1047 and BD1063, further confirming specificity as a receptor-mediated event.  The transient rise in [Ca2+]i occurred in the absence of extracellular Ca2+ and was completely eliminated by pretreatment of cells with thapsigargin.  Thus, sigma-2 receptors stimulate a transient release of Ca2+ from the endoplasmic reticulum.  Prolonged exposure of cells to sigma-receptor ligands resulted in a latent and sustained rise in [Ca2+]i, with a pharmacol. profile identical to that of the transient rise.  This sustained rise in [Ca2+]i was affected by neither the removal of extracellular Ca2+ nor thapsigargin pretreatment, suggesting latent sigma-2 receptor-induced release from thapsigargin-insensitive intracellular Ca2+ stores.  Sigma-2 receptors may use Ca2+ signals in producing cellular effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9ZFHG8sRG97Vg90H21EOLACvtfcHk0ljZi-XCdg5zKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhslWktLY%253D&md5=d59f985633ba21f7bdd0c19962707aac</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVilner%26aufirst%3DB.%2BJ.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3DModulation%2520of%2520cellular%2520calcium%2520by%2520sigma-2%2520receptors%253A%2520release%2520from%2520intracellular%2520stores%2520in%2520human%2520SK-N-SH%2520neuroblastoma%2520cells%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D292%26spage%3D900%26epage%3D911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilke, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupardus, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruoho, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, M. B.</span></span> <span> </span><span class="NLM_article-title">Sigma receptor photolabeling and sigma receptor-mediated modulation of potassium channels in tumor cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">18387</span>– <span class="NLM_lpage">18392</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.26.18387</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1074%2Fjbc.274.26.18387" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=18387-18392&author=R.+A.+Wilkeauthor=R.+P.+Mehtaauthor=P.+J.+Lupardusauthor=Y.+Chenauthor=A.+E.+Ruohoauthor=M.+B.+Jackson&title=Sigma+receptor+photolabeling+and+sigma+receptor-mediated+modulation+of+potassium+channels+in+tumor+cells&doi=10.1074%2Fjbc.274.26.18387"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.26.18387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.26.18387%26sid%3Dliteratum%253Aachs%26aulast%3DWilke%26aufirst%3DR.%2BA.%26aulast%3DMehta%26aufirst%3DR.%2BP.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DRuoho%26aufirst%3DA.%2BE.%26aulast%3DJackson%26aufirst%3DM.%2BB.%26atitle%3DSigma%2520receptor%2520photolabeling%2520and%2520sigma%2520receptor-mediated%2520modulation%2520of%2520potassium%2520channels%2520in%2520tumor%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D18387%26epage%3D18392%26doi%3D10.1074%2Fjbc.274.26.18387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span> <span> </span><span class="NLM_article-title">Sigma-2 receptor ligands and their perspectives in cancer diagnosis and therapy</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">532</span>– <span class="NLM_lpage">566</span>, <span class="refDoi"> DOI: 10.1002/med.21297</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1002%2Fmed.21297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=23922215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsl2qsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=532-566&author=Y.-S.+Huangauthor=H.-L.+Luauthor=L.-J.+Zhangauthor=Z.+Wu&title=Sigma-2+receptor+ligands+and+their+perspectives+in+cancer+diagnosis+and+therapy&doi=10.1002%2Fmed.21297"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-2 Receptor Ligands and Their Perspectives in Cancer Diagnosis and Therapy</span></div><div class="casAuthors">Huang, Yun-Sheng; Lu, He-Lin; Zhang, Lang-Jun; Wu, Zongwen</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">532-566</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The sigma-2 receptor is highly expressed in various rapidly proliferating cancer cells and regarded as a cancer cell biomarker.  Selective sigma-2 ligands have been shown to specifically label the tumor sites, induce cancer cells to undergo apoptosis, and inhibit tumor growth.  Sigma-2 ligands are potentially useful as cancer diagnostics, anticancer therapeutics, or adjuvant anticancer treatment agents.  However, both the cloning of this receptor and the identification of its endogenous ligand have not been successful, and the lack of structural information has severely hindered the understanding of its physiol. roles, its signaling pathways, and the development of more selective sigma-2 ligands.  Recent data have implicated that sigma-2 binding sites are within the lipid rafts and that PGRMC1 (progesterone receptor membrane component 1) complex and sigma-2 receptor may be coupled with EGFR (epidermal growth factor receptor), mTOR (mammalian target of rapamycin), caspases, and ion channels.  Due to its promising applications in cancer management, there are rapidly increasing research efforts that are being directed into this field.  This review article updates the current understanding of sigma-2 receptor and its potential physiol. roles, applications, interaction with other effectors, with special focuses on the development of sigma-2 ligands, their chem. structures, pharmacol. profiles, applications in imaging and anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSJIQdLSWe4LVg90H21EOLACvtfcHk0ljixvohgLGIfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsl2qsrk%253D&md5=bce2e9be88f6cbb9e547f00b4734ce6a</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fmed.21297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21297%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.-S.%26aulast%3DLu%26aufirst%3DH.-L.%26aulast%3DZhang%26aufirst%3DL.-J.%26aulast%3DWu%26aufirst%3DZ.%26atitle%3DSigma-2%2520receptor%2520ligands%2520and%2520their%2520perspectives%2520in%2520cancer%2520diagnosis%2520and%2520therapy%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2014%26volume%3D34%26spage%3D532%26epage%3D566%26doi%3D10.1002%2Fmed.21297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guitart, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codony, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monroy, X.</span></span> <span> </span><span class="NLM_article-title">Sigma receptors: biology and therapeutic potential</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">319</span>, <span class="refDoi"> DOI: 10.1007/s00213-004-1920-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1007%2Fs00213-004-1920-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=15197533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BD2cXls1antrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2004&pages=301-319&author=X.+Guitartauthor=X.+Codonyauthor=X.+Monroy&title=Sigma+receptors%3A+biology+and+therapeutic+potential&doi=10.1007%2Fs00213-004-1920-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma receptors: biology and therapeutic potential</span></div><div class="casAuthors">Guitart, Xavier; Codony, Xavier; Monroy, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">301-319</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A review.  More than 20 yr after the identification of the sigma receptors as a unique binding site in the brain and in the peripheral organs, several questions regarding this receptor are still open.  Only one of the subtypes of the receptor has been cloned to date, but the endogenous ligand still remains unknown, and the possible assocn. of the receptor with a conventional second messenger system is controversial.  From the very beginning, the sigma receptors were assocd. with various central nervous system disorders such as schizophrenia or movement disorders.  Today, after hundreds of papers dealing with the importance of sigma receptors in brain function, it is widely accepted that sigma receptors represent a new and different avenue in the possible pharmacol. treatment of several brain-related disorders.  In this review, what is known about the biol. of the sigma receptor regarding its putative structure and its distribution in the central nervous system is summarized first.  The role of sigma receptors regulating cellular functions and other neurotransmitter systems is also addressed, as well as a short overview of the possible endogenous ligands.  Finally, although no specific sigma ligand has reached the market, different pharmacol. approaches to the alleviation and treatment of several central nervous system disorders and deficits, including schizophrenia, pain, memory deficits, etc., are discussed, with an overview of different compds. and their potential therapeutic use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsmhBCbR6bHrVg90H21EOLACvtfcHk0ljixvohgLGIfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXls1antrc%253D&md5=16430485c5f2539b56b1a784cf0c064c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1007%2Fs00213-004-1920-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-004-1920-9%26sid%3Dliteratum%253Aachs%26aulast%3DGuitart%26aufirst%3DX.%26aulast%3DCodony%26aufirst%3DX.%26aulast%3DMonroy%26aufirst%3DX.%26atitle%3DSigma%2520receptors%253A%2520biology%2520and%2520therapeutic%2520potential%26jtitle%3DPsychopharmacology%26date%3D2004%26volume%3D174%26spage%3D301%26epage%3D319%26doi%3D10.1007%2Fs00213-004-1920-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Waarde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rybczynska, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramakrishnan, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishiwata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsinga, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dierckx, R. A. J. O.</span></span> <span> </span><span class="NLM_article-title">Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligands</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3519</span>– <span class="NLM_lpage">3537</span>, <span class="refDoi"> DOI: 10.2174/138161210793563365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.2174%2F138161210793563365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=21050178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BC3MXis1KqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=3519-3537&author=A.+van%0AWaardeauthor=A.+A.+Rybczynskaauthor=N.+K.+Ramakrishnanauthor=K.+Ishiwataauthor=P.+H.+Elsingaauthor=R.+A.+J.+O.+Dierckx&title=Sigma+receptors+in+oncology%3A+therapeutic+and+diagnostic+applications+of+sigma+ligands&doi=10.2174%2F138161210793563365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligands</span></div><div class="casAuthors">van Waarde, Aren; Rybczynska, Anna A.; Ramakrishnan, Nisha K.; Ishiwata, Kiichi; Elsinga, Philip H.; Dierckx, Rudi A. J. O.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">3519-3537</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Sigma receptors (subtypes sigma-1 and sigma-2) are a unique class of binding sites expressed throughout the mammalian body.  The endogenous ligand for these sites has not been identified, but steroid hormones (particularly progesterone), sphingolipid-derived amines and N,N-dimethyltryptamine can bind with fairly high affinity.  Sigma receptors are overexpressed in rapidly proliferating cells, like cancer cells.  Particularly the sigma-2 subtype is upregulated when cells divide and down regulated when they become quiescent.  Sigma ligands, esp. sigma-2 agonists, can inhibit proliferation and induce apoptosis by a mechanism involving changes in cytosolic Ca2+, ceramide and sphingolipid levels.  Tumor cells are much more sensitive to such treatment than cells from their tissue of origin.  Sigma ligands induce apoptosis not only in drug-sensitive but also in drug-resistant cancer cells (e.g., cells with p53 mutations, or caspase dysfunction).  Moreover, sigma ligands may abrogate P-glycoprotein-mediated drug resistance and at subtoxic doses, they can potentiate the effect of conventional cytostatics.  Thus, sigma-2 agonists may be developed as antineoplastic agents for the treatment of drug-resistant tumors.  A large no. of radiolabeled sigma ligands has been prepd. for SPECT (single-photon emission computed tomog.) and PET (positron emission tomog.) imaging.  Such radiopharmaceuticals can be used for tumor detection, tumor staging, and evaluation of anti-tumor therapy.  There is still a need for the development of ligands with (1) high selectivity for the sigma-2 subtype, (2) defined action (agonist or antagonist) and (3) optimal pharmacokinetics (low affinity for P-glycoprotein, high and specific tumor uptake, and rapid washout from non-target tissues).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX-vSPpRtU37Vg90H21EOLACvtfcHk0ljixvohgLGIfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXis1KqsA%253D%253D&md5=e77adeaf932e2fa8eca70ec0e4e84ec6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.2174%2F138161210793563365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161210793563365%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BWaarde%26aufirst%3DA.%26aulast%3DRybczynska%26aufirst%3DA.%2BA.%26aulast%3DRamakrishnan%26aufirst%3DN.%2BK.%26aulast%3DIshiwata%26aufirst%3DK.%26aulast%3DElsinga%26aufirst%3DP.%2BH.%26aulast%3DDierckx%26aufirst%3DR.%2BA.%2BJ.%2BO.%26atitle%3DSigma%2520receptors%2520in%2520oncology%253A%2520therapeutic%2520and%2520diagnostic%2520applications%2520of%2520sigma%2520ligands%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2010%26volume%3D16%26spage%3D3519%26epage%3D3537%26doi%3D10.2174%2F138161210793563365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berardi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abate, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferorelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colabufo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrone, R.</span></span> <span> </span><span class="NLM_article-title">1-Cyclohexylpiperazine and 3,3-dimethylpiperidine derivatives as sigma-1 (σ1) and sigma-2 (σ2) receptor ligands: a review</span>. <i>Cent. Nerv. Syst. Agents Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">219</span>, <span class="refDoi"> DOI: 10.2174/1871524910909030205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.2174%2F1871524910909030205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=20021355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWnt7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=205-219&author=F.+Berardiauthor=C.+Abateauthor=S.+Ferorelliauthor=N.+Colabufoauthor=R.+Perrone&title=1-Cyclohexylpiperazine+and+3%2C3-dimethylpiperidine+derivatives+as+sigma-1+%28%CF%831%29+and+sigma-2+%28%CF%832%29+receptor+ligands%3A+a+review&doi=10.2174%2F1871524910909030205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">1-Cyclohexylpiperazine and 3,3-dimethylpiperidine derivatives as sigma-1 (σ1) and sigma-2 (σ2) receptor ligands: a review</span></div><div class="casAuthors">Berardi, Francesco; Abate, Carmen; Ferorelli, Savina; Colabufo, Nicola Antonio; Perrone, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Central Nervous System Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">205-219</span>CODEN:
                <span class="NLM_cas:coden">CNSAC3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5249</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Herein the evolution in the development of new sigma (σ) receptor ligands since the middle '90s by our research group is reported.  In the effort to contribute to the identification of the structural features for high-affinity ligands selective vs. serotonin, dopamine and other CNS-related receptors, two general classes of (naphthalene)alkylamine compds. were prepd. and explored, with the aim of addressing the affinities toward the two recognized σ receptor subtypes.  The common template of these compds. was mainly an unsubstituted or methoxy-substituted naphthalene or tetralin nucleus, linked by an alkyl spacer to a substituted piperazine or piperidine ring.  The design of new ligands was thought keeping in mind their possible application as PET diagnostic tools and fluorescence tools.  High-affinity σ2 receptor ligands were found among N-cyclohexylpiperazine derivs., such as 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (3) (PB 28), when they were assayed in radioligand binding with [3H]-DTG in rat liver.  Unfortunately, these ligands were all devoid of a significant selectivity relative to σ1 receptor whose binding was assayed with (+)-[3H]-pentazocine in guinea pig brain.  Nevertheless, compd. 3 had previously shown to be 40-fold selective with a slightly different binding method in animals' tissues.  Moreover, it demonstrated 46-fold and 59-fold σ2 vs. σ1 receptor binding selectivity in MCF7 and MCF7 ADR tumor cell lines resp.  In the class of piperazines, also high-affinity σ1 receptor ligands were found, possibly due to the presence of a double N-atom and an addnl. reverse mode of binding.  Piperidine derivs. were investigated as high-affinity and selective σ1 receptor ligands leading to some 3,3-dimethylpiperidines such as 3,3-dimethyl-1-[3-(6-methoxynaphthalen-1-yl)propyl]piperidine (69) which resulted to be highly selective relative to the σ2 receptor.  For the best ligands, functional assays were conducted to investigate agonist/antagonist activity.  The effect of chirality in the intermediate methyl-alkyl chain was explored for a class of 4-methylpiperidines linked to some (4-chlorophenoxy)alkyl moieties, and compd. (-)-(S)-92 emerged as the most selective σ1 relative to σ2 receptor ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsL585s521T7Vg90H21EOLACvtfcHk0ljixvohgLGIfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWnt7rP&md5=b7b181e35900b4891c89cc05cd0713ce</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.2174%2F1871524910909030205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871524910909030205%26sid%3Dliteratum%253Aachs%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DAbate%26aufirst%3DC.%26aulast%3DFerorelli%26aufirst%3DS.%26aulast%3DColabufo%26aufirst%3DN.%26aulast%3DPerrone%26aufirst%3DR.%26atitle%3D1-Cyclohexylpiperazine%2520and%25203%252C3-dimethylpiperidine%2520derivatives%2520as%2520sigma-1%2520%2528%25CF%25831%2529%2520and%2520sigma-2%2520%2528%25CF%25832%2529%2520receptor%2520ligands%253A%2520a%2520review%26jtitle%3DCent.%2520Nerv.%2520Syst.%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D205%26epage%3D219%26doi%3D10.2174%2F1871524910909030205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perregaard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moltzen, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, C.</span></span> <span> </span><span class="NLM_article-title">sigma. Ligands with Subnanomolar Affinity and Preference for the.sigma.2 Binding Site. 1. 3-(.omega.-Aminoalkyl)-1H-indoles</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1998</span>– <span class="NLM_lpage">2008</span>, <span class="refDoi"> DOI: 10.1021/jm00011a019</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00011a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=1998-2008&author=J.+Perregaardauthor=E.+K.+Moltzenauthor=E.+Meierauthor=C.+Sanchez&title=sigma.+Ligands+with+Subnanomolar+Affinity+and+Preference+for+the.sigma.2+Binding+Site.+1.+3-%28.omega.-Aminoalkyl%29-1H-indoles&doi=10.1021%2Fjm00011a019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm00011a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00011a019%26sid%3Dliteratum%253Aachs%26aulast%3DPerregaard%26aufirst%3DJ.%26aulast%3DMoltzen%26aufirst%3DE.%2BK.%26aulast%3DMeier%26aufirst%3DE.%26aulast%3DSanchez%26aufirst%3DC.%26atitle%3Dsigma.%2520Ligands%2520with%2520Subnanomolar%2520Affinity%2520and%2520Preference%2520for%2520the.sigma.2%2520Binding%2520Site.%25201.%25203-%2528.omega.-Aminoalkyl%2529-1H-indoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D1998%26epage%3D2008%26doi%3D10.1021%2Fjm00011a019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vangveravong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span> <span> </span><span class="NLM_article-title">Conformationally-flexible benzamide analogues as dopamine D3 and σ2 receptor ligands</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">195</span>– <span class="NLM_lpage">202</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2003.09.083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2Fj.bmcl.2003.09.083" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=195-202&author=R.+H.+Machauthor=Y.+Huangauthor=R.+A.+Freemanauthor=L.+Wuauthor=S.+Vangveravongauthor=R.+R.+Luedtke&title=Conformationally-flexible+benzamide+analogues+as+dopamine+D3+and+%CF%832+receptor+ligands&doi=10.1016%2Fj.bmcl.2003.09.083"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2003.09.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2003.09.083%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DFreeman%26aufirst%3DR.%2BA.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DVangveravong%26aufirst%3DS.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26atitle%3DConformationally-flexible%2520benzamide%2520analogues%2520as%2520dopamine%2520D3%2520and%2520%25CF%25832%2520receptor%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D195%26epage%3D202%26doi%3D10.1016%2Fj.bmcl.2003.09.083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maier, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wünsch, B.</span></span> <span> </span><span class="NLM_article-title">Novel spiropiperidines as highly potent and subtype selective σ-receptor ligands. Part 1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">438</span>– <span class="NLM_lpage">448</span>, <span class="refDoi"> DOI: 10.1021/jm010992z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm010992z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=438-448&author=C.+A.+Maierauthor=B.+W%C3%BCnsch&title=Novel+spiropiperidines+as+highly+potent+and+subtype+selective+%CF%83-receptor+ligands.+Part+1&doi=10.1021%2Fjm010992z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm010992z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010992z%26sid%3Dliteratum%253Aachs%26aulast%3DMaier%26aufirst%3DC.%2BA.%26aulast%3DW%25C3%25BCnsch%26aufirst%3DB.%26atitle%3DNovel%2520spiropiperidines%2520as%2520highly%2520potent%2520and%2520subtype%2520selective%2520%25CF%2583-receptor%2520ligands.%2520Part%25201%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D438%26epage%3D448%26doi%3D10.1021%2Fjm010992z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maier, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wünsch, B.</span></span> <span> </span><span class="NLM_article-title">Novel σ receptor ligands. Part 2. SAR of spiro[[2]benzopyran-1,4‘-piperidines] and spiro[[2]benzofuran-1,4‘-piperidines] with carbon substituents in position 3</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">4923</span>– <span class="NLM_lpage">4930</span>, <span class="refDoi"> DOI: 10.1021/jm020889p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020889p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4923-4930&author=C.+A.+Maierauthor=B.+W%C3%BCnsch&title=Novel+%CF%83+receptor+ligands.+Part+2.+SAR+of+spiro%5B%5B2%5Dbenzopyran-1%2C4%E2%80%98-piperidines%5D+and+spiro%5B%5B2%5Dbenzofuran-1%2C4%E2%80%98-piperidines%5D+with+carbon+substituents+in+position+3&doi=10.1021%2Fjm020889p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm020889p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020889p%26sid%3Dliteratum%253Aachs%26aulast%3DMaier%26aufirst%3DC.%2BA.%26aulast%3DW%25C3%25BCnsch%26aufirst%3DB.%26atitle%3DNovel%2520%25CF%2583%2520receptor%2520ligands.%2520Part%25202.%2520SAR%2520of%2520spiro%255B%255B2%255Dbenzopyran-1%252C4%25E2%2580%2598-piperidines%255D%2520and%2520spiro%255B%255B2%255Dbenzofuran-1%252C4%25E2%2580%2598-piperidines%255D%2520with%2520carbon%2520substituents%2520in%2520position%25203%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4923%26epage%3D4930%26doi%3D10.1021%2Fjm020889p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rack, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fröhlich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schepmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wünsch, B.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and pharmacological evaluation of spirocyclic ó(1) receptor ligands with exocyclic amino moiety (increased distance 1)</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3141</span>– <span class="NLM_lpage">3151</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2011.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2Fj.bmc.2011.04.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=3141-3151&author=E.+Rackauthor=R.+Fr%C3%B6hlichauthor=D.+Schepmannauthor=B.+W%C3%BCnsch&title=Design%2C+synthesis+and+pharmacological+evaluation+of+spirocyclic+%C3%B3%281%29+receptor+ligands+with+exocyclic+amino+moiety+%28increased+distance+1%29&doi=10.1016%2Fj.bmc.2011.04.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DRack%26aufirst%3DE.%26aulast%3DFr%25C3%25B6hlich%26aufirst%3DR.%26aulast%3DSchepmann%26aufirst%3DD.%26aulast%3DW%25C3%25BCnsch%26aufirst%3DB.%26atitle%3DDesign%252C%2520synthesis%2520and%2520pharmacological%2520evaluation%2520of%2520spirocyclic%2520%25C3%25B3%25281%2529%2520receptor%2520ligands%2520with%2520exocyclic%2520amino%2520moiety%2520%2528increased%2520distance%25201%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D3141%26epage%3D3151%26doi%3D10.1016%2Fj.bmc.2011.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grosse
Maestrup, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schepmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheunemann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wünsch, B.</span></span> <span> </span><span class="NLM_article-title">Synthesis of spirocyclic sigma1 receptor ligands as potential PET radiotracers, structure-affinity relationships and in vitro metabolic stability</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3630</span>– <span class="NLM_lpage">3641</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.03.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2Fj.bmc.2009.03.060" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=3630-3641&author=E.+Grosse%0AMaestrupauthor=C.+Wieseauthor=D.+Schepmannauthor=A.+Hillerauthor=S.+Fischerauthor=M.+Scheunemannauthor=P.+Brustauthor=B.+W%C3%BCnsch&title=Synthesis+of+spirocyclic+sigma1+receptor+ligands+as+potential+PET+radiotracers%2C+structure-affinity+relationships+and+in+vitro+metabolic+stability&doi=10.1016%2Fj.bmc.2009.03.060"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.03.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.03.060%26sid%3Dliteratum%253Aachs%26aulast%3DGrosse%2BMaestrup%26aufirst%3DE.%26aulast%3DWiese%26aufirst%3DC.%26aulast%3DSchepmann%26aufirst%3DD.%26aulast%3DHiller%26aufirst%3DA.%26aulast%3DFischer%26aufirst%3DS.%26aulast%3DScheunemann%26aufirst%3DM.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DW%25C3%25BCnsch%26aufirst%3DB.%26atitle%3DSynthesis%2520of%2520spirocyclic%2520sigma1%2520receptor%2520ligands%2520as%2520potential%2520PET%2520radiotracers%252C%2520structure-affinity%2520relationships%2520and%2520in%2520vitro%2520metabolic%2520stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D3630%26epage%3D3641%26doi%3D10.1016%2Fj.bmc.2009.03.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oberdorf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schepmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holenz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wünsch, B.</span></span> <span> </span><span class="NLM_article-title">Thiophene bioisosteres of spirocyclic sigma receptor ligands. 1. N-substituted spiro[piperidine-4,4’-thieno[3,2-c]pyrans]</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">6531</span>– <span class="NLM_lpage">6537</span>, <span class="refDoi"> DOI: 10.1021/jm8007739</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8007739" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6531-6537&author=C.+Oberdorfauthor=D.+Schepmannauthor=J.+M.+Velaauthor=J.+L.+Diazauthor=J.+Holenzauthor=B.+W%C3%BCnsch&title=Thiophene+bioisosteres+of+spirocyclic+sigma+receptor+ligands.+1.+N-substituted+spiro%5Bpiperidine-4%2C4%E2%80%99-thieno%5B3%2C2-c%5Dpyrans%5D&doi=10.1021%2Fjm8007739"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm8007739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8007739%26sid%3Dliteratum%253Aachs%26aulast%3DOberdorf%26aufirst%3DC.%26aulast%3DSchepmann%26aufirst%3DD.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DDiaz%26aufirst%3DJ.%2BL.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DW%25C3%25BCnsch%26aufirst%3DB.%26atitle%3DThiophene%2520bioisosteres%2520of%2520spirocyclic%2520sigma%2520receptor%2520ligands.%25201.%2520N-substituted%2520spiro%255Bpiperidine-4%252C4%25E2%2580%2599-thieno%255B3%252C2-c%255Dpyrans%255D%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6531%26epage%3D6537%26doi%3D10.1021%2Fjm8007739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schläger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schepmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Würthwein, E.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wünsch, B.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-affinity relationships of novel spirocyclic sigma receptor ligands with furopyrazole structure</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2992</span>– <span class="NLM_lpage">3001</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2007.12.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2Fj.bmc.2007.12.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=2992-3001&author=T.+Schl%C3%A4gerauthor=D.+Schepmannauthor=E.-U.+W%C3%BCrthweinauthor=B.+W%C3%BCnsch&title=Synthesis+and+structure-affinity+relationships+of+novel+spirocyclic+sigma+receptor+ligands+with+furopyrazole+structure&doi=10.1016%2Fj.bmc.2007.12.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.12.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.12.045%26sid%3Dliteratum%253Aachs%26aulast%3DSchl%25C3%25A4ger%26aufirst%3DT.%26aulast%3DSchepmann%26aufirst%3DD.%26aulast%3DW%25C3%25BCrthwein%26aufirst%3DE.-U.%26aulast%3DW%25C3%25BCnsch%26aufirst%3DB.%26atitle%3DSynthesis%2520and%2520structure-affinity%2520relationships%2520of%2520novel%2520spirocyclic%2520sigma%2520receptor%2520ligands%2520with%2520furopyrazole%2520structure%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D2992%26epage%3D3001%26doi%3D10.1016%2Fj.bmc.2007.12.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruckner, R.</span>; <span class="NLM_string-name">Wender, P. A.</span>; <span class="NLM_string-name">Beifuss, K.</span>; <span class="NLM_string-name">Zettlmeier, W.</span></span> <i>Organic Mechanisms</i>; <span class="NLM_publisher-name">Springer-Verlag</span>: <span class="NLM_publisher-loc">Berlin</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1007%2F978-3-642-03651-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=R.+Bruckner&author=P.+A.+Wender&author=K.+Beifuss&author=W.+Zettlmeier&title=Organic+Mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-03651-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-642-03651-4%26sid%3Dliteratum%253Aachs%26aulast%3DBruckner%26aufirst%3DR.%26btitle%3DOrganic%2520Mechanisms%26pub%3DSpringer-Verlag%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rack, E.</span></span> <span> </span><span class="NLM_article-title">Struktur-Affinitäts- und Selektivitätsuntersuchungen Spirocyclischer Sigma-Rezeptorliganden mit Exocyclischer Aminfunktion</span>. Doctoral Dissertation, University of Münster, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=E.+Rack&title=Struktur-Affinit%C3%A4ts-+und+Selektivit%C3%A4tsuntersuchungen+Spirocyclischer+Sigma-Rezeptorliganden+mit+Exocyclischer+Aminfunktion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRack%26aufirst%3DE.%26atitle%3DStruktur-Affinit%25C3%25A4ts-%2520und%2520Selektivit%25C3%25A4tsuntersuchungen%2520Spirocyclischer%2520Sigma-Rezeptorliganden%2520mit%2520Exocyclischer%2520Aminfunktion%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Søby, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikkelsen, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomsen, C.</span></span> <span> </span><span class="NLM_article-title">Lu 28–179 labels a σ2-site in rat and human brain</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1016/S0028-3908(02)00071-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2FS0028-3908%2802%2900071-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=95-100&author=K.+K.+S%C3%B8byauthor=J.+D.+Mikkelsenauthor=E.+Meierauthor=C.+Thomsen&title=Lu+28%E2%80%93179+labels+a+%CF%832-site+in+rat+and+human+brain&doi=10.1016%2FS0028-3908%2802%2900071-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2802%2900071-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252802%252900071-0%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25B8by%26aufirst%3DK.%2BK.%26aulast%3DMikkelsen%26aufirst%3DJ.%2BD.%26aulast%3DMeier%26aufirst%3DE.%26aulast%3DThomsen%26aufirst%3DC.%26atitle%3DLu%252028%25E2%2580%2593179%2520labels%2520a%2520%25CF%25832-site%2520in%2520rat%2520and%2520human%2520brain%26jtitle%3DNeuropharmacology%26date%3D2002%26volume%3D43%26spage%3D95%26epage%3D100%26doi%3D10.1016%2FS0028-3908%2802%2900071-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCracken, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pouw, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Costa, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, W. D.</span></span> <span> </span><span class="NLM_article-title">Conformationally restricted analogs of BD1008 and an antisense oligodeoxynucleotide targeting σ1 receptors produce anti-cocaine effects in mice</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>419</i></span>,  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1016/S0014-2999(01)00968-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2FS0014-2999%2801%2900968-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=11426838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksFCktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=419&publication_year=2001&pages=163-174&author=R.+R.+Matsumotoauthor=K.+A.+McCrackenauthor=M.+J.+Friedmanauthor=B.+Pouwauthor=B.+R.+De+Costaauthor=W.+D.+Bowen&title=Conformationally+restricted+analogs+of+BD1008+and+an+antisense+oligodeoxynucleotide+targeting+%CF%831+receptors+produce+anti-cocaine+effects+in+mice&doi=10.1016%2FS0014-2999%2801%2900968-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Conformationally restricted analogs of BD1008 and an antisense oligodeoxynucleotide targeting σ1 receptors produce anti-cocaine effects in mice</span></div><div class="casAuthors">Matsumoto, Rae R.; McCracken, Kari A.; Friedman, Michele J.; Pouw, Buddy; De Costa, Brian R.; Bowen, Wayne D.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">419</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">163-174</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Cocaine's ability to interact with σ receptors suggests that these proteins mediate some of its behavioral effects.  Therefore, three novel σ receptor ligands with antagonist activity were evaluated in Swiss Webster mice: BD1018 (3S-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]nonane), BD1063 (1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine), and LR132 (1R,2S-(+)-cis-N-[2-(3,4-dichlorophenyl)ethyl]-2-(1-pyrrolidinyl)cyclohexylamine).  Competition binding assays demonstrated that all three compds. have high affinities for σ1 receptors.  The three compds. vary in their affinities for σ2 receptors and exhibit negligible affinities for dopamine, opioid, GABAA and NMDA receptors.  In behavioral studies, pre-treatment of mice with BD1018, BD1063, or LR132 significantly attenuated cocaine-induced convulsions and lethality.  Moreover, post-treatment with LR132 prevented cocaine-induced lethality in a significant proportion of animals.  In contrast to the protection provided by the putative antagonists, the well-characterized σ receptor agonist di-o-tolylguanidine (DTG) and the novel σ receptor agonist BD1031 (3R-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]nonane) each worsened the behavioral toxicity of cocaine.  At doses where alone, they produced no significant effects on locomotion, BD1018, BD1063 and LR132 significantly attenuated the locomotor stimulatory effects of cocaine.  To further validate the hypothesis that the anti-cocaine effects of the novel ligands involved antagonism of σ receptors, an antisense oligodeoxynucleotide against σ1 receptors was also shown to significantly attenuate the convulsive and locomotor stimulatory effects of cocaine.  Together, the data suggests that functional antagonism of σ receptors is capable of attenuating a no. of cocaine-induced behaviors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo12XhXmu0jirVg90H21EOLACvtfcHk0li4QuWujNmDAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksFCktrY%253D&md5=ac2940d96fffd28b2ab9a1f61ddc5454</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2801%2900968-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252801%252900968-2%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DR.%2BR.%26aulast%3DMcCracken%26aufirst%3DK.%2BA.%26aulast%3DFriedman%26aufirst%3DM.%2BJ.%26aulast%3DPouw%26aufirst%3DB.%26aulast%3DDe%2BCosta%26aufirst%3DB.%2BR.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3DConformationally%2520restricted%2520analogs%2520of%2520BD1008%2520and%2520an%2520antisense%2520oligodeoxynucleotide%2520targeting%2520%25CF%25831%2520receptors%2520produce%2520anti-cocaine%2520effects%2520in%2520mice%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D419%26spage%3D163%26epage%3D174%26doi%3D10.1016%2FS0014-2999%2801%2900968-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, T.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parish, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabeshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Privat, A.</span></span> <span> </span><span class="NLM_article-title">PRE-084, a σ selective PCP derivative, attenuates MK-801-induced impairment of learning in mice</span>. <i>Pharmacol., Biochem. Behav.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">859</span>– <span class="NLM_lpage">869</span>, <span class="refDoi"> DOI: 10.1016/0091-3057(94)90235-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2F0091-3057%2894%2990235-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1994&pages=859-869&author=T.+Mauriceauthor=T.-P.+Suauthor=D.+W.+Parishauthor=T.+Nabeshimaauthor=A.+Privat&title=PRE-084%2C+a+%CF%83+selective+PCP+derivative%2C+attenuates+MK-801-induced+impairment+of+learning+in+mice&doi=10.1016%2F0091-3057%2894%2990235-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2F0091-3057%2894%2990235-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-3057%252894%252990235-6%26sid%3Dliteratum%253Aachs%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.-P.%26aulast%3DParish%26aufirst%3DD.%2BW.%26aulast%3DNabeshima%26aufirst%3DT.%26aulast%3DPrivat%26aufirst%3DA.%26atitle%3DPRE-084%252C%2520a%2520%25CF%2583%2520selective%2520PCP%2520derivative%252C%2520attenuates%2520MK-801-induced%2520impairment%2520of%2520learning%2520in%2520mice%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1994%26volume%3D49%26spage%3D859%26epage%3D869%26doi%3D10.1016%2F0091-3057%2894%2990235-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span> <i>APEX3</i>; <span class="NLM_publisher-name">Bruker AXS Inc.</span>: <span class="NLM_publisher-loc">Madison, WI, U.S.</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+APEX3%3B+Bruker+AXS+Inc.%3A+Madison%2C+WI%2C+U.S.%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DAPEX3%26pub%3DBruker%2520AXS%2520Inc%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span> <i>SAINT</i>; <span class="NLM_publisher-name">Bruker AXS Inc.</span>: <span class="NLM_publisher-loc">Madison, WI, U.S.</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+SAINT%3B+Bruker+AXS+Inc.%3A+Madison%2C+WI%2C+U.S.%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSAINT%26pub%3DBruker%2520AXS%2520Inc%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span> <i>SADABS</i>; <span class="NLM_publisher-name">Bruker AXS Inc.</span>: <span class="NLM_publisher-loc">Madison, WI, U.S.</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+SADABS%3B+Bruker+AXS+Inc.%3A+Madison%2C+WI%2C+U.S.%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSADABS%26pub%3DBruker%2520AXS%2520Inc%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> <span> </span><span class="NLM_article-title">SHELXT - integrated space-group and crystal-structure determination</span>. <i>Acta Crystallogr., Sect. A: Found. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1107/S2053273314026370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1107%2FS2053273314026370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=25643710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsF2ntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=3-8&author=G.+M.+Sheldrick&title=SHELXT+-+integrated+space-group+and+crystal-structure+determination&doi=10.1107%2FS2053273314026370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">SHELXT - Integrated space-group and crystal-structure determination</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A: Foundations and Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-8</span>CODEN:
                <span class="NLM_cas:coden">ACSAD7</span>;
        ISSN:<span class="NLM_cas:issn">2053-2733</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The new computer program SHELXT employs a novel dual-space algorithm to solve the phase problem for single-crystal reflection data expanded to the space group P1.  Missing data are taken into account and the resoln. extended if necessary.  All space groups in the specified Laue group are tested to find which are consistent with the P1 phases.  After applying the resulting origin shifts and space-group symmetry, the solns. are subject to further dual-space recycling followed by a peak search and summation of the electron d. around each peak.  Elements are assigned to give the best fit to the integrated peak densities and if necessary addnl. elements are considered.  An isotropic refinement is followed for non-centrosym. space groups by the calcn. of a Flack parameter and, if appropriate, inversion of the structure.  The structure is assembled to maximize its connectivity and centered optimally in the unit cell.  SHELXT has already solved many thousand structures with a high success rate, and is optimized for multiprocessor computers.  It is, however, unsuitable for severely disordered and twinned structures because it is based on the assumption that the structure consists of atoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfRi0LYeHvuLVg90H21EOLACvtfcHk0lixrqDcy4Qx_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsF2ntQ%253D%253D&md5=cd76fcff223162a8fdaddbd0f3b24b94</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1107%2FS2053273314026370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053273314026370%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DSHELXT%2520-%2520integrated%2520space-group%2520and%2520crystal-structure%2520determination%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Adv.%26date%3D2015%26volume%3D71%26spage%3D3%26epage%3D8%26doi%3D10.1107%2FS2053273314026370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span> <i>XP-Interactive
Molecular Graphics</i>, version <span class="NLM_edition">5.1</span>; <span class="NLM_publisher-name">Bruker AXS Inc.</span>: <span class="NLM_publisher-loc">Madison, WI, U.S.</span>, <span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+XP-Interactive%0AMolecular+Graphics%2C+version+5.1%3B+Bruker+AXS+Inc.%3A+Madison%2C+WI%2C+U.S.%2C+1998."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DXP-Interactive%250AMolecular%2520Graphics%26pub%3DBruker%2520AXS%2520Inc%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bradford, M.
M.</span></span> <span> </span><span class="NLM_article-title">A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1016/0003-2697(76)90527-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2F0003-2697%2876%2990527-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=942051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaE28XksVehtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1976&pages=248-254&author=M.%0AM.+Bradford&title=A+rapid+and+sensitive+method+for+the+quantitation+of+microgram+quantities+of+protein+utilizing+the+principle+of+protein-dye+binding&doi=10.1016%2F0003-2697%2876%2990527-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</span></div><div class="casAuthors">Bradford, Marion M.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">248-54</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    </div><div class="casAbstract">A protein detn. method that involves the binding of coomassie Brilliant Blue G 250 to protein is described.  The binding of the dye to protein causes a shift in the absorption max. of the dye from 465 to 595 nm, and it is the increase in absorption at 595 nm that is monitored.  This assay is very reproducible and rapid with the dye binding process virtually complete in ∼ 2 min with good color stability for 1 hr.  There is little or no interference from cations such as Na+ or K+ nor from carbohydrates such as sucrose.  A small amt. of color is developed in the presence of strongly alk. buffering agents, but the assay may be run accurately by the use of proper buffer controls.  The only components found to give excessive interfering color in the assay are relatively large amts. of detergents such as Na dodecyl sulfate, Triton X 100, and commercial glassware detergents.  Interference by small amts. of detergent may be eliminated by the use of proper control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN_T_d0trcNrVg90H21EOLACvtfcHk0ljmqnGuXp83ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XksVehtrY%253D&md5=43f388a493becc4193c7a49d9de0e1db</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2876%2990527-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252876%252990527-3%26sid%3Dliteratum%253Aachs%26aulast%3DBradford%26aufirst%3DM.%2BM.%26atitle%3DA%2520rapid%2520and%2520sensitive%2520method%2520for%2520the%2520quantitation%2520of%2520microgram%2520quantities%2520of%2520protein%2520utilizing%2520the%2520principle%2520of%2520protein-dye%2520binding%26jtitle%3DAnal.%2520Biochem.%26date%3D1976%26volume%3D72%26spage%3D248%26epage%3D254%26doi%3D10.1016%2F0003-2697%2876%2990527-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stoscheck, C. M.</span></span> <span> </span><span class="NLM_article-title">Quantitation of protein</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>182</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1016/0076-6879(90)82008-P</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2F0076-6879%2890%2982008-P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=2314256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaK3MXitValsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=1990&pages=50-68&author=C.+M.+Stoscheck&title=Quantitation+of+protein&doi=10.1016%2F0076-6879%2890%2982008-P"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitation of protein</span></div><div class="casAuthors">Stoscheck, Christa M.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">Guide Protein Purif.</span>),
    <span class="NLM_cas:pages">50-68</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    </div><div class="casAbstract">A review with 48 refs.  Assays that are easy to perform, require simple instrumentation, and are highly sensitive including methods to conc. samples or to eliminate interfering reagents are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0a7IlHri16bVg90H21EOLACvtfcHk0ljmqnGuXp83ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXitValsLw%253D&md5=78d0376e0fdafecd901d5e0c9139dc14</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2F0076-6879%2890%2982008-P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0076-6879%252890%252982008-P%26sid%3Dliteratum%253Aachs%26aulast%3DStoscheck%26aufirst%3DC.%2BM.%26atitle%3DQuantitation%2520of%2520protein%26jtitle%3DMethods%2520Enzymol.%26date%3D1990%26volume%3D182%26spage%3D50%26epage%3D68%26doi%3D10.1016%2F0076-6879%2890%2982008-P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yung-Chi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=4202581" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=C.+Yung-Chiauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28KI%29+and+the+concentration+of+inhibitor+which+causes+50%25+inhibition+%28I50%29+of+an+enzymatic+reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DYung-Chi%26aufirst%3DC.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528KI%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2525%2520inhibition%2520%2528I50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeHaven-Hudkins, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleissner, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford-Rice, F. Y.</span></span> <span> </span><span class="NLM_article-title">Characterization of the binding of [3H](+)-pentazocine to σ recognition sites in guinea pig brain</span>. <i>Eur. J. Pharmacol., Mol. Pharmacol. Sect.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>227</i></span>,  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">378</span>, <span class="refDoi"> DOI: 10.1016/0922-4106(92)90153-M</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2F0922-4106%2892%2990153-M" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1359973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaK3sXhtl2lsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=227&publication_year=1992&pages=371-378&author=D.+L.+DeHaven-Hudkinsauthor=L.+C.+Fleissnerauthor=F.+Y.+Ford-Rice&title=Characterization+of+the+binding+of+%5B3H%5D%28%2B%29-pentazocine+to+%CF%83+recognition+sites+in+guinea+pig+brain&doi=10.1016%2F0922-4106%2892%2990153-M"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the binding of [3H](+)-pentazocine to σ recognition sites in guinea pig brain</span></div><div class="casAuthors">DeHaven-Hudkins, Diane L.; Fleissner, Lorraine C.; Ford-Rice, Felicia Y.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology, Molecular Pharmacology Section</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">227</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">371-8</span>CODEN:
                <span class="NLM_cas:coden">EJPPET</span>;
        ISSN:<span class="NLM_cas:issn">0922-4106</span>.
    </div><div class="casAbstract">The selective σ-opioid compd. (+)-pentazocine was radiolabeled and its binding characteristics in guinea pig brain membranes were investigated.  [3H](+)-Pentazocine bound to a single high-affinity site with a KD = 2.9 nM and a Bmax = 1998 fmol/mg protein.  Satn. was achieved at a ligand concn. of 15 nM.  The maximal specific binding was obsd. at 37° and was >90% of total binding.  The equil. was reached by 120 min and dissocn. was complete by 420 min, with a t1/2 of 121 min.  Li+, Ca2+, and Mg2+ inhibited the binding at high concns., and the binding was insensitive to adenyl and guanyl nucleotides.  Stereoselectivity was obsd. for the inhibition of binding by benzomorphans, 3-(3-hydroxyphenyl)-N-propylpiperidine and butaclamol.  The (+)-enantiomers and α-diastereomers of pentazocine and cyclazocine were more potent than their corresponding (-)-enantiomers and β-diastereomers.  The rank order of potency for the σ ref. agents to displace [3H](+)-pentazocine binding was similar to that reported using the 3H-labeled σ-ligands dextromethorphan, 1,3-di(2-tolyl)guanidine, and (+)-3-(3-hydroxyphenyl)-N-propylpiperidine.  Haloperidol, (+)-pentazocine, (+)-3-(3-hydroxyphenyl)-N-propylpiperidine and rimcazole were competitive inhibitors of binding to the [3H](+)-pentazocine-defined σ recognition site, suggesting that these different structural classes of compds. all bind to a single mol. entity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqptZ7zLKpE3bVg90H21EOLACvtfcHk0ljAhVop6e1ZVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhtl2lsbs%253D&md5=323649e2b05dedbaa1dd6e9e77255d75</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2F0922-4106%2892%2990153-M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0922-4106%252892%252990153-M%26sid%3Dliteratum%253Aachs%26aulast%3DDeHaven-Hudkins%26aufirst%3DD.%2BL.%26aulast%3DFleissner%26aufirst%3DL.%2BC.%26aulast%3DFord-Rice%26aufirst%3DF.%2BY.%26atitle%3DCharacterization%2520of%2520the%2520binding%2520of%2520%255B3H%255D%2528%252B%2529-pentazocine%2520to%2520%25CF%2583%2520recognition%2520sites%2520in%2520guinea%2520pig%2520brain%26jtitle%3DEur.%2520J.%2520Pharmacol.%252C%2520Mol.%2520Pharmacol.%2520Sect.%26date%3D1992%26volume%3D227%26spage%3D371%26epage%3D378%26doi%3D10.1016%2F0922-4106%2892%2990153-M" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Childers, S. R.</span></span> <span> </span><span class="NLM_article-title">Ibogaine possesses a selective affinity for σ2 receptors</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">PL57</span>– <span class="NLM_lpage">PL62</span>, <span class="refDoi"> DOI: 10.1016/0024-3205(95)00301-L</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2F0024-3205%2895%2900301-L" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=7603301" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1995&pages=PL57-PL62&author=R.+H.+Machauthor=C.+R.+Smithauthor=S.+R.+Childers&title=Ibogaine+possesses+a+selective+affinity+for+%CF%832+receptors&doi=10.1016%2F0024-3205%2895%2900301-L"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2895%2900301-L&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252895%252900301-L%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DSmith%26aufirst%3DC.%2BR.%26aulast%3DChilders%26aufirst%3DS.%2BR.%26atitle%3DIbogaine%2520possesses%2520a%2520selective%2520affinity%2520for%2520%25CF%25832%2520receptors%26jtitle%3DLife%2520Sci.%26date%3D1995%26volume%3D57%26spage%3DPL57%26epage%3DPL62%26doi%3D10.1016%2F0024-3205%2895%2900301-L" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 6 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Giuseppe Romeo, Federica Bonanno, Lisa L. Wilson, Emanuela Arena, Maria N. Modica, Valeria Pittalà, Loredana Salerno, Orazio Prezzavento, Jay P. McLaughlin, <span class="NLM_string-name hlFld-ContribAuthor">Sebastiano Intagliata</span>. </span><span class="cited-content_cbyCitation_article-title">Development of New Benzylpiperazine Derivatives as σ1 Receptor Ligands with in Vivo Antinociceptive and Anti-Allodynic Effects. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (11)
                                     , 2003-2012. <a href="https://doi.org/10.1021/acschemneuro.1c00106" title="DOI URL">https://doi.org/10.1021/acschemneuro.1c00106</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.1c00106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.1c00106%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDevelopment%252Bof%252BNew%252BBenzylpiperazine%252BDerivatives%252Bas%252B%2525CF%2525831%252BReceptor%252BLigands%252Bwith%252Bin%252BVivo%252BAntinociceptive%252Band%252BAnti-Allodynic%252BEffects%26aulast%3DRomeo%26aufirst%3DGiuseppe%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D26022021%26date%3D10052021%26date%3D21052021%26volume%3D12%26issue%3D11%26spage%3D2003%26epage%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Na Ye, Wangzhi Qin, Sheng Tian, Qingfeng Xu, Eric A. Wold, Jia Zhou, <span class="NLM_string-name hlFld-ContribAuthor">Xue-Chu Zhen</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (24)
                                     , 15187-15217. <a href="https://doi.org/10.1021/acs.jmedchem.0c01192" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01192</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01192%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecules%252BSelectively%252BTargeting%252BSigma-1%252BReceptor%252Bfor%252Bthe%252BTreatment%252Bof%252BNeurological%252BDiseases%26aulast%3DYe%26aufirst%3DNa%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D09072020%26date%3D28102020%26volume%3D63%26issue%3D24%26spage%3D15187%26epage%3D15217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Elisabeth Kronenberg, Frauke Weber, Stefanie Brune, Dirk Schepmann, Carmen Almansa, Kristina Friedland, Erik Laurini, Sabrina Pricl, <span class="NLM_string-name hlFld-ContribAuthor">Bernhard Wünsch</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Structure–Affinity Relationships of Spirocyclic Benzopyrans with Exocyclic Amino Moiety. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (8)
                                     , 4204-4217. <a href="https://doi.org/10.1021/acs.jmedchem.9b00449" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00449</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00449%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BStructure%2525E2%252580%252593Affinity%252BRelationships%252Bof%252BSpirocyclic%252BBenzopyrans%252Bwith%252BExocyclic%252BAmino%252BMoiety%26aulast%3DKronenberg%26aufirst%3DElisabeth%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D14032019%26date%3D12042019%26date%3D02042019%26volume%3D62%26issue%3D8%26spage%3D4204%26epage%3D4217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melanie  Bergkemper</span>, <span class="hlFld-ContribAuthor ">Dirk  Schepmann</span>, <span class="hlFld-ContribAuthor ">Bernhard  Wünsch</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of σ Receptor Ligands with a Spirocyclic System Connected with a Tetrahydroisoquinoline Moiety via Different Linkers. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (7)
                                     , 1184-1197. <a href="https://doi.org/10.1002/cmdc.202000861" title="DOI URL">https://doi.org/10.1002/cmdc.202000861</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000861%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSynthesis%252Bof%252B%2525CF%252583%252BReceptor%252BLigands%252Bwith%252Ba%252BSpirocyclic%252BSystem%252BConnected%252Bwith%252Ba%252BTetrahydroisoquinoline%252BMoiety%252Bvia%252BDifferent%252BLinkers%26aulast%3DBergkemper%26aufirst%3DMelanie%26date%3D2021%26date%3D2021%26volume%3D16%26issue%3D7%26spage%3D1184%26epage%3D1197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melanie  Bergkemper</span>, <span class="hlFld-ContribAuthor ">Elisabeth  Kronenberg</span>, <span class="hlFld-ContribAuthor ">Dirk  Schepmann</span>, <span class="hlFld-ContribAuthor ">Friedrich‐Alexander  Ludwig</span>, <span class="hlFld-ContribAuthor ">Peter  Brust</span>, <span class="hlFld-ContribAuthor ">Bernhard  Wünsch</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Affinity Relationships of Fluorinated Spirocyclic σ
              2
              Receptor Ligands with an Exocyclic Benzylamino Moiety. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (15)
                                     , 1392-1402. <a href="https://doi.org/10.1002/cmdc.201900284" title="DOI URL">https://doi.org/10.1002/cmdc.201900284</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900284%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DStructure%2525E2%252580%252593Affinity%252BRelationships%252Bof%252BFluorinated%252BSpirocyclic%252B%2525CF%252583%252B2%252BReceptor%252BLigands%252Bwith%252Ban%252BExocyclic%252BBenzylamino%252BMoiety%26aulast%3DBergkemper%26aufirst%3DMelanie%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D15%26spage%3D1392%26epage%3D1402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michele  Montaruli</span>, <span class="hlFld-ContribAuthor ">Domenico  Alberga</span>, <span class="hlFld-ContribAuthor ">Fulvio  Ciriaco</span>, <span class="hlFld-ContribAuthor ">Daniela  Trisciuzzi</span>, <span class="hlFld-ContribAuthor ">Anna Rita  Tondo</span>, <span class="hlFld-ContribAuthor ">Giuseppe Felice  Mangiatordi</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>. </span><span class="cited-content_cbyCitation_article-title">Accelerating Drug Discovery by Early Protein Drug Target Prediction Based on a Multi-Fingerprint Similarity Search †. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (12)
                                     , 2233. <a href="https://doi.org/10.3390/molecules24122233" title="DOI URL">https://doi.org/10.3390/molecules24122233</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24122233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24122233%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAccelerating%252BDrug%252BDiscovery%252Bby%252BEarly%252BProtein%252BDrug%252BTarget%252BPrediction%252BBased%252Bon%252Ba%252BMulti-Fingerprint%252BSimilarity%252BSearch%252B%2525E2%252580%2525A0%26aulast%3DMontaruli%26aufirst%3DMichele%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D12%26spage%3D2233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01183&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of σ receptor ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01183&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Spirocyclic σ Receptor Ligands with Exocyclic Amino Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01183&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and reaction conditions: (a) 2,4-dimethylbenzylamine, NaBH(OAc)<sub>3</sub>, HOAc, THF, 20 h, rt; <b>6a</b>, 30%; <b>6b</b>, 44%; (b) 1-cyclohexylpiperazine, NaBH(OAc)<sub>3</sub>, HOAc, THF, 23 h, rt; <b>6c</b>, 9%; <b>6d</b>, 38%; (c) 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride, NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 43 h, rt; <b>6e</b>, 19%; <b>6f</b>, 37%.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal structures of the <i>trans</i>- and <i>cis</i>-configured acetalic isoquinoline derivatives <b>6e</b> and <b>6f</b>. Thermal ellipsoids are shown at 30% and 50%, respectively. CCDC numbers are the following: <b>6e</b>, 1855388; <b>6f</b>, 1855389.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01183&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Spirocyclic σ Receptor Ligands with Fluoroethyl Side Chain<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01183&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and reaction conditions: (a) HCl, THF, 3–4 d, rt; <b>10a</b>, 71%; <b>10b</b>, 80%; <b>10c</b>, 86%; <b>10d</b>, 81%; <b>10e</b>, 86%; <b>10f</b>, 74%. (b) Ph<sub>3</sub>P═CHCO<sub>2</sub>Et, toluene, 3–5 d, reflux; <b>11a</b>, 39%; <b>11b</b>, 79%; <b>11c</b>, 52%; <b>11d</b>, 89%; <b>11e</b>, 94%; <b>11f</b>, 77%; (c) LiAlH<sub>4</sub>, Et<sub>2</sub>O, 2–4 h, −20 °C; <b>12a</b>, 79%; <b>12b</b>, 82%; <b>12c</b>, 85%; <b>12d</b>, 82%; <b>12e</b>, 71%; <b>12f</b>, 69%; (d) DAST, CH<sub>2</sub>Cl<sub>2</sub>, 1 h, −78 °C, then 20 h, rt; <b>13a</b>, 67%; <b>13b</b>, 22%; <b>13c</b>, 67%; <b>13d</b>, 13%, <b>13e</b>, 21%; <b>13f</b>, 27%. <b>10</b>–<b>13a</b>,<b>b</b>: NR<sub>2</sub> = 2,4-dimethylbenzylamino. <b>10</b>–<b>13c</b>,<b>d</b>: NR<sub>2</sub> = 4-cyclohexylpiperazin-1-yl. <b>10</b>–<b>13e</b>,<b>f</b>: NR<sub>2</sub> = 6,7-dimethoxyisoquinolin-2-yl. For structures see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Spirocyclic σ Receptor Ligands with [1-(4-Fluorophenyl)indol-3-yl]propyl Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01183&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and reaction conditions: (a) 1-bromo-4-fluorobenzene, CuI, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 2 d, reflux; 78%; (b) ClCO<sub>2</sub>Et, NH<sub>3</sub>, Et<sub>3</sub>N, THF, 3 h, 0 °C; 97%; (c) LiAlH<sub>4</sub>, THF, 2 h, reflux; 64%; (d) ketone <b>5</b>, NaBH(OAc)<sub>3</sub>, HOAc, THF, 20 h, rt; <b>18a</b>, 30%; <b>18b</b>, 42%.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the Spirocyclic Building Block <b>24</b> with Fluoroethyl Side Chain<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01183&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and reaction conditions: (a) HCl, THF, 3 d, rt; 95%; (b) Ph<sub>3</sub>P═CHCO<sub>2</sub>Et, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 2 d, reflux; 63%; (c) ethylene glycol, CH(OCH<sub>3</sub>)<sub>3</sub>, <i>p</i>-toluenesulfonic acid (<i>p</i>-TsOH), CH<sub>2</sub>Cl<sub>2</sub>, 17 h, rt; 88%; (d) LiAlH<sub>4</sub>, Et<sub>2</sub>O, 2 h, 81%; (e) DAST, CH<sub>2</sub>Cl<sub>2</sub>, 1 h, −78 °C, then 20 h rt; 49%; (f) 2 M HCl, Et<sub>2</sub>O, 3 d, 40 °C; 95%.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Spirocyclic σ Receptor Ligands with Benzo[7]annulenyl Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01183&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and reaction conditions: (a) H<sub>2</sub>, 10% Pd/C, CH<sub>3</sub>OH, 20 h, rt; <b>25a</b>, 72%; <b>25b</b>, 89%; (b) NaBH(OAc)<sub>3</sub>, HOAc, CH<sub>2</sub>Cl<sub>2</sub>, 3 h, rt; <b>27a</b>, 48%; (c) NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 12 h, rt; <b>27b</b>, 28%.</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Spirocyclic σ Receptor Ligands with Benzo[7]annulenyl Moiety and Fluoroethyl Side Chain<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01183&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and reaction conditions: (a) benzylamine, NaBH(OAc)<sub>3</sub>, HOAc, THF, 3 h, rt; <b>28a</b>, 45%; <b>28b</b>, 45%; (b) NH<sub>4</sub>HCO<sub>2</sub>, 10% Pd/C, CH<sub>3</sub>OH, 2–4.5 h, 65 °C; <b>29a</b>, 96%; <b>29b</b>, 88%; (c) NaBH(OAc)<sub>3</sub>, HOAc, CH<sub>2</sub>Cl<sub>2</sub>, 1 d, rt; <b>30a</b>, 76%; <b>30b</b>, 81%.</p></p></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effects of fluoroethyl derivatives <b>13c</b> (left) and <b>13d</b> (right) and the reference compound <b>34</b> (left and right) on mechanical allodynia induced by intraplantar (ipl) administration of capsaicin in mice. Animals were treated sc with <b>13c</b>, <b>13d</b>, <b>34</b> or their solvent (HPMC, dose 0) 30 min before capsaicin. Each bar and vertical line represents the mean ± SEM of values obtained in 6–8 animals. One-way analysis of variance followed by the Bonferroni test was used to determine statistically significant differences between values obtained in mice treated with <b>13c</b>, <b>13d</b>, or <b>34</b> in comparison with control animals (HPMC-treated, dose 0) value (<sup>##</sup><i>P</i> < 0.01) and between the values obtained in mice treated with the same dose of <b>13c</b> and <b>34</b> (left) or the same dose of <b>13d</b> and <b>34</b> (right) (**<i>P</i> < 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01183&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/medium/jm-2018-01183y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of fluoroethyl derivatives <b>13c</b> (left) or <b>13d</b> (right) alone and in combination with the σ<sub>1</sub> receptor agonist <b>35</b> on mechanical allodynia induced by intraplantar (ipl) administration of capsaicin in mice. Animals were treated sc with <b>35</b> 5 min before administration of <b>13c</b> or <b>13d</b>, which were sc administered 30 min before capsaicin. Each bar and vertical line represents the mean ± SEM of values obtained in 6–8 animals. One-way analysis of variance followed by the Bonferroni test was used to determine statistically significant differences between values obtained in mice treated with <b>13c</b>, <b>13d</b>, or their combination with <b>35</b> in comparison with the value obtained in control animals (HPMC-treated, dose 0) (<sup>##</sup><i>P</i> < 0.01) and between the values obtained in mice treated with <b>13c</b> and <b>13c</b> + <b>35</b> (left) or <b>13d</b> and <b>13d</b> + <b>35</b> (right) (**<i>P</i> < 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b01183/20181101/images/large/jm-2018-01183y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01183&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i92">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70752" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70752" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 67 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eades, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huppler, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, P. E.</span></span> <span> </span><span class="NLM_article-title">The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>197</i></span>,  <span class="NLM_fpage">517</span>– <span class="NLM_lpage">532</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=945347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaE28XltlOhurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=1976&pages=517-532&author=W.+R.+Martinauthor=C.+G.+Eadesauthor=J.+A.+Thompsonauthor=R.+E.+Hupplerauthor=P.+E.+Gilbert&title=The+effects+of+morphine-+and+nalorphine-like+drugs+in+the+nondependent+and+morphine-dependent+chronic+spinal+dog"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog</span></div><div class="casAuthors">Martin, W. R.; Eades, C. G.; Thompson, J. A.; Huppler, R. E.; Gilbert, P. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">517-32</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Three different syndromes produced by congeners of morphine sulfate (I sulfate) [64-31-3] were identified in the nondependent chronic spinal dog.  These syndromes were attributed to interaction of agonists with three distinguishable receptors (μ, κ and σ).  I was the prototype agonist for the μ receptor, ketocyclazocine lactate [59985-33-0] for the κ receptor and SKF-10,047 lactate [59985-34-1] for the σ receptor.  The I syndrome (μ) in the dog was characterized by miosis, bradycardia, hypothermia, a general depression of the nociceptive responses and indifferences to environmental stimuli.  Ketocyclazocine (κ) constricted pupils, depressed the flexor reflex and produced sedation but did not markedly alter pulse rate or the skin twitch reflex.  SKF-10,047 (σ) caused mydriasis, tachypnea, tachycardia and mania.  The effects of these three drugs was antagonized by the pure antagonist naltrexone-HCl, indicating that they are agonists.  Further, chronic administration of I, ketocyclazocine and SKF-10,047 induced tolerance to their agonistic effects.  I suppressed abstinence in I-dependent dogs while ketocyclazocine did not.  Ketocyclazocine at best pptd. only a liminal abstinence syndrome in the I-dependent dog, indicating that it had little affinity for the I receptor.  Ketocyclazocine thus appears to be a selective agonist at the κ receptor.  Buprenorphine-HCl [53152-21-9] was a partial agonist of the μ type which both suppressed and pptd. abstinence in the I-dependent dog while I and d-propoxyphene-HCl [1639-60-7] were stronger agonists.  Apomorphine-HCl [314-19-2] and SKF-10,047 produced similar pharmacol. effects suggesting that σ activity may involve a dopaminergic mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6rgyf41iRTbVg90H21EOLACvtfcHk0lgMcVckC1satw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XltlOhurw%253D&md5=ca7c637f336ac9ecc2c3bb040dbcdbee</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DW.%2BR.%26aulast%3DEades%26aufirst%3DC.%2BG.%26aulast%3DThompson%26aufirst%3DJ.%2BA.%26aulast%3DHuppler%26aufirst%3DR.%2BE.%26aulast%3DGilbert%26aufirst%3DP.%2BE.%26atitle%3DThe%2520effects%2520of%2520morphine-%2520and%2520nalorphine-like%2520drugs%2520in%2520the%2520nondependent%2520and%2520morphine-dependent%2520chronic%2520spinal%2520dog%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1976%26volume%3D197%26spage%3D517%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tam, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, L.</span></span> <span> </span><span class="NLM_article-title">Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">5618</span>– <span class="NLM_lpage">5621</span>, <span class="refDoi"> DOI: 10.1073/pnas.81.17.5618</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1073%2Fpnas.81.17.5618" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=6147851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaL2cXmtVCiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1984&pages=5618-5621&author=S.+W.+Tamauthor=L.+Cook&title=Sigma+opiates+and+certain+antipsychotic+drugs+mutually+inhibit+%28%2B%29-%5B3H%5D+SKF+10%2C047+and+%5B3H%5Dhaloperidol+binding+in+guinea+pig+brain+membranes&doi=10.1073%2Fpnas.81.17.5618"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">σ Opiates and certain antipsychotic drugs mutually inhibit (+)-[3H]SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes</span></div><div class="casAuthors">Tam, S. William; Cook, Leonard</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5618-21</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The relationship between binding of antipsychotic drugs and σ psychotomimetic opiates to binding sites for the σ agonist 3H-labeled (+)-SKF 10,047  [58640-82-7] and to dopamine D2 sites was investigated.  In guinea pig brain membranes, (+)-[3H]SKF 10,047 bound to a single class of sites with a Kd of 4 × 10-8M and a Bmax of 333 fmol/mg of protein.  This binding was different from μ, κ, or δ opiate receptor binding.  It was inhibited by opiates that produce psychotomimetic activities but not by opiates that lack such activities.  Some antipsychotic drugs inhibited (+)-[3H]SKF 10,047 binding with high to moderate affinities in the following order of potency: haloperidol  [52-86-8] > perphenazine  [58-39-9] > fluphenazine  [69-23-8] > acetophenazine  [2751-68-0] > trifluoperazine  [117-89-5] > molindone  [7416-34-4] ≥ pimozide  [2062-78-4] ≥ thioridazine  [50-52-2] ≥ chlorpromazine  [50-53-3] ≥ triflupromazine  [146-54-3].  However, there were other antipsychotic drugs such as spiperone  [749-02-0] and clozapine  [5786-21-0] that showed low affinity for the (+)-[3H]SKF 10,047 binding sites.  Affinities of antipsychotic drugs for (+)-[3H]SKF 10,047 binding sites did not correlate with those for [3H]spiperone (dopamine D2) sites.  [3H]-Haloperidol binding in whole brain membranes was also inhibited by the σ opiates pentazocine  [359-83-1], cyclazocine  [3572-80-3], and (+)-SKF 10,047.  In the striatum, about half of the saturable [3H]haloperidol binding was to [3H]spiperone (D2) sites and the other half was to sites similar to (+)-[3H]SKF 10,047 binding sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3J2yT0mD-vLVg90H21EOLACvtfcHk0lidmOYUMn6A0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXmtVCiu7w%253D&md5=bdb8459ffe1755e96b9cba9d63186817</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1073%2Fpnas.81.17.5618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.81.17.5618%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DS.%2BW.%26aulast%3DCook%26aufirst%3DL.%26atitle%3DSigma%2520opiates%2520and%2520certain%2520antipsychotic%2520drugs%2520mutually%2520inhibit%2520%2528%252B%2529-%255B3H%255D%2520SKF%252010%252C047%2520and%2520%255B3H%255Dhaloperidol%2520binding%2520in%2520guinea%2520pig%2520brain%2520membranes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1984%26volume%3D81%26spage%3D5618%26epage%3D5621%26doi%3D10.1073%2Fpnas.81.17.5618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tam, S. W.</span></span> <span> </span><span class="NLM_article-title">Naloxone-inaccessible sigma receptor in rat central nervous system</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">6703</span>– <span class="NLM_lpage">6707</span>, <span class="refDoi"> DOI: 10.1073/pnas.80.21.6703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1073%2Fpnas.80.21.6703" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1983&pages=6703-6707&author=S.+W.+Tam&title=Naloxone-inaccessible+sigma+receptor+in+rat+central+nervous+system&doi=10.1073%2Fpnas.80.21.6703"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1073%2Fpnas.80.21.6703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.80.21.6703%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DS.%2BW.%26atitle%3DNaloxone-inaccessible%2520sigma%2520receptor%2520in%2520rat%2520central%2520nervous%2520system%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1983%26volume%3D80%26spage%3D6703%26epage%3D6707%26doi%3D10.1073%2Fpnas.80.21.6703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellewell, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGarry, K. A.</span></span> <span> </span><span class="NLM_article-title">Evidence for a multi-site model of the rat brain sigma receptor</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>163</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">318</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(89)90200-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2F0014-2999%2889%2990200-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=2542066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaL1MXktlGru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=1989&pages=309-318&author=W.+D.+Bowenauthor=S.+B.+Hellewellauthor=K.+A.+McGarry&title=Evidence+for+a+multi-site+model+of+the+rat+brain+sigma+receptor&doi=10.1016%2F0014-2999%2889%2990200-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for a multi-site model of the rat brain σ receptor</span></div><div class="casAuthors">Bowen, Wayne D.; Hellewell, Susan B.; McGarry, Kelly A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">309-18</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">UV irradn. of rat brain membranes at 254 nm, a treatment which modifies UV absorbing residues in proteins, decreased binding of both (+)-3-[3H](3-hydroxyphenyl)-N-(1-propyl)piperidine ([3H](+)-3-PPP) and 1,3-di-o-[3H]tolylguanidine ([3H]DTG) to σ receptors.  For [3H](+)-3-PPP, this was due to a decreased Bmax.  In contrast, irradn. markedly increased binding of (+)-N-[3H]allylnormetazocine ([3H](+)-SKF 10,047) due to a decrease in the Kd.  Both unlabeled DTG and haloperidol were competitive inhibitors of [3H](+)-3-PPP binding to untreated membranes, causing an increase in the Kd and no change in the Bmax.  The benzomorphans, (+)-SKF 10,047 and (+)-pentazocine, were uncompetitive inhibitors, causing a decrease in both the Kd and Bmax for [3H](+)-3-PPP.  Finally, the ability of DTG and (+)-3-PPP to inhibit binding of [3H](+)-SKF 10,047 was markedly reduced by UV irradn., whereas irradn. had little effect on the potency of unlabeled (+)-SKF 10,047 and (+)-pentazocine.  These data suggest that σ-related (+)-benzomorphans and non-benzomorphans interact either with distinct, allosterically coupled sites on the same σ receptor macromol. or with different populations of σ receptor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpz--JsUNQSebVg90H21EOLACvtfcHk0lidmOYUMn6A0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXktlGru70%253D&md5=f738cac19d6abf591fcf96d03f66687d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2889%2990200-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252889%252990200-8%26sid%3Dliteratum%253Aachs%26aulast%3DBowen%26aufirst%3DW.%2BD.%26aulast%3DHellewell%26aufirst%3DS.%2BB.%26aulast%3DMcGarry%26aufirst%3DK.%2BA.%26atitle%3DEvidence%2520for%2520a%2520multi-site%2520model%2520of%2520the%2520rat%2520brain%2520sigma%2520receptor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1989%26volume%3D163%26spage%3D309%26epage%3D318%26doi%3D10.1016%2F0014-2999%2889%2990200-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quirion, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itzhak, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junien, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musacchio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothman, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsung-Ping, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, D. P.</span></span> <span> </span><span class="NLM_article-title">A proposal for the classification of sigma binding sites</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1016/0165-6147(92)90030-A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2F0165-6147%2892%2990030-A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1315463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A280%3ADyaK383ksFGrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1992&pages=85-86&author=R.+Quirionauthor=W.+D.+Bowenauthor=Y.+Itzhakauthor=J.+L.+Junienauthor=J.+Musacchioauthor=R.+B.+Rothmanauthor=S.+Tsung-Pingauthor=S.+W.+Tamauthor=D.+P.+Taylor&title=A+proposal+for+the+classification+of+sigma+binding+sites&doi=10.1016%2F0165-6147%2892%2990030-A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A proposal for the classification of sigma binding sites</span></div><div class="casAuthors">Quirion R; Bowen W D; Itzhak Y; Junien J L; Musacchio J M; Rothman R B; Su T P; Tam S W; Taylor D P</div><div class="citationInfo"><span class="NLM_cas:title">Trends in pharmacological sciences</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">85-6</span>
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9QiJWG_oOy3p3bfzSLaX5fW6udTcc2eaSwucNTIO0irntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK383ksFGrsQ%253D%253D&md5=bdbde1d04c3c3e627e4ff512102ddf5d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2892%2990030-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252892%252990030-A%26sid%3Dliteratum%253Aachs%26aulast%3DQuirion%26aufirst%3DR.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26aulast%3DItzhak%26aufirst%3DY.%26aulast%3DJunien%26aufirst%3DJ.%2BL.%26aulast%3DMusacchio%26aufirst%3DJ.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DTsung-Ping%26aufirst%3DS.%26aulast%3DTam%26aufirst%3DS.%2BW.%26aulast%3DTaylor%26aufirst%3DD.%2BP.%26atitle%3DA%2520proposal%2520for%2520the%2520classification%2520of%2520sigma%2520binding%2520sites%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1992%26volume%3D13%26spage%3D85%26epage%3D86%26doi%3D10.1016%2F0165-6147%2892%2990030-A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Privat, A.</span></span> <span> </span><span class="NLM_article-title">Modulation by neurosteroids of the in vivo (+)-[3H]SKF-10,047 binding to sigma 1 receptors in the mouse forebrain</span>. <i>J. Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">734</span>– <span class="NLM_lpage">743</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1097-4547(19961215)46:6<734::AID-JNR10>3.0.CO;2-U</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1002%2F%28SICI%291097-4547%2819961215%2946%3A6%3C734%3A%3AAID-JNR10%3E3.0.CO%3B2-U" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=8978508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaK28Xns1ekurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1996&pages=734-743&author=T.+Mauriceauthor=F.+J.+Romanauthor=A.+Privat&title=Modulation+by+neurosteroids+of+the+in+vivo+%28%2B%29-%5B3H%5DSKF-10%2C047+binding+to+sigma+1+receptors+in+the+mouse+forebrain&doi=10.1002%2F%28SICI%291097-4547%2819961215%2946%3A6%3C734%3A%3AAID-JNR10%3E3.0.CO%3B2-U"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation by neurosteroids of the in vivo (+)-[3H]SKF-10,047 binding to σ1 receptors in the mouse forebrain</span></div><div class="casAuthors">Maurice, Tangui; Roman, Francois J.; Privat, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">734-743</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss</span>)
        </div><div class="casAbstract">Recent reports suggest an interaction between neuro-(active)steroids and sigma1 (σ1) receptors, affecting biochem. parameters as well as physiol. responses mediated by σ1 ligands in the rodent brain.  In this study, the authors examd. the modulation by neurosteroids of the haloperidol-sensitive in vivo (+)-[3H]SKF-10,047 binding to σ1 sites in the mouse hippocampus and cortex.  Progesterone (PROG; 2-40 mg/kg), pregnenolone sulfate (PREGS; 10-40 mg/kg), and dehydroepiandrosterone sulfate (DHEAS); 10-40 mg/kg were administered systemically 10 min before the radioactive tracer.  The total amt. of (+)-[3H]SKF-10,047 bound in each structure was significantly affected by PROG and PREGS only at the highest dose tested and was unaffected by DHEAS.  However, bound to free (B/F) radioactivity ratios were highly significantly decreased by 30-40% in each structure by PROG and PREGS.  DHEAS, at 40 mg/kg, induced a significant 20% decrease in the hippocampus.  Furthermore, the in vivo (+)-[3H]SKF-10,047 binding parameters were diminished in pregnant female mice compared to non-pregnant or male mice.  These results confirm the in vitro binding results, bring a direct in vivo demonstration of the interaction between neurosteroids and σ1 receptors, and show that physiol. modulations of the steroidal concns. affect the σ1 systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpryJS-9i3X0LVg90H21EOLACvtfcHk0lg0VPm2Axf6bQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xns1ekurc%253D&md5=1034f429f7a7d34decb83db0060d2b22</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-4547%2819961215%2946%3A6%3C734%3A%3AAID-JNR10%3E3.0.CO%3B2-U&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-4547%252819961215%252946%253A6%253C734%253A%253AAID-JNR10%253E3.0.CO%253B2-U%26sid%3Dliteratum%253Aachs%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DRoman%26aufirst%3DF.%2BJ.%26aulast%3DPrivat%26aufirst%3DA.%26atitle%3DModulation%2520by%2520neurosteroids%2520of%2520the%2520in%2520vivo%2520%2528%252B%2529-%255B3H%255DSKF-10%252C047%2520binding%2520to%2520sigma%25201%2520receptors%2520in%2520the%2520mouse%2520forebrain%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D1996%26volume%3D46%26spage%3D734%26epage%3D743%26doi%3D10.1002%2F%28SICI%291097-4547%2819961215%2946%3A6%3C734%3A%3AAID-JNR10%3E3.0.CO%3B2-U" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junien, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Privat, A.</span></span> <span> </span><span class="NLM_article-title">Dehydroepiandrosterone sulfate attenuates dizocilpine-induced learning impairment in mice via sigma 1-receptors</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">164</span>, <span class="refDoi"> DOI: 10.1016/S0166-4328(97)86061-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2FS0166-4328%2897%2986061-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1997&pages=159-164&author=T.+Mauriceauthor=J.+L.+Junienauthor=A.+Privat&title=Dehydroepiandrosterone+sulfate+attenuates+dizocilpine-induced+learning+impairment+in+mice+via+sigma+1-receptors&doi=10.1016%2FS0166-4328%2897%2986061-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0166-4328%2897%2986061-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-4328%252897%252986061-5%26sid%3Dliteratum%253Aachs%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DJunien%26aufirst%3DJ.%2BL.%26aulast%3DPrivat%26aufirst%3DA.%26atitle%3DDehydroepiandrosterone%2520sulfate%2520attenuates%2520dizocilpine-induced%2520learning%2520impairment%2520in%2520mice%2520via%2520sigma%25201-receptors%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D1997%26volume%3D83%26spage%3D159%26epage%3D164%26doi%3D10.1016%2FS0166-4328%2897%2986061-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romieu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Fardon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span> <span> </span><span class="NLM_article-title">Sigma 1 receptor-related neuroactive steroids modulate cocaine-induced reward</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3572</span>– <span class="NLM_lpage">3576</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.23-09-03572.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1523%2FJNEUROSCI.23-09-03572.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=12736327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslGntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=3572-3576&author=P.+Romieuauthor=R.+Martin-Fardonauthor=W.+D.+Bowenauthor=T.+Maurice&title=Sigma+1+receptor-related+neuroactive+steroids+modulate+cocaine-induced+reward&doi=10.1523%2FJNEUROSCI.23-09-03572.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">σ1 Receptor-related neuroactive steroids modulate cocaine-induced reward</span></div><div class="casAuthors">Romieu, Pascal; Martin-Fardon, Remi; Bowen, Wayne D.; Maurice, Tangui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3572-3576</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The σ1 receptor is critically involved in the rewarding effect of cocaine, as measured using the conditioned place preference (CPP) procedure in mice.  Neuroactive steroids exert rapid neuromodulatory effects in the brain by interacting with GABAA, NMDA, and σ1 receptors.  At the σ1 receptor level, 3β-hydroxy-5-androsten-17-one [dehydroepiandrosterone (DHEA)] and 3β-hydroxy-5-pregnen-20-one (pregnenolone) act as agonists, whereas 4-pregnene-3,20-dione (progesterone) is an efficient antagonist.  The present study sought to investigate the action of neuroactive steroids in acquisition of cocaine-induced CPP in C57BL/6 mice.  None of these steroids induced CPP alone.  However, pretreatment with DHEA or pregnenolone (5-20 mg/kg, s.c.) during conditioning with cocaine (10 mg/kg, i.p.) increased the conditioned score.  On the contrary, pretreatment with either progesterone (10 or 20 mg/kg, s.c.) or finasteride (25 mg/kg, twice a day), a 5α-reductase inhibitor, blocked acquisition of cocaine (20 mg/kg)-induced CPP.  A crossed pharmacol. was obsd. between steroids and σ1 ligands.  The σ1 antagonist N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(dimethylamino)ethylamine blocked cocaine-induced CPP and its potentiation by DHEA or pregnenolone.  Progesterone blocked cocaine-induced CPP and its potentiation by the σ1 agonist igmesine.  These results showed that neuroactive steroids play a role in cocaine-induced appetence, through their interaction with the σ1 receptor.  Therefore, neuroendocrine control of cocaine addiction may not involve solely glucocorticoids.  The importance of neuroactive steroids as factors of individual vulnerability to drug addiction should, thus, be considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGZv5oasaAH7Vg90H21EOLACvtfcHk0lg0VPm2Axf6bQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslGntbw%253D&md5=4f45c1ac0e562d735fb69c91aff38ed3</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.23-09-03572.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.23-09-03572.2003%26sid%3Dliteratum%253Aachs%26aulast%3DRomieu%26aufirst%3DP.%26aulast%3DMartin-Fardon%26aufirst%3DR.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26aulast%3DMaurice%26aufirst%3DT.%26atitle%3DSigma%25201%2520receptor-related%2520neuroactive%2520steroids%2520modulate%2520cocaine-induced%2520reward%26jtitle%3DJ.%2520Neurosci.%26date%3D2003%26volume%3D23%26spage%3D3572%26epage%3D3576%26doi%3D10.1523%2FJNEUROSCI.23-09-03572.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fontanilla, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johannessen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajipour, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozzi, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruoho, A. E.</span></span> <span> </span><span class="NLM_article-title">The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>323</i></span>,  <span class="NLM_fpage">934</span>– <span class="NLM_lpage">937</span>, <span class="refDoi"> DOI: 10.1126/science.1166127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1126%2Fscience.1166127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=19213917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhslSgsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2009&pages=934-937&author=D.+Fontanillaauthor=M.+Johannessenauthor=A.+R.+Hajipourauthor=N.+V.+Cozziauthor=M.+B.+Jacksonauthor=A.+E.+Ruoho&title=The+hallucinogen+N%2CN-dimethyltryptamine+%28DMT%29+is+an+endogenous+sigma-1+receptor+regulator&doi=10.1126%2Fscience.1166127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator</span></div><div class="casAuthors">Fontanilla, Dominique; Johannessen, Molly; Hajipour, Abdol R.; Cozzi, Nicholas V.; Jackson, Meyer B.; Ruoho, Arnold E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">5916</span>),
    <span class="NLM_cas:pages">934-937</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The sigma-1 receptor is widely distributed in the central nervous system and periphery.  Originally mischaracterized as an opioid receptor, the sigma-1 receptor binds a vast no. of synthetic compds. but does not bind opioid peptides; it is currently considered an orphan receptor.  The sigma-1 receptor pharmacophore includes an alkylamine core, also found in the endogenous compd. N,N-dimethyltryptamine (DMT).  DMT acts as a hallucinogen, but its receptor target has been unclear.  DMT bound to sigma-1 receptors and inhibited voltage-gated sodium ion (Na+) channels in both native cardiac myocytes and heterologous cells that express sigma-1 receptors.  DMT induced hypermobility in wild-type mice but not in sigma-1 receptor knockout mice.  These biochem., physiol., and behavioral expts. indicate that DMT is an endogenous agonist for the sigma-1 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAp8p0wmc1wLVg90H21EOLACvtfcHk0liLHIjF3-8TUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhslSgsbw%253D&md5=480f24607d42dbe5c5fcd9cdc8ee5e5c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.1166127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1166127%26sid%3Dliteratum%253Aachs%26aulast%3DFontanilla%26aufirst%3DD.%26aulast%3DJohannessen%26aufirst%3DM.%26aulast%3DHajipour%26aufirst%3DA.%2BR.%26aulast%3DCozzi%26aufirst%3DN.%2BV.%26aulast%3DJackson%26aufirst%3DM.%2BB.%26aulast%3DRuoho%26aufirst%3DA.%2BE.%26atitle%3DThe%2520hallucinogen%2520N%252CN-dimethyltryptamine%2520%2528DMT%2529%2520is%2520an%2520endogenous%2520sigma-1%2520receptor%2520regulator%26jtitle%3DScience%26date%3D2009%26volume%3D323%26spage%3D934%26epage%3D937%26doi%3D10.1126%2Fscience.1166127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruoho, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, U. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontanilla, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mavlyutov, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajipour, A. R.</span></span> <span> </span><span class="NLM_article-title">The ligand binding region of the sigma-1 receptor: studies utilizing photoaffinity probes, sphingosine and N-alkylamines</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">920</span>– <span class="NLM_lpage">929</span>, <span class="refDoi"> DOI: 10.2174/138161212799436584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.2174%2F138161212799436584" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=920-929&author=A.+E.+Ruohoauthor=U.+B.+Chuauthor=S.+Ramachandranauthor=D.+Fontanillaauthor=T.+Mavlyutovauthor=A.+R.+Hajipour&title=The+ligand+binding+region+of+the+sigma-1+receptor%3A+studies+utilizing+photoaffinity+probes%2C+sphingosine+and+N-alkylamines&doi=10.2174%2F138161212799436584"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F138161212799436584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212799436584%26sid%3Dliteratum%253Aachs%26aulast%3DRuoho%26aufirst%3DA.%2BE.%26aulast%3DChu%26aufirst%3DU.%2BB.%26aulast%3DRamachandran%26aufirst%3DS.%26aulast%3DFontanilla%26aufirst%3DD.%26aulast%3DMavlyutov%26aufirst%3DT.%26aulast%3DHajipour%26aufirst%3DA.%2BR.%26atitle%3DThe%2520ligand%2520binding%2520region%2520of%2520the%2520sigma-1%2520receptor%253A%2520studies%2520utilizing%2520photoaffinity%2520probes%252C%2520sphingosine%2520and%2520N-alkylamines%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2012%26volume%3D18%26spage%3D920%26epage%3D929%26doi%3D10.2174%2F138161212799436584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moebius, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flandorfer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knaus, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Striessnig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glossmann, H.</span></span> <span> </span><span class="NLM_article-title">Purification, molecular cloning, and expression of the mammalian sigma1-binding site</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">8072</span>– <span class="NLM_lpage">8077</span>, <span class="refDoi"> DOI: 10.1073/pnas.93.15.8072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1073%2Fpnas.93.15.8072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=8755605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaK28XksFSqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=8072-8077&author=M.+Hannerauthor=F.+F.+Moebiusauthor=A.+Flandorferauthor=H.+G.+Knausauthor=J.+Striessnigauthor=E.+Kempnerauthor=H.+Glossmann&title=Purification%2C+molecular+cloning%2C+and+expression+of+the+mammalian+sigma1-binding+site&doi=10.1073%2Fpnas.93.15.8072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Purification, molecular cloning, and expression of the mammalian sigma1-binding site</span></div><div class="casAuthors">Hanner, Markus; Moebius, Fabian F.; Flandorfer, Astrid; Knaus, Hans-Guenther; Striessnig, Joerg; Kempner, Ellis; Glossman, Hartmut</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">8072-8077</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Sigma-ligands comprise several chem. unrelated drugs such as haloperidol, pentazocine, and ditolylguanidine, which bind to a family of low mol. mass proteins in the endoplasmic reticulum.  These so-called sigma-receptors are believed to mediate various pharmacol. effects of sigma-ligands by as yet unknown mechanisms.  Based on their opposite enantioselectivity for benzomorphans and different mol. masses, two subtypes are differentiated.  We purified the sigma1-binding site as a single 30-kDa protein from guinea pig liver employing the benzomorphan (+)[3H]pentazocine and the aryladize (-)[3H]azidopamil as specific probes.  The purified (+)[3H]pentazocine-binding protein retained its high affinity for haloperidol, pentazocine, and ditolylguanidine.  Partial amino acid sequence obtained after trypsinolysis revealed no homol. to known proteins.  Radiation inactivation of the pentazocine-labeled sigma1-binding site yielded a mol. mass of 24 kDa.  The corresponding cDNA was cloned using degenerate oligonucleotides and cDNA library screening.  Its open reading frame encoded a 25.3-kDa protein with at least one putative transmembrane segment.  The protein expressed in yeast cells transformed with the cDNA showed the pharmacol. characteristics of the brain and liver sigma1-binding site.  The deduced amino acid sequence was structurally unrelated to known mammalian proteins but it shared homol. with fungal proteins involved in sterol synthesis.  Northern blots showed high densities of the sigma1-binding site mRNA in sterol-producing tissues.  This is also in agreement with the known ability of sigma1-binding sites to interact with steroids, such as progesterone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3kp2l6ZPKdrVg90H21EOLACvtfcHk0liLHIjF3-8TUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XksFSqsr8%253D&md5=01c7d3bbab83dd5d18531845213bf267</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.15.8072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.15.8072%26sid%3Dliteratum%253Aachs%26aulast%3DHanner%26aufirst%3DM.%26aulast%3DMoebius%26aufirst%3DF.%2BF.%26aulast%3DFlandorfer%26aufirst%3DA.%26aulast%3DKnaus%26aufirst%3DH.%2BG.%26aulast%3DStriessnig%26aufirst%3DJ.%26aulast%3DKempner%26aufirst%3DE.%26aulast%3DGlossmann%26aufirst%3DH.%26atitle%3DPurification%252C%2520molecular%2520cloning%252C%2520and%2520expression%2520of%2520the%2520mammalian%2520sigma1-binding%2520site%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26spage%3D8072%26epage%3D8077%26doi%3D10.1073%2Fpnas.93.15.8072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leibach, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganapathy, V.</span></span> <span> </span><span class="NLM_article-title">Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 sigma receptor</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>241</i></span>,  <span class="NLM_fpage">535</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1997.7840</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1006%2Fbbrc.1997.7840" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=241&publication_year=1997&pages=535-540&author=P.+Sethauthor=F.+H.+Leibachauthor=V.+Ganapathy&title=Cloning+and+structural+analysis+of+the+cDNA+and+the+gene+encoding+the+murine+type+1+sigma+receptor&doi=10.1006%2Fbbrc.1997.7840"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1997.7840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1997.7840%26sid%3Dliteratum%253Aachs%26aulast%3DSeth%26aufirst%3DP.%26aulast%3DLeibach%26aufirst%3DF.%2BH.%26aulast%3DGanapathy%26aufirst%3DV.%26atitle%3DCloning%2520and%2520structural%2520analysis%2520of%2520the%2520cDNA%2520and%2520the%2520gene%2520encoding%2520the%2520murine%2520type%25201%2520sigma%2520receptor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1997%26volume%3D241%26spage%3D535%26epage%3D540%26doi%3D10.1006%2Fbbrc.1997.7840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kekuda, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leibach, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganapathy, V.</span></span> <span> </span><span class="NLM_article-title">Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1)</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>229</i></span>,  <span class="NLM_fpage">553</span>– <span class="NLM_lpage">558</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1996.1842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1006%2Fbbrc.1996.1842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=8954936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaK28Xns1ehtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=1996&pages=553-558&author=R.+Kekudaauthor=P.+D.+Prasadauthor=Y.+J.+Feiauthor=F.+H.+Leibachauthor=V.+Ganapathy&title=Cloning+and+functional+expression+of+the+human+type+1+sigma+receptor+%28hSigmaR1%29&doi=10.1006%2Fbbrc.1996.1842"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1)</span></div><div class="casAuthors">Kekuda, Ramesh; Prasad, Puttur D.; Fei, You-Jun; Leibach, Frederich H.; Ganapathy, Vadivel</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">229</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">553-558</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">We have isolated a cDNA clone from a human placental choriocarcinoma cell (JAR) cDNA library which codes for a functional type 1 sigma receptor.  An RT-PCR product obtained from guinea pig kidney mRNA using primers specific for the guineas pig sigma receptor cDNA was used to screen the cDNA library.  The hSigmaR1 cDNA predicts a protein of 223 amino acids with a single putative transmembrane domain.  The amino acid sequence exhibits 93% identity with the guinea pig sigma receptor.  When functionally expressed in HeLa cells, the hSigmaR1 cDNA enhances the binding of [3H]-haloperidol, a sigma receptor ligand, to the HeLa cell membranes.  The inhibitor specificity of the cloned hSigmaR1 indicates that it is the type 1 sigma receptor.  Several human tissues, including placenta, liver, and brain, and several human cell lines express the SigmaR1 mRNA (1.7 kb) to a variable extent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSSxDn_6je4bVg90H21EOLACvtfcHk0lh9-lQdD3W7ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xns1ehtrw%253D&md5=8a128351bb8a55e5b3fc3dd31d879b90</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1996.1842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1996.1842%26sid%3Dliteratum%253Aachs%26aulast%3DKekuda%26aufirst%3DR.%26aulast%3DPrasad%26aufirst%3DP.%2BD.%26aulast%3DFei%26aufirst%3DY.%2BJ.%26aulast%3DLeibach%26aufirst%3DF.%2BH.%26aulast%3DGanapathy%26aufirst%3DV.%26atitle%3DCloning%2520and%2520functional%2520expression%2520of%2520the%2520human%2520type%25201%2520sigma%2520receptor%2520%2528hSigmaR1%2529%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1996%26volume%3D229%26spage%3D553%26epage%3D558%26doi%3D10.1006%2Fbbrc.1996.1842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hellewell, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feinstein, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orringer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, W. D.</span></span> <span> </span><span class="NLM_article-title">Rat liver and kidney contain high densities of σ1 and σ2 receptors: characterization by ligand binding and photoaffinity labeling</span>. <i>Eur. J. Pharmacol., Mol. Pharmacol. Sect.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>268</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1016/0922-4106(94)90115-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2F0922-4106%2894%2990115-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=7925616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaK2cXkslelsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1994&pages=9-18&author=S.+B.+Hellewellauthor=A.+Bruceauthor=G.+Feinsteinauthor=J.+Orringerauthor=W.+Williamsauthor=W.+D.+Bowen&title=Rat+liver+and+kidney+contain+high+densities+of+%CF%831+and+%CF%832+receptors%3A+characterization+by+ligand+binding+and+photoaffinity+labeling&doi=10.1016%2F0922-4106%2894%2990115-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Rat liver and kidney contain high densities of σ1 and σ2 receptors: characterization by ligand binding and photoaffinity labeling</span></div><div class="casAuthors">Hellewell, Susan B.; Bruce, Ashley; Feinstein, Glen; Orringer, Jeffrey; Williams, Wanda; Bowen, Wayne D.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology, Molecular Pharmacology Section</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-18</span>CODEN:
                <span class="NLM_cas:coden">EJPPET</span>;
        ISSN:<span class="NLM_cas:issn">0922-4106</span>.
    </div><div class="casAbstract">Rat liver and kidney were investigated for the presence of sigma (σ) receptor subtypes by radioligand binding with three highly selective σ probes and by photoaffinity labeling using [3H]azido-di-o-tolylguanidine ([3H]azido-DTG). [3H](+)-Pentazocine, a highly selective σ1 probe, bound to sites in liver membranes with Kd = 7.5 nM and Bmax = 2929 fmol/mg protein. [3H](+)-Pentazocine binding sites in kidney had Kd = 23.3 nM and Bmax = 229 fmol/mg protein. [3H]1,3-Di-o-tolylguanidine ([3H]DTG) and [3H](+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine ([3H](+)-3-PPP) label both σ1 and σ2 receptor.  Parameters for [3H]DTG in the liver were Kd = 17.9 nM and Bmax = 11,895 fmol/mg protein.  Similar parameters were obsd. for [3H](+)-3-PPP, Kd = 51.9 nM and Bmax = 11 070 fmol/mg protein. [3H]DTG bound to rat kidney with Kd = 45.8 nM and Bmax = 1190 fmol/mg protein.  The observation that either [3H]DTG or [3H](+)-3-PPP and [3H](+)-3-PPP labeled a higher no. of sites relative to [3H](+)-pentazocine suggested that liver and kidney contain both subtypes of σ receptor.  This was confirmed by competition studies vs. [3H](+)-pentazocine and [3H]DTG (in the presence of dextrallorphan to mask σ1 sites).  In both tissues, [3H](+)-pentazocine labeled sites with high affinity for haloperidol and enantioselectivity for (+)-benzomorphans over (-)-benzomorphans. [3H]DTG + dextrallorphan labeled sites in both tissues which also had high affinity for haloperidol, but which had the characteristic σ2 property of low affinity for (+)-benzomorphans and enantioselectivity for (-)-benzomorphans over the corresponding (+)-isomer.  Similar results were obtained with [3H](+)-3-PPP + dextrallorphan.  Several novel aryl diamines, such as 1S,2R-cis-N-[2-(3,4-dichlorophenyl)ethyl]- N-methyl-2-(1-pyrrolidinyl)cyclohexylamine (BD737) and N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylamine (BD1008), bound to both sites with high affinity.  Photoaffinity labeling with 10 nM [3H]azido-DTG resulted in specific labeling of polypeptides of 25 kDa and 21.5 kDa.  Dextrallorphan (100 nM or 500 nM) completely blocked labeling of the 25 kDa polypeptide, but had no effect on labeling of the lower mol. wt. protein. (+)-10,11-Dihydro-5-methyl-5H-dibenzo[a,d]cyclohepten-5,10-imine ((+)-MK-801) had no effect on labeling of either polypeptide.  These data are consistent with the notion that the 25 kDa and 21.5 kDa proteins represent σ1 and σ2 receptors, resp.  Thus, rat liver and kidney contain high densities of σ1 and σ2 receptors, with σ2 sites comprising 75-80% of the total σ population.  The high d. of σ receptor subtypes may indicate important functions in hepatic and renal tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOgAMHz8C8c7Vg90H21EOLACvtfcHk0lh9-lQdD3W7ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkslelsbc%253D&md5=aeefd275781454593365b4b0d127a8a6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2F0922-4106%2894%2990115-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0922-4106%252894%252990115-5%26sid%3Dliteratum%253Aachs%26aulast%3DHellewell%26aufirst%3DS.%2BB.%26aulast%3DBruce%26aufirst%3DA.%26aulast%3DFeinstein%26aufirst%3DG.%26aulast%3DOrringer%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DW.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3DRat%2520liver%2520and%2520kidney%2520contain%2520high%2520densities%2520of%2520%25CF%25831%2520and%2520%25CF%25832%2520receptors%253A%2520characterization%2520by%2520ligand%2520binding%2520and%2520photoaffinity%2520labeling%26jtitle%3DEur.%2520J.%2520Pharmacol.%252C%2520Mol.%2520Pharmacol.%2520Sect.%26date%3D1994%26volume%3D268%26spage%3D9%26epage%3D18%26doi%3D10.1016%2F0922-4106%2894%2990115-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurpinar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manglik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the human σ1 receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>532</i></span>,  <span class="NLM_fpage">527</span>– <span class="NLM_lpage">530</span>, <span class="refDoi"> DOI: 10.1038/nature17391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1038%2Fnature17391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=27042935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlsl2gt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=532&publication_year=2016&pages=527-530&author=H.+R.+Schmidtauthor=S.+Zhengauthor=E.+Gurpinarauthor=A.+Koehlauthor=A.+Manglikauthor=A.+C.+Kruse&title=Crystal+structure+of+the+human+%CF%831+receptor&doi=10.1038%2Fnature17391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the human σ1 receptor</span></div><div class="casAuthors">Schmidt, Hayden R.; Zheng, Sanduo; Gurpinar, Esin; Koehl, Antoine; Manglik, Aashish; Kruse, Andrew C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">532</span>
        (<span class="NLM_cas:issue">7600</span>),
    <span class="NLM_cas:pages">527-530</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The human σ1 receptor is an enigmatic endoplasmic reticulum (ER)-resident transmembrane protein implicated in a variety of disorders including depression, drug addiction, and neuropathic pain.  Recently, an addnl. connection to amyotrophic lateral sclerosis has emerged from studies of human genetics and mouse models.  Unlike many transmembrane receptors that belong to large, extensively studied families such as G-protein-coupled receptors or ligand-gated ion channels, the σ1 receptor is an evolutionary isolate with no discernible similarity to any other human protein.  Despite its increasingly clear importance in human physiol. and disease, the mol. architecture of the σ1 receptor and its regulation by drug-like compds. remain poorly defined.  Here, the authors report crystal structures of the human σ1 receptor in complex with 2 chem. divergent ligands, PD 144418 and 4-(N-benzylpiperidin-4-yl)-4-iodobenzamide (4-IBP).  The structures revealed a trimeric architecture with a single transmembrane domain in each protomer.  The C-terminal domain of the receptor showed an extensive flat, hydrophobic membrane-proximal surface, suggesting an intimate assocn. with the cytosolic surface of the ER membrane in cells.  This domain included a cupin-like β-barrel with the ligand-binding site buried at its center.  This large, hydrophobic ligand-binding cavity showed remarkable plasticity in ligand recognition, binding the 2 ligands in similar positions despite dissimilar chem. structures.  Taken together, these results revealed the overall architecture, oligomerization state, and mol. basis for ligand recognition by this important but poorly understood protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokQBAf03Pml7Vg90H21EOLACvtfcHk0lh9-lQdD3W7ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlsl2gt7o%253D&md5=fb6df7814060fbd05ba41261ad1061f5</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature17391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature17391%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DH.%2BR.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DGurpinar%26aufirst%3DE.%26aulast%3DKoehl%26aufirst%3DA.%26aulast%3DManglik%26aufirst%3DA.%26aulast%3DKruse%26aufirst%3DA.%2BC.%26atitle%3DCrystal%2520structure%2520of%2520the%2520human%2520%25CF%25831%2520receptor%26jtitle%3DNature%26date%3D2016%26volume%3D532%26spage%3D527%26epage%3D530%26doi%3D10.1038%2Fnature17391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, T.-P.</span></span> <span> </span><span class="NLM_article-title">Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">596</span>– <span class="NLM_lpage">610</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.08.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2Fj.cell.2007.08.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=17981125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWitrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=596-610&author=T.+Hayashiauthor=T.-P.+Su&title=Sigma-1+receptor+chaperones+at+the+ER-mitochondrion+interface+regulate+Ca%282%2B%29+signaling+and+cell+survival&doi=10.1016%2Fj.cell.2007.08.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca2+ signaling and cell survival</span></div><div class="casAuthors">Hayashi, Teruo; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">596-610</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Communication between the endoplasmic reticulum (ER) and mitochondrion is important for bioenergetics and cellular survival.  The ER supplies Ca2+ directly to mitochondria via inositol 1,4,5-trisphosphate receptors (IP3Rs) at close contacts between the two organelles referred to as mitochondrion-assocd. ER membrane (MAM).  We found here that the ER protein sigma-1 receptor (Sig-1R), which is implicated in neuroprotection, carcinogenesis, and neuroplasticity, is a Ca2+-sensitive and ligand-operated receptor chaperone at MAM.  Normally, Sig-1Rs form a complex at MAM with another chaperone, BiP.  Upon ER Ca2+ depletion or via ligand stimulation, Sig-1Rs dissoc. from BiP, leading to a prolonged Ca2+ signaling into mitochondria via IP3Rs.  Sig-1Rs can translocate under chronic ER stress.  Increasing Sig-1Rs in cells counteracts ER stress response, whereas decreasing them enhances apoptosis.  These results reveal that the orchestrated ER chaperone machinery at MAM, by sensing ER Ca2+ concns., regulates ER-mitochondrial interorganellar Ca2+ signaling and cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFqHhdVumdO7Vg90H21EOLACvtfcHk0li2Fl2CyiOg7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWitrzK&md5=7bb4e806d7ad895f9ed1a8c4f7eb7f6c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.08.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.08.036%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.-P.%26atitle%3DSigma-1%2520receptor%2520chaperones%2520at%2520the%2520ER-mitochondrion%2520interface%2520regulate%2520Ca%25282%252B%2529%2520signaling%2520and%2520cell%2520survival%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D596%26epage%3D610%26doi%3D10.1016%2Fj.cell.2007.08.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weissman, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedreen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">London, E. D.</span></span> <span> </span><span class="NLM_article-title">Sigma receptors in post-mortem human brains</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>247</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">33</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=2845055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaL1cXmt1agtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=247&publication_year=1988&pages=29-33&author=A.+D.+Weissmanauthor=T.+P.+Suauthor=J.+C.+Hedreenauthor=E.+D.+London&title=Sigma+receptors+in+post-mortem+human+brains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma receptors in post-mortem human brains</span></div><div class="casAuthors">Weissman, Arthur D.; Su, Tsung Ping; Hedreen, John C.; London, Edythe D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">247</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-33</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The pharmacol. profile and regional distribution of σ-receptors in human autopsy brains were detd. with [3H]haloperidol as the ligand, in the presence of 50 nM spiperone to block binding to D2 dopamine sites.  Specific binding in the cerebellum was to a single and saturable class of receptors with Kd 0.95 nM and max. binding = 358 fmol/mg protein.  Inhibition studies of the nondopamine [3H]haloperiodol binding site in human cerebellar membranes revealed stereospecific binding and a pharmacol. profile similar to that of specific σ-binding sites characterized in rodent brains with [3H]haloperiodol, N-[3H]allylnormetazocine, and di-o-[3H]tolylguanidine as radioligands.  The densities of σ-sites in the brain were highest in the cerebellum, nucleus accumbens, and cerebral cortex.  A post-mortem simulation study was performed with guinea pig brains due to the concern that σ-receptors might deteriorate in the human brain before assay.  However, this site was remarkably stable and insensitive to long periods of cooling or freezing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMrj71ILka9rVg90H21EOLACvtfcHk0li2Fl2CyiOg7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXmt1agtL4%253D&md5=551fd162f7aba3ebe2c8d08bc7c629d6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeissman%26aufirst%3DA.%2BD.%26aulast%3DSu%26aufirst%3DT.%2BP.%26aulast%3DHedreen%26aufirst%3DJ.%2BC.%26aulast%3DLondon%26aufirst%3DE.%2BD.%26atitle%3DSigma%2520receptors%2520in%2520post-mortem%2520human%2520brains%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1988%26volume%3D247%26spage%3D29%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Samovilova, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagornaya, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinogradov, V. A.</span></span> <span> </span><span class="NLM_article-title">(+)-[3H]SKF 10,047 sites in rat liver</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>147</i></span>,  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">264</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(88)90784-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2F0014-2999%2888%2990784-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=3366176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaL1cXhvVSnsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=1988&pages=259-264&author=N.+N.+Samovilovaauthor=L.+V.+Nagornayaauthor=V.+A.+Vinogradov&title=%28%2B%29-%5B3H%5DSKF+10%2C047+sites+in+rat+liver&doi=10.1016%2F0014-2999%2888%2990784-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">(+)-[3H]SK & F 10,047 binding sites in rat liver</span></div><div class="casAuthors">Samovilova, N. N.; Nagornaya, L. V.; Vinogradov, V. A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">259-64</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Stereospecific binding sites for (+)-[3H]SKF 10,047 were demonstrated in rat liver.  These binding sites are σ-opioid receptors, and this was confirmed by their binding properties: reversibility, saturability, stereospecificity, effects of ions and various pharmacol. drugs on (+)-[3H]SKF 10,047 binding.  Apparently, (+)-[3H]SKF 10,047 binding sites in liver and brain are a part of novel sigmergic regulatory system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFdpImXhfaEbVg90H21EOLACvtfcHk0li2Fl2CyiOg7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhvVSnsbo%253D&md5=1c9d70a805fba66cec42147d8cfc109c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2888%2990784-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252888%252990784-4%26sid%3Dliteratum%253Aachs%26aulast%3DSamovilova%26aufirst%3DN.%2BN.%26aulast%3DNagornaya%26aufirst%3DL.%2BV.%26aulast%3DVinogradov%26aufirst%3DV.%2BA.%26atitle%3D%2528%252B%2529-%255B3H%255DSKF%252010%252C047%2520sites%2520in%2520rat%2520liver%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1988%26volume%3D147%26spage%3D259%26epage%3D264%26doi%3D10.1016%2F0014-2999%2888%2990784-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ela, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eilam, Y.</span></span> <span> </span><span class="NLM_article-title">Sigma receptor ligands modulate contractility, Ca++ influx and beating rate in cultured cardiac myocytes</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>269</i></span>,  <span class="NLM_fpage">1300</span>– <span class="NLM_lpage">1309</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=8014874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaK2cXkslelu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=1300-1309&author=C.+Elaauthor=J.+Bargauthor=Z.+Vogelauthor=Y.+Hasinauthor=Y.+Eilam&title=Sigma+receptor+ligands+modulate+contractility%2C+Ca%2B%2B+influx+and+beating+rate+in+cultured+cardiac+myocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma receptor ligands modulate contractility, Ca++ influx and beating rate in cultured cardiac myocytes</span></div><div class="casAuthors">Ela, Catherine; Barg, Jacob; Vogel, Zvi; Hasin, Yonathan; Eilam, Yael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1300-9</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Specific binding of [3H]-1,3-di-o-tolylguanidine (DTG) and (+)-[3H]-(3-hydroxyphenyl)-N-(1-propyl)-piperidine [(+)-3-PPP] to membranes of cultured cardiac myocytes from neonatal rats revealed the presence of sigma receptors on these cells.  Exposure of cultured cardiomyocytes to nanomolar concns. of (+)-3-PPP, (+)-pentazocine and haloperidol induced specific patterns of changes in contractility of elec. paced cultures.  The amplitude of systolic cell-motion (ASM) decreased by 10 to 25% 1 to 2 min after drug addn., then transiently increased (3-10 min) and finally decreased to about 75% of control level.  Fluorescence measurements on indo-1 loaded cardiomyocytes revealed drug-induced changes in the size of the concn. of free cytosolic calcium ([Ca++]i)-transients, similar to the changes obsd. in ASM.  These changes appear to be mediated by corresponding changes in the rates of 45Ca++ influx which increased 2 to 7 min after the addn. of (+)-3-PPP and decrease to 50% of the control level thereafter.  Preincubation with thapsigargin, which depletes the sarcoplasmic reticulum-Ca++ stores, did not affect the pattern of changes in ASM, induced by the subsequent addn. of (+)-3-PPP.  This indicates that the changes in [Ca++]i are not mediated by sarcoplasmic reticulum-Ca++ transport systems.  Exposure to sigma ligands did not affect the apparent sensitivity of the myofilaments to Ca++, as indicated by the relationships between changes in ASM and in [Ca++]i-transients.  Cultures which were not paced, contracted spontaneously at a const. rhythm.  Sigma receptor ligands caused changes in beating frequencies which were followed by irregular contractions.  The present work suggests that sigma receptors may have an important role in regulating contractility, beating rates, and Ca++ fluxes in cardiac myocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVM-XyqI5Y9rVg90H21EOLACvtfcHk0li2Fl2CyiOg7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkslelu7s%253D&md5=a5623b7000ad4089ca80f168f5f619a9</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEla%26aufirst%3DC.%26aulast%3DBarg%26aufirst%3DJ.%26aulast%3DVogel%26aufirst%3DZ.%26aulast%3DHasin%26aufirst%3DY.%26aulast%3DEilam%26aufirst%3DY.%26atitle%3DSigma%2520receptor%2520ligands%2520modulate%2520contractility%252C%2520Ca%252B%252B%2520influx%2520and%2520beating%2520rate%2520in%2520cultured%2520cardiac%2520myocytes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1994%26volume%3D269%26spage%3D1300%26epage%3D1309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morin-Surun, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denavit-Saubié, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baulieu, E.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monnet, F. P.</span></span> <span> </span><span class="NLM_article-title">Intracellular σ1 receptor modulates phospholipase C and protein kinase C activities in the brainstem</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">8196</span>– <span class="NLM_lpage">8199</span>, <span class="refDoi"> DOI: 10.1073/pnas.96.14.8196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1073%2Fpnas.96.14.8196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10393971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaK1MXltVOrsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=8196-8199&author=M.+P.+Morin-Surunauthor=T.+Collinauthor=M.+Denavit-Saubi%C3%A9author=E.-E.+Baulieuauthor=F.+P.+Monnet&title=Intracellular+%CF%831+receptor+modulates+phospholipase+C+and+protein+kinase+C+activities+in+the+brainstem&doi=10.1073%2Fpnas.96.14.8196"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular σ1 receptor modulates phospholipase C and protein kinase C activities in the brainstem</span></div><div class="casAuthors">Morin-Surun, M. P.; Collin, T.; Denavit-Saubie, M.; Baulieu, E.-E.; Monnet, F. P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">8196-8199</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Most physiol. effects of σ1 receptor ligands are sensitive to pertussis toxin, suggesting a coupling with cell membrane-bound G proteins.  However, the cloning of the σ1 receptor has allowed the identification of an intracellular protein anchored on the endoplasmic reticulum.  Here, we show, using the isolated adult guinea pig brainstem prepn., that activation of the σ1 receptor results in its translocation from the cytosol to the vicinity of the cell membrane and induces a robust and rapid decrease in hypoglossal activity, which is mediated by phospholipase C.  The subsequent activation of protein kinase C β1 and β2 isoforms and the phosphorylation of a protein of the same mol. wt. as the cloned σ1 receptor lead to a desensitization of the σ1 motor response.  Our results indicate that the intracellular σ1 receptor regulates several components implicated in plasma membrane-bound signal transduction.  This might be an example of a mechanism by which an intracellular receptor modulates metabotropic responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEDyEaAzNqjbVg90H21EOLACvtfcHk0lgn0DRFAwg58w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltVOrsLY%253D&md5=0e7890bbd263ddb3368d6ab32799769f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.14.8196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.14.8196%26sid%3Dliteratum%253Aachs%26aulast%3DMorin-Surun%26aufirst%3DM.%2BP.%26aulast%3DCollin%26aufirst%3DT.%26aulast%3DDenavit-Saubi%25C3%25A9%26aufirst%3DM.%26aulast%3DBaulieu%26aufirst%3DE.-E.%26aulast%3DMonnet%26aufirst%3DF.%2BP.%26atitle%3DIntracellular%2520%25CF%25831%2520receptor%2520modulates%2520phospholipase%2520C%2520and%2520protein%2520kinase%2520C%2520activities%2520in%2520the%2520brainstem%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D8196%26epage%3D8199%26doi%3D10.1073%2Fpnas.96.14.8196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, T.-P.</span></span> <span> </span><span class="NLM_article-title">Intracellular dynamics of sigma-1 receptors (sigma(1) binding sites) in NG108–15 cells</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>306</i></span>,  <span class="NLM_fpage">726</span>– <span class="NLM_lpage">733</span>, <span class="refDoi"> DOI: 10.1124/jpet.103.051292</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1124%2Fjpet.103.051292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=12730356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlslGlu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2003&pages=726-733&author=T.+Hayashiauthor=T.-P.+Su&title=Intracellular+dynamics+of+sigma-1+receptors+%28sigma%281%29+binding+sites%29+in+NG108%E2%80%9315+cells&doi=10.1124%2Fjpet.103.051292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular dynamics of σ-1 receptors (σ1 binding sites) in NG108-15 cells</span></div><div class="casAuthors">Hayashi, Teruo; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">306</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">726-733</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The σ-1 receptors bind diverse kinds of psychoactive compds., including cocaine, and translocate upon stimulation by these compds.  However, the exact intracellular localization and dynamics of σ-1 receptors have been unclear.  We recently found that σ-1 receptors specifically localize on cholesterol-enriched loci on the endoplasmic reticulum (ER) membrane that function as neutral lipid storage sites (i.e., ER lipid droplets or ER-LDs) from which neutral lipids bud out to form cytosolic lipid droplets.  By combining immunocytochem. and real-time monitoring of enhanced yellow fluorescent protein (EYFP)-tagged σ-1 receptors (Sig-1R-EYFP) in living cells, we characterized the σ-1 receptor translocation in this study.  (+)-Pentazocine, a selective σ-1 receptor agonist, causes a significant decrease of σ-1 receptors in ER-LDs and a diffused distribution of σ-1 receptors over the entire endoplasmic reticulum reticular network in NG108-15 cells.  In the presence of σ-1 receptor agonists, Sig-1R-EYFP move out from ER-LDs and slide along the endoplasmic reticulum network toward nuclear envelope and the tip of neurites.  Fluorescence recovery after photo-bleaching anal. demonstrates that Sig-1R-EYFP on endoplasmic reticulum reticular network are highly mobile compared with those in ER-LDs.  A sucrose gradient fractionation study shows that (+)-pentazocine shifts σ-1 receptors from ER-LD membranes to higher d. membranes.  These results indicate that σ-1 receptors localize on ER-LDs and upon stimulation translocate on continuous endoplasmic reticulum reticular network toward peripheries of cells.  Because σ-1 receptors specifically target ER lipid storage sites and compartmentalize neutral lipids therein, these results suggest that σ-1 receptors' dynamic translocation might affect lipid transport and distribution in neuronal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokTnv4NnuBm7Vg90H21EOLACvtfcHk0lgn0DRFAwg58w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlslGlu7g%253D&md5=8fac13ecd5adc16fddf5440fc6d098f7</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.051292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.051292%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.-P.%26atitle%3DIntracellular%2520dynamics%2520of%2520sigma-1%2520receptors%2520%2528sigma%25281%2529%2520binding%2520sites%2529%2520in%2520NG108%25E2%2580%259315%2520cells%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D306%26spage%3D726%26epage%3D733%26doi%3D10.1124%2Fjpet.103.051292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, T.-P.</span></span> <span> </span><span class="NLM_article-title">Sigma-1 Receptor Chaperones and Diseases</span>. <i>Cent. Nerv. Syst. Agents Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.2174/1871524910909030184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.2174%2F1871524910909030184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=20021352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWnt7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=184-189&author=S.-Y.+Tsaiauthor=T.+Hayashiauthor=T.+Moriauthor=T.-P.+Su&title=Sigma-1+Receptor+Chaperones+and+Diseases&doi=10.2174%2F1871524910909030184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptor chaperones and diseases</span></div><div class="casAuthors">Tsai, Shang-Yi; Hayashi, Teruo; Mori, Tomohisa; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Central Nervous System Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">184-189</span>CODEN:
                <span class="NLM_cas:coden">CNSAC3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5249</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Chaperones are proteins that assist the correct folding of other protein clients either when the clients are being synthesized or at their functional localities.  Chaperones are responsible for certain diseases.  The sigma-1 receptor is recently identified as a receptor chaperone whose activity can be activated/deactivated by specific ligands.  Under physiol. conditions, the sigma-1 receptor chaperones the functional IP3 receptor at the endoplasmic reticulum and mitochondrion interface to ensure proper Ca2+ signaling from endoplasmic reticulum into mitochondrion.  However, under pathol. conditions whereby cells encounter enormous stress that results in the endoplasmic reticulum losing its global Ca2+ homeostasis, the sigma-1 receptor translocates and counteracts the arising apoptosis.  Thus, the sigma-1 receptor is a receptor chaperone essential for the metabotropic receptor signaling and for the survival against cellular stress.  The sigma-1 receptor has been implicated in many diseases including addiction, pain, depression, stroke, and cancer.  Whether the chaperone activity of the sigma-1 receptor attributes to those diseases awaits further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBHVqBwWpruLVg90H21EOLACvtfcHk0lgn0DRFAwg58w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWnt7rM&md5=2a24b524318a17026caadb8e64e908c6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F1871524910909030184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871524910909030184%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DS.-Y.%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.-P.%26atitle%3DSigma-1%2520Receptor%2520Chaperones%2520and%2520Diseases%26jtitle%3DCent.%2520Nerv.%2520Syst.%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D184%26epage%3D189%26doi%3D10.2174%2F1871524910909030184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuevas, J.</span></span> <span> </span><span class="NLM_article-title">Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons</span>. <i>J. Neurophysiol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">2867</span>– <span class="NLM_lpage">2879</span>, <span class="refDoi"> DOI: 10.1152/jn.2002.87.6.2867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1152%2Fjn.2002.87.6.2867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=12037190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BD38XltFSks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2002&pages=2867-2879&author=H.+Zhangauthor=J.+Cuevas&title=Sigma+receptors+inhibit+high-voltage-activated+calcium+channels+in+rat+sympathetic+and+parasympathetic+neurons&doi=10.1152%2Fjn.2002.87.6.2867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons</span></div><div class="casAuthors">Zhang, Hongling; Cuevas, Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurophysiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2867-2879</span>CODEN:
                <span class="NLM_cas:coden">JONEA4</span>;
        ISSN:<span class="NLM_cas:issn">0022-3077</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">Studies on the expression and cellular function of sigma receptors in autonomic neurons were conducted in neonatal rat intracardiac and superior cervical (SCG) ganglia.  Individual neurons from SCG and intracardiac ganglia were shown to express transcripts encoding the sigma-1 receptor using single-cell RT-PCR techniques.  The relationship between sigma receptors and calcium channels was studied in isolated neurons of these ganglia under voltage-clamp mode using the perforated-patch configuration of the whole cell patch-clamp recording technique.  Bath application of sigma receptor agonists was shown to rapidly depress peak calcium channel currents in a reversible manner in both SCG and intracardiac ganglion neurons.  The inhibition of barium (IBa) currents was dose-dependent, and half-maximal inhibitory concn. (IC50) values for haloperidol, ibogaine, (+)-pentazocine, and 1,3-Di-O-tolylguanidine (DTG) were 6, 31, 61, and 133 μM, resp.  The rank order potency of haloperidol > ibogaine > (+)-pentazocine > DTG is consistent with the effects on calcium channels being mediated by a sigma-2 receptor.  Preincubation of neurons with the irreversible sigma receptor antagonist, metaphit, blocked DTG-mediated inhibition of Ca2+ channel currents.  Maximum inhibition of calcium channel currents was ≥95%, suggesting that sigma receptors block all calcium channel subtypes found on the cell body of these neurons, which includes N-, L-, P/Q-, and R-type calcium channels.  In addn. to depressing peak Ca2+ channel current, sigma receptors altered the biophys. properties of these channels.  Following sigma receptor activation, Ca2+ channel inactivation rate was accelerated, and the voltage dependence of both steady-state inactivation and activation shifted toward more neg. potentials.  Expts. on the signal transduction cascade coupling sigma receptors and Ca2+ channels demonstrated that neither cell dialysis nor intracellular application of 100 μM guanosine 5'-O-(2-thiodiphosphate) trilithium salt (GDP-β-S) abolished the modulation of IBa by sigma receptor agonists.  These data suggest that neither a diffusible cytosolic second messenger nor a G protein is involved in this pathway.  Activation of sigma receptors on sympathetic and parasympathetic neurons is likely to modulate cell-to-cell signaling in autonomic ganglia and thus the regulation of cardiac function by the peripheral nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8TEGVj60pJLVg90H21EOLACvtfcHk0ljQspeTpkbPgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltFSks74%253D&md5=7d0aebce61514d66065e60dda149e038</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1152%2Fjn.2002.87.6.2867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fjn.2002.87.6.2867%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DCuevas%26aufirst%3DJ.%26atitle%3DSigma%2520receptors%2520inhibit%2520high-voltage-activated%2520calcium%2520channels%2520in%2520rat%2520sympathetic%2520and%2520parasympathetic%2520neurons%26jtitle%3DJ.%2520Neurophysiol.%26date%3D2002%26volume%3D87%26spage%3D2867%26epage%3D2879%26doi%3D10.1152%2Fjn.2002.87.6.2867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soriani, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foll, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monnet, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaudry, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cazin, L.</span></span> <span> </span><span class="NLM_article-title">A-Current down-modulated by sigma receptor in frog pituitary melanotrope cells through a G protein-dependent pathway</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">328</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10087020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaK1MXit1KhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1999&pages=321-328&author=O.+Sorianiauthor=F.+L.+Follauthor=F.+Romanauthor=F.+P.+Monnetauthor=H.+Vaudryauthor=L.+Cazin&title=A-Current+down-modulated+by+sigma+receptor+in+frog+pituitary+melanotrope+cells+through+a+G+protein-dependent+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A-current down-modulated by σ receptor in frog pituitary melanotrope cells through a G protein-dependent pathway</span></div><div class="casAuthors">Soriani, Olivier; Le Foll, Frank; Roman, Francois; Monnet, Francois P.; Vaudry, Hubert; Cazin, Lionel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">321-328</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Gramicidin perforated patch-clamp recordings were used to study the effects of 2 σ 1 receptor ligands, (+)-N-cyclopropylmethyl-N-methyl-1,4-diphenyl-1-ethyl-but-3-en-1-ylaminehydrochloride (JO 1784) and (+)-pentazocine, on the transient outward potassium current (IA) in cultured frog melanotrope cells.  (+)-Pentazocine reversibly decreased the current amplitude in a dose-dependent manner.  The effects of (+)-pentazocine were mimicked by JO 1784 and were markedly reduced by the σ 1 receptor antagonist, N,N-dipropyl-2-[4-methoxy-3-2(2-phenylethoxy)phenyl]-ethylamine monohydrochloride (NE 100).  Inactivation rate of IA was best fitted with a double exponential function, yielding time consts. of 23.7 and 112.5 ms.  (+)-Pentazocine (20 μM) accelerated the current decay, decreasing the time consts. to 10.7 and 59 ms, resp.  Current-voltage expts. revealed that (+)-pentazocine (20 μM) did neither modify the open-state I/V curves nor the voltage dependence of IA.  However, (+)-pentazocine (20 μM) shifted the steady-state inactivation curve toward more neg. potentials and increased the time const. of the time-dependent removal of inactivation.  In whole-cell expts., internal dialysis of guanosine-5'-O-(3-thiophosphate) (100 μM) irreversibly prolonged the response to (+)-pentazocine.  In addn., cholera toxin pretreatment (1 μg/mL; 12 h) suppressed the inhibition of IA by (+)-pentazocine (20 μM).  It is concluded that in frog melanotrope cells, a cholera toxin-sensitive, G protein-dependent inhibition of IA through a σ 1 receptor activation, at least partially, underlies the excitatory effect of σ ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBI9uiiiXYGbVg90H21EOLACvtfcHk0ljQspeTpkbPgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXit1KhtrY%253D&md5=f04b547693f49eacc5997bd756519634</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoriani%26aufirst%3DO.%26aulast%3DFoll%26aufirst%3DF.%2BL.%26aulast%3DRoman%26aufirst%3DF.%26aulast%3DMonnet%26aufirst%3DF.%2BP.%26aulast%3DVaudry%26aufirst%3DH.%26aulast%3DCazin%26aufirst%3DL.%26atitle%3DA-Current%2520down-modulated%2520by%2520sigma%2520receptor%2520in%2520frog%2520pituitary%2520melanotrope%2520cells%2520through%2520a%2520G%2520protein-dependent%2520pathway%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D289%26spage%3D321%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soriani, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Foll, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaudry, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cazin, L.</span></span> <span> </span><span class="NLM_article-title">The sigma-ligand (+)-pentazocine depresses M current and enhances calcium conductances in frog melanotrophs</span>. <i>Am. J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>277</i></span>,  <span class="NLM_fpage">E73</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1152/ajpendo.1999.277.1.E73</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1152%2Fajpendo.1999.277.1.E73" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=1999&pages=E73-80&author=O.+Sorianiauthor=F.+Le+Follauthor=L.+Galasauthor=F.+Romanauthor=H.+Vaudryauthor=L.+Cazin&title=The+sigma-ligand+%28%2B%29-pentazocine+depresses+M+current+and+enhances+calcium+conductances+in+frog+melanotrophs&doi=10.1152%2Fajpendo.1999.277.1.E73"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1152%2Fajpendo.1999.277.1.E73&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpendo.1999.277.1.E73%26sid%3Dliteratum%253Aachs%26aulast%3DSoriani%26aufirst%3DO.%26aulast%3DLe%2BFoll%26aufirst%3DF.%26aulast%3DGalas%26aufirst%3DL.%26aulast%3DRoman%26aufirst%3DF.%26aulast%3DVaudry%26aufirst%3DH.%26aulast%3DCazin%26aufirst%3DL.%26atitle%3DThe%2520sigma-ligand%2520%2528%252B%2529-pentazocine%2520depresses%2520M%2520current%2520and%2520enhances%2520calcium%2520conductances%2520in%2520frog%2520melanotrophs%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D1999%26volume%3D277%26spage%3DE73%26epage%3D80%26doi%3D10.1152%2Fajpendo.1999.277.1.E73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, D.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, P.</span></span> <span> </span><span class="NLM_article-title">Neurosteroid dehydroepiandrosterone sulphate inhibits persistent sodium currents in rat medial prefrontal cortex via activation of sigma-1 receptors</span>. <i>Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>210</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1016/j.expneurol.2007.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2Fj.expneurol.2007.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=18035354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVWis7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=2008&pages=128-136&author=Z.-X.+Chengauthor=D.-M.+Lanauthor=P.-Y.+Wuauthor=Y.-H.+Zhuauthor=Y.+Dongauthor=L.+Maauthor=P.+Zheng&title=Neurosteroid+dehydroepiandrosterone+sulphate+inhibits+persistent+sodium+currents+in+rat+medial+prefrontal+cortex+via+activation+of+sigma-1+receptors&doi=10.1016%2Fj.expneurol.2007.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Neurosteroid dehydroepiandrosterone sulphate inhibits persistent sodium currents in rat medial prefrontal cortex via activation of sigma-1 receptors</span></div><div class="casAuthors">Cheng, Zheng-Xiang; Lan, Dan-Mei; Wu, Pei-Ying; Zhu, Yan-Hua; Dong, Yi; Ma, Lan; Zheng, Ping</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">210</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">128-136</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Dehydroepiandrosterone sulfate is one of the most important neurosteroids.  In the present paper, we studied the effect of dehydroepiandrosterone sulfate on persistent sodium currents and its mechanism and functional consequence with whole-cell patch clamp recording method combined with a pharmacol. approach in the rat medial prefrontal cortex slices.  The results showed that dehydroepiandrosterone sulfate inhibited the amplitude of persistent sodium currents and the inhibitory effect was significant at 0.1 μM, reached max. at 1 μM and decreased with the increase in the concns. of above 1 μM.  The effect of dehydroepiandrosterone sulfate on persistent sodium currents was canceled by the Gi protein inhibitor and the protein kinase C inhibitor, but not by the protein kinase A inhibitor.  The effect of dehydroepiandrosterone sulfate on persistent sodium currents was also canceled by the sigma-1 receptor blockers and the sigma-1 receptor agonist could mimic the effect of dehydroepiandrosterone sulfate.  Dehydroepiandrosterone sulfate had no significant influence on neuronal excitability but could significantly inhibit chem. inhibition of mitochondria-evoked increase in persistent sodium currents.  These results suggest that dehydroepiandrosterone sulfate inhibits persistent sodium currents via the activation of sigma-1 receptors-Gi protein-protein kinase C-coupled signaling pathway, and the main functional consequence of this effect of DHEAS is presumably to protect neurons under ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo69uQz-5-SLVg90H21EOLACvtfcHk0liwddJ8HX1DwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVWis7o%253D&md5=c79ecd56505459124cca3431353b9b1e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2007.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2007.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DZ.-X.%26aulast%3DLan%26aufirst%3DD.-M.%26aulast%3DWu%26aufirst%3DP.-Y.%26aulast%3DZhu%26aufirst%3DY.-H.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DP.%26atitle%3DNeurosteroid%2520dehydroepiandrosterone%2520sulphate%2520inhibits%2520persistent%2520sodium%2520currents%2520in%2520rat%2520medial%2520prefrontal%2520cortex%2520via%2520activation%2520of%2520sigma-1%2520receptors%26jtitle%3DExp.%2520Neurol.%26date%3D2008%26volume%3D210%26spage%3D128%26epage%3D136%26doi%3D10.1016%2Fj.expneurol.2007.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Renaudo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">L’Hoste, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guizouarn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borgèse, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soriani, O.</span></span> <span> </span><span class="NLM_article-title">Cancer cell cycle modulated by a functional coupling between sigma-1 receptors and Cl- channels</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">2259</span>– <span class="NLM_lpage">2267</span>, <span class="refDoi"> DOI: 10.1074/jbc.M607915200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1074%2Fjbc.M607915200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=2259-2267&author=A.+Renaudoauthor=S.+L%E2%80%99Hosteauthor=H.+Guizouarnauthor=F.+Borg%C3%A8seauthor=O.+Soriani&title=Cancer+cell+cycle+modulated+by+a+functional+coupling+between+sigma-1+receptors+and+Cl-+channels&doi=10.1074%2Fjbc.M607915200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M607915200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M607915200%26sid%3Dliteratum%253Aachs%26aulast%3DRenaudo%26aufirst%3DA.%26aulast%3DL%25E2%2580%2599Hoste%26aufirst%3DS.%26aulast%3DGuizouarn%26aufirst%3DH.%26aulast%3DBorg%25C3%25A8se%26aufirst%3DF.%26aulast%3DSoriani%26aufirst%3DO.%26atitle%3DCancer%2520cell%2520cycle%2520modulated%2520by%2520a%2520functional%2520coupling%2520between%2520sigma-1%2520receptors%2520and%2520Cl-%2520channels%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D2259%26epage%3D2267%26doi%3D10.1074%2Fjbc.M607915200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romieu, P.</span></span> <span> </span><span class="NLM_article-title">Involvement of the sigma1 receptor in the appetitive effects of cocaine</span>. <i>Pharmacopsychiatry</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">Suppl. 3</span>),  <span class="NLM_fpage">198</span>– <span class="NLM_lpage">207</span>, <span class="refDoi"> DOI: 10.1055/s-2004-832678</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1055%2Fs-2004-832678" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2004&pages=198-207&issue=Suppl.+3&author=T.+Mauriceauthor=P.+Romieu&title=Involvement+of+the+sigma1+receptor+in+the+appetitive+effects+of+cocaine&doi=10.1055%2Fs-2004-832678"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1055%2Fs-2004-832678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2004-832678%26sid%3Dliteratum%253Aachs%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DRomieu%26aufirst%3DP.%26atitle%3DInvolvement%2520of%2520the%2520sigma1%2520receptor%2520in%2520the%2520appetitive%2520effects%2520of%2520cocaine%26jtitle%3DPharmacopsychiatry%26date%3D2004%26volume%3D37%26issue%3DSuppl.%25203%26spage%3D198%26epage%3D207%26doi%3D10.1055%2Fs-2004-832678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.-Y.</span></span> <span> </span><span class="NLM_article-title">Roles of sigma-1 receptors in Alzheimer’s disease</span>. <i>Int. J. Clin. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">4808</span>– <span class="NLM_lpage">4820</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=26131055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A280%3ADC%252BC2MbptFynsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=4808-4820&author=J.-L.+Jinauthor=M.+Fangauthor=Y.-X.+Zhaoauthor=X.-Y.+Liu&title=Roles+of+sigma-1+receptors+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of sigma-1 receptors in Alzheimer's disease</span></div><div class="casAuthors">Jin Jia-Li; Fang Min; Zhao Yan-Xin; Liu Xue-Yuan</div><div class="citationInfo"><span class="NLM_cas:title">International journal of clinical and experimental medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">4808-20</span>
        ISSN:<span class="NLM_cas:issn">1940-5901</span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the leading cause of senile dementia all over the world.  Still no existing drugs can effectively reverse the cognitive impairment.  However, Sigma-1 (σ-1) receptors have been long implicated in multiple neurological and psychiatric conditions over these years.  In this review, we discuss the current understanding of σ-1 receptor functions.  Through regulation of lipid rafts, secretases, kinases, neuroceptors and ion channels, σ-1 receptors can influence cellular signal transduction, TCA cycle, oxidative stress, neuron plasticity and neurotransmitter release etc.  Based on this, we suggest the key cellular mechanisms linking σ-1 receptor to Alzheimer's disease.  Besides, we detail the evidences showing that σ-1 receptors agonists, being the promising compounds for treatment of cognitive dysfunction, exhibit robust neuroprotection and anti-amnesia effect against Aβ neurotoxicity in the progress of Alzheimer's disease.  The evidence comes from animal models, preclinical studies in humans and full clinical trials.  In addition, the questions to be solved regarding this receptor are also presented.  When concerned with NMDAR, σ-1 receptor activation may result in two totally different influences on AD.  Utilization of σ-1 agents early in AD remains an overlooked therapeutic opportunity.  This article may pave the way for further studies about sigma-1 receptor on Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQtgNNdI_x_xG52AMpI4GK2fW6udTcc2eZfdVBP1xoKPrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MbptFynsQ%253D%253D&md5=9a885f6b442e658b1037e96c4fabdfa1</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DJ.-L.%26aulast%3DFang%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DY.-X.%26aulast%3DLiu%26aufirst%3DX.-Y.%26atitle%3DRoles%2520of%2520sigma-1%2520receptors%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Med.%26date%3D2015%26volume%3D8%26spage%3D4808%26epage%3D4820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhir, A.</span></span> <span> </span><span class="NLM_article-title">sigma-1 receptors in major depression and anxiety</span>. <i>Expert Rev. Neurother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1021</span>– <span class="NLM_lpage">1034</span>, <span class="refDoi"> DOI: 10.1586/ern.09.40</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1586%2Fern.09.40" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=19589051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1egtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=1021-1034&author=S.+K.+Kulkarniauthor=A.+Dhir&title=sigma-1+receptors+in+major+depression+and+anxiety&doi=10.1586%2Fern.09.40"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">σ-1 receptors in major depression and anxiety</span></div><div class="casAuthors">Kulkarni, Shrinivas K.; Dhir, Ashish</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1021-1034</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Major depression and anxiety are two of the major psychiatric disorders that have some overlapping pathophysiologies, the most significant being the dysfunction in the monoaminergic, GABAergic and glutamatergic systems.  A large no. of drugs that alter these neurotransmitter levels/systems are effective in the treatment of major depression and anxiety.  However, full remission of the clin. symptoms has not been achieved, perhaps owing to the complex pathophysiol. of the diseases.  Thus, the search for newer targets and target-specific drugs continues.  Recently, the role of σ-receptors, particularly the σ-1 receptor subtype, has been identified as a target for the pathophysiol. of neuropsychiatric disorders, and σ-1 receptor modulators are considered to be the drugs of the future for the treatment of major depression and anxiety.  The present review attempts to discuss the role of σ-1 receptors in the pathophysiol. of major depression and anxiety and also tries to position the use of its receptor modulators in the treatment of these two major disorders.  The role of σ-1 receptors in the mechanism of antidepressant action of venlafaxine, bupropion, neurosteroids and one of the herbal antidepressants, berberine, is reviewed.  Although, σ-1 receptor modulators may be future therapeutic options, either as individual agents or adjuvants in the treatment of mental disorders, the topic needs further preclin. and clin. exploration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSBtnV2P59xLVg90H21EOLACvtfcHk0liwddJ8HX1DwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1egtL0%253D&md5=a26dd8928fbbb21fa2f137c4b6b4bc29</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1586%2Fern.09.40&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fern.09.40%26sid%3Dliteratum%253Aachs%26aulast%3DKulkarni%26aufirst%3DS.%2BK.%26aulast%3DDhir%26aufirst%3DA.%26atitle%3Dsigma-1%2520receptors%2520in%2520major%2520depression%2520and%2520anxiety%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2009%26volume%3D9%26spage%3D1021%26epage%3D1034%26doi%3D10.1586%2Fern.09.40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niitsu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, K.</span></span> <span> </span><span class="NLM_article-title">Sigma-1 receptor agonists as therapeutic drugs for cognitive impairment in neuropsychiatric diseases</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">875</span>– <span class="NLM_lpage">883</span>, <span class="refDoi"> DOI: 10.2174/138161212799436476</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.2174%2F138161212799436476" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=22288409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvVSqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=875-883&author=T.+Niitsuauthor=M.+Iyoauthor=K.+Hashimoto&title=Sigma-1+receptor+agonists+as+therapeutic+drugs+for+cognitive+impairment+in+neuropsychiatric+diseases&doi=10.2174%2F138161212799436476"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptor agonists as therapeutic drugs for cognitive impairment in neuropsychiatric diseases</span></div><div class="casAuthors">Niitsu, Tomihisa; Iyo, Masaomi; Hashimoto, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">875-883</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cognitive impairment is a core feature of patients with neuropsychiatric diseases such as schizophrenia and psychotic depression.  The drugs currently used to treat cognitive impairment have significant limitations, ensuring that the search for more effective therapies remains active.  Endoplasmic reticulum protein sigma-1 receptors are unique binding sites in the brain that exert a potent effect on multiple neurotransmitter systems.  Accumulating evidence suggests that sigma-1 receptors play a role in both the pathophysiol. of neuropsychiatric diseases, and the mechanistic action of some therapeutic drugs, such as the selective serotonin reuptake inhibitors (SSRIs), donepezil and neurosteroids.  Among SSRIs, fluvoxamine, a potent sigma-1 receptor agonist, has the highest affinity at sigma-1 receptors.  Sigma-1 receptor agonists greatly potentiate nerve-growth factor (NGF)-induced neurite outgrowth in PC12 cells, an effect that is antagonized by treatment with the selective sigma-1 receptor antagonist NE-100.  Furthermore, phencyclidine (PCP)-induced cognitive impairment, assocd. with animal models of schizophrenia is significantly improved by sub-chronic administration of sigma-1 receptor agonists such as fluvoxamine, SA4503 (cutamesine) and donepezil.  This effect is antagonized by co-administration of NE-100.  A positron emission tomog. (PET) study using the specific sigma-1 receptor ligand [11C]SA4503 demonstrates that fluvoxamine and donepezil bind to sigma-1 receptors in the healthy human brain.  In clin. studies, some sigma-1 receptor agonists, including fluvoxamine, donepezil and neurosteroids, improve cognitive impairment and clin. symptoms in neuropsychiatric diseases.  In this article, we review the recent findings on sigma-1 receptor agonists as potential therapeutic drugs for the treatment of cognitive impairment in schizophrenia and psychotic depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbtEOCYECSSbVg90H21EOLACvtfcHk0lgM7-rxAO0gWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvVSqt7o%253D&md5=b64d4ca448cf6d78910df4944255686e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F138161212799436476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212799436476%26sid%3Dliteratum%253Aachs%26aulast%3DNiitsu%26aufirst%3DT.%26aulast%3DIyo%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DK.%26atitle%3DSigma-1%2520receptor%2520agonists%2520as%2520therapeutic%2520drugs%2520for%2520cognitive%2520impairment%2520in%2520neuropsychiatric%2520diseases%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2012%26volume%3D18%26spage%3D875%26epage%3D883%26doi%3D10.2174%2F138161212799436476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zamanillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. M.</span></span> <span> </span><span class="NLM_article-title">Sigma 1 receptor: a new therapeutic target for pain</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>716</i></span>,  <span class="NLM_fpage">78</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2013.01.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2Fj.ejphar.2013.01.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=23500210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt12ju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=716&publication_year=2013&pages=78-93&author=D.+Zamanilloauthor=L.+Romeroauthor=M.+Merlosauthor=J.+M.+Vela&title=Sigma+1+receptor%3A+a+new+therapeutic+target+for+pain&doi=10.1016%2Fj.ejphar.2013.01.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma 1 receptor: A new therapeutic target for pain</span></div><div class="casAuthors">Zamanillo, Daniel; Romero, Luz; Merlos, Manuel; Vela, Jose Miguel</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">716</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">78-93</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sigma 1 receptor (σ1 receptor) is a unique ligand-regulated mol. chaperone located mainly in the endoplasmic reticulum and the plasma membrane. σ1 receptor is activated under stress or pathol. conditions and interacts with several neurotransmitter receptors and ion channels to modulate their function.  The effects reported preclinically with σ1 receptor ligands are consistent with a role for σ1 receptor in central sensitization and pain hypersensitivity and suggest a potential therapeutic use of σ1 receptor antagonists for the management of neuropathic pain as monotherapy.  Moreover, data support their use in opioid adjuvant therapy: combination of σ1 receptor antagonists and opioids results in potentiation of opioid analgesia, without significant increases in opioid-related unwanted effects.  Results from clin. trials using selective σ1 receptor antagonists in several pain conditions are eagerly awaited to ascertain the potential of σ1 receptor modulation in pain therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZl3UX9-U94rVg90H21EOLACvtfcHk0lgM7-rxAO0gWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt12ju70%253D&md5=7eba2c57ef558fbc50fb90d7067ab2e8</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2013.01.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2013.01.068%26sid%3Dliteratum%253Aachs%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3DSigma%25201%2520receptor%253A%2520a%2520new%2520therapeutic%2520target%2520for%2520pain%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D716%26spage%3D78%26epage%3D93%26doi%3D10.1016%2Fj.ejphar.2013.01.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finnerup, N. B.</span></span> <span> </span><span class="NLM_article-title">Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">924</span>– <span class="NLM_lpage">935</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(14)70102-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2FS1474-4422%2814%2970102-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=25142459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A280%3ADC%252BC2M7mvVOguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=924-935&author=T.+S.+Jensenauthor=N.+B.+Finnerup&title=Allodynia+and+hyperalgesia+in+neuropathic+pain%3A+clinical+manifestations+and+mechanisms&doi=10.1016%2FS1474-4422%2814%2970102-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms</span></div><div class="casAuthors">Jensen Troels S; Finnerup Nanna B</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">924-35</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Allodynia (pain due to a stimulus that does not usually provoke pain) and hyperalgesia (increased pain from a stimulus that usually provokes pain) are prominent symptoms in patients with neuropathic pain.  Both are seen in various peripheral neuropathies and central pain disorders, and affect 15-50% of patients with neuropathic pain.  Allodynia and hyperalgesia are classified according to the sensory modality (touch, pressure, pinprick, cold, and heat) that is used to elicit the sensation.  Peripheral sensitisation and maladaptive central changes contribute to the generation and maintenance of these reactions, with separate mechanisms in different subtypes of allodynia and hyperalgesia.  Pain intensity and relief are important measures in clinical pain studies, but might be insufficient to capture the complexity of the pain experience.  Better understanding of allodynia and hyperalgesia might provide clues to the underlying pathophysiology of neuropathic pain and, as such, they represent new or additional endpoints in pain trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTMEle2RONFvZPq5LRczm8ffW6udTcc2eaIXteBUCamnrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7mvVOguw%253D%253D&md5=0a472896d219627cee6a4db77ade7d09</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2814%2970102-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252814%252970102-4%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DT.%2BS.%26aulast%3DFinnerup%26aufirst%3DN.%2BB.%26atitle%3DAllodynia%2520and%2520hyperalgesia%2520in%2520neuropathic%2520pain%253A%2520clinical%2520manifestations%2520and%2520mechanisms%26jtitle%3DLancet%2520Neurol.%26date%3D2014%26volume%3D13%26spage%3D924%26epage%3D935%26doi%3D10.1016%2FS1474-4422%2814%2970102-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Entrena, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobos, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieto, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cendán, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gris, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">del Pozo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamanillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J. M.</span></span> <span> </span><span class="NLM_article-title">Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: studies with selective sigma-1 ligands and sigma-1 knockout mice</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">252</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1016/j.pain.2009.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2Fj.pain.2009.03.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=19375855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BD1MXls1Ortr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2009&pages=252-261&author=J.+M.+Entrenaauthor=E.+J.+Cobosauthor=F.+R.+Nietoauthor=C.+M.+Cend%C3%A1nauthor=G.+Grisauthor=E.+del+Pozoauthor=D.+Zamanilloauthor=J.+M.+Baeyens&title=Sigma-1+receptors+are+essential+for+capsaicin-induced+mechanical+hypersensitivity%3A+studies+with+selective+sigma-1+ligands+and+sigma-1+knockout+mice&doi=10.1016%2Fj.pain.2009.03.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: Studies with selective sigma-1 ligands and sigma-1 knockout mice</span></div><div class="casAuthors">Entrena, Jose Manuel; Cobos, Enrique Jose; Nieto, Francisco Rafael; Cendan, Cruz Miguel; Gris, Georgia; Del Pozo, Esperanza; Zamanillo, Daniel; Baeyens, Jose Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">252-261</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We evaluated the role of σ1 receptors on capsaicin-induced mech. hypersensitivity and on nociceptive pain induced by punctate mech. stimuli, using wild-type and σ1 receptor knockout (σ1-KO) mice and selective σ1 receptor-acting drugs.  Mutation in σ1-KO mice was confirmed by PCR anal. of genomic DNA and, at the protein level, by [3H](+)-pentazocine binding assays.  Both wild-type and σ1-KO mice not treated with capsaicin showed similar responses to different intensities of mech. stimuli (0.05-8 g force), ranging from innocuous to noxious, applied to the hind paw.  This indicates that σ1 gene inactivation does not modify the perception of punctate mech. stimuli.  The intraplantar (i.pl.) administration of capsaicin induced dose-dependent mech. allodynia in wild-type mice (markedly reducing both the threshold force necessary to induce paw withdrawal and the latency to paw withdrawal induced by a given force).  In contrast, capsaicin was completely unable to induce mech. hypersensitivity in σ1-KO mice.  The high-affinity and selective σ1 antagonists BD-1063, BD-1047 and NE-100, administered s.c. dose-dependently inhibited mech. allodynia induced by capsaicin (1 μg,i.pl.), yielding ED50 (mg/kg) values of 15.80 ± 0.93, 29.31 ± 1.65 and 40.74 ± 7.20, resp.  The effects of the σ1 antagonists were reversed by the σ1 agonist PRE-084 (32 mg/kg, s.c.).  None of the drugs tested modified the responses induced by a painful mech. punctate stimulus (4 g force) in nonsensitized animals.  These results suggest that σ1 receptors are essential for capsaicin-induced mech. hypersensitivity, but are not involved in mech. nociceptive pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxwYUgwwMlprVg90H21EOLACvtfcHk0lgM7-rxAO0gWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXls1Ortr0%253D&md5=e51c7b76ea146ba992c7d1768e1da9a3</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2009.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2009.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DNieto%26aufirst%3DF.%2BR.%26aulast%3DCend%25C3%25A1n%26aufirst%3DC.%2BM.%26aulast%3DGris%26aufirst%3DG.%26aulast%3Ddel%2BPozo%26aufirst%3DE.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DSigma-1%2520receptors%2520are%2520essential%2520for%2520capsaicin-induced%2520mechanical%2520hypersensitivity%253A%2520studies%2520with%2520selective%2520sigma-1%2520ligands%2520and%2520sigma-1%2520knockout%2520mice%26jtitle%3DPain%26date%3D2009%26volume%3D143%26spage%3D252%26epage%3D261%26doi%3D10.1016%2Fj.pain.2009.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Díaz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuberes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berrocal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contijoch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christmann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Port, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holenz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laggner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serafini, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgueño, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamanillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almansa, C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of the 1-arylpyrazole class of σ(1) receptor antagonists: identification of 4-{2–5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxyethyl}morpholine (S1RA, E-52862)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8211</span>– <span class="NLM_lpage">8224</span>, <span class="refDoi"> DOI: 10.1021/jm3007323</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3007323" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8211-8224&author=J.+L.+D%C3%ADazauthor=R.+Cuberesauthor=J.+Berrocalauthor=M.+Contijochauthor=U.+Christmannauthor=A.+Fern%C3%A1ndezauthor=A.+Portauthor=J.+Holenzauthor=H.+Buschmannauthor=C.+Laggnerauthor=M.+T.+Serafiniauthor=J.+Burgue%C3%B1oauthor=D.+Zamanilloauthor=M.+Merlosauthor=J.+M.+Velaauthor=C.+Almansa&title=Synthesis+and+biological+evaluation+of+the+1-arylpyrazole+class+of+%CF%83%281%29+receptor+antagonists%3A+identification+of+4-%7B2%E2%80%935-methyl-1-%28naphthalen-2-yl%29-1H-pyrazol-3-yloxyethyl%7Dmorpholine+%28S1RA%2C+E-52862%29&doi=10.1021%2Fjm3007323"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm3007323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3007323%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25ADaz%26aufirst%3DJ.%2BL.%26aulast%3DCuberes%26aufirst%3DR.%26aulast%3DBerrocal%26aufirst%3DJ.%26aulast%3DContijoch%26aufirst%3DM.%26aulast%3DChristmann%26aufirst%3DU.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DPort%26aufirst%3DA.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DBuschmann%26aufirst%3DH.%26aulast%3DLaggner%26aufirst%3DC.%26aulast%3DSerafini%26aufirst%3DM.%2BT.%26aulast%3DBurgue%25C3%25B1o%26aufirst%3DJ.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520the%25201-arylpyrazole%2520class%2520of%2520%25CF%2583%25281%2529%2520receptor%2520antagonists%253A%2520identification%2520of%25204-%257B2%25E2%2580%25935-methyl-1-%2528naphthalen-2-yl%2529-1H-pyrazol-3-yloxyethyl%257Dmorpholine%2520%2528S1RA%252C%2520E-52862%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8211%26epage%3D8224%26doi%3D10.1021%2Fjm3007323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahn, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span> <span> </span><span class="NLM_article-title">Identification of the gene that codes for the σ2 receptor</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">7160</span>– <span class="NLM_lpage">7165</span>, <span class="refDoi"> DOI: 10.1073/pnas.1705154114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1073%2Fpnas.1705154114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=28559337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovVSisrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=7160-7165&author=A.+Alonauthor=H.+R.+Schmidtauthor=M.+D.+Woodauthor=J.+J.+Sahnauthor=S.+F.+Martinauthor=A.+C.+Kruse&title=Identification+of+the+gene+that+codes+for+the+%CF%832+receptor&doi=10.1073%2Fpnas.1705154114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the gene that codes for the σ2 receptor</span></div><div class="casAuthors">Alon, Assaf; Schmidt, Hayden R.; Wood, Michael D.; Sahn, James J.; Martin, Stephen F.; Kruse, Andrew C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">7160-7165</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The σ2 receptor is an enigmatic protein that has attracted significant attention because of its involvement in diseases as diverse as cancer and neurol. disorders.  Unlike virtually all other receptors of medical interest, it has eluded mol. cloning since its discovery, and the gene that codes for the receptor remains unknown, precluding the use of modern biol. methods to study its function.  Using a chem. biol. approach, we purified the σ2 receptor from tissue, revealing its identity as TMEM97, an endoplasmic reticulum-resident transmembrane protein that regulates the sterol transporter NPC1.  We show that TMEM97 possesses the full suite of mol. properties that define the σ2 receptor, and we identify Asp29 and Asp56 as essential for ligand recognition.  Cloning the σ2 receptor resolves a longstanding mystery and will enable therapeutic targeting of this potential drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsoAS9Q6KtY7Vg90H21EOLACvtfcHk0lhYA2Ae75siVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXovVSisrw%253D&md5=71d3c246ebe6ac84c33980b97cb9889c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1705154114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1705154114%26sid%3Dliteratum%253Aachs%26aulast%3DAlon%26aufirst%3DA.%26aulast%3DSchmidt%26aufirst%3DH.%2BR.%26aulast%3DWood%26aufirst%3DM.%2BD.%26aulast%3DSahn%26aufirst%3DJ.%2BJ.%26aulast%3DMartin%26aufirst%3DS.%2BF.%26aulast%3DKruse%26aufirst%3DA.%2BC.%26atitle%3DIdentification%2520of%2520the%2520gene%2520that%2520codes%2520for%2520the%2520%25CF%25832%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26spage%3D7160%26epage%3D7165%26doi%3D10.1073%2Fpnas.1705154114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, F. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, B. de</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, K. C.</span></span> <span> </span><span class="NLM_article-title">Sigma receptors: biology and function</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">402</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1990&pages=355-402&author=J.+M.+Walkerauthor=W.+D.+Bowenauthor=F.+O.+Walkerauthor=R.+R.+Matsumotoauthor=B.+de+Costaauthor=K.+C.+Rice&title=Sigma+receptors%3A+biology+and+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DJ.%2BM.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26aulast%3DWalker%26aufirst%3DF.%2BO.%26aulast%3DMatsumoto%26aufirst%3DR.%2BR.%26aulast%3DCosta%26aufirst%3DB.%2Bde%26aulast%3DRice%26aufirst%3DK.%2BC.%26atitle%3DSigma%2520receptors%253A%2520biology%2520and%2520function%26jtitle%3DPharmacol.%2520Rev.%26date%3D1990%26volume%3D42%26spage%3D355%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, W. D.</span></span> <span> </span><span class="NLM_article-title">Sigma receptors: recent advances and new clinical potentials</span>. <i>Pharm. Acta Helv.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1016/S0031-6865(99)00034-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2FS0031-6865%2899%2900034-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=211-218&author=W.+D.+Bowen&title=Sigma+receptors%3A+recent+advances+and+new+clinical+potentials&doi=10.1016%2FS0031-6865%2899%2900034-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0031-6865%2899%2900034-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0031-6865%252899%252900034-5%26sid%3Dliteratum%253Aachs%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3DSigma%2520receptors%253A%2520recent%2520advances%2520and%2520new%2520clinical%2520potentials%26jtitle%3DPharm.%2520Acta%2520Helv.%26date%3D2000%26volume%3D74%26spage%3D211%26epage%3D218%26doi%3D10.1016%2FS0031-6865%2899%2900034-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vilner, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, W. D.</span></span> <span> </span><span class="NLM_article-title">Modulation of cellular calcium by sigma-2 receptors: release from intracellular stores in human SK-N-SH neuroblastoma cells</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">900</span>– <span class="NLM_lpage">911</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10688603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhslWktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2000&pages=900-911&author=B.+J.+Vilnerauthor=W.+D.+Bowen&title=Modulation+of+cellular+calcium+by+sigma-2+receptors%3A+release+from+intracellular+stores+in+human+SK-N-SH+neuroblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of cellular calcium by sigma-2 receptors: release from intracellular stores in human SK-N-SH neuroblastoma cells</span></div><div class="casAuthors">Vilner, Bertold J.; Bowen, Wayne D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">900-911</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Human SK-N-SH neuroblastoma cells expressed sigma-1 and sigma-2 receptors with similar pharmacol. profiles to those of rodent-derived tissues, although sigma-2 receptors exhibited some affinity differences that might suggest heterogeneity or species differences.  Structurally diverse sigma ligands produced two types of increases in intracellular (cytosolic) Ca2+ concn. ([Ca2+]i) in these cells.  CB-64D, CB-64L, JL-II-147, BD737, LR172, BD1008, haloperidol, reduced haloperidol, and ibogaine all produced an immediate, dose-dependent, and transient rise in [Ca2+]i.  Sigma-inactive compds. structurally similar to the most active sigma ligands and ligands for several neurotransmitter receptors produced little or no effect.  The high activity of CB-64D and ibogaine (sigma-2-selective ligands) compared with the low activity of (+)-pentazocine and other (+)-benzomorphans (sigma-1-selective ligands), in addn. to enantioselectivity for CB-64D over CB-64L, strongly indicated mediation by sigma-2 receptors.  The effect of CB-64D and BD737 was blocked by the sigma antagonists BD1047 and BD1063, further confirming specificity as a receptor-mediated event.  The transient rise in [Ca2+]i occurred in the absence of extracellular Ca2+ and was completely eliminated by pretreatment of cells with thapsigargin.  Thus, sigma-2 receptors stimulate a transient release of Ca2+ from the endoplasmic reticulum.  Prolonged exposure of cells to sigma-receptor ligands resulted in a latent and sustained rise in [Ca2+]i, with a pharmacol. profile identical to that of the transient rise.  This sustained rise in [Ca2+]i was affected by neither the removal of extracellular Ca2+ nor thapsigargin pretreatment, suggesting latent sigma-2 receptor-induced release from thapsigargin-insensitive intracellular Ca2+ stores.  Sigma-2 receptors may use Ca2+ signals in producing cellular effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9ZFHG8sRG97Vg90H21EOLACvtfcHk0lhWFE1MDCgTAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhslWktLY%253D&md5=d59f985633ba21f7bdd0c19962707aac</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVilner%26aufirst%3DB.%2BJ.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3DModulation%2520of%2520cellular%2520calcium%2520by%2520sigma-2%2520receptors%253A%2520release%2520from%2520intracellular%2520stores%2520in%2520human%2520SK-N-SH%2520neuroblastoma%2520cells%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D292%26spage%3D900%26epage%3D911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilke, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupardus, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruoho, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, M. B.</span></span> <span> </span><span class="NLM_article-title">Sigma receptor photolabeling and sigma receptor-mediated modulation of potassium channels in tumor cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">18387</span>– <span class="NLM_lpage">18392</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.26.18387</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1074%2Fjbc.274.26.18387" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=18387-18392&author=R.+A.+Wilkeauthor=R.+P.+Mehtaauthor=P.+J.+Lupardusauthor=Y.+Chenauthor=A.+E.+Ruohoauthor=M.+B.+Jackson&title=Sigma+receptor+photolabeling+and+sigma+receptor-mediated+modulation+of+potassium+channels+in+tumor+cells&doi=10.1074%2Fjbc.274.26.18387"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.26.18387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.26.18387%26sid%3Dliteratum%253Aachs%26aulast%3DWilke%26aufirst%3DR.%2BA.%26aulast%3DMehta%26aufirst%3DR.%2BP.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DRuoho%26aufirst%3DA.%2BE.%26aulast%3DJackson%26aufirst%3DM.%2BB.%26atitle%3DSigma%2520receptor%2520photolabeling%2520and%2520sigma%2520receptor-mediated%2520modulation%2520of%2520potassium%2520channels%2520in%2520tumor%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D18387%26epage%3D18392%26doi%3D10.1074%2Fjbc.274.26.18387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span> <span> </span><span class="NLM_article-title">Sigma-2 receptor ligands and their perspectives in cancer diagnosis and therapy</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">532</span>– <span class="NLM_lpage">566</span>, <span class="refDoi"> DOI: 10.1002/med.21297</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1002%2Fmed.21297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=23922215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsl2qsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=532-566&author=Y.-S.+Huangauthor=H.-L.+Luauthor=L.-J.+Zhangauthor=Z.+Wu&title=Sigma-2+receptor+ligands+and+their+perspectives+in+cancer+diagnosis+and+therapy&doi=10.1002%2Fmed.21297"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-2 Receptor Ligands and Their Perspectives in Cancer Diagnosis and Therapy</span></div><div class="casAuthors">Huang, Yun-Sheng; Lu, He-Lin; Zhang, Lang-Jun; Wu, Zongwen</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">532-566</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The sigma-2 receptor is highly expressed in various rapidly proliferating cancer cells and regarded as a cancer cell biomarker.  Selective sigma-2 ligands have been shown to specifically label the tumor sites, induce cancer cells to undergo apoptosis, and inhibit tumor growth.  Sigma-2 ligands are potentially useful as cancer diagnostics, anticancer therapeutics, or adjuvant anticancer treatment agents.  However, both the cloning of this receptor and the identification of its endogenous ligand have not been successful, and the lack of structural information has severely hindered the understanding of its physiol. roles, its signaling pathways, and the development of more selective sigma-2 ligands.  Recent data have implicated that sigma-2 binding sites are within the lipid rafts and that PGRMC1 (progesterone receptor membrane component 1) complex and sigma-2 receptor may be coupled with EGFR (epidermal growth factor receptor), mTOR (mammalian target of rapamycin), caspases, and ion channels.  Due to its promising applications in cancer management, there are rapidly increasing research efforts that are being directed into this field.  This review article updates the current understanding of sigma-2 receptor and its potential physiol. roles, applications, interaction with other effectors, with special focuses on the development of sigma-2 ligands, their chem. structures, pharmacol. profiles, applications in imaging and anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSJIQdLSWe4LVg90H21EOLACvtfcHk0lhWFE1MDCgTAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsl2qsrk%253D&md5=bce2e9be88f6cbb9e547f00b4734ce6a</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fmed.21297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21297%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.-S.%26aulast%3DLu%26aufirst%3DH.-L.%26aulast%3DZhang%26aufirst%3DL.-J.%26aulast%3DWu%26aufirst%3DZ.%26atitle%3DSigma-2%2520receptor%2520ligands%2520and%2520their%2520perspectives%2520in%2520cancer%2520diagnosis%2520and%2520therapy%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2014%26volume%3D34%26spage%3D532%26epage%3D566%26doi%3D10.1002%2Fmed.21297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guitart, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codony, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monroy, X.</span></span> <span> </span><span class="NLM_article-title">Sigma receptors: biology and therapeutic potential</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">319</span>, <span class="refDoi"> DOI: 10.1007/s00213-004-1920-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1007%2Fs00213-004-1920-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=15197533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BD2cXls1antrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2004&pages=301-319&author=X.+Guitartauthor=X.+Codonyauthor=X.+Monroy&title=Sigma+receptors%3A+biology+and+therapeutic+potential&doi=10.1007%2Fs00213-004-1920-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma receptors: biology and therapeutic potential</span></div><div class="casAuthors">Guitart, Xavier; Codony, Xavier; Monroy, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">301-319</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A review.  More than 20 yr after the identification of the sigma receptors as a unique binding site in the brain and in the peripheral organs, several questions regarding this receptor are still open.  Only one of the subtypes of the receptor has been cloned to date, but the endogenous ligand still remains unknown, and the possible assocn. of the receptor with a conventional second messenger system is controversial.  From the very beginning, the sigma receptors were assocd. with various central nervous system disorders such as schizophrenia or movement disorders.  Today, after hundreds of papers dealing with the importance of sigma receptors in brain function, it is widely accepted that sigma receptors represent a new and different avenue in the possible pharmacol. treatment of several brain-related disorders.  In this review, what is known about the biol. of the sigma receptor regarding its putative structure and its distribution in the central nervous system is summarized first.  The role of sigma receptors regulating cellular functions and other neurotransmitter systems is also addressed, as well as a short overview of the possible endogenous ligands.  Finally, although no specific sigma ligand has reached the market, different pharmacol. approaches to the alleviation and treatment of several central nervous system disorders and deficits, including schizophrenia, pain, memory deficits, etc., are discussed, with an overview of different compds. and their potential therapeutic use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsmhBCbR6bHrVg90H21EOLACvtfcHk0lhWFE1MDCgTAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXls1antrc%253D&md5=16430485c5f2539b56b1a784cf0c064c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1007%2Fs00213-004-1920-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-004-1920-9%26sid%3Dliteratum%253Aachs%26aulast%3DGuitart%26aufirst%3DX.%26aulast%3DCodony%26aufirst%3DX.%26aulast%3DMonroy%26aufirst%3DX.%26atitle%3DSigma%2520receptors%253A%2520biology%2520and%2520therapeutic%2520potential%26jtitle%3DPsychopharmacology%26date%3D2004%26volume%3D174%26spage%3D301%26epage%3D319%26doi%3D10.1007%2Fs00213-004-1920-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Waarde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rybczynska, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramakrishnan, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishiwata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsinga, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dierckx, R. A. J. O.</span></span> <span> </span><span class="NLM_article-title">Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligands</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3519</span>– <span class="NLM_lpage">3537</span>, <span class="refDoi"> DOI: 10.2174/138161210793563365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.2174%2F138161210793563365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=21050178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BC3MXis1KqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=3519-3537&author=A.+van%0AWaardeauthor=A.+A.+Rybczynskaauthor=N.+K.+Ramakrishnanauthor=K.+Ishiwataauthor=P.+H.+Elsingaauthor=R.+A.+J.+O.+Dierckx&title=Sigma+receptors+in+oncology%3A+therapeutic+and+diagnostic+applications+of+sigma+ligands&doi=10.2174%2F138161210793563365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligands</span></div><div class="casAuthors">van Waarde, Aren; Rybczynska, Anna A.; Ramakrishnan, Nisha K.; Ishiwata, Kiichi; Elsinga, Philip H.; Dierckx, Rudi A. J. O.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">3519-3537</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Sigma receptors (subtypes sigma-1 and sigma-2) are a unique class of binding sites expressed throughout the mammalian body.  The endogenous ligand for these sites has not been identified, but steroid hormones (particularly progesterone), sphingolipid-derived amines and N,N-dimethyltryptamine can bind with fairly high affinity.  Sigma receptors are overexpressed in rapidly proliferating cells, like cancer cells.  Particularly the sigma-2 subtype is upregulated when cells divide and down regulated when they become quiescent.  Sigma ligands, esp. sigma-2 agonists, can inhibit proliferation and induce apoptosis by a mechanism involving changes in cytosolic Ca2+, ceramide and sphingolipid levels.  Tumor cells are much more sensitive to such treatment than cells from their tissue of origin.  Sigma ligands induce apoptosis not only in drug-sensitive but also in drug-resistant cancer cells (e.g., cells with p53 mutations, or caspase dysfunction).  Moreover, sigma ligands may abrogate P-glycoprotein-mediated drug resistance and at subtoxic doses, they can potentiate the effect of conventional cytostatics.  Thus, sigma-2 agonists may be developed as antineoplastic agents for the treatment of drug-resistant tumors.  A large no. of radiolabeled sigma ligands has been prepd. for SPECT (single-photon emission computed tomog.) and PET (positron emission tomog.) imaging.  Such radiopharmaceuticals can be used for tumor detection, tumor staging, and evaluation of anti-tumor therapy.  There is still a need for the development of ligands with (1) high selectivity for the sigma-2 subtype, (2) defined action (agonist or antagonist) and (3) optimal pharmacokinetics (low affinity for P-glycoprotein, high and specific tumor uptake, and rapid washout from non-target tissues).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX-vSPpRtU37Vg90H21EOLACvtfcHk0lh1otZXPMMeww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXis1KqsA%253D%253D&md5=e77adeaf932e2fa8eca70ec0e4e84ec6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.2174%2F138161210793563365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161210793563365%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BWaarde%26aufirst%3DA.%26aulast%3DRybczynska%26aufirst%3DA.%2BA.%26aulast%3DRamakrishnan%26aufirst%3DN.%2BK.%26aulast%3DIshiwata%26aufirst%3DK.%26aulast%3DElsinga%26aufirst%3DP.%2BH.%26aulast%3DDierckx%26aufirst%3DR.%2BA.%2BJ.%2BO.%26atitle%3DSigma%2520receptors%2520in%2520oncology%253A%2520therapeutic%2520and%2520diagnostic%2520applications%2520of%2520sigma%2520ligands%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2010%26volume%3D16%26spage%3D3519%26epage%3D3537%26doi%3D10.2174%2F138161210793563365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berardi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abate, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferorelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colabufo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrone, R.</span></span> <span> </span><span class="NLM_article-title">1-Cyclohexylpiperazine and 3,3-dimethylpiperidine derivatives as sigma-1 (σ1) and sigma-2 (σ2) receptor ligands: a review</span>. <i>Cent. Nerv. Syst. Agents Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">219</span>, <span class="refDoi"> DOI: 10.2174/1871524910909030205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.2174%2F1871524910909030205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=20021355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWnt7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=205-219&author=F.+Berardiauthor=C.+Abateauthor=S.+Ferorelliauthor=N.+Colabufoauthor=R.+Perrone&title=1-Cyclohexylpiperazine+and+3%2C3-dimethylpiperidine+derivatives+as+sigma-1+%28%CF%831%29+and+sigma-2+%28%CF%832%29+receptor+ligands%3A+a+review&doi=10.2174%2F1871524910909030205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">1-Cyclohexylpiperazine and 3,3-dimethylpiperidine derivatives as sigma-1 (σ1) and sigma-2 (σ2) receptor ligands: a review</span></div><div class="casAuthors">Berardi, Francesco; Abate, Carmen; Ferorelli, Savina; Colabufo, Nicola Antonio; Perrone, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Central Nervous System Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">205-219</span>CODEN:
                <span class="NLM_cas:coden">CNSAC3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5249</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Herein the evolution in the development of new sigma (σ) receptor ligands since the middle '90s by our research group is reported.  In the effort to contribute to the identification of the structural features for high-affinity ligands selective vs. serotonin, dopamine and other CNS-related receptors, two general classes of (naphthalene)alkylamine compds. were prepd. and explored, with the aim of addressing the affinities toward the two recognized σ receptor subtypes.  The common template of these compds. was mainly an unsubstituted or methoxy-substituted naphthalene or tetralin nucleus, linked by an alkyl spacer to a substituted piperazine or piperidine ring.  The design of new ligands was thought keeping in mind their possible application as PET diagnostic tools and fluorescence tools.  High-affinity σ2 receptor ligands were found among N-cyclohexylpiperazine derivs., such as 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (3) (PB 28), when they were assayed in radioligand binding with [3H]-DTG in rat liver.  Unfortunately, these ligands were all devoid of a significant selectivity relative to σ1 receptor whose binding was assayed with (+)-[3H]-pentazocine in guinea pig brain.  Nevertheless, compd. 3 had previously shown to be 40-fold selective with a slightly different binding method in animals' tissues.  Moreover, it demonstrated 46-fold and 59-fold σ2 vs. σ1 receptor binding selectivity in MCF7 and MCF7 ADR tumor cell lines resp.  In the class of piperazines, also high-affinity σ1 receptor ligands were found, possibly due to the presence of a double N-atom and an addnl. reverse mode of binding.  Piperidine derivs. were investigated as high-affinity and selective σ1 receptor ligands leading to some 3,3-dimethylpiperidines such as 3,3-dimethyl-1-[3-(6-methoxynaphthalen-1-yl)propyl]piperidine (69) which resulted to be highly selective relative to the σ2 receptor.  For the best ligands, functional assays were conducted to investigate agonist/antagonist activity.  The effect of chirality in the intermediate methyl-alkyl chain was explored for a class of 4-methylpiperidines linked to some (4-chlorophenoxy)alkyl moieties, and compd. (-)-(S)-92 emerged as the most selective σ1 relative to σ2 receptor ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsL585s521T7Vg90H21EOLACvtfcHk0lh1otZXPMMeww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWnt7rP&md5=b7b181e35900b4891c89cc05cd0713ce</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.2174%2F1871524910909030205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871524910909030205%26sid%3Dliteratum%253Aachs%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DAbate%26aufirst%3DC.%26aulast%3DFerorelli%26aufirst%3DS.%26aulast%3DColabufo%26aufirst%3DN.%26aulast%3DPerrone%26aufirst%3DR.%26atitle%3D1-Cyclohexylpiperazine%2520and%25203%252C3-dimethylpiperidine%2520derivatives%2520as%2520sigma-1%2520%2528%25CF%25831%2529%2520and%2520sigma-2%2520%2528%25CF%25832%2529%2520receptor%2520ligands%253A%2520a%2520review%26jtitle%3DCent.%2520Nerv.%2520Syst.%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D205%26epage%3D219%26doi%3D10.2174%2F1871524910909030205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perregaard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moltzen, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, C.</span></span> <span> </span><span class="NLM_article-title">sigma. Ligands with Subnanomolar Affinity and Preference for the.sigma.2 Binding Site. 1. 3-(.omega.-Aminoalkyl)-1H-indoles</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1998</span>– <span class="NLM_lpage">2008</span>, <span class="refDoi"> DOI: 10.1021/jm00011a019</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00011a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=1998-2008&author=J.+Perregaardauthor=E.+K.+Moltzenauthor=E.+Meierauthor=C.+Sanchez&title=sigma.+Ligands+with+Subnanomolar+Affinity+and+Preference+for+the.sigma.2+Binding+Site.+1.+3-%28.omega.-Aminoalkyl%29-1H-indoles&doi=10.1021%2Fjm00011a019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm00011a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00011a019%26sid%3Dliteratum%253Aachs%26aulast%3DPerregaard%26aufirst%3DJ.%26aulast%3DMoltzen%26aufirst%3DE.%2BK.%26aulast%3DMeier%26aufirst%3DE.%26aulast%3DSanchez%26aufirst%3DC.%26atitle%3Dsigma.%2520Ligands%2520with%2520Subnanomolar%2520Affinity%2520and%2520Preference%2520for%2520the.sigma.2%2520Binding%2520Site.%25201.%25203-%2528.omega.-Aminoalkyl%2529-1H-indoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D1998%26epage%3D2008%26doi%3D10.1021%2Fjm00011a019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vangveravong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span> <span> </span><span class="NLM_article-title">Conformationally-flexible benzamide analogues as dopamine D3 and σ2 receptor ligands</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">195</span>– <span class="NLM_lpage">202</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2003.09.083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2Fj.bmcl.2003.09.083" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=195-202&author=R.+H.+Machauthor=Y.+Huangauthor=R.+A.+Freemanauthor=L.+Wuauthor=S.+Vangveravongauthor=R.+R.+Luedtke&title=Conformationally-flexible+benzamide+analogues+as+dopamine+D3+and+%CF%832+receptor+ligands&doi=10.1016%2Fj.bmcl.2003.09.083"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2003.09.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2003.09.083%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DFreeman%26aufirst%3DR.%2BA.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DVangveravong%26aufirst%3DS.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26atitle%3DConformationally-flexible%2520benzamide%2520analogues%2520as%2520dopamine%2520D3%2520and%2520%25CF%25832%2520receptor%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D195%26epage%3D202%26doi%3D10.1016%2Fj.bmcl.2003.09.083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maier, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wünsch, B.</span></span> <span> </span><span class="NLM_article-title">Novel spiropiperidines as highly potent and subtype selective σ-receptor ligands. Part 1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">438</span>– <span class="NLM_lpage">448</span>, <span class="refDoi"> DOI: 10.1021/jm010992z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm010992z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=438-448&author=C.+A.+Maierauthor=B.+W%C3%BCnsch&title=Novel+spiropiperidines+as+highly+potent+and+subtype+selective+%CF%83-receptor+ligands.+Part+1&doi=10.1021%2Fjm010992z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm010992z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010992z%26sid%3Dliteratum%253Aachs%26aulast%3DMaier%26aufirst%3DC.%2BA.%26aulast%3DW%25C3%25BCnsch%26aufirst%3DB.%26atitle%3DNovel%2520spiropiperidines%2520as%2520highly%2520potent%2520and%2520subtype%2520selective%2520%25CF%2583-receptor%2520ligands.%2520Part%25201%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D438%26epage%3D448%26doi%3D10.1021%2Fjm010992z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maier, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wünsch, B.</span></span> <span> </span><span class="NLM_article-title">Novel σ receptor ligands. Part 2. SAR of spiro[[2]benzopyran-1,4‘-piperidines] and spiro[[2]benzofuran-1,4‘-piperidines] with carbon substituents in position 3</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">4923</span>– <span class="NLM_lpage">4930</span>, <span class="refDoi"> DOI: 10.1021/jm020889p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020889p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4923-4930&author=C.+A.+Maierauthor=B.+W%C3%BCnsch&title=Novel+%CF%83+receptor+ligands.+Part+2.+SAR+of+spiro%5B%5B2%5Dbenzopyran-1%2C4%E2%80%98-piperidines%5D+and+spiro%5B%5B2%5Dbenzofuran-1%2C4%E2%80%98-piperidines%5D+with+carbon+substituents+in+position+3&doi=10.1021%2Fjm020889p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm020889p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020889p%26sid%3Dliteratum%253Aachs%26aulast%3DMaier%26aufirst%3DC.%2BA.%26aulast%3DW%25C3%25BCnsch%26aufirst%3DB.%26atitle%3DNovel%2520%25CF%2583%2520receptor%2520ligands.%2520Part%25202.%2520SAR%2520of%2520spiro%255B%255B2%255Dbenzopyran-1%252C4%25E2%2580%2598-piperidines%255D%2520and%2520spiro%255B%255B2%255Dbenzofuran-1%252C4%25E2%2580%2598-piperidines%255D%2520with%2520carbon%2520substituents%2520in%2520position%25203%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4923%26epage%3D4930%26doi%3D10.1021%2Fjm020889p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rack, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fröhlich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schepmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wünsch, B.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and pharmacological evaluation of spirocyclic ó(1) receptor ligands with exocyclic amino moiety (increased distance 1)</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3141</span>– <span class="NLM_lpage">3151</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2011.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2Fj.bmc.2011.04.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=3141-3151&author=E.+Rackauthor=R.+Fr%C3%B6hlichauthor=D.+Schepmannauthor=B.+W%C3%BCnsch&title=Design%2C+synthesis+and+pharmacological+evaluation+of+spirocyclic+%C3%B3%281%29+receptor+ligands+with+exocyclic+amino+moiety+%28increased+distance+1%29&doi=10.1016%2Fj.bmc.2011.04.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DRack%26aufirst%3DE.%26aulast%3DFr%25C3%25B6hlich%26aufirst%3DR.%26aulast%3DSchepmann%26aufirst%3DD.%26aulast%3DW%25C3%25BCnsch%26aufirst%3DB.%26atitle%3DDesign%252C%2520synthesis%2520and%2520pharmacological%2520evaluation%2520of%2520spirocyclic%2520%25C3%25B3%25281%2529%2520receptor%2520ligands%2520with%2520exocyclic%2520amino%2520moiety%2520%2528increased%2520distance%25201%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D3141%26epage%3D3151%26doi%3D10.1016%2Fj.bmc.2011.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grosse
Maestrup, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schepmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheunemann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wünsch, B.</span></span> <span> </span><span class="NLM_article-title">Synthesis of spirocyclic sigma1 receptor ligands as potential PET radiotracers, structure-affinity relationships and in vitro metabolic stability</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3630</span>– <span class="NLM_lpage">3641</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.03.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2Fj.bmc.2009.03.060" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=3630-3641&author=E.+Grosse%0AMaestrupauthor=C.+Wieseauthor=D.+Schepmannauthor=A.+Hillerauthor=S.+Fischerauthor=M.+Scheunemannauthor=P.+Brustauthor=B.+W%C3%BCnsch&title=Synthesis+of+spirocyclic+sigma1+receptor+ligands+as+potential+PET+radiotracers%2C+structure-affinity+relationships+and+in+vitro+metabolic+stability&doi=10.1016%2Fj.bmc.2009.03.060"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.03.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.03.060%26sid%3Dliteratum%253Aachs%26aulast%3DGrosse%2BMaestrup%26aufirst%3DE.%26aulast%3DWiese%26aufirst%3DC.%26aulast%3DSchepmann%26aufirst%3DD.%26aulast%3DHiller%26aufirst%3DA.%26aulast%3DFischer%26aufirst%3DS.%26aulast%3DScheunemann%26aufirst%3DM.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DW%25C3%25BCnsch%26aufirst%3DB.%26atitle%3DSynthesis%2520of%2520spirocyclic%2520sigma1%2520receptor%2520ligands%2520as%2520potential%2520PET%2520radiotracers%252C%2520structure-affinity%2520relationships%2520and%2520in%2520vitro%2520metabolic%2520stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D3630%26epage%3D3641%26doi%3D10.1016%2Fj.bmc.2009.03.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oberdorf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schepmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holenz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wünsch, B.</span></span> <span> </span><span class="NLM_article-title">Thiophene bioisosteres of spirocyclic sigma receptor ligands. 1. N-substituted spiro[piperidine-4,4’-thieno[3,2-c]pyrans]</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">6531</span>– <span class="NLM_lpage">6537</span>, <span class="refDoi"> DOI: 10.1021/jm8007739</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8007739" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6531-6537&author=C.+Oberdorfauthor=D.+Schepmannauthor=J.+M.+Velaauthor=J.+L.+Diazauthor=J.+Holenzauthor=B.+W%C3%BCnsch&title=Thiophene+bioisosteres+of+spirocyclic+sigma+receptor+ligands.+1.+N-substituted+spiro%5Bpiperidine-4%2C4%E2%80%99-thieno%5B3%2C2-c%5Dpyrans%5D&doi=10.1021%2Fjm8007739"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm8007739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8007739%26sid%3Dliteratum%253Aachs%26aulast%3DOberdorf%26aufirst%3DC.%26aulast%3DSchepmann%26aufirst%3DD.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DDiaz%26aufirst%3DJ.%2BL.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DW%25C3%25BCnsch%26aufirst%3DB.%26atitle%3DThiophene%2520bioisosteres%2520of%2520spirocyclic%2520sigma%2520receptor%2520ligands.%25201.%2520N-substituted%2520spiro%255Bpiperidine-4%252C4%25E2%2580%2599-thieno%255B3%252C2-c%255Dpyrans%255D%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6531%26epage%3D6537%26doi%3D10.1021%2Fjm8007739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schläger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schepmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Würthwein, E.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wünsch, B.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-affinity relationships of novel spirocyclic sigma receptor ligands with furopyrazole structure</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2992</span>– <span class="NLM_lpage">3001</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2007.12.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2Fj.bmc.2007.12.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=2992-3001&author=T.+Schl%C3%A4gerauthor=D.+Schepmannauthor=E.-U.+W%C3%BCrthweinauthor=B.+W%C3%BCnsch&title=Synthesis+and+structure-affinity+relationships+of+novel+spirocyclic+sigma+receptor+ligands+with+furopyrazole+structure&doi=10.1016%2Fj.bmc.2007.12.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.12.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.12.045%26sid%3Dliteratum%253Aachs%26aulast%3DSchl%25C3%25A4ger%26aufirst%3DT.%26aulast%3DSchepmann%26aufirst%3DD.%26aulast%3DW%25C3%25BCrthwein%26aufirst%3DE.-U.%26aulast%3DW%25C3%25BCnsch%26aufirst%3DB.%26atitle%3DSynthesis%2520and%2520structure-affinity%2520relationships%2520of%2520novel%2520spirocyclic%2520sigma%2520receptor%2520ligands%2520with%2520furopyrazole%2520structure%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D2992%26epage%3D3001%26doi%3D10.1016%2Fj.bmc.2007.12.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruckner, R.</span>; <span class="NLM_string-name">Wender, P. A.</span>; <span class="NLM_string-name">Beifuss, K.</span>; <span class="NLM_string-name">Zettlmeier, W.</span></span> <i>Organic Mechanisms</i>; <span class="NLM_publisher-name">Springer-Verlag</span>: <span class="NLM_publisher-loc">Berlin</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1007%2F978-3-642-03651-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=R.+Bruckner&author=P.+A.+Wender&author=K.+Beifuss&author=W.+Zettlmeier&title=Organic+Mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-03651-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-642-03651-4%26sid%3Dliteratum%253Aachs%26aulast%3DBruckner%26aufirst%3DR.%26btitle%3DOrganic%2520Mechanisms%26pub%3DSpringer-Verlag%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rack, E.</span></span> <span> </span><span class="NLM_article-title">Struktur-Affinitäts- und Selektivitätsuntersuchungen Spirocyclischer Sigma-Rezeptorliganden mit Exocyclischer Aminfunktion</span>. Doctoral Dissertation, University of Münster, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=E.+Rack&title=Struktur-Affinit%C3%A4ts-+und+Selektivit%C3%A4tsuntersuchungen+Spirocyclischer+Sigma-Rezeptorliganden+mit+Exocyclischer+Aminfunktion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRack%26aufirst%3DE.%26atitle%3DStruktur-Affinit%25C3%25A4ts-%2520und%2520Selektivit%25C3%25A4tsuntersuchungen%2520Spirocyclischer%2520Sigma-Rezeptorliganden%2520mit%2520Exocyclischer%2520Aminfunktion%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Søby, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikkelsen, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomsen, C.</span></span> <span> </span><span class="NLM_article-title">Lu 28–179 labels a σ2-site in rat and human brain</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1016/S0028-3908(02)00071-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2FS0028-3908%2802%2900071-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=95-100&author=K.+K.+S%C3%B8byauthor=J.+D.+Mikkelsenauthor=E.+Meierauthor=C.+Thomsen&title=Lu+28%E2%80%93179+labels+a+%CF%832-site+in+rat+and+human+brain&doi=10.1016%2FS0028-3908%2802%2900071-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2802%2900071-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252802%252900071-0%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25B8by%26aufirst%3DK.%2BK.%26aulast%3DMikkelsen%26aufirst%3DJ.%2BD.%26aulast%3DMeier%26aufirst%3DE.%26aulast%3DThomsen%26aufirst%3DC.%26atitle%3DLu%252028%25E2%2580%2593179%2520labels%2520a%2520%25CF%25832-site%2520in%2520rat%2520and%2520human%2520brain%26jtitle%3DNeuropharmacology%26date%3D2002%26volume%3D43%26spage%3D95%26epage%3D100%26doi%3D10.1016%2FS0028-3908%2802%2900071-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCracken, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pouw, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Costa, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, W. D.</span></span> <span> </span><span class="NLM_article-title">Conformationally restricted analogs of BD1008 and an antisense oligodeoxynucleotide targeting σ1 receptors produce anti-cocaine effects in mice</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>419</i></span>,  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1016/S0014-2999(01)00968-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2FS0014-2999%2801%2900968-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=11426838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksFCktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=419&publication_year=2001&pages=163-174&author=R.+R.+Matsumotoauthor=K.+A.+McCrackenauthor=M.+J.+Friedmanauthor=B.+Pouwauthor=B.+R.+De+Costaauthor=W.+D.+Bowen&title=Conformationally+restricted+analogs+of+BD1008+and+an+antisense+oligodeoxynucleotide+targeting+%CF%831+receptors+produce+anti-cocaine+effects+in+mice&doi=10.1016%2FS0014-2999%2801%2900968-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Conformationally restricted analogs of BD1008 and an antisense oligodeoxynucleotide targeting σ1 receptors produce anti-cocaine effects in mice</span></div><div class="casAuthors">Matsumoto, Rae R.; McCracken, Kari A.; Friedman, Michele J.; Pouw, Buddy; De Costa, Brian R.; Bowen, Wayne D.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">419</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">163-174</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Cocaine's ability to interact with σ receptors suggests that these proteins mediate some of its behavioral effects.  Therefore, three novel σ receptor ligands with antagonist activity were evaluated in Swiss Webster mice: BD1018 (3S-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]nonane), BD1063 (1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine), and LR132 (1R,2S-(+)-cis-N-[2-(3,4-dichlorophenyl)ethyl]-2-(1-pyrrolidinyl)cyclohexylamine).  Competition binding assays demonstrated that all three compds. have high affinities for σ1 receptors.  The three compds. vary in their affinities for σ2 receptors and exhibit negligible affinities for dopamine, opioid, GABAA and NMDA receptors.  In behavioral studies, pre-treatment of mice with BD1018, BD1063, or LR132 significantly attenuated cocaine-induced convulsions and lethality.  Moreover, post-treatment with LR132 prevented cocaine-induced lethality in a significant proportion of animals.  In contrast to the protection provided by the putative antagonists, the well-characterized σ receptor agonist di-o-tolylguanidine (DTG) and the novel σ receptor agonist BD1031 (3R-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]nonane) each worsened the behavioral toxicity of cocaine.  At doses where alone, they produced no significant effects on locomotion, BD1018, BD1063 and LR132 significantly attenuated the locomotor stimulatory effects of cocaine.  To further validate the hypothesis that the anti-cocaine effects of the novel ligands involved antagonism of σ receptors, an antisense oligodeoxynucleotide against σ1 receptors was also shown to significantly attenuate the convulsive and locomotor stimulatory effects of cocaine.  Together, the data suggests that functional antagonism of σ receptors is capable of attenuating a no. of cocaine-induced behaviors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo12XhXmu0jirVg90H21EOLACvtfcHk0lgdY20Gv9El8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksFCktrY%253D&md5=ac2940d96fffd28b2ab9a1f61ddc5454</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2801%2900968-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252801%252900968-2%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DR.%2BR.%26aulast%3DMcCracken%26aufirst%3DK.%2BA.%26aulast%3DFriedman%26aufirst%3DM.%2BJ.%26aulast%3DPouw%26aufirst%3DB.%26aulast%3DDe%2BCosta%26aufirst%3DB.%2BR.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3DConformationally%2520restricted%2520analogs%2520of%2520BD1008%2520and%2520an%2520antisense%2520oligodeoxynucleotide%2520targeting%2520%25CF%25831%2520receptors%2520produce%2520anti-cocaine%2520effects%2520in%2520mice%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D419%26spage%3D163%26epage%3D174%26doi%3D10.1016%2FS0014-2999%2801%2900968-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, T.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parish, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabeshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Privat, A.</span></span> <span> </span><span class="NLM_article-title">PRE-084, a σ selective PCP derivative, attenuates MK-801-induced impairment of learning in mice</span>. <i>Pharmacol., Biochem. Behav.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">859</span>– <span class="NLM_lpage">869</span>, <span class="refDoi"> DOI: 10.1016/0091-3057(94)90235-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2F0091-3057%2894%2990235-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1994&pages=859-869&author=T.+Mauriceauthor=T.-P.+Suauthor=D.+W.+Parishauthor=T.+Nabeshimaauthor=A.+Privat&title=PRE-084%2C+a+%CF%83+selective+PCP+derivative%2C+attenuates+MK-801-induced+impairment+of+learning+in+mice&doi=10.1016%2F0091-3057%2894%2990235-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2F0091-3057%2894%2990235-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-3057%252894%252990235-6%26sid%3Dliteratum%253Aachs%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.-P.%26aulast%3DParish%26aufirst%3DD.%2BW.%26aulast%3DNabeshima%26aufirst%3DT.%26aulast%3DPrivat%26aufirst%3DA.%26atitle%3DPRE-084%252C%2520a%2520%25CF%2583%2520selective%2520PCP%2520derivative%252C%2520attenuates%2520MK-801-induced%2520impairment%2520of%2520learning%2520in%2520mice%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1994%26volume%3D49%26spage%3D859%26epage%3D869%26doi%3D10.1016%2F0091-3057%2894%2990235-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span> <i>APEX3</i>; <span class="NLM_publisher-name">Bruker AXS Inc.</span>: <span class="NLM_publisher-loc">Madison, WI, U.S.</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+APEX3%3B+Bruker+AXS+Inc.%3A+Madison%2C+WI%2C+U.S.%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DAPEX3%26pub%3DBruker%2520AXS%2520Inc%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span> <i>SAINT</i>; <span class="NLM_publisher-name">Bruker AXS Inc.</span>: <span class="NLM_publisher-loc">Madison, WI, U.S.</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+SAINT%3B+Bruker+AXS+Inc.%3A+Madison%2C+WI%2C+U.S.%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSAINT%26pub%3DBruker%2520AXS%2520Inc%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span> <i>SADABS</i>; <span class="NLM_publisher-name">Bruker AXS Inc.</span>: <span class="NLM_publisher-loc">Madison, WI, U.S.</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+SADABS%3B+Bruker+AXS+Inc.%3A+Madison%2C+WI%2C+U.S.%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSADABS%26pub%3DBruker%2520AXS%2520Inc%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> <span> </span><span class="NLM_article-title">SHELXT - integrated space-group and crystal-structure determination</span>. <i>Acta Crystallogr., Sect. A: Found. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1107/S2053273314026370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1107%2FS2053273314026370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=25643710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsF2ntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=3-8&author=G.+M.+Sheldrick&title=SHELXT+-+integrated+space-group+and+crystal-structure+determination&doi=10.1107%2FS2053273314026370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">SHELXT - Integrated space-group and crystal-structure determination</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A: Foundations and Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-8</span>CODEN:
                <span class="NLM_cas:coden">ACSAD7</span>;
        ISSN:<span class="NLM_cas:issn">2053-2733</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The new computer program SHELXT employs a novel dual-space algorithm to solve the phase problem for single-crystal reflection data expanded to the space group P1.  Missing data are taken into account and the resoln. extended if necessary.  All space groups in the specified Laue group are tested to find which are consistent with the P1 phases.  After applying the resulting origin shifts and space-group symmetry, the solns. are subject to further dual-space recycling followed by a peak search and summation of the electron d. around each peak.  Elements are assigned to give the best fit to the integrated peak densities and if necessary addnl. elements are considered.  An isotropic refinement is followed for non-centrosym. space groups by the calcn. of a Flack parameter and, if appropriate, inversion of the structure.  The structure is assembled to maximize its connectivity and centered optimally in the unit cell.  SHELXT has already solved many thousand structures with a high success rate, and is optimized for multiprocessor computers.  It is, however, unsuitable for severely disordered and twinned structures because it is based on the assumption that the structure consists of atoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfRi0LYeHvuLVg90H21EOLACvtfcHk0lgkst6yfJg9Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsF2ntQ%253D%253D&md5=cd76fcff223162a8fdaddbd0f3b24b94</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1107%2FS2053273314026370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053273314026370%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DSHELXT%2520-%2520integrated%2520space-group%2520and%2520crystal-structure%2520determination%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Adv.%26date%3D2015%26volume%3D71%26spage%3D3%26epage%3D8%26doi%3D10.1107%2FS2053273314026370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span> <i>XP-Interactive
Molecular Graphics</i>, version <span class="NLM_edition">5.1</span>; <span class="NLM_publisher-name">Bruker AXS Inc.</span>: <span class="NLM_publisher-loc">Madison, WI, U.S.</span>, <span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+XP-Interactive%0AMolecular+Graphics%2C+version+5.1%3B+Bruker+AXS+Inc.%3A+Madison%2C+WI%2C+U.S.%2C+1998."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DXP-Interactive%250AMolecular%2520Graphics%26pub%3DBruker%2520AXS%2520Inc%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bradford, M.
M.</span></span> <span> </span><span class="NLM_article-title">A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1016/0003-2697(76)90527-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2F0003-2697%2876%2990527-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=942051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaE28XksVehtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1976&pages=248-254&author=M.%0AM.+Bradford&title=A+rapid+and+sensitive+method+for+the+quantitation+of+microgram+quantities+of+protein+utilizing+the+principle+of+protein-dye+binding&doi=10.1016%2F0003-2697%2876%2990527-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</span></div><div class="casAuthors">Bradford, Marion M.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">248-54</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    </div><div class="casAbstract">A protein detn. method that involves the binding of coomassie Brilliant Blue G 250 to protein is described.  The binding of the dye to protein causes a shift in the absorption max. of the dye from 465 to 595 nm, and it is the increase in absorption at 595 nm that is monitored.  This assay is very reproducible and rapid with the dye binding process virtually complete in ∼ 2 min with good color stability for 1 hr.  There is little or no interference from cations such as Na+ or K+ nor from carbohydrates such as sucrose.  A small amt. of color is developed in the presence of strongly alk. buffering agents, but the assay may be run accurately by the use of proper buffer controls.  The only components found to give excessive interfering color in the assay are relatively large amts. of detergents such as Na dodecyl sulfate, Triton X 100, and commercial glassware detergents.  Interference by small amts. of detergent may be eliminated by the use of proper control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN_T_d0trcNrVg90H21EOLACvtfcHk0lgkst6yfJg9Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XksVehtrY%253D&md5=43f388a493becc4193c7a49d9de0e1db</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2876%2990527-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252876%252990527-3%26sid%3Dliteratum%253Aachs%26aulast%3DBradford%26aufirst%3DM.%2BM.%26atitle%3DA%2520rapid%2520and%2520sensitive%2520method%2520for%2520the%2520quantitation%2520of%2520microgram%2520quantities%2520of%2520protein%2520utilizing%2520the%2520principle%2520of%2520protein-dye%2520binding%26jtitle%3DAnal.%2520Biochem.%26date%3D1976%26volume%3D72%26spage%3D248%26epage%3D254%26doi%3D10.1016%2F0003-2697%2876%2990527-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stoscheck, C. M.</span></span> <span> </span><span class="NLM_article-title">Quantitation of protein</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>182</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1016/0076-6879(90)82008-P</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2F0076-6879%2890%2982008-P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=2314256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaK3MXitValsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=1990&pages=50-68&author=C.+M.+Stoscheck&title=Quantitation+of+protein&doi=10.1016%2F0076-6879%2890%2982008-P"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitation of protein</span></div><div class="casAuthors">Stoscheck, Christa M.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">Guide Protein Purif.</span>),
    <span class="NLM_cas:pages">50-68</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    </div><div class="casAbstract">A review with 48 refs.  Assays that are easy to perform, require simple instrumentation, and are highly sensitive including methods to conc. samples or to eliminate interfering reagents are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0a7IlHri16bVg90H21EOLACvtfcHk0lgkst6yfJg9Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXitValsLw%253D&md5=78d0376e0fdafecd901d5e0c9139dc14</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2F0076-6879%2890%2982008-P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0076-6879%252890%252982008-P%26sid%3Dliteratum%253Aachs%26aulast%3DStoscheck%26aufirst%3DC.%2BM.%26atitle%3DQuantitation%2520of%2520protein%26jtitle%3DMethods%2520Enzymol.%26date%3D1990%26volume%3D182%26spage%3D50%26epage%3D68%26doi%3D10.1016%2F0076-6879%2890%2982008-P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yung-Chi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=4202581" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=C.+Yung-Chiauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28KI%29+and+the+concentration+of+inhibitor+which+causes+50%25+inhibition+%28I50%29+of+an+enzymatic+reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DYung-Chi%26aufirst%3DC.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528KI%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2525%2520inhibition%2520%2528I50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeHaven-Hudkins, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleissner, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford-Rice, F. Y.</span></span> <span> </span><span class="NLM_article-title">Characterization of the binding of [3H](+)-pentazocine to σ recognition sites in guinea pig brain</span>. <i>Eur. J. Pharmacol., Mol. Pharmacol. Sect.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>227</i></span>,  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">378</span>, <span class="refDoi"> DOI: 10.1016/0922-4106(92)90153-M</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2F0922-4106%2892%2990153-M" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1359973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=1%3ACAS%3A528%3ADyaK3sXhtl2lsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=227&publication_year=1992&pages=371-378&author=D.+L.+DeHaven-Hudkinsauthor=L.+C.+Fleissnerauthor=F.+Y.+Ford-Rice&title=Characterization+of+the+binding+of+%5B3H%5D%28%2B%29-pentazocine+to+%CF%83+recognition+sites+in+guinea+pig+brain&doi=10.1016%2F0922-4106%2892%2990153-M"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the binding of [3H](+)-pentazocine to σ recognition sites in guinea pig brain</span></div><div class="casAuthors">DeHaven-Hudkins, Diane L.; Fleissner, Lorraine C.; Ford-Rice, Felicia Y.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology, Molecular Pharmacology Section</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">227</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">371-8</span>CODEN:
                <span class="NLM_cas:coden">EJPPET</span>;
        ISSN:<span class="NLM_cas:issn">0922-4106</span>.
    </div><div class="casAbstract">The selective σ-opioid compd. (+)-pentazocine was radiolabeled and its binding characteristics in guinea pig brain membranes were investigated.  [3H](+)-Pentazocine bound to a single high-affinity site with a KD = 2.9 nM and a Bmax = 1998 fmol/mg protein.  Satn. was achieved at a ligand concn. of 15 nM.  The maximal specific binding was obsd. at 37° and was >90% of total binding.  The equil. was reached by 120 min and dissocn. was complete by 420 min, with a t1/2 of 121 min.  Li+, Ca2+, and Mg2+ inhibited the binding at high concns., and the binding was insensitive to adenyl and guanyl nucleotides.  Stereoselectivity was obsd. for the inhibition of binding by benzomorphans, 3-(3-hydroxyphenyl)-N-propylpiperidine and butaclamol.  The (+)-enantiomers and α-diastereomers of pentazocine and cyclazocine were more potent than their corresponding (-)-enantiomers and β-diastereomers.  The rank order of potency for the σ ref. agents to displace [3H](+)-pentazocine binding was similar to that reported using the 3H-labeled σ-ligands dextromethorphan, 1,3-di(2-tolyl)guanidine, and (+)-3-(3-hydroxyphenyl)-N-propylpiperidine.  Haloperidol, (+)-pentazocine, (+)-3-(3-hydroxyphenyl)-N-propylpiperidine and rimcazole were competitive inhibitors of binding to the [3H](+)-pentazocine-defined σ recognition site, suggesting that these different structural classes of compds. all bind to a single mol. entity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqptZ7zLKpE3bVg90H21EOLACvtfcHk0lidRwxB0E16DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhtl2lsbs%253D&md5=323649e2b05dedbaa1dd6e9e77255d75</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2F0922-4106%2892%2990153-M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0922-4106%252892%252990153-M%26sid%3Dliteratum%253Aachs%26aulast%3DDeHaven-Hudkins%26aufirst%3DD.%2BL.%26aulast%3DFleissner%26aufirst%3DL.%2BC.%26aulast%3DFord-Rice%26aufirst%3DF.%2BY.%26atitle%3DCharacterization%2520of%2520the%2520binding%2520of%2520%255B3H%255D%2528%252B%2529-pentazocine%2520to%2520%25CF%2583%2520recognition%2520sites%2520in%2520guinea%2520pig%2520brain%26jtitle%3DEur.%2520J.%2520Pharmacol.%252C%2520Mol.%2520Pharmacol.%2520Sect.%26date%3D1992%26volume%3D227%26spage%3D371%26epage%3D378%26doi%3D10.1016%2F0922-4106%2892%2990153-M" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Childers, S. R.</span></span> <span> </span><span class="NLM_article-title">Ibogaine possesses a selective affinity for σ2 receptors</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">PL57</span>– <span class="NLM_lpage">PL62</span>, <span class="refDoi"> DOI: 10.1016/0024-3205(95)00301-L</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=10.1016%2F0024-3205%2895%2900301-L" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;key=7603301" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1995&pages=PL57-PL62&author=R.+H.+Machauthor=C.+R.+Smithauthor=S.+R.+Childers&title=Ibogaine+possesses+a+selective+affinity+for+%CF%832+receptors&doi=10.1016%2F0024-3205%2895%2900301-L"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2895%2900301-L&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252895%252900301-L%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DSmith%26aufirst%3DC.%2BR.%26aulast%3DChilders%26aufirst%3DS.%2BR.%26atitle%3DIbogaine%2520possesses%2520a%2520selective%2520affinity%2520for%2520%25CF%25832%2520receptors%26jtitle%3DLife%2520Sci.%26date%3D1995%26volume%3D57%26spage%3DPL57%26epage%3DPL62%26doi%3D10.1016%2F0024-3205%2895%2900301-L" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i89"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01183">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_04267"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01183">10.1021/acs.jmedchem.8b01183</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Purity data of all compounds, <sup>1</sup>H and <sup>13</sup>C NMR spectra, HPLC chromatograms (purity), and experimental details of in vitro assays (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01183/suppl_file/jm8b01183_si_001.pdf">PDF</a>)</p></li><li><p class="inline">checkCIF/PLATON report (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01183/suppl_file/jm8b01183_si_002.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01183/suppl_file/jm8b01183_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01183/suppl_file/jm8b01183_si_001.pdf">jm8b01183_si_001.pdf (5.15 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01183/suppl_file/jm8b01183_si_002.pdf">jm8b01183_si_002.pdf (313.3 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01183/suppl_file/jm8b01183_si_003.csv">jm8b01183_si_003.csv (3.64 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01183&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-21%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01183%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01183" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991f809bdf24fd","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
